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Admission to the intensive care unit with critical illness can result in significant 
and wide-ranging impairments for survivors, which often persist for many years 
following resolution of the index illness and are now recognised as ‘post intensive 
care syndrome’.  One component of this syndrome, peripheral skeletal muscle 
wasting and dysfunction that develop during critical illness are described as 
intensive care unit-acquired weakness (ICU-AW) and account for residual deficits 
in physical functional ability in post ICU patients.  This thesis comprised studies 
examining the clinical assessment and treatment of patients with ICU-AW 
investigating the Medical Research Council sum-score (MRC-SS) tool, the most 
commonly reported technique for diagnosing ICU-AW, use of ultrasound to 
measure peripheral skeletal muscle architecture during critical illness, and 
exercise-based rehabilitation for critical illness survivors with ICU-AW.   
 
Moderate levels of inter-observer agreement and limited clinical predictive value 
using the MRC-SS for ICU-AW diagnosis were demonstrated, highlighting the 
challenges of the volitional manual muscle testing approach.  Investigation of 
ultrasound to assess peripheral skeletal muscle architecture provided data to 
support technical application of this tool as a potential surrogate marker for 
strength in ICU patients where direct measurement may be limited.  Post hospital 
discharge exercise-based rehabilitation for critical illness survivors with ICU-AW 
was explored in a pilot feasibility randomised controlled trial.  Whilst no 
improvement in outcome was evident, process evaluation revealed methodological 
factors for further investigation in the design and conduct of a larger-scale trial, 
including development of an intervention effective beyond the extent of natural 
recovery observed.  Follow-up of patients without ICU-AW highlighted the 
limitations of adopting the MRC-SS threshold to categorise diagnosis and ongoing 
rehabilitation requirements.  A national UK survey revealed failure to implement 
published guidance on rehabilitation following critical illness following hospital 
discharge due to lack of funding, resources and managerial prioritisation, and 
suggests the need for a robust evidence base to support service delivery to address 
the currently unmet clinical need in this patient population.   
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1.1 Introduction  
 
Admission to the intensive care unit (ICU) with critical illness can have profound 
and long-lasting physical and psychological effects for the patient, their family and 
their care-givers.  Frequently, these impairments persist many years beyond 
resolution of the index illness.  Skeletal muscle wasting and weakness occurring 
during the period of mechanical ventilation and immobilisation associated with 
ICU admission are considered significant drivers underlying much of the physical 
impairment observed in survivors of critical illness.  Early identification of those 
patients at most risk of acquiring such muscle dysfunction, commonly known as 
intensive care unit-acquired weakness (ICU-AW), is essential for delivering 
targeted rehabilitation and therapeutic interventions.  Volitional measures for 
assessing muscle force are limited in critically ill patients requiring active 
engagement, cooperation and cognition for optimum performance.  However non-
volitional measures can be technically challenging in the ICU environment and 
require skilled personnel for interpretation.  Effort-independent techniques with 
clinical utility for monitoring the trajectory of muscle loss are most likely to be 
implemented in a widespread and effective manner.  Meanwhile, strategies for 
ameliorating deconditioning and frailty observed in critical illness patients 
commence within the ICU once clinical stability is achieved.  Whilst novel 
technologies and adjuncts such as electrical stimulation can be considered, 
typically physiotherapeutic rehabilitation involves a hierarchical progression of 
functional manoeuvres such as sitting over the edge of the bed, standing and 
ultimately walking.  This concept of early mobilisation has gained an increasing 
profile and the continuation of exercise therapy and rehabilitation following 
transfer to the ward and beyond hospital discharge in a seamless rehabilitation 
pathway is strongly advocated.  However, data to support the latter stages of this 
continuum are lacking, albeit a more focussed exercise approach appears common.  
In particular, data from randomised controlled trials are limited.  Furthermore, 
despite publication of national UK guidelines to direct this area of clinical practice, 
widespread implementation remains limited and reflects an inconsistent approach 




1.2 Historical introduction 
 
Skeletal muscle wasting was first described as a syndrome associated with ill and 
dying patients by Hippocrates, giving rise to the clinical term cachexia (from the 
Greek kakos, meaning bad, and hexis, meaning habit or state of being).  In the 19th 
century, William Osler reported the physical manifestation of prolonged sepsis, 
observing how “the loss of flesh (becomes) more noticeable and the weakness is 
pronounced” in these severely ill patients [1].   
 
Decades later, the first references to muscle pathology in critically ill patients of 
the early modern medical era were appearing in the literature.  In 1956 Hunter 
published a report of “neostigmine-resistant curarization”, with reference to a 
cohort of patients in whom weakness and difficulty in liberation from mechanical 
ventilation following neuromuscular blockade had been observed [2].  The earliest 
detailed description of a specific myopathic presentation subsequent to critical 
illness, and the condition now commonly referred to as critical illness myopathy 
(CIM) [3], came in 1977 when MacFarlane and colleagues described the protracted 
physical deficits observed post status asthmaticus [4].  Electromyographic 
impairments were evident during the acute phase of ventilator weaning in the 
absence of affected nerve conduction velocity and during subsequent analysis at 
2months, at which stage distal leg muscle weakness remained present.  A wealth of 
research since this first report has substantiated these findings, and further 
identified the accompanying myopathic alterations supported by muscle histology 
samples taken on biopsy [5].  Critical illness polyneuropathy (CIP) was first 
described by Bolton and colleagues throughout the 1980s and early 1990s [6-9], 
with detailed electrophysiological studies outlining reductions in compound motor 
and sensory nerve action potentials in patients presenting with flaccid, areflexic 
limbs and failure to liberate from the ventilator. 
 
The terms intensive care unit-acquired weakness (ICU-AW) [10] or paresis (ICU-AP) 
[11] have emerged more recently as terms to reflect the clinical weakness 
observed in critically ill patients prior to classification as either CIP, CIM or in 
many cases, a combination involving both syndromes.  Furthermore, these broader 
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terms relate more closely to the spectrum of physical and functional impairments 
associated with critical illness, not unique to an electrophysiological diagnosis. 
 
The origins of rehabilitation for patients with critical illness, and the detrimental 
effect of prolonged immobilisation can also be traced in historical medicine.  With 
significant foresight, William Dock in 1944 and Richard Asher in 1947 described 
the deleterious outcomes affecting all bodily systems in acutely ill patients 
consigned to bed in suitably alarming entitled commentaries “The Evil Sequelae of 
Complete Bed Rest” and “The Dangers of Going to Bed”, respectively [12, 13].  
Asher advocated the role of the healthcare practitioner in facilitating early 
mobilisation and reported perhaps the first evidence of the effect of this practice – 
namely, fewer post-operative complications and a quicker return to work.  The 
potential advantages of this practice in postoperative patients were later echoed in 
an editorial published in the British Medical Journal in 1948 [14].  Petty [15], an 
intensivist, later described ICUs of the 1960s where patients requiring mechanical 
ventilation were awake, alert and sitting out in chairs, engaging with people 
around them and their environment.  In the 1970s, early reports were published 
on the implementation of portable devices for supporting ambulation in ventilated 
patients, and the significant clinical benefits achieved including improved weaning 
[16, 17].   
 
Significantly Asher [12], reflecting on both the physical and mental impairments 
experienced by ill patients almost seventy years ago, described a rehabilitation 
approach incorporating respiratory weaning, physical exercise and occupational 
therapy, unaware that this would become the cornerstone of extensive 
international multidisciplinary research into the management of recovery in 
critically ill patients over the last decade. 
 
1.3 Acquired critical illness neuromuscular disorders  
 
Neuromuscular dysfunction occurs early during critical illness and gives rise to a 
number of complications for survivors during the ICU admission and following 
discharge, including protracted requirements for mechanical ventilation and 
delayed weaning, increased ICU and hospital lengths of stay and mortality, and 
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ongoing physical and psychological impairment requiring intensive rehabilitation 
intervention.   
 
1.3.1 Definitions and classification 
 
Multiple synonymous terminology is used in the literature to describe syndromes 
of the peripheral nerve and muscle evident in critically ill patients including 
pathology-specific critical illness myopathy (CIM) [3] and polyneuropathy (CIP) 
[9], and references for mixed presentations such as critical illness 
polyneuromyopathy (CINM) [18], and the more global description of intensive care 
unit-acquired weakness (ICU-AW) [10] (Table 1-1).  A more detailed description of 
the variable taxonomy of critical illness neuromuscular disorders is provided by 
Stevens et al [5], as part of a roundtable meeting of experts in 2009.   
 
Table 1-1 Terminology describing neuromuscular deficit in critical illness 
 
Term Definition 
Intensive care unit-acquired weakness (ICU-
AW) 
Clinical weakness attributable to the systemic 
inflammatory response from index critical 
illness; no neurologic or metabolic aetiology  
Critical illness myopathy (CIM) 
 
Acute primary myopathy with reduced 
amplitude of sensory nerve action potentials, 
low-amplitude motor unit potentials +/-
fibrillation and reduced excitability on direct 
muscle stimulation 
Critical illness polyneuropathy (CIP) Sensorimotor axonal polyneuropathy with 
reduced compound muscle and sensory nerve 
action potential amplitudes but normal nerve 
conduction velocity 
Critical illness polyneuromyopathy (CINM) Syndrome involving overlap between both CIP 
and CIM 
[3, 5, 19] 
 
ICU-AW has been suggested as an overarching term to describe critical illness 
neuromuscular disease with further sub-classifications possible depending on 
available diagnostic information [5, 19] (Figure 1-1).  Use of this term, to simplify a 
complex clinical condition, has been supported by many to encourage greater 
identification and reporting of patients presenting with critical illness-related 
peripheral muscle weakness [19].  If ICU-AW is present, electrophysiological 
investigations such as electromyography, nerve conduction studies and muscle 
histology offer data to accurately diagnose CIM, CIP or CINM, albeit the clinical 
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application of these tests is variable.  Indeed, such testing may not be feasible or 
readily available in all ICUs.  More importantly, electrophysiological abnormalities 
are evident in the majority of patients early on critical illness and thus these 













Adapted from [5, 19] 
 
Abbreviations:  ICU-AW = intensive care unit-acquired weakness.  EMG = electromyography.  CIM = 
critical illness myopathy.  CIP = critical illness polyneuropathy.  CINM = critical illness 
polyneuromyopathy. 
 
Figure 1-1 Schematic classification neuromuscular disease in critical illness 
 
1.3.2 Diagnostic criteria 
 
ICU-AW is a clinical diagnosis of global peripheral skeletal muscle weakness.  
Diagnostic criteria for this presentation are embedded in a thorough and detailed 
clinical assessment undertaken at the bedside, and a process of exclusion of 
differential diagnoses [5].  Typically patients present with difficulty in weaning 
from mechanical ventilation and/or profound generalised weakness and impaired 
mobilisation [19, 21].  Conversely diagnostic criteria for CIM, CIP, CINM relate 
closely to findings established from electrophysiologic investigations. Table 1-2 
summarises diagnostic criteria for these presentations.   
 
Critically ill patient at risk of neuromuscular dysfunction 
ICU-AW EMG, nerve conduction, muscle 
histology evidence of neuropathy or 
myopathy 
CINM 
CLINICAL          
ASSESSMENT 
SEVERE, PROLONGED OR 





Table 1-2 Diagnostic criteria for critical illness-related neuromuscular 
presentations  
 
ICU-AW CIM CIP CINM 
Generalised weakness 
post critical illness 
 
Diffuse, symmetric in 
nature, of proximal 
and distal peripheral 
skeletal muscles with 










All other causes of 
weakness excluded 




>80% of lower normal 
limit in ≥2 nerves 
 
Needle EMG in ≥2 
muscle groups shows 
short-duration, low-



















decreased to <80% of 




decreased to <80% of 








Absence of a 
decremental response 
on repetitive nerve 
stimulation 
Criteria for ICU-AW, 
CIP and CIM met 
[3, 5, 19] 
 
Abbreviations:  ICU-AW = intensive care unit-acquired weakness.  CIP = critical illness polyneuropathy.  
CIM = critical illness myopathy.  CINM = critical illness polyneuromyopathy.  MRC = Medical Research 




1.3.2.1 Limitations of a diagnosis of CIM, CIP or CINM in critically ill patients 
 
Whilst beneficial for providing detailed data to characterise nerve and muscle 
pathology in critically ill patients, electrophysiological investigation 
(electromyography, nerve conduction study, muscle biopsy) has a number of 
clinical and pragmatic caveats.  Such invasive testing is costly, has associated 
clinical risk such as bleeding and infection, and requires high levels of operator 
skill for implementation as well as clinician expertise for interpretation, therefore 
rendering general availability of these tests limited.  Furthermore, technical 
difficulties arise associated with the ICU environment including peripheral 
oedema, signal artefact from other electrical devices, and presence of pressure 
monitoring lines and devices [5, 22]. 
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Confirming CIM, CIP or CINM has value in diagnostic utility.  However, these 
neuromyopathic conditions often show limited relation to the severity and 
distribution of ICU-AW.  Furthermore, presence of electrophysiologic and 
histologic abnormalities in critically ill muscle may not clearly translate to other 
clinically relevant outcomes [11, 20, 23].  Clinical assessment is sufficiently reliable 
for diagnosing weakness in a critically ill patient; that peripheral muscle and 
diaphragm electromyography has been shown to not be associated with ICU length 
of stay or duration of mechanical ventilation, failing to either alter diagnosis or 
predict outcome, suggests that electromyography may add limited clinically useful  
information [24, 25].  
 
Of therapeutic importance for the clinician, there is currently no specific treatment 
for CINM and little known about its long-term outcome and rehabilitative 
requirements [26].  Hence there is justification for focussing on optimising those 
aspects of intensive care management that may modify the severity of ICU-AW, 
such as pharmacotherapy, that directly and indirectly adversely impact on skeletal 
muscle and early mobilisation, which can be applied to ‘high risk’ critically ill 
patients, rather than placing emphasis on an electrophysiological sub-diagnosis 
[19].  In addition clinical recovery precedes recovery of electrophysiological 
abnormalities,  and changes in peripheral muscle strength are often inconsistent 
with underlying electrophysiological changes [24, 27].  In essence, even if 
electrophysiological testing is employed for detailed diagnosis, the value of the test 
result and repeat measures has limited clinical value.    
 
1.3.3 Risk factors for development of ICU-AW  
 
Lack of experimental models to investigate ICU-AW in isolation has resulted in 
prospective observational cohort studies and clinical trials  providing much of the 
existing data detailing known risk factors for its development [19].  Illness severity 
at ICU admission, female gender, systemic inflammation, hyperglycaemia and 
duration of ICU stay have all been reported as independent risk factors for the 
development of neuromuscular weakness in critically ill patients [8, 19, 28-32].  
Multi-organ failure and prolonged immobilisation have also been widely reported 
as associated with its onset.  Whilst administration of aminoglycoside antibiotic 
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[30] and corticosteroid [28] medication have previously been suggested as 
potentially harmful, more recently these have not been proven as independent risk 
factors [32].  Furthermore, a recent integrative review of the evidence related to 
use of neuromuscular blocking agents in modern critical care practice concluded 
that use of these drugs, in general, was less of a risk factor for the development of 
ICU-AW [33].  
 
1.4 Measurement of peripheral skeletal muscle strength in critically ill 
patients 
 
Quantitative assessment of peripheral skeletal muscle strength is necessary for 
establishing ICU-AW and can assist in monitoring progression and predicting 
outcome in critically ill patients, in particular regarding physical functional 
performance and ongoing rehabilitation requirements.  A number of available 
measurement techniques have been reported including both volitional and non-
volitional methods. 
 
1.4.1 Volitional assessment of peripheral skeletal muscle strength 
 
Routine measurement typically involves a process of manual muscle testing 
(MMT), evaluating the magnitude of force generated during a maximum voluntary 
contraction.  Specific cut-off values have been identified for ICU-AW diagnosis.  
Sequential scores may be used to longitudinally chart muscle strength in critically 
ill patients throughout their admission, and following ICU discharge. 
 
1.4.1.1 Medical Research Council Sum-score 
 
One of the most commonly reported MMT techniques in the literature for 
determining ICU-AW is the Medical Research Council sum-score (MRC-SS).  Based 
on the MRC scale for assessing muscle strength [34], modification and 
development in critically ill patients, more specifically those patients with Guillan-
Barré syndrome, resulted in refinement to six functional upper and lower limb 
muscle groups (shoulder abduction, elbow flexion, wrist extension, hip flexion, 
knee extension, ankle dorsiflexion) [35].  Patients are assessed in either supine or 
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seated positions, and muscle groups are assessed bilaterally on a scale ranging 
from 0 (no visible contraction, no strength) to 5 (normal power), producing 
composite scores ranging from 0 (complete paralysis) to 60 (normal strength).  An 
MRC-SS of less than 48 out of 60 i.e. a score of 4 or less out of 5 in each muscle 
group assessed, is considered diagnostic of ICU-AW [11, 36, 37], with scores of less 
than 36 classified as severe weakness [38].  More recently, a collapsed four-point 
scoring system has been developed (0=paralysis, 1=severe weakness, 2=slight 
weakness, 3=normal power) to minimise disparity in differentiating between 
levels in the earlier MRC-grading system, but to date its use has been restricted to 
neurological conditions with further validation required in the critically ill 
population before it can be considered in the ICU population [39]. 
 
Using the commonly reported MRC-SS cut-off of less than 48 out of 60, a number of 
prospective studies have reported prevalence of ICU-AW ranging between 24% 
and 65% [11, 30, 37, 40].  Furthermore, a diagnosis of ICU-AW has been shown to 
be associated with prolonged weaning, delayed rehabilitation, increased hospital 
length of stay and mortality in both the ICU and hospital [11, 29, 30, 36, 37, 40-43], 
albeit one of these studies assessed the severe weakness (<36/60) threshold [43]. 
 
1.4.1.2 Dynamometry  
 
Dynamometry is an alternative form of MMT used for measurement of strength in 
critically ill patients.  Adopting standardised procedures for operator 
implementation, dynamometry is a valid and reproducible technique [44] which 
can be used during both ICU admission and following discharge [36, 45].  Many 
devices are lightweight, small and portable increasing their clinical usefulness.  A 
direct relationship has been demonstrated between handheld dynamometry used 
to measure grip strength, and ICU-AW measured using the MRC-SS; ICU-AW was 
diagnosed at a cut-off level of 11kg-force for males and 7kg-force for females [36].  
Hence, grip strength may offer a quick and simple alternative to comprehensive 
manual muscle testing  with the additional benefit of data detailing the normal 




1.4.1.3 Limitations of volitional peripheral skeletal muscle testing 
 
Whilst appealing for a variety of clinical and pragmatic reasons, the use of MMT to 
diagnose ICU-AW in critically ill patients has a number of caveats.  The volitional 
nature of testing restricts ability to distinguish true loss of muscle strength from 
poor motivation and impaired cognition.  Whilst positive results confirm intact 
muscle strength, inability to perform the test or scoring a low value can be 
influenced by a number of causal factors, including non-muscular related as well as 
submaximal effort.  Extraneous circumstances, such as pain and level of analgesia, 
level of sedation, arterial monitoring and venous access lines, patient motivation 
and compliance with assessment influence test outcome, can adversely affect 
validity and reliability of results.  Waak et al [48] broadly summarise the muscle 
strength measurement bias as arising from an interaction between factors relating 
to subject cooperation, technical considerations, pharmacological paralysis and 
regional barriers.    
 
Screening for awakeness 
 
When performing MMT patients must be sufficiently awake, alert and cognitively 
intact to follow the instructions necessary for testing each muscle.  Screening tools 
can facilitate assessment of this such gauging patient response to simple 
commands such as ‘Open your eyes’ or ‘Nod your head’ [11, 36, 37], and ensuring 
sedation scores are within acceptable and appropriate levels for testing [49].  
Clinicians must be confident that patients perform their maximum volitional effort 
in the correct testing position, albeit this may not be feasible within the ICU 
environment. 
 
Sensitivity of the MRC grading scale 
 
Ordinal and nonlinear in nature, the MRC scale for grading muscle strength is 
flawed in construct with differential sensitivity evident across the range of scores 
which may result in a ceiling effect [38, 50].  For example, scores at level 3 or 
below incorporate gravity as an objective reference quantity, whereas for levels 4 
and 5, quantity of additional resistance is not specified nor is it measured during 
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testing.  Grade 4 strength may encompass a wide range of muscle strength, and 
establishing a true ‘normal’ (level 5) for a critically ill patient is challenging.  In 
essence, discriminant ability of the scale above level 3 is poor [51], and validity and 
reliability depend upon the context of the interaction between clinician and 
patient, and the experience and individual judgement of the clinician in delivering 
and interpreting the assessment [52].  Subtle changes in muscle strength may 
remain undetected by manual muscle testing despite significant 
electrophysiological changes [27], nor does the MRC-SS include distal muscle 
groups such as those in the hand and fingers that may show early signs of 
weakness [5]. 
 
Protocol for muscle group assessment 
 
When conducting MRC-SS assessments muscle groups can be assessed either 
isometrically, at one point in range, or through range of movement [53], but this is 
not clarified in the original instructions [35] nor consistently documented as part 
of the testing procedure.  Not only could this potentially lead to discrepancies in 
isolated measurements, but limitations in comparison of values scored 
longitudinally and involving more than one clinician.  Furthermore these two 
techniques are not comparable and cannot be used interchangeably.  Reliability 
and agreement for the diagnosis of ICU-AW have been reported as higher for the 
isometric technique [54], however, it is vital that clinicians adopt a standardised 
testing protocol for all aspects of testing including patient and examiner position, 
contraction time, instruction and encouragement given, number of repetitions and 
duration of rest periods, in addition to method of strength assessment [55].  
Written as well as visual descriptions of the performing the isometric testing 
process have been reported [38, 56, 57].    
 
In patients able to achieve anti-gravity strength, dynamometry has been suggested 
as a more sensitive tool for assessment of muscle strength [55].  However, there 
are variations in the testing process for various muscle groups which are 
important to consider, and again standardisation of protocol is important.  
Handheld dynamometry for grip strength involves the ‘make test’ where the 
examiner holds the device steady to match patient exertion (or the patient holds 
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the device themselves depending on the model used), as opposed to the ‘break test’ 
used for other peripheral skeletal muscle groups, where the examiner exerts force 
sufficient to overcome the patient’s effort and they are no longer able to maintain 
the testing position [58].  One limitation of this technique is reliance on the ability 
of the tester to demonstrate this level of resistance at the upper ranges of patient 
ability.  Recent data suggest dynamometry may be most reliable at mild to 
moderate strength levels, similar to that observed at MRC levels 3-4 [50].   
 
Clinician agreement  
 
Contrasting results for inter-observer agreement of MMT have been reported.  In 
stable outpatients recovering from critical illness high levels of inter-rater 
reliability between clinicians for MRC-SS testing have been demonstrated 
(intraclass correlation coefficient (ICC) 0.99) [59].  Overall Kappa scores for 
agreement of the binary outcome of ICU-AW diagnosis also indicated very good 
agreement albeit confidence intervals were wide (Kappa (95%CI) 0.88 (0.44-1.0)) 
[59].  Weaker levels of agreement for ICU-AW diagnosis were evident when testing 
was applied to a mixed cohort of more acute patients within the ICU and following 
discharge to the ward, although wide variability in scores was again evident  
(Kappa (95%CI) 0.76 (0.44-1.0)) [60].  Furthermore, only a third of patients in 
whom testing was attempted whilst in the ICU were able to complete the measure, 
with only fair agreement for ICU-AW diagnosis reported (Kappa 0.38).  Higher 
levels of agreement were seen in a larger cohort of patients tested whilst still in the 
ICU (Kappa 0.68±0.09), albeit these were chronically critical ill patients with ICU 
length of stay of approximately three weeks, and less than one third remaining 
mechanically ventilated at the time of testing [38].  In this study, inter-observer 
agreement for hand-held dynamometry (HHD) was greater than for MRC-SS, 
although cut-offs for diagnosis of ICU-AW using HHD [36], were not examined.  
Finally Baldwin et al [50] demonstrated ranges of inter-rater consistency (ICC 
(95%CI) 0.78 (0.32-0.93) to 0.95 (0.84-9.98)) and test-retest agreement (0.82 
(0.39-0.94) to 0.92 (0.78-0.97)) of HHD for three major muscle groups (handgrip, 
elbow flexion and knee extension) [50].  Whilst beneficial for validation of the 
dynamometry technique, only handgrip thresholds for diagnosing ICU-AW have 
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been established, and these were, as previously, disappointingly not analysed in 
this dataset.   
 
Relationship with physical function and clinical outcome 
 
There are currently no data to confirm a relationship between ICU-AW and 
physical functional ability.  Whilst the threshold for MRC-SS of less than 48 out of 
60 provides a potentially logical representation of ‘functional’ muscle weakness i.e. 
to meet this score muscle groups fail to demonstrate movement against resistance,  
clinically important levels of ICU-AW have yet to be determined and subclinical 
levels currently may be missed [21].  Further studies in this area will define 
clinically significant weakness, as deficits in physical functional performance may 
be present in patients scoring greater than 48 out of 60.  This has the potential to 
significantly inform provision of rehabilitation intervention to those with 
demonstrable impairment regardless of ICU-AW diagnosis based on MRC-SS 
assessment.  Performance of a physical functional task is the coherent combination 
of complex motor tasks, whereas MMT assesses individual isolated muscle actions 
and therefore a linear relationship between these two variables is unlikely.  In a 
cohort of surgical ICU patients, for every one unit increase in strength, a 5% 
relative decrease in the odds of mortality has been shown [61] although this did 
not examine the clinical outcome in terms of the ICU-AW threshold value.  
Importantly, the clinical utility and predictive value of manual muscle testing, in 
particular the MRC-SS, for diagnosis of ICU-AW requires further investigation.   
 
1.4.2 Non-volitional assessment of peripheral skeletal muscle strength 
 
Non-volitional techniques to assess peripheral skeletal muscle strength depend on 
supra-maximal external stimulation, via electrical or magnetic means, of the motor 
nerve supply to the muscle.  In this way, the muscle force generated is not 
dependent on volitional patient effort, the influences of cooperation, motivation 
and external environmental factors are removed.  Reliable and objective values can 
therefore be obtained in patients who may be sedated and mechanically ventilated.  
Available techniques include measurement of adductor pollicis (AP) force using 
ulnar nerve stimulation [23, 62, 63], quadriceps force elicited by femoral nerve 
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stimulation [64, 65] and ankle dorsiflexor muscle force (ADMF) evoked by 
peroneal nerve stimulation [65-67]. 
 
1.4.2.1 Adductor pollicis muscle strength and ulnar nerve stimulation 
 
The technique of measuring AP force involves the use of a hand board to 
immobilise during stimulation the hand and forearm in supination [62, 63, 68].  A 
strain gauge, mounted on the board and connected to a metal loop positioned 
around the proximal phalanx of the thumb (in abduction) by an inextensible metal 
chain, transmits force generated.  To minimise rotation of the wrist the hand and 
forearm are encased in a rigid plastic splint with access to the ulnar nerve for 
stimulation.  
 
In a study comparing a cohort of patients with sepsis and multiorgan failure to 
healthy subjects after limb immobilisation, Eikermann et al [23] demonstrated 
significant reductions in AP force in the critically ill cohort (20±16 vs. 65±19N; 
p<0.01).  The characteristics of muscle function assessed included the force 
generation at variable stimulus frequencies ranging from 10-80Hz (force-
frequency relationship), single twitch muscle contraction and half relaxation times 
(time elapsed for 50% decrease in force from peak following final stimulus pulse at 
10Hz) as well as fatigue at low frequency stimulation (20min of intermittent titanic 
stimulation achieving 50% maximum AP force).   
 
Whilst offering one method for non-volitional assessment of muscle force 
production, tetanic motor nerve stimulation at high frequencies can be painful, 
resulting in limited patient tolerability [62].  An alternative is assessment of 
muscle contractility involving measurement of the force response to supramaximal 
stimulation i.e. where further increases in stimulation intensity do not elicit 
production of larger forces.  Adductor pollicis twitch tension (TwAP), measured 
using both electrical and magnetic stimulation, was found to be significantly 
reduced in critically ill patients compared to age-matched healthy controls (n=20 
in each arm, 4.2 (2.2-6.7)N vs. 7.1 (4.4-9.8)N; p<0.01) [63].  Similar significant 
differences between ICU patients and healthy controls for TwAP were also 
reported by Pickles et al from a larger cohort [69] (3.6±1.2N vs. 7.3±2.4N; 
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p<0.001).  Weakness assessed by TwAP developed within the first week of ICU 
admission and this remained low throughout the three-week ICU admission period 
of measurement. 
 
TwAP has a number of advantages as a measure of muscle strength.  Isometric 
twitch tension such TwAP assumes the relationship between force produced by 
the single twitch and the force produced by high frequency stimulation and the 
resultant tetanic contraction (or truly maximal MVC) is constant.  For adductor 
pollicis, the range of TwAP/MVC ratios is narrow, confirming this relationship [63].  
In addition, magnetic stimulation is preferable as the stimulating coil requires less 
accuracy for placement and less surface pressure.  Magnetic stimulation is virtually 
painless as the firing threshold for motor fibres is much less than for sensory fibres 
[70].  Furthermore, stimulating currents are produced in situ such that their 
intensities can be very low, as opposed to electrical stimulation techniques that 
require relatively high stimulating currents to overcome skin resistance [71].  
Finally, the TwAP technique is well tolerated, even in critically ill patients, and has 
clinical utility causing minimal disruption to patient position or interacting with 
treatments. 
 
1.4.2.2 Quadriceps muscle strength and femoral nerve stimulation 
 
The quadriceps is an important muscle for locomotion and other functional 
activities.  Polkey et al [64] described a technique of supramaximal magnetic 
stimulation of the femoral nerve using a 70mm figure-of-eight coil placed high in 
the femoral triangle, lateral to the femoral artery and over the femoral nerve, 
which was found be simple to perform, painless and reproducible.  Quadriceps 
twitch tension (TwQ) is determined following supramaximal stimulation, and the 
mean TwQ/MVC ratio has been reported as 0.15 for both men and women [72] 
This technique has been used to demonstrate quadriceps muscle contractility in 
healthy subjects and patients with chronic respiratory disease [64, 65, 73].  
However, the measurement process involves subject positioning in supine on a 
bespoke testing bench with knee flexion at 90o.  Quadriceps force is measured by 
an inextensible strap positioned around the ankle joint and connected to a strain 
gauge.  For these reasons it is rarely feasible to conduct these measurements in 
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critically ill patients in the ICU environment.  Furthermore, supramaximal 
electrical femoral nerve stimulation is feasible but technically challenging with 
limited reproducibility, and transcutaneous electrical stimulation activates only a 
fraction of muscle via peripheral femoral nerve branches and hence is submaximal 
making this approach less clinically helpful in the ICU [74]. 
 
Only one group have recently published data on non-volitional assessment of 
quadriceps force in critically ill patients in the ICU.  Vivodtzev et al [75] and 
colleagues assessed 13 consecutive sedated and mechanically ventilated patients 
with organ failure, and then repeated measurements after awakening in nine of the 
cohort.  Mean Twq was 1.8±1.3kg for the whole group of patients.  TwQ was double 
in COPD patients ()compared to ICU patients (p <0.001), and four times higher in 
healthy subjects (p <0.001).  There was no significant difference in TwQ between 
ICU patients whether sedated or awake. 
 
1.4.2.3 Ankle dorsiflexor muscle strength and peroneal nerve stimulation 
 
Ankle dorsiflexor muscle force (ADMF) can be measured using peroneal nerve 
stimulation.  In critically ill patients mechanically ventilated for seven days, peak 
torque has been shown to be significantly reduced (median (IQR) 3.3 (2.5)Nm vs. 
4.1 (2.0)Nm, p=0.0003 for single pulse stimulation; similarly significant results for 
double, triple and quadruple pulse stimulation), contraction time significantly 
reduced (104 (37)ms vs. 116 (53)ms, p=0.0001), and half-relaxation time 
significantly increased (115 (45)ms vs. 110 (31)ms, p=0.01) compared to healthy 
controls [66].  In addition, Seymour et al [65] reported tetanic contraction force at 
100Hz electrical stimulation equal to that obtained during MVC manoeuvres, and 
tolerability of the technique in healthy subjects and patients with chronic 
respiratory disease.  Access to the site of assessment, the distal lower limb, is often 
unrestricted in critically ill patients and measurement requires no alteration in 






1.4.2.4 Technical considerations 
 
Standardisation of non-volitional techniques for measuring muscle strength in 
critically ill patients is vital for optimising reliability and validity of data 
acquisition, given its relative advantages over volitional methods.  Stimulation 
intensity must be supramaximal to result in contraction of the entire muscle.  For 
electrical stimulation this is typically 5-20% above that required for maximal 
response [20] indicated by a plateau in CMAP amplitude or force response.  
Stimulation intensity depends on both the current applied and the pulse duration.  
Adequate skin preparation is a further prerequisite of nerve stimulation, involving 
abrasion and cleansing to ensure acceptable electrical contact.  Correct placement 
of electrodes ensures stimulation of the desired nerve only, and selection of 
appropriately sized electrodes ensures optimal current density.  Muscle preload 
directly affects force production and should be standardised throughout the 
protocol either through setting a specified preload via the force transducer, or 
defining joint position during measurement [20]. 
 
Muscle temperature significantly influences skeletal muscle function [76].  Low 
skin and muscle temperature can be common in septic critically ill patients with 
impaired peripheral circulation, which can be further exacerbated by 
vasoconstrictive medications.  Strategies to maintain a constant muscle 
temperature during testing are necessary to minimise variation in mechanical 
muscle properties influencing results [77].   
 
Potentiation is the phenomenon by which preceding muscle contraction (either 
volitional or non-volitional in origin) enhances or reinforces the response to 
stimulation, resulting in greater force production [78, 79].  Potentiation is often 
most evident at low stimulation frequencies, such as the single twitch response.  In 
these circumstances, resting the muscle completely for 20 minutes prior to testing 
produces stable, unpotentiated twitch responses, whilst a standard protocol 
involving 30 second intervals between twitches can avoid twitch-on-twitch 
potentiation [63].  Consideration must be given to avoid trains of stimuli that cause 




1.4.2.5 Limitations of non-volitional peripheral skeletal muscle testing 
 
Non-volitional techniques for assessing muscle force remove volitional influences 
and, if a standardised approach is adopted, can produce robust data.  However, 
expensive specialist equipment is required to perform these measurements with 
trained personnel required for their implementation and analysis of the results.  In 
addition, there are practical limitations to testing all muscle groups in critically ill 
patients within the ICU.  Few normative data for comparative purposes exist, and it 
remains uncertain which peripheral skeletal muscle group or single muscle, if any, 
best reflects global muscle weakness.  Indeed, patients with critical illness related 
skeletal muscle weakness tend to demonstrate proximal to distal weakness, 
suggesting that this pathological process lacks uniformity across all skeletal 
muscles 
 
1.4.3 Summary  
 
Both volitional and non-volitional methods for the assessment and measurement 
of peripheral skeletal muscle strength are available for use with critically ill 
patients.  Each mode of assessment has relative advantages, but neither is without 
clinical, technical or pragmatic limitations.  Simple, clinically pragmatic, but also 
effort-independent and objective alternatives are required to monitor the 
trajectory of peripheral skeletal muscle dysfunction during critical illness.  More 
recently, ultrasound of peripheral skeletal muscle architecture e.g. cross-sectional 
area has emerged as a commonly reported potential technique for this purpose. 
 
1.5 Ultrasound for assessment of peripheral skeletal muscle during critical 
illness 
 
B-mode ultrasound of peripheral skeletal muscle architecture has increasingly 
been used as a tool for measuring muscle dysfunction in critically ill patients [80-
83].  It has a number of beneficial properties for this purpose, and in addition to 
the machine being widely accessible with a large proportion of ICUs commonly 
using ultrasound for venous line and chest drain insertion, it has become an 
inexpensive, quick, simple and portable technique.  Furthermore, it is effort-
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independent, free of ionising radiation, can be performed at the bedside, and with 
training can be implemented by non-specialist clinicians.  For these reasons it has 
the potential for widespread clinical applicability.  Significantly ultrasound has 
been highlighted as a valid and reliable alternative to the ‘gold standard’ of 
magnetic resonance imaging (MRI) [84], with recent improvements in ultrasound 
technology producing muscle images of much greater resolution than typical MRI, 
therefore making the ultrasound technique a valuable tool for clinical and research 
purposes [84, 85].  Previous data have shown that ultrasound measurements of 
quadriceps rectus femoris muscle cross-sectional area in healthy subjects and 
patients with chronic respiratory disease not only correlate with volitional 
(quadriceps maximum voluntary contraction, r=0.80, p<0.001 and r=0.78, p<0.001 
respectively) and non-volitional (quadriceps twitch tension, r=0.72, p<0.001 and 
r=0.69, p<0.001 respectively) measures of quadriceps strength, but also with 
similar values of cross-sectional area acquired via computed tomography (CT) 
(intraclass correlation coefficient=0.88), another common scanning process but 
one which involves radiation exposure [73].  However, similar data are currently 
lacking in the critical illness population.  Nonetheless, ultrasound has been used as 
a practical alternative to MRI and CT to provide real-time data on a range of 
peripheral skeletal muscle architecture features including muscle cross-sectional 
area, muscle layer thickness and echo intensity in critically ill patients [81-83, 85, 
86]. 
 
1.5.1 Principles of ultrasound 
 
Ultrasound imaging is based on the principles of sound-waves and the echoes 
produced.  A specific ultrasound transducer emits high frequency sound waves; the 
image created depends upon analysis of the temporal and acoustic properties of 
the returning echoes [87, 88].  Most biological tissues are comprised mainly of 
water such that they both reflect and transmit a proportion of the sound waves 
delivered.  When the ultrasound beam encounters tissues with different acoustical 
properties e.g. muscle, fascia, or bone, the result is a reflection of the sound waves, 
termed acoustical impedance.  Energy reflected from a tissue assists in generating 
an image of its boundary whereas the transmitted sound penetrates deeper to 
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facilitate further echo delineation [88].  Hence ultrasound has the potential to map 
both superficial and deep tissue layers.   
 
The final image produced using ultrasound results from complex computer 
analysis of the returning echoes [87-89].  Pixel location is determined by the time 
difference between sending and receiving each relative sound wave, such that 
those returning earliest are from closer structures, and those returning later, from 
more distant locations.  Echo intensity, the ‘grey value’ of the image, is determined 
by the number of returning echoes per square area.  Amplitude of sound waves 
determines image brightness.  However, as sound waves lose power with depth of 
penetration, those travelling from deeper tissues may require further amplification 
to account for this energy dissipation, known as time-gain compensation.  
Additional modifications to generate ultrasound images include signal 
rectification, compression and subtraction akin to the filtering processes involved 
in electrophysiological signal management.  Finally, ultrasound image resolution is 
directly proportional to sound frequency, whereas depth of penetration is 
inversely proportional.  Hence higher frequency probes can image more superficial 
structures with greater detail.  Both linear and curvilinear probes are available for 
imaging peripheral skeletal muscle [89]. 
 
1.5.1.1 B-mode ultrasound imaging 
 
B-mode ultrasound imaging produces cross-sectional images of tissues and organ 
borders [90].  In keeping with the main principles of all ultrasound images, it is 
constructed of the echoes generated by reflection of ultrasound waves from 
different tissue boundaries.  The brightness of the image at each echo point is 
related to the amplitude of each echo, giving rise to the term B-mode, or 
‘brightness’ mode.   
 
B-mode images closely reflect the anatomical view that might be observed if the 
body were dissected in that same plane.  Abnormal anatomical boundaries 
indicating pathology can often be identified.  B-mode images are often produced by 
linear transducer arrays i.e. a large number of small transducers arranged in a 
straight line, that offer a wide, rectangular field of view and are useful for 
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superficial structures.  Curvilinear probes operate in the same manner, albeit the 
array of transducers along the front face of the probe is arranged in a curve, as 
opposed to a straight line, and have the additional advantage that the field of view 
becomes wider with depth.   
 
1.5.2 Assessment of peripheral skeletal muscle architecture using 
ultrasound 
 
Muscle has fairly distinct sonographic features in comparison with surrounding 
structures.  Normal muscle appears with low echo intensity i.e. relatively black, 
and divided by sheets of echogenic perimysial connective tissue resulting in a 
speckled appearance in the transverse plane, whereas in the longitudinal plane, 
hyperechoic lines are visible forming a pennate structure [87, 91].  The epimysium 
bordering the muscle is highly echogenic meaning that the outline of a muscle can 
easily be identified.  Bone echo is strong and distinct in healthy subjects, with 
anechoic bone shadow evident underneath, and this can provide a useful reference 
structure for identification of certain muscles [88]. 
 
A number of characteristics of muscle architecture can be assessed using 
ultrasound.  By marking the inner echogenic muscle border muscle size in the form 
of both cross-sectional area (CSA, also referred to as anatomical cross-sectional 
area) and muscle layer thickness can be measured using either in-built online, or 
offline software.  The same process can be utilised in the evaluation of muscle echo 
intensity, a measure of the grey-scale of the image and which may reflect muscle 
composition.  Echo intensity can also be scored subjectively using a visual grading 
scale (the Heckmatt score [92]), or simply by describing the distribution of echo 
intensity within a muscle as either homogenous or inhomogenous.  However 
whilst visual evaluation provide useful information, it is acknowledged that these 
subjective forms of assessment are less reliable demonstrating weaker inter-
observer agreement.  Objective scoring, given that it is quick to perform with 
greater accuracy, should be used where possible.  Finally, muscle images obtained 
longitudinally through the muscle, permit measurement of pennation angle (the 
angle of insertion of muscle fibres into the muscle aponeurosis).  Provided 
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reference markers of known distance are marked on images at the time of 
acquisition, all these parameters can be measured offline following assessment. 
 
Measurement points for ultrasound of quadriceps muscle architecture include 
50% muscle length [93, 94], mid-point between greater trochanter and lateral 
knee joint line [95, 96], three-fifths distance from anterior superior iliac spine 
(ASIS) and superior patellar border[73], half femur height [97], two-thirds 
distance from ASIS and superior patellar border [82, 85], and mid-point between 
ASIS and superior patellar border [82].  This lack of standardisation of measuring 
points between studies restricts comparison between results. 
 
1.5.2.1 Physiological cross-sectional area 
 
Physiological cross-sectional area (PCSA) is a measure derived from the 
anatomical cross-sectional area and pennation angle of a muscle.  PCSA was 
developed to account for the complex geometry of muscle fibre arrangement that 
results in measurements taken in anatomical planes potentially underestimating 
the true force-generating capacity of the muscle by not accounting for the cross-
sectional area of all individual muscle fibres [98].  PCSA is defined as the total 
cross-sectional area of all muscle fibres at right angles to their long axes [94, 99, 
100]. 
 
Muscle fibre arrangement can be inconsistent between muscles of different sizes 
despite similarities in muscle fibre diameter, hence estimations of force-generating 
capacity cannot be estimated from muscle fibre diameter alone as fibre 
arrangement is an important contributing factor [98].  The majority of human 
skeletal muscles demonstrate a pennate arrangement whereby muscle fibres 
insert at angles relative to the force-generating axis of the muscle, termed the 
pennation angle [94, 99, 101].  The quadriceps muscle is an example of such a 
muscle arrangement.  An alternative is a parallel, or longitudinal architecture in 
which muscle fibres run parallel to the muscle length [98].   
 
The anatomical CSA of a muscle is that cross-sectional area measured at an angle 
perpendicular to the force-generating axis in the anatomical plane.  In a parallel-
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fibred muscle this equates to the PCSA, as the anatomical CSA will transect all 
muscle fibres at right angles [102].  In a pennate muscle, the anatomical CSA will 
only cross a number of fibres and hence is disproportionate to PCSA [98, 102].  In 
order to calculate PCSA, the following equation is used 
 
PCSA (cm2) = ACSA (cm2) cos  
 
where   is pennation angle [94, 98], and cosine of pennation angle normalises fibre 
angulation to the line of action of the muscle [99]. 
 
Theoretically, muscle fibres generating force with a pennation angle of 0° i.e. 
parallel muscles, will transmit all that given force along the muscle axis whereas a 
pennate arrangement of muscle fibres will result in a loss of force production at 
the tendon as this force will be proportional to the cosine of the pennation angle 
[97, 98].  Although muscles appear to have been designed with a biological flaw 
that results in a loss of usable force-generating capacity, the design represents a 
‘space-saving strategy’ as if all muscles demonstrated parallel fibre arrangement 
this would preclude their location in a large number of sites throughout the body 
[98].  Hence, whilst muscle fibres arranged such that there is a pennation angle has 
an ‘energy cost’ in terms of force generation, this allows more contractile units to 
be sited in parallel for a given ACSA [97, 98] (Figure 1-2). 
 
That said, a complex relationship exists between force production at the tendon, 
the amount of contractile material and angle of pennation [97].  Aagaard et al [94] 
report that pennation angles up to an upper limit of 45° contribute to producing 
PCSAs that are proportional to the maximum force-generating capacity of a muscle, 
but despite their suggestion that pennation angle could influence force generation 
at any given anatomical CSA this association has not been found by other authors 
[97].  In addition, the relationships described thus far regarding pennation angle 
and PCSA assume the muscle is in a resting state.  Factors such as alteration of 
pennation angle during contraction and muscle fibre rotation between the 
aponeurosis and axis of movement may alter values obtained and hence, any 
relationships between these parameters [98, 99].  Furthermore, no data have 
reported the potential effect of anthropomorphic factors on pennation angle. 
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A. Effect of pennation 
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A. Schematic representation of effect of pennation angle on force production. Fibres 
oriented parallel to force-generating axis transmit all force in that direction.  In 
this example, a pennation angle of 30° results in fibres transmitting force equal to 
cosine of the pennation angle i.e. 0.87 or 87%. 
 
B. Pennation can increase the relative amount of force-generating material into a 
given anatomical cross-sectional area compared to that of a muslce with fibres 
arranged in parallel. 
 
(adapted from [98]) 
 
Figure 1-2 Effect of muscle fibre pennation 
 
 
1.6 Summary  
 
Ultrasound of peripheral skeletal muscle is an effort-independent technique with 
the potential for widespread clinical utility for monitoring the trajectory of muscle 
dysfunction during critical illness, including from the point of ICU admission, with 
the advantage that a range of characteristics of muscle architecture can be 
measured.  Establishing inter-observer agreement between clinicians for the 
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technique will facilitate this process.  In addition, previous data reporting a 
relationship between anatomical cross-sectional area and muscle force suggest the 
validity of ultrasound measurements as a surrogate where force cannot reliably be 
measured.  The concept of physiological cross-sectional area may provide more 
clinically useful data, but this requires further investigation.  As ultrasound 
emerges as a popular research technique utilised in observational studies of 
critically ill patients, a systematic review and evaluation of the available data is 
important in order to assist in standardising measurement protocols and 
identifying the characteristics of peripheral skeletal muscle architecture commonly 
employed to monitor muscle wasting. 
 
1.7 Post intensive care syndrome and rehabilitation for survivors of critical 
illness 
 
Advances in modern intensive care medicine have resulted in greater survival 
rates from an admission to the ICU with critical illness, including many patients 
with complex and chronic co-morbidities.  As a consequence, the prevalence of 
reported impairment in survivors of critical illness has grown significantly.  The 
volume of evidence from observational follow-up studies of post ICU patients is 
extensive, and characterises the varying and often pronounced morbidity in this 
population including physical and functional [103-108], cognitive [109-112], 
psychological [113-115] and health-related quality of life [116-119].  In addition, 
data have been collected examining the healthcare utilisation and socioeconomic 
impact of critical illness [103, 120, 121], and to consider the burden experienced 
by family and care-givers [122-124].   
 
This spectrum of impairment following critical illness has recently been described 
as ‘post intensive care syndrome’ [125], a concept designed to encompass the 
multi-faceted nature of post ICU disability (Figure 1-3).  Importantly, follow-up of 
this population ranges from six months [126-128] to 5 years [105, 116, 129] 
providing valuable data on the trajectory of recovery for these patients which may 
assist in the timely delivery of appropriate rehabilitation strategies [130].  Indeed 
it has been suggested that even longer-term follow-up beyond 5 years may be 
required to fully appreciate the challenges associated with critical illness 
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survivorship that may not become apparent during the short to medium-term 
















 (adapted from [125]) 
 
Abbreviations: PTSD = post traumatic stress disorder 
 
Figure 1-3 Conceptual diagram outlining post intensive care syndrome             
 
 
1.7.1 Rehabilitation following critical illness 
 
Rehabilitation is an integral component in the recovery of survivors of critical 
illness [125, 132-134].  In order to address the complexity and magnitude of 
symptoms present in patients, a comprehensive multimodal and interdisciplinary 
rehabilitation package is required [125, 135].  Exercise-based rehabilitation is 
advocated in the management of ICU-AW and the physical and functional disability 
arising from muscle wasting and weakness secondary to critical illness.  Data have 
reported the effectiveness of exercise-based interventions delivered at all three 
stages of the patient pathway; within the ICU, following transfer to the ward and 
post hospital discharge.  In the UK, rehabilitation following critical illness has been 
profiled by the publication of guidelines in 2009 by the National Institute for 
Health and Care Excellence (NICE) [136], and the emphasis towards a seamless 






























transition of care and delivery of rehabilitation for patients across the spectrum of 
critical illness from ICU admission to recovery in the community.     
 
1.7.1.1 Early mobilisation in the ICU 
 
Early mobilisation (EM) of patients within the ICU has received significant interest 
in recent years [137-142], with a number of quality improvement projects 
reported to enhance and develop clinical services [143-147].  Early mobilisation 
can be defined as “...the intensification and early application of physical therapy 
administered to critically ill patients” typically commencing within the first forty-
eight hours of ICU admission following achievement of clinical stability [148].  The 
aim is to preserve or restore the integrity of musculoskeletal strength and function, 
and minimise physical and functional impairment and disability during recovery. 
Shifts in practice within intensive care medicine, in particular with regard early 
weaning of patients onto spontaneous modes of ventilation, have facilitated the 
integration of EM into the management of critically ill patients.  In particular early 
transition into pressure support ventilation, even when patients violate 
conventional screening criteria for readiness-to-wean such as partial pressure of 
arterial oxygen to fraction of inspired oxygen ratio and positive end-expiratory 
pressure thresholds, neurological ‘awakeness’ and cardiovascular stability, has 
been shown to be safe and successful and increases the opportunity for patients to 
actively engage with rehabilitation [149]. 
 
Typically EM is characterised by a hierarchical progression of increasingly 
functional activities.  Positioning and assessment of joint range of motion in 
sedated patients, progress to sitting over the edge of the bed, standing, marching 
on the spot and walking away from the bed-space in patients able to actively 
participate and engage with rehabilitation.  Long-term patients can additionally be 
prescribed a bespoke exercise programme.  These levels of exercise therapy have 
received international consensus on their definition by development of an agreed 
list of simple activity codes to facilitate accurate recording of patient treatment 
[150].  In addition to the aforementioned ‘traditional’ forms of EM, use of assistive 
technologies such as electrical muscle stimulation [151], passive cycle ergometry 
[152] and interactive video-game systems [153] can also be used to facilitate 
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prompt commencement of exercise.  An extensive body of work has demonstrated 
the safety [154-158] and feasibility [137, 154, 159, 160] of EM interventions.  
Berney et al [155] reported no adverse event during delivery of EM in over 600 
ICU exercise sessions.  Furthermore clinical management algorithms based on 
consensus of expert opinion have been developed to facilitate decision-making of 
appropriate physical treatments to deliver depending on patient status e.g. 
unconscious, physiologically stable and deconditioned [161].   
 
A number of randomised controlled trials have investigated the effect of a range of 
EM interventions.  One of the earliest studies investigated a stepwise pulmonary 
rehabilitation-style programme in mechanically-ventilated patients with chronic 
obstructive pulmonary disease recovering from acute respiratory failure in a 
respiratory ICU.  Nava [162] found that intervention group patients demonstrated 
significantly improved 6MWT distances (from time first able to mobilise to 
hospital discharge) (p<0.0001, exact values not reported).  Maximum inspiratory 
pressure and visual analogue scale score for breathlessness were also significantly 
more improved in patients receiving the rehabilitation.  Whilst these data are 
notable for their report well before the current interest in early mobilisation arose, 
it should be recognised that the patient cohort were prolonged ICU patients with 
less acuity, and the environment more akin to a long-term weaning unit than those 
that have been investigated more recently.     
 
In 2009, Schweickert and colleagues compared standard care with an early 
physical and occupational therapy intervention comprising sedation interruption 
and progressive levels of physical and functional activity including transfers, bed 
mobility, standing and gait training commencing within 72hours of mechanical 
ventilation [163].  A greater percentage of patients receiving the intervention were 
found to return to independent functional status at hospital discharge (59% vs. 
35%, p=0.02).  In addition duration of mechanical ventilation (median (IQR) 3.4 
(2.3-7.3)days vs. 6.1 (4.0-9.6)days, p=0.02) and number of ICU delirium days (2.0 
(0.0-6.0)days vs. 4.0 (2.0-7.0)days, p=0.03) was also significantly better in the 
intervention arm.  Ventilator-free days and Barthel score at hospital discharge 
approached statistical significance for difference between groups (p=0.05 for both 
outcomes).  These findings, whilst demonstrating a positive effect from the EM 
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intervention, are limited in generalisability to ICU practice outside of the study 
country (North America) due to international differences in ‘standard’ ICU 
physiotherapy practice.  Furthermore, strict sedation and weaning protocols were 
adhered to during the trial, which may not be in operation across all ICUs and 
which may have also influenced findings. 
 
Burtin et al [164] studied the effect of bedside cycle ergometry for 20minutes per 
day in prolonged ICU stay patients.  In this RCT, conducted in Europe, both groups 
received standard respiratory physiotherapy and passive or active upper and 
lower limb movements.  At ICU discharge quadriceps force and physical function 
were not different between groups.  However by hospital discharge 6MWT was 
significantly higher in the treatment group compared to the control group (median 
(IQR) 196 (126-329)m vs. 143 (37-226)m, p<0.05).  Similarly the physical function 
domain of the SF-36 questionnaire was greater in those receiving the intervention 
(21 (18-23)points vs. 15 (14-23)points, p<0.01), as was improvement in 
quadriceps force from ICU to hospital discharge (1.83±0.91Nkg to 2.37±0.62Nkg, 
p<0.01 vs. 1.86±0.78Nkg to 2.03±0.75Nkg, p=0.11). 
 
As the volume of published data examining EM in patients in the ICU has grown, a 
number of narrative [148, 165-168] and systematic [169-171] reviews have been 
undertaken collating and summarising findings.  Whilst a variety of studies 
including case series and observational cohorts have been reported in the former 
publications, one of the latter reviews by Kayambu et al [169] additionally 
incorporated meta-analyses of data from eligible randomised controlled trial data, 
and thus represents the most robust form of evidence to determine the effects of 
EM in critically ill patients.  Pooling findings from RCT and quasi-RCT studies, the 
authors concluded a significant positive effect favouring physical therapy for 
improving quality of life (Hedges g=0.4, 95%CI 0.08-0.71), physical function 
(g=0.46, 95%CI 0.13-0.78), peripheral muscle strength (g=0.27, 95%CI 0.02-0.52) 
and respiratory muscle strength (g=0.51, 95%CI 0.12-0.89).  Length of hospital 
stay (g=-0.34, 95%CI -0.53- -0.15), length of ICU stay (g=-0.34, 95%CI -0.51- -0.18) 
showed significant reductions, and ventilator-free days increased (g=0.38, 95%CI 
0.16-0.59).   Interestingly, there was no effect on mortality observed.  However 
exercise interventions were shown to vary considerably and further investigation 
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with larger sample sizes was advised to determine the mechanisms by which 
specific physical therapy strategies may demonstrate effect.  The definition and 
clinically beneficial level, in terms of type, frequency and intensity of EM, currently 
remain undefined [148].  
 
1.7.1.2 Ward-based physical rehabilitation 
 
Far fewer studies have examined the effect of ward-based interventions for post 
ICU patients.  Typically physiotherapeutic management of patients is directed 
towards hospital discharge planning, and the adequate level of mobility required 
for this to occur.  Generic rehabilitation and support services may be available to 
patients including intermediate care, supported discharge and community therapy 
services but in the UK, as well as Europe, North America and Australia, these are 
for defined short periods of time with little scope for addressing more complex 
presentations, and rarely targeted specifically at post ICU patients.  Furthermore, 
the level of mobility that reflects suitability for hospital discharge may not at all 
reflect premorbid function and this is not often accurately assessed in clinical 
practice. 
 
A combined ward-based physiotherapy and nutritional rehabilitation package was 
evaluated by Salisbury et al [172] involving development of a unique generic 
rehabilitation assistant post [173].  This position was found to be a successful and 
valuable role for facilitating continuity of care for patients during the ICU-ward 
transition, and offering greater flexibility in the delivery of ward-based 
rehabilitation [173].  During the pilot phase of implementation of this post, a 
significant increase in the frequency of physiotherapy (median (IQR) 8.2 (7.1-10.6) 
vs. 2.6 (1.8-4.2)visits, p<0.002) and dietetic (4.9 (3.4-8.4) vs. 1.2 (0.6-2.1)visits, 
p<0.001) visits in intervention compared to control patients was evident  [172].  
This model of intervention is currently under investigation in a larger randomised 
controlled trial, with results pending [174, 175]. 
 
Interestingly Hopkins et al [176] found that of 65 patients who had received early 
mobility in their respiratory ICU, activity levels had decreased in 55% of patients 
on the first full ward day.  Nearly twenty-five percent of patients who had walked 
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more than 100 feet at ICU discharge failed to mobilise at all on their first ward day, 
over one-third achieved less than their original distance, and only 41% 
demonstrated a comparable distance.  These data highlight the importance of 
ensuring adequate delivery of rehabilitation therapy to patients to not only 
maintain but enhance performance.  The role of a ward-based exercise therapy 
rehabilitation assistant could be wholly beneficial in the transition pathway from 
ICU to the ward, but further data are required. 
 
Both Denehy et al [177] and Jones et al [178] have investigated the effectiveness of 
interventions conducted on the ward and that continued following hospital 
discharge.  Denehy et al [177] utilised a bespoke exercise-based programme of up 
to one hour of cardiovascular, strength and functional activity, whereas Jones et al 
[178] developed a self-help rehabilitation manual.  The primary end-point for 
Denehy et al’s study was 6MWT distance at 12 months post ICU discharge, and 
whilst their intervention arm performed numerically better on the 6MWT at 
hospital discharge than those receiving usual care, the study was not powered to 
detect differences between groups following the ward-based period, nor were 
exploratory statistical analyses conducted to examine these data.  The self-help 
rehabilitation manual adopted by Jones et al [178] was found to result in improved 
physical function at 8 weeks and 6 months post ICU discharge with a trend 
towards lower rates of depression, but again no outcome measures were evaluated 
following the ward-based period of intervention delivery to evaluate effect at this 
stage of the patient pathway. 
 
1.7.1.3 Exercise-based rehabilitation following hospital discharge 
 
Emerging data are appearing in the literature regarding effectiveness of exercise-
based post hospital discharge rehabilitation interventions.  Three recent 
randomised controlled trials have failed to show benefit, albeit this may be due to 
the methodology employed, the nature of the intervention and in particular, failure 
to stratify patients according to the presence of peripheral muscle weakness [177, 
179, 180].  Furthermore, the lack of acknowledgement given to the standard level 
of rehabilitation and exercise therapy provided in usual practice would have 
reduced differences evident between control and intervention arms.  Indeed, 
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control group patients received a standard level of rehabilitation within the ICU 
[177, 180] exceeding that delivered as the intervention in the previously described 
North American trial by Schweickert et al [163] which may have influenced 
subsequent patient ability at the later stage post hospital discharge. 
 
However, recent pilot RCT data have demonstrated a significant improvement in 
6MWT (p<0.001) and balance (p<0.05) as a result of cardiopulmonary exercise 
although these findings are preliminary, pending recruitment of the complete 
sample size, numerical values were not provided, and follow-up data beyond the 
immediate programme completion point have not been reported [181].  Further 
data also available in abstract form only, demonstrated no significant differences 
between groups for the primary outcomes of improvement in peak oxygen 
consumption (15.3% vs 17.7% for control and treatment respectively) and 
anaerobic threshold (16.2% vs 13.9%) following a seven week supervised exercise 
programme [182].  However greater improvements were observed in treatment 
patients compared to controls for SF-36 PCS (8.0 vs 4.1 points, p=0.048) and MCS 
(10.6 vs 4.0 points, p=0.017), and also peak power output (47.7% vs 20.4%, 
p=0.024). 
 
A combined cognitive and physical intervention has shown greater improvements 
in patients in the intervention group for TUAG compared to control although these 
did not reach statistical significance (treatment effect -1.1, 95%CI (-4.1 to 2.0), 
p=0.051) [183].  In contrast to previous findings detailed above, balance scores did 
not differ between groups in this study at baseline or completion, albeit these were 
self-reported measures as opposed to results of objective assessment.  However, 
little detail of the physical component of the intervention was reported by Jackson 
et al [183] in order to interpret these findings further. 
 
Self-directed manuals have been investigated in two trials with contrasting results.  
Cuthbertson et al [184] demonstrated no significant improvement in physical (SF-
36 PCS, mean (SD) 42.0 (10.6)points vs. 40.8 (11.9)points, effect size 1.1 (95%CI -
1.9 to 4.2), p=0.46) or mental (SF-36 MCS, effect size 0.4 (-3.0 to 3.7), p=0.83) 
health-related quality of life, and furthermore that ICU follow-up was a more costly 
approach than standard care.  In contrast, Jones et al [178] observed significant 
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improvements in SF-36 PF domain (p=0.006, raw values not reported) at 8 weeks 
and 6months following ICU discharge in intervention patients receiving a six-week 
rehabilitation manual incorporating physical, psychological and psychosocial 
advice.  Ensuring robust strategies are in place to promote and monitor adherence 
to self-directed programmes are vital for their effective use, and this could have 
attributed to these differing findings.      
 
Finally, in an uncontrolled observational cohort study of a six-session supervised 
cardiovascular training programme, significant improvements in exercise capacity 
(ISWT, from 278 (185-370) at baseline to 438 (370-510) at completion, p<0.001; 
6MWT, from 180 (100-280) at baseline to 340 (250-450) at completion, p<0.001) 
and anxiety (baseline, 8.2 (5.0-11.0)points to completion, 6.2 (4.0-8.8)points, 
p=0.001) and depression (baseline 7.2 (5.3-9.0) to completion 4.4 (2.0-6.5), 
p=0.001).  However the nature of study design employed by McWilliams et al [185] 
precludes determining the true effect of the intervention.   
 
A previous integrative review of post hospital discharge rehabilitation 
programmes for survivors of critical illness highlighted the variability in structure, 
content, type and format of delivery of physical interventions employed in trials 
[186].  This review included both published data available at the time, and trial 
registry and protocol sources of information in order to examine as wide a range of 
evidence to explore the characteristics of physical treatments under investigation.  
Building on the findings of that review, Table 1-3 and Table 1-4 present a 
comprehensive update on the current evidence base for studies investigating 
physical rehabilitation interventions delivered following hospital discharge in 
survivors of critical illness.  A number of important factors related to features of 
exercise-based post hospital discharge rehabilitation interventions are highlighted. 
 
Timing of intervention delivery 
 
In the chronic obstructive pulmonary disease patient population, early pulmonary 
rehabilitation delivered one week following acute exacerbation is both safe and 
effective, with fewer hospital attendances [187] and improvements in exercise 
capacity and health status [188] observed.  Adopting a similar approach for the 
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post critical illness population would seem appropriate.  In those studies where 
the time-frame for commencing post hospital discharge interventions are 
specified, this ranges from one week [180], two weeks [177, 189] and up to four 
months [179].  In many cases the rehabilitation programme commences during the 
in-patient stay [177, 178, 184, 190], representing a seamless continuation of the 
programme at the post hospital discharge stage.  In addition this has the potential 
to maximise benefit and adherence if patients are familiar and already engaged 
with the rehabilitation process, and the staff involved.  A protracted delay in 
baseline assessment and initiation of post hospital discharge exercise 
interventions could reduce any potential effect size from natural recovery 
occurring in the interim period.  Trials investigating interventions at this stage of 
the patient pathway should accurately monitor the trajectory of recovery from the 
point of hospital discharge up until the intervention is commenced.  This, in 
combination with a control arm, will facilitate determining the real effect of any 




Variability in detail reported by studies limits this area and a range of exercise 
components are included.  Cardiovascular aerobic exercise is the most commonly 
reported feature of post hospital discharge exercise-based rehabilitation 
programmes [177, 179, 180, 185, 189, 191, 192] including activities such as 
treadmill walking, ground walking and cycling.  Initial exercise prescription is 
based on results of walking tests or cycle ergometry, and target exercise intensities 
incorporate use of perceived rate of exertion scales or physiological parameters 
such as heart rate reserve or oxygen consumption.  The Borg score, aiming to 
achieve levels of moderate exertion, is commonly utilised [177, 179, 180, 185, 
189], although it has not been demonstrated that this level of exertion confers 
benefit to physical, functional or health-related quality of life outcomes.  For those 
studies that include unsupervised exercise sessions, use of measures such as the 
Borg score and heart rate can be taught to patients to ensure this exercise is both 
safe and at a suitable level of intensity.  Progression of cardiovascular exercise is 
based on reassessment of similar measures, although as patients progress in 
ability, use of functional tests could also be of value.   
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Strength exercises are included in a number of programmes, commonly using the 
repetition maximum principle to guide initial prescription and subsequent 
progression of weights used [177, 180, 189, 191].  Where functional activities are 
employed, [177, 183, 189], such as sit-to-stand or transfers, it is important that 
these are standardised and clearly described to ensure objectivity and 
reproducibility with regard interpreting their potential effect. 
 
Structure and format 
 
Supervised, hospital-based, outpatient programmes are the most common style of 
rehabilitation programme.  Sessions vary between once and twice-weekly, ranging 
40-60minutes of exercise, with programmes typically between six to eight weeks 
duration (Table 1-3).  Supervising exercise sessions allows clinicians to ensure 
patients are exercising safely and correctly, and that exercises can be progressed 
as soon as necessary.  In addition some patients may benefit from the 
psychological support of peers.  Data from the field of pulmonary rehabilitation 
suggests enhanced clinical and patient-centred outcomes as a result of supervised 
sessions [193].  However such a format may not be feasible for those patients 
whose geographical area of residency precludes repeated visits to the hospital, or 
for those who prefer not to exercise in a group setting.  Nonetheless unsupervised 
home-based programmes rely wholly on patient engagement and motivation for 
adherence, and reliance on them to correctly learn and carry out the specific 
exercises.  An in-depth and detailed training package would therefore be a 
prerequisite, as well as regular telephone contact to review patient progress and 
manage any queries arising throughout the programme.  It is acknowledged that 
documentation in home exercise diaries can be variable, and therefore use of 
pedometers or accelerometers could be used to supplement these records, and 
provide structured and objective feedback for patients regarding levels of exercise. 
 
Evaluation of intervention effectiveness 
 
There is currently no consensus on which outcomes should be used to evaluate 
effectiveness of exercise-based rehabilitation programmes at any stage of the 
patient pathway.  Studies investigating the post hospital discharge stage of 
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recovery utilise a range of physiological, clinical, patient and healthcare utilisation 
outcomes, with outcome measures including oxygen consumption and anaerobic 
threshold, exercise capacity, physical and mental health-related quality of life, 
physical activity, return to work and cost effectiveness (Table 1-4).  In the future, 
development of a core set of outcomes for evaluation of interventional trials of 
post critical illness rehabilitation would facilitate protocol standardisation and 
comparison of results.    
 
The current state of the evidence base for post hospital discharge rehabilitation for 
survivors of critical illness highlights the lack of conclusive data on the optimum 
timing, dose and format of delivery of such interventions.  Acknowledgment that 
patients continue to experience physical functional deficits for up to five years 
following the index critical illness [105], highlights the need for a longitudinal 
approach to the management of post critical illness disability [194].  Future 
research must focus on post hospital discharge exercise therapy and rehabilitation 
interventions that are delivered at various time points following hospital discharge 
according to the trajectory of recovery of the individual patient [130], as this 
approach could demonstrate enhanced benefit by addressing the heterogeneity of 










Structure/format Exercise component Participant contact 
Batterham et al, 2014 
[179, 195] 
 













Aerobic exercise (cycle 
ergometry) 
 
Exercise intensity target level 
12-14 on the 20point Borg 





40minutes brisk walk) 
Minimum 2 supervised 
sessions per week at 
outpatient classes 
Usual care 
Denehy et al, 2013*  
[177, 196] 
 







Hospital outpatient and 
home-based, 
commencing within 
2weeks post hospital 
discharge 
 
60minutes, twice weekly 
for 8weeks 
 
Completion defined as 
attending >70% (>11 





resistance strength training 
and functional exercise; 
unsupervised home walking 
programme once weekly 
 
Prescribed from pre-
outpatient 6MWT, cycle 
ergometer, 5RM 
 
Intensity of 4-6 on modified 
Borg Scale, and commenced at 
70% peak walking speed 
Minimum 2 supervised 
sessions per week at 
outpatient classes 
Usual care (no outpatient 
exercise classes) 
 
Transfer to rehabilitation 
facility if deemed 
necessary by ward 
physiotherapist involved 







Battle et al, 2013       
[181, 191] 
 
Published data in 









Up to 60minutes, twice-
weekly for 6weeks 
Cardiovascular (treadmill, 
cycle ergometer, rowing 
machine, stepper), balance 
and strengthening exercises 
Minimum 2 supervised 
sessions per week at 
outpatient classes 
No treatment 
Connolly et al, 2013 
[189, 197] 
 
Published data in 








within two weeks of 
hospital discharge 
 
Up to 40mins, twice-
weekly for 16 sessions 
Cardiovascular (treadmill, 
static cycle, walking), 
strength, balance and 
function; unsupervised home 
exercise programme once 
weekly 
Minimum 2 supervised 
sessions per week at 
outpatient classes 
Once weekly telephone 
call 
McWilliams et al, 2013 
[182] 
 








Seven week exercise and 
education programme 
Not detailed Not detailed No intervention 
Jackson et al, 2012 [183] 
 








physical and functional 
rehabilitation for 
12weeks 
Lower extremity function and 
endurance (e.g. chair stands, 




according to patient ability 
 
Exercise prescriptions 
individually tailored according 
to functional status 
 
Unsupervised independent 
home exercise programme 
12 visits, six face-to-face, 





after hospital discharge as 








Elliott et al, 2011      
[180, 198] 
 











up to 5 sessions/week 
unsupervised, for 8 
weeks 
Graded, individualised 
programme of walking, upper 
and lower limb strengthening, 
core stabilisation, flexibility 
and stretches 
 
Exercise manual accompanied 
exercise advice, focus on 
endurance and strength 
training 
 
Exercise intensity determined 
using 6MWT distance and 
Borg score; exercise 
prescription based on results 
of 6MWT, 8RM 
3 home visits with 
supervised sessions 60-




care e.g. visits to general 
practitioner 
O’Neill et al, 2011 [192] 
 












home exercise programme 
accompanied by a written 
exercise manual 
Minimum 2 supervised 
sessions per week at 
outpatient classes 
Standard care 
Griffiths et al, 2010*  
 








based, commencing in 
hospital on the ward 
 
60minutes, once-weekly, 
duration of programme 




Two unsupervised home 
exercise sessions 
Minimum 1 supervised 




combinations of a dietary 
supplement, enhanced PT 
programme, ICU recovery 
manual and placebo 
nutritional supplement 








Clinic appointments at 
3m and 9m 
No intensive care follow-












in hospital on the ward 
 
Three month programme 
Individualised, self-directed 
following review by 
physiotherapist 
discharge 
McWilliams et al, 2009 
[185] 
 






based, commencing up to 
3 weeks post hospital 
discharge 
 
Up to 20mins, once 
weekly for six weeks 
 
Exercise and education 
(1hr session) 
Cardiovascular exercise 
involving all major muscle 
groups with periods of active 
recovery 
 
Four different exercise 
intensity levels determined by 
varying ration of exercise to 
active recovery, to achieve 
target Borg scores (3-4) and 
heart rate reserve (50-60% 
for high risk patients, 60-70% 
for low risk patients) 
 
Two unsupervised home 
exercise sessions 
Minimum of one 
supervised session per 
week at outpatient class 
Not applicable 
Jones et al, 2003* [178] 
 










and psychosocial advice; 
duration of programme 




Individually tailored to 
patients 
 
Three phone calls during 
intervention period 
Routine ICU follow-up 
(contact by telephone on 
three occasions post 
hospital discharge, and 2 
attendances at dedicated 
ICU follow-up clinic at 
8weeks and 6m) 
*Study involves rehabilitation intervention commencing prior to hospital discharge.  Only information relevant to post hospital discharge stage of delivery presented.   
 







Table 1-4 Outcome measure, assessment and results of post hospital discharge rehabilitation programmes 
 
Study Outcomes/outcome measures Assessments Results 
Batterham et al, 
2014  
 
Published data and 
trial registration  
Fitness – anaerobic threshold, mlO2/kg/minute 
(primary) 
 
Quality of life – SF-36, EQ-5D (primary) 
 
Time to return to work 
Mental health – HADS 
Habitual physical activity  




Small benefit from the intervention for AT of 1.8 (95%CI 0.4-
3.2)mlO2/kg/min at week 9, not sustained at week 26.  Possible 
beneficial effect on SF-36 physical function (3.4, (95%CI -1.4 to 
8.2)points) domain at week 9, and mental health domain at week 
26 (4.4 (95%CI -2.4 to 11.2)points) 
Denehy et al, 2013* 
[177, 196] 
 
Published data in 
full, and protocol 
Physical function – 6MWT (primary) TUAG, PFIT 
 
Patient-reported – SF-36, AQoL 
Baseline, ICU discharge, 
3m, 6m, 12m post ICU 
discharge 
No significant difference between groups at hospital discharge, 3m, 
6m, and 12m post ICU discharge, for 6MWT, TUAG, or PFIT.  Rate of 
change over time and mean between-group differences in 6MWT 
from first assessment greater in the intervention group up to 3m 
 
No between-group differences in AQoL or SF-36 v2 domains at any 
time point 
Battle et al, 2013 
[181, 191] 
 
Published data in 
abstract form, and 
trial registration 
Cardiopulmonary fitness – 6MWT (primary) 
 
Balance – Berg Balance Score 
Grip strength – handgrip dynamometry 
Anxiety and depression - HADS 
Baseline, 7 weeks, 6m 
and 1 year 
Preliminary results; significantly greater improvements in 
cardiopulmonary fitness (p<0.001) and balance (p<0.05) in the 
exercise group (n=10) compared to control (n=10) at 7weeks; 
Numerically, but not statistically significant, greater improvements 
in anxiety, depression and grip strength 
Connolly et al, 
2013 [189, 197] 
 
Published data in 
abstract form, and 
trial registration 
Exercise capacity – ISWT, 6MWT 
HRQL – SF-36, HADS 
Physical function – TUAG, STS-5, Barthel scale 




(3months post hospital 
discharge) 
No significant difference between control and intervention for any 
outcome; both groups demonstrating improvements beyond 







McWilliams et al, 
2013 [182] 
 
Published data in 
abstract form 
CPET – peak oxygen consumption (VO2) and 
anaerobic threshold (primary) 
 
HRQL – SF-36  
CPET – other parameters 
Hospital discharge 
(24±13days) and at 8-
10weeks  
No significant difference between groups in improvements in peak 
VO2 (15.3% vs 17.7% for control and treatment) and anaerobic 
threshold (16.2% vs 13.9%); significantly greater improvements in 
treatment than control groups for SF-36 PCS (8.0 vs 4.1, p=0.048), 
and MCS (10.6 vs 4.0, p=0.017) 
 
Improved peak power output also evident in treatment vs control 
groups (47.7% vs 20.4%, p=0.024)  
Jackson et al, 2012# 
[183] 
 
Published data in 
full 
Cognitive function – TOWER  (primary) 
 
Physical function – TUAG (primary) 
 
Cognition – MMSE, DQ 
Physical function – ABC scale 
Daily function – FAQ, Katz ADL Scale 
Hospital discharge 
(baseline) and 3m 
Greater improvement in intervention group for TUAG compared to 
control, although non-significant.  Self-efficacy scores of ABC did 
not differ between groups  
Elliott et al, 2011 
[180, 198] 
 
Published data in 
full, and protocol 
Physical function – SF-36 PF domain 
 
HRQL – SF-36 other components 
Exercise capacity – 6MWT 
Baseline (one week post 
hospital discharge), 8 
weeks and 26weeks 
Both control and intervention groups demonstrated significant and 
clinically important improvements in SF-36 v2 PF scores and 
6MWT distance at 8weeks, which continued to 26weeks.  No 
significant group effects or group by time interactions.    





Physical function – SF-36 PF domain (primary) 
 
Physical function – RMI 
Hand function – handgrip dynamometry, NHPT 
Exercise capacity – ISWT 
HRQL – FLP, SF-36, HADS 
Self-efficacy – ‘Readiness to change’ questionnaire, 
CDSE Scale, EQ-5D 
Breathlessness – MRC Dyspnoea 
Healthcare utilisation  












Exercise capacity – 6MWT (primary, at 3m) 
 
Insulin resistance – improved levels (at 1yr) 
HRQL – not specified (at 1yr)) 
Muscle mass and bone density – DEXA scanning (at 
1yr) 
Baseline, 3m and 1yr  Not available 
Cuthbertson et al, 
2009 [184, 199] 
 
Published data in 
full, and protocol 
HRQL – SF-36 PCS and MCS (at 12m, primary) 
 
HRQL – SF-36 (at 6m) 
QALYs – EQ-5D 
PTSD symptoms – DTS 
Anxiety and depression – HADS 
Healthcare utilisation and patient satisfaction 
Baseline, 6m and 12m No significant difference in SF-36 PCS or MCS, or any secondary 
outcomes, between control and intervention groups at 12m.   
 
Intervention significantly more costly 
McWilliams et al, 
2009 [185] 
 
Published data in 
full 
Exercise capacity – ISWT and 6MWT (primary) 
 
Anxiety and depression - HADS 
One week pre- and post-
intervention 
Significant improvements in exercise capacity (ISWT median 
change 160m, p<0.001, 6MWT median 160m, p<0.001) and anxiety 
and depression (p=0.001) 
Jones et al, 2003* 
[178] 
 
Published data in 
full 
Depression and anxiety – HADS 
Phobic symptoms – Fear Index 
PTSD symptoms – Impacts of Events Scale 
HRQL – SF-36 physical function 
Baseline, 8weeks and 6m 
post ICU discharge 
Significant improvements in SF-36 physical function in intervention 
group compared to control at 8weeks and 6m (p=0.006), with a 
trend towards lower rates of depression at 8weeks (12% vs. 25%) 
 
No difference between groups in anxiety or PTSD symptoms 
*Study involves rehabilitation intervention commencing prior to hospital discharge.  Only information relevant to post hospital discharge stage of delivery presented.  #Data for physical function only presented.    
 
Abbreviations: 6MWT = Six Minute Walk Test.  TUAG = Timed Up And Go.  PFIT = Physical Function in ICU Test.  SF-36 = Short-Form 36 v2 questionnaire.  AQoL = Assessment of Quality of Life.  ICU = intensive care unit.  
HADS =Hospital Anxiety and Depression Scale.  ISWT = Incremental Shuttle Walk Test.  HRQL = health-related quality of life.  STS-5 = Sit to Stand x5.  EQ-5D = European Quality of Life-5Dimensions.  CPET = 
cardiopulmonary exercise testing.  PCS = Physical Component Score.  MCS = Mental Component Score.  TOWER = Delis-Kaplan Tower Test.  MMSE = mini-mental state evaluation.  DQ = Dysexecutive questionnaire.  ABC = 
Activities Balance and Confidence scale.  FAQ = Functional Activities Questionnaire.  ADL = Activities of Daily Living.  PF = Physical Function.  RMI = Rivermead Mobility Index.  NHPT = Nine Hole Peg Test.  FLP = Functional 
Limitations Profile.  CDSE = Chronic Disease Self-Efficacy scale.  MRC = Medical Research Council.  DEXA = dual energy x-ray absorptiometry.  QALYs = quality adjusted life years.  PTSD = post traumatic stress disorder.  DTS 







1.7.2 NICE Clinical Guideline CG83 
 
In 2009, the National Institute for Health and Care Excellence (NICE) published 
clinical guideline NICE CG83, ‘Rehabilitation after critical illness’ [136].  This 
document represented a significant landmark in the management of survivors of 
critical illness with ongoing impairment and disability, and served to promote the 
clinical and research agenda surrounding rehabilitation for post ICU patients.  
NICE CG83 outlined three stages of the patient pathway where rehabilitation was 
advocated for delivery in a structured and coordinated fashion by a 
multidisciplinary team.  Following comprehensive clinical assessment and 
identification of those patients ‘at risk’, rehabilitation commences in the ICU and 
continues following transfer to the ward and post hospital discharge.  The 
transition between stages should be marked by a seamless handover between 
clinicians responsible for patient management in the different environments, 
including verbal and documented summaries of progress to that stage and 
reappraisal of patient ability and individual goals.  Ideally a keyworker facilitates 
this process.  Specifically at the stage of hospital discharge, it is recommended that 
patients undergo a functional assessment of physical and non-physical dimensions 
and the impact on activities of daily living.  Ongoing rehabilitation needs are 
identified with referral into necessary follow-up and/or rehabilitation services.  
Following hospital discharge, at the 2-3month period, a review of the patient 
should re-evaluate progress against the earlier functional assessment and if 
recovery is suboptimal or there is evidence of new impairment, further referrals to 
rehabilitation services are advised.   
 
However, one significant limitation to NICE CG83 has been the lack of substantial 
evidence supporting physical interventions, or describing detail of optimal 
rehabilitation programmes to address impairment and outcome measures to use 
for evaluation.  For clinicians working with post critical illness patients on a daily 
basis, the ‘Who, What, Where, When and How’ questions required to clearly 
identify changes in practice remained unanswered.  Consequently, wider uptake 
and application of the guidelines in a standardised and comprehensive approach 




Two UK surveys have been conducted gauging adherence to NICE CG83.  In 2011, 
Appleton et al [200] targeted lead medical and physiotherapy clinicians at all ICUs 
across Scotland achieving a near complete response rate across both professions 
using a telephone survey.  Of these, only a minority had actually read the 
guidelines (14% and 30%, respectively), and of those that had only two-thirds 
considered them a useful document.  The authors found that few of the 
recommendations from NICE CG83 were being adopted in Scottish ICUs, notably a 
consistent approach to the assessment of physical and psychological morbidity, 
delivery of active physical rehabilitation strategies whilst patients are in the ICU, 
and limited provision of assessment or therapy to address ongoing impairment 
beyond ICU discharge.  However, this survey lacks generalisablity of findings 
through data acquisition in one region only, and furthermore content of the survey 
emphasised practice within the ICU with little examination of ward-based or post 
hospital discharge stages of care.   
 
More recently, Berry et al [201] systematically examined all recommendations 
from NICE CG83.  Questionnaires were distributed across a number of UK critical 
care networks and completed by ICU nursing staff.  Greatest adherence to 
recommended practice was evident during the ICU stay, with just over half of all 
units surveyed compliant with implementation.  However further examination of 
individual components revealed that the lowest level of uptake related to 
comprehensive clinical patient assessment and goal-setting.  From ICU discharge 
onwards, levels of adherence overall declined with the lowest evident at the post 
hospital discharge.  Often the recommendations in greatest effect were those 
regarding information-giving, either during handover of care between clinicians or 
involving communication with families.  Least operational were recommendations 
that related to the actual delivery of rehabilitation interventions.  Notably at all 
stages, a proportion of respondents indicated that they had no action plan in place 
to address non-compliance.  Whilst causes for this were not specifically explored, 
one potential reason could be the lack of usefulness of the guidelines reported by 
Appleton et al [200].  Only one third of respondents indicated review and 
functional reassessment for patients at 2-3months post hospital discharge with 
few follow-up services available, which were mainly nurse-led, not formally 
commissioned or evaluated, and funded mainly from ICU budgets. 
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Whilst offering a comprehensive review of the individual recommendations 
pertaining to each stage of the patient pathway, there are also limitations to this 
survey.  Data collection was significantly restricted, with a 60% response rate from 
an overall cohort of ICUs that excluded key regional areas.  Missing data further 
limited analyses, and it was not clear whether respondents were in clinical roles 
that would give them sufficient insight to respond appropriately. 
 
Nonetheless, these two surveys highlight the inconsistent application of NICE CG83 
in the clinical setting, particularly at the post hospital stage.  However, a more 
comprehensive survey of practice across the UK may provide a more accurate 
picture of NICE CG83 guideline implementation.  Furthermore, given the low 
adherence reported to date, a more detailed exploration of the barriers that exist 
to service provision would also provide valuable data for considering strategies to 
optimise wider adherence.  With regard to the delivery of exercise-based 
interventions to address physical functional deficits, detailed surveys targeted at 
relevant members of the multidisciplinary team who are able to provide the most 




This comprehensive literature review has summarised the background behind the 
studies undertaken in this thesis.  There are limitations to the current forms of 
volitional manual muscle testing used to assess ICU-AW, in particular the MRC-SS, 
and as a clinical diagnostic tool there are currently no data reporting test 
characteristics in terms of inter-rater reliability and clinical outcome, which are 
essential facets of this test that must be investigated.  However, ultrasound is a 
useful non-volitional technique that is developing an increased profile for 
assessing a variety of peripheral skeletal muscle architecture parameters, and for 
which there is evidence for its use in monitoring the trajectory of muscle wasting 
during critical illness.  Despite this, further work comparing the anatomical and 
physiological cross-sectional area of rectus femoris is required and indeed 
required to confirm its relationship with peripheral skeletal muscle force which 
would validate its use a surrogate measure.  Exercise-based rehabilitation has been 
advocated to address the ongoing physical functional impairment resulting from 
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ICU-AW throughout the patient pathway from ICU admission to hospital discharge 
and beyond.  Specifically, hospital discharge marks the transition of clinical 
management from hospital to the community at which point follow-up of post 
critical care patients and rehabilitation for such patients may become more 
inconsistent with limited available services.  There are limited data that have 
investigated the barriers to delivery of rehabilitation at this stage and little is 
known of the optimum structure of a post hospital discharge exercise-based 
rehabilitation programmes.  Establishing an evidence-base for an exercise and 
rehabilitation intervention at this stage of recovery would be beneficial for not 
only enhancing patient management but also would be clinically useful in 
informing specialist national guidance. 
 
1.9 Aims of thesis 
 
The overarching research framework of this thesis was to (1) investigate the 
clinical predictive value of peripheral skeletal muscle weakness in critically ill 
patients within the ICU measured with volitional techniques (2) establish the 
clinical validity of measuring physiological rectus femoris cross-sectional area (3) 
investigate the clinical usefulness of ultrasound as a non-invasive method to assess 
muscle wasting (4) investigate the effect exercise-based rehabilitation following 
critical illness on clinical outcome and (5) determine the barriers to delivery of 
exercise-based rehabilitation in the post hospital discharge stage of recovery.  This 
work has been based on the relationship between peripheral skeletal muscle 
wasting and weakness that occurs as a consequence of critical illness and the goal 
to promote physical activity to enhance skeletal muscle function by embedding 





                                         
Figure 1-4 Overarching research framework   
 
Study One (Chapter 3) aimed to (1) determine inter-observer agreement for the 
Medical Research Council-Sum Score for critically ill patients whilst in the ICU, 
against simulated weakness presentations and (2) investigate the clinical 
predictive value of Medical Research Council sum-score in critically ill patients 
whilst in the ICU. 
 
Study Two (Chapters 4 and 5) aimed to establish the clinical validity of measuring 
physiological rectus femoris cross-sectional area as a marker of muscle force 
production as well as assessing the clinical usefulness of ultrasound in the 
assessment of peripheral skeletal muscle architecture during critical illness. 
 
Study Three (Chapter 6) investigated the effect of exercise-based rehabilitation 
following hospital discharge in survivors of critical illness with ICU-AW.  
Embedded in this study was an observational cohort study to assess the trajectory 
of recovery in patients without ICU-AW.   
 
Study Four (Chapter 7) aimed to determine the prevalence, delivery and barriers 
to establishing post hospital discharge follow-up and rehabilitation services across 












































2.1 Ethical approval 
 
The studies reported in this thesis were approved by London Westminster 
Research Ethics Committee (formerly St.Thomas’ Hospital Research Ethics 
Committee), REC study code 09/H0802/80.  Site-specific approval for the studies 
to be performed was granted by the Research & Development Departments of 
St.Thomas’ Hospital, London (study registration code RJ1 09/N153) and King’s 
College Hospital, London (study registration code KCH 1412).  All participants gave 




Post critical illness patients involved in these studies were recruited from the 
General Intensive Care Units and High Dependency Units of St.Thomas’ Hospital, 
and King’s College Hospital, London.  Healthy subjects were recruited from 
hospital and research staff at both sites, their relatives, and from a registered bank 
of healthy volunteers with prior experience of participating in clinical studies at 
both sites.  All participants received information leaflets regarding the relevant 
study to read thoroughly prior to consenting.  A copy of the consent form was 
given to all participants. 
 
2.3 Assessment of intensive care unit-acquired weakness 
 
Intensive care unit-acquired weakness (ICU-AW) was assessed using the Medical 
Research Council sum-score (MRC-SS) [35].  A measure of global peripheral 
skeletal muscle strength, six functional upper and lower limb muscle groups are 
assessed bilaterally using the MRC scale ranging from 0 (no contraction) to 5 
(normal power) [34] (Table 2-1).  Total scores range from 0 (paralysis) to 60 
(complete/normal strength).  Measurements were performed in either supine or 
seated positions, following a standardised protocol for each assessment position 
(Appendix I).  An MRC-SS of less than 48 out of 60 was considered diagnostic of 





Table 2-1 Medical Research Council sum-score 
 
Muscle Groups Assessed Medical Research Council Strength Grade 
Shoulder abduction 0 – no visible contraction 
Elbow flexion 1 – visible contraction but no limb movement 
Wrist extension 2 – active movement with gravity eliminated 
Hip flexion 3 – active movement against gravity 
Knee extension 4 – active movement against gravity and 
resistance 
Ankle dorsiflexion 5 – active movement against full 
resistance/normal power 
 
2.4 Measures of exercise capacity 
 
The gold standard measurement of exercise capacity typically involves use of 
laboratory-based incremental tests e.g. cycle or treadmill ergometry to achieve 
maximum performance [202].  However, in the clinical context of rehabilitation 
programmes, where access to equipment and resources may be more limited, 
simple field-based exercise tests such as the Incremental Shuttle Walk Test (ISWT) 
and Six Minute Walk Test (6MWT) can be used to assess exercise capacity [203, 
204]. 
 
2.4.1 Incremental Shuttle Walk Test 
 
The ISWT is an externally-paced exercise test during which subjects achieve a 
symptom-limited maximum performance [205] allowing objective measurement of 
exercise capacity.  Standardised, pre-recorded instructions are given (Glenfield 
Hospital, Leicester, UK).  Subjects walk up and down a 10m course (shuttle), 
located in a quiet, flat area and marked out by two cones inset 0.5m from the end 






Figure 2-1 Outline of Incremental Shuttle Walk Test course 
 
Reproduced with permission from Alison J et al, The Pulmonary Rehabilitation Toolkit on behalf of The 
Australian Lung Foundation (2009) [206])  
 
Walking pace is dictated by a pre-set audio signal on a pre-recorded disc (Glenfield 
Hospital, Leicester, UK) played on a conventional CD player.  As the test progresses 
through each level, beep signals quicken requiring the subject to walk at 
progressively quicker speeds to reach the end of each shuttle in time.  There are 
twelve levels in total, with an increasing number of shuttles to complete in each.  
Initial walking speed for Level 1 is 0.5m/s increasing by 0.17m/s at each level.  
Subjects completing a shuttle prior to the beep signal were instructed to wait until 
the beep signalled again before proceeding with the next shuttle.  Standardised 
pre-test advice and verbal prompts were given to increase speed if the subject was 
more than 0.5m away from the cone when the beep sounded, and to increase 
walking pace slightly at the start of each new level. Number of shuttles completed 
by each subject was totalled.  Use of mobility aids and supplemental oxygen were 
recorded. 
 
Blood pressure was measured prior to commencing the test.  Fingertip heart rate 
(HR) and oxygen saturation (SpO2) were recorded prior to and during the test 
using a pulse oximeter (Nonin Onyx®9500 Fingertip Pulse OximeterTM, Nonin 
Medical Inc, Plymouth, MN, USA).  This is a small, lightweight, portable, 
commercially available device, accurate in measuring SpO2 (range 70-100%) and 
HR (range 20-250bpm) in accordance with International Organisation for 
Standardisation guidelines (ISO 9919:2005, Standard Specification for Pulse 
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Oximeters for Accuracy) (Nonin Onyx®9500 Instructions for Use, ©2006), and 
which meets international standards for measurement of pulse oximetry during 
exercise testing [202]. 
 
Breathlessness was quantified prior to and on completion of the test using the 
Modified Borg scale (MBS) and a visual analogue scale (VAS).  The MBS is based on 
an original scale rating perceived exertion developed by Borg [207] and is a 
reliable and valid tool for measuring breathlessness in respiratory disease [208].  
Subjects are asked to rate their perceived levels of breathlessness on a scale 
ranging from a minimum of 0 (no breathlessness) to 10 (maximal breathlessness).  
These same two reference points were used on a VAS to rate subjects’ perceived 
levels of breathlessness.  Symptoms of leg fatigue were similarly assessed using the 
MBS and a VAS, with 0 indicating no leg fatigue, discomfort or tiredness and 10 
being the maximum experience of these symptoms.  
 
Termination of the ISWT occurred if the subject completed all shuttles at each level 
of the test, or conversely became unable to maintain the required pace necessary 
to complete each shuttle (reflected in a reaching a distance more than 0.5m away 
from the cone when the beep signalled) [205].  The test could also be terminated 
by the subject if they became too breathless to continue, and/or the investigator if 
cardiopulmonary or other systemic symptoms manifested e.g. 85% maximum 
heart rate achieved, persistent desaturation [205, 206].  At the end of the test SpO2 
and HR were monitored during a two minute recovery period, and total number of 
shuttles completed was recorded. 
 
An initial practice test was undertaken at baseline for familiarisation purposes and 
to account for a learning effect.  Tests were separated by a minimum of 30minutes, 
and the best result of the two was recorded [206].  A minimum clinically important 
difference (MCID) for the ISWT has been reported as 47.5m [209], albeit derived 
from patients with chronic obstructive pulmonary disease, and the test is valid as a 
measure of functional capacity, correlating strongly with performance during a 





2.4.2 Six Minute Walking Test 
 
The Six Minute Walking Test (6MWT) is a self-paced, sub-maximal walking test 
[211, 212].  Subjects mobilise as far as possible at their own pace, for six minutes 
along a pre-determined 10m course (marked out with two cones each inset 0.5m 
from each end) without running or jogging.  Standardised pre-test instruction is 
given and subjects are informed as each minute of the test passes [212]. 
 
Breathlessness and leg fatigue were measured prior to and on completion of the 
test using Borg and VAS scores as previously described.  Blood pressure was 
measured at the beginning of the test.  HR and SpO2 were measured at the start of 
the test, at each minute interval during the test, and on completion using a pulse 
oximeter (as per the ISWT).  Rest periods during the six minute period are allowed 
and recorded.  The test concludes at the end of six minutes.  However, as with the 
ISWT, the test can be terminated at an earlier time by either the subject or the 
investigator with reasons for early termination noted.  Total distance walked at the 
end of six minutes was calculated.  Use of mobility aids and supplemental oxygen 
were permitted and documented.  Previous reports have identified an MCID for the 
6MWT as 54m [213].  Recently this has reduced to 35m [214], and 25m [215]. 
 
2.4.3 Difference between ISWT and 6MWT 
 
Whilst the ISWT can replicate maximal performance that may potentially be 
achieved under laboratory conditions [210], as a self-paced, sub-maximal field test 
the 6MWT can be considered useful for measuring functional walking capacity that 
may be evident during the course of daily activity [211].  Predicted 6MWT 
distances for healthy adults can be calculated from reference equations [216, 217], 
and a distance of <350m has been shown to be predictive of mortality in the 







2.5 Measures of health-related quality of life 
 
2.5.1 Short-Form 36 version 2 questionnaire  
 
The Short-Form 36 version 2 questionnaire (SF-36) surveys multiple aspects of 
health-related quality of life (HRQL) [219] (Appendix II).  Individual items 
incorporated in questions are collapsed down into eight scales or domains 
(Physical Functioning, Role-Physical, Bodily Pain, General Health, Vitality, Social 
Functioning, Role-Emotional, Mental Health) which are further summarised in two 
component measures of Physical and Mental Component Scores [219].  The 
questionnaire is either self-completed by patients or administered by the 
researcher.  Higher scores indicate greater levels of quality of life.  In the studies 
reported in this thesis, the ‘Acute Recall’ version of the SF-36 questionnaire was 
employed.  In this version, the symptom recall period respondents are asked to 
consider is reduced to one week, compared to four weeks adopted in the ‘Standard’ 
version of the tool.  The rationale for this recall period is an enhanced sensitivity to 
recent changes in health status [220], and which was therefore considered more 
applicable to the acute post critical illness patient population.      
 
The SF-36 has been used widely in differing patient groups, and normal values for 
age, gender and a number chronic diseases have been determined [219, 221].  In 
the ICU population, the SF-36 has been shown to be an acceptable tool for 
measuring HRQL, demonstrating reliability, content validity, and responsiveness to 
change [222-224].  A five point difference in score is considered to be clinically 
meaningful [219].  Furthermore a change of 10 points in the physical function 
domain is considered reflective of significant clinical improvement in this measure 
in critically ill patients [225], and this has been shown to be the MCID for patients 
with chronic respiratory conditions [226, 227].  However MCID values for each 
domain of the SF-36, and each component score have yet to be determined for the 







2.5.2 Hospital Anxiety and Depression Scale  
 
The Hospital Anxiety and Depression scale (HADS) [228] comprises fourteen 
questions that detect symptoms of anxiety and depression (Appendix III).  The 
questionnaire can be self-completed or researcher-administered.  Total scores, and 
component anxiety and depression scores, can be obtained.  Higher scores indicate 
a worse level of HRQL.  In ICU survivors, the HADS has been shown to perform as 
well as other anxiety and depression scores for symptom detection [114]. 
 
2.6 Assessment of peripheral skeletal muscle strength 
 
In this thesis, the target peripheral skeletal muscle group was quadriceps femoris, 
and the target muscle was rectus femoris.  The rational for focussing on this 
muscle group was its functional importance in many activities such as standing, 
stepping and walking.  For this reason, the London Respiratory Muscle Group and 
King’s Health Partners Clinical Respiratory Physiology Group have developed 
extensive experience in the measurement of both quadriceps muscle strength, and 
rectus femoris cross-sectional area in both healthy subjects and a range of clinical 
conditions.   
 
2.6.1 Quadriceps maximum voluntary contraction and twitch tension 
 
Quadriceps strength was assessed using the technique of isometric maximum 
voluntary contraction (QMVC), and twitch tension (TwQ) following magnetic 
stimulation of the femoral nerve.  Equipment set-up was similar to the previous 
description of a strength-testing bench system [74] (Figure 2-2).  Subjects were 
positioned near supine on a purpose-built plinth that allowed the lower leg to be 
fixed at 90o knee flexion.  The ankle was placed in an inextensible strap 
approximately one inch above the lateral malleolus which was then connected to a 
strain gauge (Strainstall UK Ltd, Cowes, UK; range 0-100kg).  Position of the strain 
gauge strap parallel to the quadriceps was checked, and care was taken to avoid 
any slack in the strap between the strain gauge and the ankle.  Analogue force 
signals from the strain gauge were amplified using a Biomedical Amplifier Pclab-
3808 (Beijing Microsignal Technology Development Company Limited, China), 
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converted to digital using a 16s Powerlab® unit (ADInstruments Pty Ltd, Castle 
Hill, Australia) with processing and analysis by Chart™ software (Version 7.1, 
ADInstruments Pty Ltd).  A two-point calibration test (0kg and a known weight of 
24.6kg) was performed prior to each use of the equipment.  
 
Participants performed isometric contractions with standardised verbal 
encouragement until a minimum of three technically acceptable traces within 5% 
were obtained.  Values reported for QMVC were the highest mean tension recorded 
over a 1 second period.  All measures were taken from the right leg. 
 
Quadriceps twitch tension was measured adopting the method of Polkey et al [64].    
Unpotentiated twitches were obtained following 20minutes of rest to minimise 
twitch potentiation.  Twitch potentiation is a physiological phenomenon whereby 
the magnitude and duration of a preceding contraction can influence twitch 
response [78, 79].  With subjects positioned in the strength testing bench, femoral 
nerve stimulation was performed using a 70mm figure-of-eight coil (Magstim Co. 
Ltd, Whitland, UK) powered by a Magstim® 200 magnetic stimulator (Magstim Co. 





Figure 2-2 Quadriceps maximum voluntary contraction and twitch tension  
 
Sequence of images demonstrating subject set-up for quadriceps maximum voluntary contraction and 
operator application of femoral nerve stimulation for twitch tension.  From left to right: subject 
position in quadriceps bench, with operator position for application of femoral nerve stimulation; 




The femoral arterial pulse was palpated to facilitate initial placement of the coil 
head high in the femoral triangle immediately lateral to this point over the femoral 
nerve.  Further minor adjustments ensured optimum stimulation site, and supra-
maximality of the response was determined.  Supramaximal stimulation is 
required to ensure maximum force generation, and was achieved through 
stimulation at various power outputs (70%, 80%, 90%, 95%, 100%) of the 
magnetic stimulator in a random order such that further increases in stimulation 
intensity did not elicit further increases in twitch tension.  A graph of twitch 
tension against power output was then generated with supramaximality judged a 
twitch tension with less than 5% difference compared with the lower output 
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(Actual values: 70%=2.66kg.  80%=5.02kg.  90%=5.91kg.  95%=7.93kg.  100%=7.89) 
 
Figure 2-3 Magnet power output against quadriceps twitch tension 
 
Quadriceps twitch tension (TwQ) was recorded as the mean of 10 maximal 
responses at 100% of magnetic stimulator power output.  Brief rest periods 
between twitches minimised twitch-on-twitch potentiation.  The level of voluntary 
quadriceps activation was determined using the twitch interpolation measure 
[229, 230].  Superimposed twitches were applied during QMVC on direct 
observation of a plateau in force generation (Ts) and immediately after relaxation 
of the quadriceps (Tr) i.e. a potentiated twitch (Figure 2-4).  The Ts:Tr ratio, 
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expressed as a percentage, calculates the proportion of voluntary muscle 
activation. 
 
Voluntary activation (%) = (1–(Ts/Tr))*100 
 
A truly maximal voluntary activation elicits a superimposed twitch with an 
amplitude of zero i.e. no further tension generation, with a linear increase in twitch 
amplitude observed as intensity of voluntary contraction decreases [231].   
 
Magnetic stimulation has few reported side-effects but contraindications to its use 
include the presence of cardiac devices and/or metallic objects within the 




Surface electromyography (EMG) of the rectus femoris muscle was also measured 
to confirm supra-maximal femoral nerve stimulation (Figure 2-4).  The skin 
directly over the muscle belly was prepared using an abrasive gel (NuPrep, Weaver 
and Company, Aurora, USA) and then wiped clean with alcohol wipes.  Once dry, 
three electrodes (ECG electrodes, ARBO*, Tyco Healthcare, Germany) were sited.  
Two electrodes were positioned over the muscle belly and a third earthed 
electrode over the patella.  EMG signals were amplified using a Biomedical 
Amplifier Pclab-3808 (Beijing Microsignal Technology Development Company 
Limited, China) with a gain of 1000 and band-pass filtered between 10Hz and 
3kHz, then converted to digital using a 16s Powerlab® unit (ADInstruments Pty 
Ltd, Castle Hill, Australia) with subsequent processing and analysis performed on a 
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a) Traces of quadriceps maximum voluntary contraction (QMVC) and quadriceps 
surface electromyography (EMG) indicating superimposed and potentiated 
twitches 
b) Detail of superimposed twitch evident above level of QMVC (magnified trace) 
Figure 2-4 Traces obtained during quadriceps maximum voluntary contraction 
and magnetic stimulation of femoral nerve 
 
 
2.6.1.2 Linearity of the QMVC strain gauge 
 
Linearity of the strain gauge used in the assessment of QMVC was demonstrated 
using a pre-determined set of weights applied sequentially to the strain gauge.  
Values of absolute weight and corresponding strain gauge output were measured 
to determine a linear relationship.  The strain gauge was found to be linear across 
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Figure 2-5 Linearity of the quadriceps strain gauge 
 
2.6.1.3  Frequency response of the QMVC strain gauge  
 
Frequency response (Fr) of the strain gauge was measured by the immediate 
release of a known weight from the strain gauge.  The response time was the time 
taken for the force to reduce from 90% to 10%, and Fr determined using the 
equation below: 
 
Fr = 1/(3*response time) 
 
For the strain gauge used in this system, response time=0.03005ms resulting in 
Fr=11.09Hz, which is acceptable for measuring quadriceps twitch force in healthy 
humans and patients with disease. 
 
2.6.1.4 Reproducibility of TwQ and Tr measurements 
 
To ensure a standardised approach the reproducibility of TwQ and Tr 
measurements were determined through repeated assessments made by the same 
investigator (BC) on the same healthy subject on the same day.  Three 
measurements were taken that were separated by a minimum of 30 minutes.  
Table 2-2 reports the mean co-efficients of variation of 7.7% and 6.2% for TwQ 




Table 2-2 Reproducibility of quadriceps twitch tension and potentiated twitch 
measurements 
 
Subject Measurement   (kg) Occasion Mean SD CV (%) 
1 2 3 
1 TwQ 19.3 14.9 15.1 16.4 2.0 12.2 
 Tr 23.9 21.6 22.0 22.5 1.0 4.4 
2 TwQ 6.1 6.6 5.5 6.1 0.4 7.3 
 Tr 10.7 11.2 10.1 10.6 0.5 4.5 
3 TwQ 7.4 6.5 6.5 6.8 0.4 5.9 
 Tr 17.2 12.3 13.9 14.5 2.0 14.1 
4 TwQ 7.7 6.5 6.5 6.9 0.6 8.3 
 Tr 9.9 9.0 10.1 9.6 0.5 5.1 
5 TwQ 10.6 9.9 9.4 10.0 0.5 5.0 
 Tr 14.4 13.6 13.6 13.9 0.4 2.8 
Mean TwQ    9.2 0.8 7.7 
 Tr    14.2 0.8 6.2 
Abbreviations: TwQ = quadriceps twitch tension.  Tr = potentiated quadriceps twitch force.  SD = 
standard deviation.  CV = coefficient of variation 
 
2.6.2  Handgrip dynamometry 
 
Maximal isometric hand-grip force was measured using a hand dynamometer 
(Baseline, Fabrication Enterprises Incorporated, Irvington, NY, USA) (Figure 2-6).  
There are five handle positions on the dynamometer, and the handle was adjusted 
to the position that ensured that the proximal interphalangeal joints rested on the 
top.  Maximum grip strength has been found using position 2 [232].  Subjects were 
seated upright, with shoulders adducted and neutrally rotated, and elbows flexed 
to 90o unsupported and without touching the trunk [233].  The dominant side was 
tested [36].  Standardised encouragement was provided to subjects to exert 
maximal force on the dynamometer.  Five technically acceptable tests were 





      
Figure 2-6 Baseline dynamometer 
 
(L) side profile with different hand positions visible and set up for handgrip position 2.  (R) front 
profile with reading gauge visible 
 
Normal handgrip strength values for both left and right side, gender and across 
twelve age groups have been determined [44].  Handgrip dynamometry has been 
successfully performed in ICU patients where cut-off values of less than 11kg for 
males and less than 7kg for females, whilst well below age-matched and sex-
matched control values, have been reported to indicate ICU-AW [36].  Indeed 
handgrip strength has been shown to be independently associated with hospital 
mortality [36]. 
 
2.6.2.1 Linearity of the dynamometer 
 
Linearity of the dynamometer was demonstrated using a method outlined by Fess 
[234].  The dynamometer was fixed in a secure position allowing addition of 
progressively greater weights to be suspended from the device.  Readings were 
taken for each weight added, and the process repeated for each handle position 
(Position 1-5).  The dynamometer was found to be linear across the range 0-27.3kg 












































































































































Figure 2-7 Linearity of the Baseline dynamometer 
 
 
2.7 Assessment of peripheral skeletal muscle architecture 
 
2.7.1 Quadriceps rectus femoris cross-sectional area 
 
Cross-sectional area of the quadriceps rectus femoris muscle (RFCSA) was 
determined using real-time B-mode ultrasonography using an 8MHz 5.6cm linear 
transducer (PLM805, Toshiba Medical Systems Ltd, Crawley, UK) and a 5MHz 
curvilinear transducer (C60x, Sonosite S Series Ultrasound, Hitchin, UK) using a 
method similar to that reported by Seymour et al [73] and de Bruin et al [95].  
Distance from the anterior superior iliac spine (ASIS) to the superior patellar 
border was measured and two points marked on the thigh, at three-fifths of this 
distance and at two-thirds.  The transducer was placed perpendicular to the long 
axis of the thigh on the superior aspect, on the two marked points and images 
recorded at both these points.  Subjects were positioned semi-supine with the leg 
rested in passive extension.  Liberal application of ultrasound gel (Aquasonic 100, 
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Parker Laboratories, Fairfield, NJ, USA) facilitated image quality, and the author 
used visual feedback to obtain the smallest cross-sectional area in each image.  
Visualisation of the femur acted as a marker for scanning depth.   Subjects were 
instructed to gently contract and relax their quadriceps muscle to assist in 
discerning the muscle outline prior to image acquisition.  Care was taken to avoid 
application of excess pressure during scanning which would compress the 
underlying muscle [84].  The inner echogenic line of the rectus femoris was 
outlined to indicate RFCSA, which was calculated using either a planimetric 
technique online (Nemio™, Toshiba Medical Systems Ltd, Crawley, UK), or offline 
using relevant software (Image J, U.S. National Institutes of Health, Maryland USA, 
http://rsb.info.nih.gov/ij/) (Figure 2-8).  To facilitate this process a reference 
distance caliper was marked and saved on the frozen image.  RFCSA was taken as 
the average of three measurements within a maximum of 10%.  
 
2.7.2 Quadriceps rectus femoris pennation angle 
 
Rectus femoris pennation angle (RFPA) was also measured at both points i.e. three-
fifths and two-thirds distance between ASIS and superior patellar border, by 
placing the transducer parallel to the long axis of the thigh in the direction of 
muscle fibres in the mid-point of the marker line for each distance point.  Image 
acquisition occurred when individual muscle fibres of rectus femoris inserting into 
the muscle aponeurosis between rectus femoris and vastus intermedius were 
visible [93, 97, 99, 102] (Figure 2-8).  Offline software was used to calculate 
pennation angle (Image J, U.S. National Institutes of Health, Maryland USA, 
http://rsb.info.nih.gov/ij/) which was considered to be the angle between muscle 
fibre and aponeurosis [93].  
 
2.7.3 Reproducibility of ultrasound measurements 
 
Reproducibility of ultrasound measurements (RFCSA) was determined through 
repeated assessments taken on the same subject on the same day.  These data are 




      
 
Figure 2-8  Ultrasonographic images of rectus femoris muscle structure 
 
(A) RFCSA as indicated by blue outline of RF muscle, other structures also identified.  (B) RFPA where θ is 
the angle between insertion of muscle fibre into aponeurosis.  
 
Abbreviations: RF = rectus femoris.  VM = vastus medialis.  VI = vastus intermedius.  VL = vastus 
lateralis.  Θ = pennation angle. 
 
 
2.7.4 Calibration of online ultrasound measuring  
 
To confirm measurement accuracy of the online ultrasound measuring system 
(planimetric technique, Nemio™, Toshiba Medical Systems Ltd, Crawley, UK), an 
item of known dimensions was placed in a scan-able medium and measured.   
Figure 2-9  demonstrates the images gained from measurement of a 10ml Luer 
syringe with known diameter of 17.2mm (Terumo UK Ltd, Egham, UK), and 
circumference of 54mm (using circumference=   where d=17.2mm).  One image 
only is shown; in practice three were taken (53.4mm, 54.1mm, 53.9mm) with an 
average circumference of 53.8mm.  The average measured circumference shows a 






      
Figure 2-9  Ultrasound images of reference measurement item for calibration of 
ultrasound machine 
 
(L) unmeasured.  (R) measured with circumference outlined in blue 
 
 
2.7.5 Agreement between online and offline image measurement 
 
To determine the level of agreement between online (planimetric technique, 
Nemio™, Toshiba Medical Systems Ltd, Crawley, UK) and offline (Image J, U.S. 
National Institutes of Health, Maryland USA, http://rsb.info.nih.gov/ij/) ultrasound 
image measurement processes, results of 117 images of RFCSA measured using both 
systems were analysed.  Bland-Altman analysis, (Figure 2-10), demonstrated mean 
differences between the two modes of measurement (95% limits of agreement -7.5 
to 5.6mm2.mean (SD) bias -0.9 (3.3)mm2).  An ICC of 1.0 (95%CI, 1.0-1.0) was 
observed. 
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Figure 2-10 Bland Altman analysis of agreement between online and offline 





Fat-free mass was determined using bio-electrical impedance analysis (Bodystat® 
1500, Bodystat®, Isle of Man, UK).  Subjects rested in a semi-supine position for at 
least 5minutes prior to placement of four electrodes, one below the right second 
metacarpal head, a second adjacent to the right ulnar head, a third below the right 
first metatarsal head and a fourth between the level of the right medial and lateral 
malleoli.  Participants with electrical cardiac devices in situ were excluded from 
these measurements to avoid potential interference with electrical signals from 
these devices that could result in cardiac symptoms.    
 
The Bodystat® 1500 automatically internally self-calibrates with each 
measurement performed.  However periodic independent checks (physical re-
calibration can only be performed by the manufacturer) were also performed 
using the specific Bodystat® calibrator supplied with the device in keeping with 
the recommended procedure (Bodystat®).  On all occasions results were the same 
as those indicated by the manufacturer. 
 
2.9 Physical function 
 
2.9.1 Barthel Index 
 
The Barthel Index [235] is a scale rating ability across a range of personal and 
functional activities of daily living.  Higher scores indicate more independent 
performance and hence a higher level of functional ability.  The index is used 
commonly within hospital settings and across a range of patient groups.  
 
2.9.2 Timed Up and Go 
 
The Timed Up and Go test (TUAG) [236] measures the speed with which an 
individual can stand up from a chair, mobilise three metres and return to their 
seated position.  Assistance required to perform this manoeuvre e.g. mobility aid, 




2.9.3 Sit to Stand 5 
 
The Sit to Stand 5 times test (STS-5) [237] measures the speed at which an 
individual can stand up and sit down from the same chair five times, and the 
assistance required to do so e.g. ranging from use of arms of the chair, to standing 
completely independently with hands across chest.  
 
2.10 Statistical analysis 
 
Statistical analysis of the data were performed using GraphPad Prism version 6.00 
for Windows (GraphPad Software, La Jolla California USA, www.graphpad.com), 
and  IBM SPSS Statistics Data Editor version 19 for Windows (IBM, US).  Power 
calculations were performed using G*Power version 3.1.3 (Universitat Kiel, 
Germany) Data were tested for normality using D’Agostino and Pearson, and 
Shapiro-Wilk normality tests, and appropriate parametric or non-parametric 
analyses applied.  A p value of less than 0.05 was considered statistically 
significant.  A range of statistical analyses are used in this thesis and are discussed 































Chapter 3    Inter-observer agreement and clinical 
predictive value of the                                        


















Intensive care unit-acquired weakness (ICU-AW) [238] is the clinical term given to 
peripheral skeletal muscle wasting and dysfunction that develops as a 
consequence of critical illness, and which is a major factor contributing to both 
short- and long-term outcome in survivors [103-105, 194].  Furthermore ICU-AW, 
and the resulting physical and functional impairment, is a significant component of 
post intensive care syndrome [125].  The diagnosis of ICU-AW is based on a simple 
clinical ‘bedside’ examination involving volitional strength assessment in the form 
of manual muscle testing, most notably the Medical Research Council sum-score 
[35].  An MRC-SS of less than 48 out of a maximum of 60 is considered diagnostic of 
ICU-AW [5].  Although this volitional method of peripheral muscle strength 
assessment is appealing in the clinical setting as it is both simple and rapid to 
perform, and requires limited expert operator and technical input, there are a 
number of caveats to its use in the critically ill population.  Inability to perform the 
test or obtaining a low value may occur as a result of non-muscular factors such as 
impaired cognition, reduced conscious level and poor motivation.  Furthermore, 
the ordinal nature of grading muscle strength results in potential variability in 
both application of testing and interpretation of results between clinicians [52].  
These limitations have led to contrasting data for diagnosing ICU-AW within the 
ICU as well as variability in the inter-observer agreement of the MRC-SS in ICU 
patients with differing levels of weakness [38, 59, 60].   
 
Nonetheless ICU-AW based on MRC-SS assessment has a reported prevalence of up 
to 65%, with observational studies showing associations with prolonged weaning, 
delayed rehabilitation, increased hospital length of stay and increased mortality 
[11, 29, 30, 36, 37, 40-42].  However such observational cohort studies do not 
necessarily demonstrate a causal relationship, nor has the association between 
global peripheral skeletal muscle strength represented by the MRC-SS and physical 
function been examined.  Furthermore, as a diagnostic test there are currently no 
reported data examining the clinical predictive value and test characteristics of the 
MRC-SS for key outcomes such as length of stay and mortality.  The principles of 




3.1.1 Diagnostic test performance characteristics 
 
The clinical merit and utility of any diagnostic test for a disease or condition 
involving a binary classification, can be evaluated by determining its accuracy 
expressed in a number of different test characteristics, based on the ability of the 
test to correctly classify individuals according to their disease status or condition.  
Typically these properties can be expressed schematically in a 2x2 contingency 
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Figure 3-1 2x2 contingency table for determining diagnostic test characteristics 
for a condition or disease 
 
Abbreviations: TP = true positive.  FP = false positive.  FN = false negative.  TN = true negative.  PPV = 
positive predictive value.  NPV = negative predictive value.   
 
In Figure 3-1, the ‘true positives’ (TP) are those individuals correctly diagnosed 
with the disease or condition and correctly accepted by the test; ‘false positives’ 
(FP) are those healthy individuals incorrectly identified with the disease or 
condition and incorrectly accepted by the test (type I error); ‘true negatives’ (TN) 
are those individuals correctly identified without the disease or condition and 
correctly rejected by the test, and ‘false negatives’ (FN) are those individuals with 
the disease or condition incorrectly identified as without the disease or condition 
and incorrectly rejected by the test (type II error). 
 
Figure 3-2 outlines this concept for the current study, using the example of the 
MRC-SS for diagnosing ICU-AW, and clinical outcomes of ICU and hospital, 

















UTP or  
<48/60 
TP FP 















Figure 3-2 2x2 contingency table for determining diagnostic test characteristics 
for Medical Research Council sum-score for clinical outcomes of mortality and 
length of stay 
 
Abbreviations: MRC-SS = Medical Research Council Sum-score.   ICU = intensive care unit.  LOS = length 
of stay.  UTP = unable to perform.  ATP = ability to perform.  TP = true positive.  FP = false positive.  FN 
= false negative.  TN = true negative.  PPV = positive predictive value.  NPV = negative predictive value.   
 
Here, the binary classifications are firstly ability to perform the test and inability to 
perform the test, and secondly diagnosis of ICU-AW using the previously reported 
‘cut-off’ of less than 48 out of 60.  Each of these classifications is then considered 
against outcomes of different ‘conditions’, namely, ICU mortality (dead/alive), 
hospital mortality (dead/alive), ICU LOS (>14days/≤14days) and hospital LOS 
(>28days/≤28days) (Figure 3-2).  True positives refer to those patients unable to 
perform the test or diagnosed with ICU-AW (MRC-SS <48/60) with associated ICU 
or hospital mortality, or LOS of greater than 14days and 28days for ICU and 
hospital LOS respectively.  False positives are those patients unable to perform the 
test or diagnosed with ICU-AW who are alive at ICU and hospital discharge or with 
LOS of less than 14days and 28days for ICU and hospital LOS respectively.  True 
negatives are those patients able to perform the test or without ICU-AW (MRC-SS 
≥48/60), and who are alive at ICU and hospital discharge or with a LOS of less than 
14days and 28days for ICU and hospital LOS respectively.  Finally, false negatives 
are those patients who are able to perform the test or without ICU-AW, with 
associated ICU or hospital mortality or protracted LOS. 
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3.1.1.1 Sensitivity and specificity 
 
Sensitivity of a diagnostic test relates to its ability to identify positive results, 
measuring the proportion of true positives which are correctly identified as such.  
It can be considered as the probability of a positive test, if a patient has a disease or 
condition.  Diagnostic tests with high sensitivity can be considered reliable 
indicators for ruling out disease when results are negative, since true positives are 
nearly always identified (low type II error rate).  Conversely, specificity relates to a 
test’s ability to identify negative results, and measures the proportion of correctly 
identified true negatives.  Specificity is the probability of a negative test result if 
the patient is well.  Highly specific tests rarely miss negative outcomes, and hence 
can be considered reliable for ruling in a disease when results are positive (low 
type I error rate).  However false positives are not accounted for when calculating 
sensitivity nor false negatives when determining specificity.  In clinical practice, 
the ideal test demonstrates very high sensitivity and specificity allowing 
identification of the majority of true cases, and exclusion of the majority of non-
cases.  However in reality there is a balance between achieving optimal levels of 
either characteristic depending on the diagnostic threshold level for each test.  
Levels ranging between 0.7 and 0.9 represent clinically useful tests [239] although 
this will also be dependent on the circumstances of test use.    
 
3.1.1.2 Receiver operating characteristic curve 
 
Receiver operating characteristic (ROC) curves are graphical representations of 
the balance between relative sensitivities and specificities of diagnostic tests at 
varying discriminatory thresholds.  Sensitivity, or true positive rate, is plotted on 
the y-axis, and false positive rate (1-specificity) on the x-axis.  ROC analysis can 
assist in identifying alternative diagnostic thresholds with more clinically 
appropriate sensitivity and/or specificity than demonstrated on existing values.    
 
3.1.1.3 Positive and negative predictive value 
 
Positive (PPV) and negative (NPV) predictive value further reflect the clinical 
application of tests and are influenced by the known true prevalence of a disease 
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or condition in a population.  The PPV is the proportion of positive results that are 
true positives, and the NPV, the proportion of negative results that are true 
negatives (Figure 3-1).         
 
3.1.2 Aims of study 
 
The aims of this study were fourfold, focussing on the use of the MRC-SS for 
diagnosis of ICU-AW: 
 
1. To investigate the differences in inter-observer agreement of ICU-AW in 
critically ill patients within the ICU and in simulated presentations of 
weakness 
2. To determine a) the clinical predictive value of ability to perform the MRC-
SS at awakening and b) the clinical predictive value of an MRC-SS less than 
48 out of 60 at awakening in critically ill patients 
3. To investigate the relationship between ICU-AW and handgrip strength 




3.2.1 Study design 
 
This was a two-part, observational study.  Study 1 determined inter-observer 
agreement of MRC-SS in ICU patients and simulated weakness presentations.  
Ethical approval was granted from the local ethical review board and written 
informed consent was gained from all participants.  Study 2 investigated the 
clinical predictive value of (a) ability to perform MRC-SS at awakening and (b) 
MRC-SS indicative of ICU-AW.  In addition, in Study 2, the relationship between 
awakening MRC-SS, and subsequent diagnosis of ICU-AW and handgrip strength 
and physical function at ICU discharge was also investigated.  The local hospital 
ICU audit committee approved Study 2 as a clinical service evaluation and hence 




3.2.2 Participants  
 
Patients ≥18years and invasively mechanically ventilated for ≥48hours were 
eligible for inclusion.  Exclusion criteria included neurological weakness, 
requirement for acute non-invasive ventilation, pregnancy, malignancy, palliation-
only orders and those admitted for routine overnight post-operative surgical 
recovery.  Separate patient cohorts were recruited for Study 1 and 2.  A healthy 
volunteer was recruited for Study 1. 
 
3.2.3 Screening for awakening and assessment of peripheral muscle strength 
 
Conscious level of patients in both Study 1 and Study 2, was determined using the 
Richmond Agitation Sedation Scale (RASS) [49].  The RASS is an ordinal scale 
ranging from -5 (unrousable) to +4 (combative behaviour), including 0 (alert and 
calm) and a nominal ‘A’ indicating the subject is asleep.  A score of -1 (drowsy) to 
+1 (restless) was considered indicative of wakefulness.   
 
Awake patients were then required to demonstrate positive response to four 
simple one-stage commands including ‘Open and close eyes’, ‘Stick out your 
tongue’ and ‘Squeeze my fingers’.  Successful completion of these commands was 
followed by muscle strength assessment using the MRC-SS.  This is a 6 point 
grading scale ranging from 0 (no visible contraction) to 5 (normal power) applied 
to six upper and lower limb muscle groups bilaterally [35] (Chapter 2.3)   ICU-AW 
was defined as an MRC-SS less than 48 out of 60 [30, 36, 40, 41, 240].  The protocol 
for screening for awakening and assessment of peripheral muscle strength is in 
keeping with previous reported studies investigating the MRC-SS and ICU-AW [11, 
36, 37].   
 
Two specialist physiotherapists with extensive clinical expertise in rehabilitation 
of critically ill patients including muscle strength assessment, conducted MRC-SS 
assessments.  A standardised protocol for performing the MRC-SS was followed at 
all times during testing (Appendix 1).  Given the volitional nature of manual muscle 
testing, strong verbal encouragement was provided during all strength 
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assessments.  Examiners tested each patient in the same position (supine or 
seated). 
 
3.2.4 Study 1 - Inter-observer agreement of MRC-SS  
 
A pragmatic sample size of 20 patients was chosen for this study.  ICU patients 
underwent MRC-SS testing, performed by both examiners separated by a minimum 
of 30 minutes.  Initial testing order between examiners of the first patient was 
randomly assigned by concealed envelope and subsequent patient testing order 
followed an alternating pattern.  MRC-SS value scored by the first testing clinician 
on each occasion was defined as the reference score.   
 
For assessment of simulated weakness, one healthy volunteer was trained 
comprehensively in the MRC-SS, including muscle groups assessed and the 
different potential levels of weakness (ranging 0-5).  After a practice period the 
healthy volunteer was then instructed to simulate the 20 reference scores in a 
random order, which were re-scored by both clinicians.  Clinician order of testing 
was again random for the first presentation, following an alternating pattern 
thereafter.  Both clinicians adopted the standard operating protocol for performing 
MRC-SS, and the healthy volunteer simulated the weakness presentations in the 
same position (seated or supine) as the original patient was tested.  At each stage 
both clinicians were blinded to each other’s and the reference score. 
 
3.2.5 Study 2 - Clinical predictive value of the MRC-SS and relationship with 
physical function and handgrip strength 
 
Daily screening of ICU patients for eligibility and suitability for MRC-SS testing 
occurred over a three month period.  MRC-SS were obtained at awakening, defined 
as the first occasion on which an MRC-SS could be measured, and at seven days 
post awakening, and compared against outcomes of ICU and hospital mortality, 
and length of stay (LOS).  Awakening scores were used to determine association 
with prospective outcomes.  Prolonged length of stay was defined a priori as 
greater than 14days and greater than 28days for ICU and hospital LOS 
respectively.   
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Patients alive at ICU discharge also completed assessment of physical function and 
handgrip strength performed within 72hours of ICU discharge.  This time-point 
was pragmatic in selection, ensuring availability of either examiner to perform 
assessments, and allowing sufficient time to ensure clinical stability of patients 
following ward transfer.  Physical function measures included the Barthel scale 
[235], a measure of functional activity performance commonly used in the in-
patient setting covering aspects of personal care, mobility and transfers and the 
Elderly Mobility Scale (EMS) [241], a validated tool for assessing mobility in frail, 
elderly subjects.  It includes assessment of functional transfers, balance and gait 
performance that may be applicable to the early stages of the rehabilitation 
process for post ICU patients.  Handgrip strength was measured using 
dynamometry. 
 
3.2.6 Statistical analysis 
 
3.2.6.1 Study 1 
 
Inter-observer agreement between clinicians for the MRC-SS in ICU patients and 
simulated presentations was determined using intra-class correlation coefficients 
(ICC) calculated using a two-way random effects for absolute agreement [242], and 
percent agreement for total MRC-SS (total number of exact MRC-SS 
measurements/total number).  Level of agreement for the binary outcome of ICU-
AW (MRC-SS <48;≥48) was determined using Cohen’s Kappa statistic with a 
grading system from ‘poor’ to ‘complete’ agreement [243].   
 
Inter-observer agreement was further evaluated by analysing individual muscle 
group scores from ICU patients, again using ICC and Kappa techniques.  This 
process was repeated for individual muscle group scores from simulated 
presentations, and furthermore for analysing each clinician’s simulated MRC-SS 
results against the reference score for both total scores and individual muscle 
group scores.  Where applicable agreement for the binary outcomes of ICU-AW 
(MRC-SS <48 and ≥48) and individual muscle group weakness (MRC score <4 and 
≥4) were employed.  Median individual muscle group scores for each clinician 
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were compared using Wilcoxon signed rank testing.  A p value <0.05 was 
considered statistically significant.     
 
3.2.6.2 Study 2 
 
Initial analysis involved Fisher’s exact test to determine association between MRC-
SS outcomes (ability to perform the test, and scoring <48/60) and clinical 
outcomes (ICU and hospital mortality, and ICU and hospital LOS).  A priori an 
extended ICU length of stay was defined as greater than 14days, and greater than 
28days for hospital LOS.  Subsequent analysis of test characteristics (sensitivity, 
specificity, positive (PPV) and negative (NPV) predictive value) was then 
performed using an a priori cut-off of 75% to be clinically acceptable.  Additional 
receiver-operator characteristic (ROC) analysis was performed on awakening 
MRC-SS measurements for each clinical outcome to assess sensitivity and 
specificity at levels of MRC-SS from 0 to 60.   
 
Continuous data for awakening MRC-SS, physical function and handgrip strength 
were analysed using Spearman’s correlation.  Physical function and handgrip 
strength were then compared according to ICU-AW diagnosis (MRC-SS <48/60; 
MRC-SS ≥48/60) with Mann-Whitney analysis.     
 




3.3.1 Study 1 – Inter-observer agreement of the MRC-SS 
 
3.3.1.1 Inter-observer agreement of the MRC-SS for ICU patients 
 
Twenty patients participated in this study.  Demographic and clinical data for the 
cohort are shown in Table 3-1.  ICU LOS prior to MRC-SS testing was 24.0 (6.8-
43.3)days, and 45% of patients were receiving invasive mechanical ventilation at 
the time of testing.  All muscle groups were tested on all occasions.  MRC-SS for 
each testing clinician was 48 (39-51) and 48 (38-51) (Figure 3-3).  Table 3-2 
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reports the MRC-SS obtained during testing from both clinicians for each patient.  
Median time between each patient’s testing by clinicians was 30 (29-33) minutes.  
Maximum difference in MRC-SS measurements for any one patient was 7 and 
agreement between clinicians’ scores was 15.0%.  The ICC was 0.94 (95%CI 0.85-
0.98) and Kappa statistic for agreement on the diagnosis of ICU-AW was 0.60 (95% 
CI 0.25-0.95).  There were seven patients for whom both clinicians agreed 
diagnosis of ICU-AW, and four where one clinician scored MRC-SS<48 and the 
other ≥48/60. 
 

















































Figure 3-3 Medical Research Council Sum-Scores for clinician testing of critically 
ill patients and simulated presentations 
 
a) MRC-SS values for critically ill patients for each clinician  
 
b) MRC-SS values for simulated presentations for each clinician 
 
Error bars indicate median and interquartile range.  Dotted line indicates cut-off value of 48/60 
below which indicates diagnosis of ICU-AW. 
 
Abbreviations: MRC-SS = Medical Research Council sum-score.  ICU = intensive care unit.  ICU-AW = 




Table 3-1 Demographic and clinical data for Study 1 and Study 2 cohorts 
 
Characteristic Range 
 Study 1: 
MRC-SS Inter- 
Observer Agreement 
n = 20 
Study 2: 
MRC-SS Clinical  
Predictive Value 
n = 94 
Age (years) 67.5 (51.8-75.0) 66.0 (54.8-76.3) 
Gender (M:F) 12:8 64:30 
APACHE II 19.5 (15.5-24.0) 17.0 (15.0-22.0) 
Admission Type   
Medical (%) 70.0 78.7 
Surgical (%) 30.0 21.3 




Chronic cardiac disease 
(%) 
65.0 55.3 
Chronic Renal disease (%) 5.0 4.0 
Chronic Liver disease (%) 0.0 10.6 
Total MV (days) 25.5 (21.0-44.0) 7.0 (4.0-16.0) 
Total MV prior to MRC-SS testing 
(days) 
21.0 (6.8-42.0) n/a 
ICU LOS total (days) 33.5 (25.5-58.0) 11.0 (6.0-25.3) 
ICU LOS prior to MRC-SS testing 
(days) 
24.0 (6.8-43.3) n/a 
Hospital LOS total (days) 52.5 (31.5-85.3) 27.0 (11.8-50.0) 
Hospital LOS prior to MRC-SS 
testing (days) 
23.5 (7.5-43.8) n/a 
Data are expressed as median (interquartile range (IQR)).  For co-morbidities, values reflect % of 
cohort with specific organ disease with overlap across categories.  Hence sum greater than 100%. 
 
Abbreviations: ICU = intensive care unit.  LOS = length of stay.  MV = mechanical ventilation.  APACHE 
= Acute Physiological and Chronic Health Evaluation.  MRC-SS = Medical Research Council sum-score.  














Table 3-2 Inter-observer agreement for MRC-SS critically ill patients; individual 
clinician scores 
 
Patient Clinician 1 MRC-SS (/60) Clinician 2 MRC-SS (/60) 
1 46 48 
2 36 32 
3 51 48 
4 26 20 
5 52 49 
6 51 45 
7 50 48 
8 45 49 
9 57 60 
10 37 39 
11 55 54 
12 22 23 
13 49 55 
14 44 44 
15 50 50 
16 41 48 
17 42 39 
18 53 56 
19 32 29 
20 51 51 
Abbreviations: MRC-SS = Medical Research Council sum-score 
 
 
Inter-observer agreement of the MRC-SS in ICU patients was also determined for 
individual muscle groups tested (Table 3-3).  Maximum percent agreement 
between clinicians was 75% for right knee extension and left ankle dorsiflexion.  
The strongest ICC for MRC scores of individual muscle groups was for left ankle 
dorsiflexion (0.86, 95%CI 0.68-0.94).  Agreement for identification of weakness 
(MRC score <4:≥4) reported using Kappa statistic, ranged from 0.43-0.88.  There 
was no evident trend towards a proximal-to-distal pattern of weakness 










Table 3-3 Inter-observer agreement for individual muscle group scores for 
critically ill patients 
 
Muscle group Kappa (95% CI) ICC (95% CI) % agreement 
Shoulder Abd L 0.8 (0.54 – 1.06) 0.85 (0.67 – 0.94) 70 
Shoulder Abd R 0.68 (0.35 – 1.01) 0.74 (0.46 – 0.89) 60 
Elbow flexion L 0.69 (0.29 – 1.1) 0.69 (0.36 – 0.86) 65 
Elbow flexion R 0.88 (0.64 – 1.11) 0.73 (0.43 – 0.88) 65 
Wrist extension L 0.74 (0.39 – 1.08) 0.74 (0.46 – 0.89) 60 
Wrist extension R 0.47 (0.06 – 0.87) 0.64 (0.27 – 0.84) 45 
Hip flexion L 0.56 (0.18 – 0.95) 0.6 (0.22 – 0.82) 55 
Hip flexion R 0.43 (0.001 -0.87) 0.76 (0.48 – 0.9) 60 
Knee extension L 0.47 (0.06 – 0.87) 0.63 (0.28 – 0.84) 35 
Knee extension R 0.57 (0.18 – 0.95) 0.69 (0.37 – 0.86) 75 
Ankle DF L 0.83 (0.5 – 1.16) 0.86 (0.68 – 0.94) 75 
Ankle DF R 0.86 (0.58 – 1.13) 0.77 (0.52 – 0.9) 45 
Kappa statistic using binary outcome of clinical weakness (Medical Research Council score <4; ≥4).  
n=20 
 
Abbreviations: Abd = abduction.  DF = dorsiflexion.  L = left.  R = right.  CI = confidence interval.  ICC = 
intra-class correlation coefficient 
 
 
Minimum, maximum and median scores for each clinician’s individual muscle 
group score for ICU patients are shown in Table 3-4.  No significant difference 
between each clinicians’ median score for any muscle group was evident with the 
exception of right wrist extension (p=0.03).  Although this muscle group 
demonstrated one of the widest 95% confidence intervals for Kappa agreement of 
weakness diagnosis, it was not the group with least percent agreement between 














Table 3-4 Individual muscle group scores for critically ill patients 
 
Muscle group Clinician 1 Clinician 2 p value 
Min Max Median 
(IQR) 
Min Max Median 
(IQR) 
Shoulder Abd L 1 5 4  
(2-4) 
2 5 3.5  
(3-4) 
0.48 
Shoulder Abd R 1 5 4  
(2-4) 
2 5 4  
(3-4) 
0.15 
Elbow flexion L 2 5 4  
(4-4) 
2 4 4  
(3.25-4) 
0.07 
Elbow flexion R 2 5 4  
(3.25-4) 
2 5 4  
(3-5) 
0.59 
Wrist extension L 2 5 4  
(4-4) 
1 5 4  
(3-4) 
0.15 
Wrist extension R 2 5 4  
(2.25-4) 
2 5 4  
(4-5) 
0.03 
Hip flexion L 2 5 4  
(2.25-5) 
2 5 4  
(3-4) 
1.0 
Hip flexion R 2 5 4  
(2-5) 
2 5 4  
(3-4) 
0.82 
Knee extension L 1 5 4  
(2-5) 
2 5 4  
(3-4.75) 
0.42 
Knee extension R 2 5 4  
(2-5) 
2 5 4  
(2-5) 
0.59 
Ankle DF L 1 5 4  
(4-5) 
0 5 4  
(4-5) 
1.0 
Ankle DF R 1 5 4  
(4-5) 
2 5 4  
(2.5-4.75) 
0.18 
p values derived from Wilcoxon signed rank test for equality of median score.  n=20.   
 
Abbreviations: Abd = abduction.  DF = dorsiflexion.  L = left.  R = right.  Min = minimum score.  Max 
=maximum score.  IQR = interquartile range.   
 
3.3.1.2 Inter-observer agreement for simulated MRC-SS presentations 
 
These data were analysed in a similar manner.  Median (IQR) MRC-SS 
measurements for the two clinicians were 47 (40-51) and 47 (41-53) (Figure 3-3).  
Table 3-5 reports MRC-SS obtained from both clinicians against the simulated 
reference score.  Ten reference MRC-SS were <48/60 including four less than 
36/60.  On all occasions where the reference score was <48/60, both clinicians 
demonstrated agreement with this and confirmed the simulated ICU-AW 
presentation.  Maximum difference between clinicians’ scores was 2 with 45.0% 
agreement.  ICC for simulated MRC-SS values was 1.0 (95%CI 0.99-1.0).  Complete 





Table 3-5 Inter-observer agreement for MRC-SS in simulated weakness 
presentations; individual clinician scores  
 
Patient Reference score Clinician 1             
MRC-SS (/60) 
Clinician 2            
MRC-SS (/60) 
1 20 20 20 
2 44 43 44 
3 22 22 21 
4 60 60 59 
5 56 56 56 
6 52 53 51 
7 32 32 32 
8 50 49 50 
9 32 32 32 
10 50 50 50 
11 42 42 43 
12 54 54 54 
13 39 40 39 
14 45 45 43 
15 45 45 45 
16 48 49 48 
17 46 45 46 
18 49 49 49 
19 51 53 52 
20 51 51 51 
Abbreviations: MRC-SS = Medical Research Council sum-score 
 
Inter-observer agreement between the two clinicians for individual muscle groups 
assessed in simulated MRC-SS presentations is shown in Table 3-6.  A minimum of 
85% agreement between clinicians was demonstrated and ICC ranged from 0.93 to 
1.0.  For the majority of muscle groups, perfect agreement was demonstrated for 
the diagnosis of clinical weakness (MRC score <4; ≥4) as indicated by Kappa 
statistic of 1.0.  The weakest level of agreement was for right hip flexion (Kappa 
0.74).  Albeit overall there were very high levels of agreement, there was no 
evident trend towards a proximal-to-distal pattern of weakness distribution across 








Table 3-6 Inter-observer agreement for individual muscle group sores for 
simulated weakness presentations 
 
Muscle group Kappa (95% CI) ICC (95% CI) % agreement  
Shoulder Abd L 1.0 (1.0 – 1.0) 1.0 (1.0-1.0) 100 
Shoulder Abd R 1.0 (1.0 – 1.0) 0.98 (0.95 – 0.99) 95 
Elbow flexion L 0.86 (0.58 – 1.13) 0.96 (0.91 – 0.99) 95 
Elbow flexion R 1.0 (1.0 – 1.0) 0.98 (0.94 – 0.99) 95 
Wrist extension L 0.88 (0.64 – 1.11) 0.95 (0.88 – 0.98) 90 
Wrist extension R 1.0 (1.0 – 1.0) 0.98 (0.95 – 0.99) 95 
Hip flexion L 1.0 (1.0 – 1.0) 1.0 (1.0-1.0) 100 
Hip flexion R 0.74 (0.39 – 1.08) 0.93 (0.82 – 0.97) 85 
Knee extension L 1.0 (1.0 – 1.0) 0.97 (0.91 – 0.99) 90 
Knee extension R 1.0 (1.0 – 1.0) 0.97 (0.92 – 0.99) 90 
Ankle DF L 0.86 (0.58 – 1.13) 0.97 (0.93 – 0.99) 90 
Ankle DF R 1.0 (1.0 – 1.0) 0.97 (0.94 – 0.99) 90 
Kappa statistic using binary outcome of clinical weakness (Medical Research Council score <4; ≥4). 
n=20 
 
Abbreviations: Abd = abduction.  DF = dorsiflexion.  L = left.  R = right.  CI = confidence interval.  ICC = 
intra-class correlation coefficient.  
 
Minimum, maximum and median scores for each clinician’s individual muscle 
group score on simulated presentations are shown in Table 3-7.  No significant 
difference between both clinicians’ median scores for individual muscle groups 
was evident, and for two muscle groups (left shoulder abduction and left hip 
flexion) both sets of scores were identical. 















Table 3-7 Individual muscle group scores for simulated weakness presentations 
 
Muscle group Rater 1 Rater 2 p value 
Min Max Median 
(IQR) 
Min Max Median 
(IQR) 
Shoulder Abd L 1 5 4  
(2-4) 
1 5 4  
(2-4) 
--- 
Shoulder Abd R 1 5 4  
(2.25-4) 
1 5 4  
(2.25-4) 
1.0 
Elbow flexion L 2 5 4  
(3.25-4) 
2 5 4  
(4-4) 
1.0 
Elbow flexion R 2 5 4  
(3-5) 
2 5 4  
(3-5) 
1.0 
Wrist extension L 1 5 4  
(3-4) 
1 5  4  
(3.25-4) 
0.35 
Wrist extension R 2 5 4  
(3-4.75) 
2 5 4  
(3-5) 
1.0 
Hip flexion L 2 5 4  
(3-4) 
2 5 4  
(3-4) 
--- 
Hip flexion R 2 5 4  
(4-5) 
2 5 4  
(3-4.75) 
0.15 
Knee extension L 2 5 4  
(2-4) 
2 5 4  
(2-5) 
0.35 
Knee extension R 2 5 4  
(2-5) 
2 5 4  
(2-5) 
0.35 
Ankle DF L 1 5 4  
(2.25-4) 
1 5 4  
(2.25-4) 
1.0 
Ankle DF R 1 5 4.5  
(2.5-5)  
1 5 4  
(2.5-5) 
1.0 
p values derived from Wilcoxon signed rank test for equality of median score.  --- = both clinicians’ 
median scores identical therefore unable to compute result.  n=20.   
 
Abbreviations: Abd = abduction.  DF = dorsiflexion.  L = left.  R = right.  Min = minimum score.  Max 
=maximum score.  IQR = interquartile range.   
 
Inter-observer agreement of each clinician’s MRC-SS from simulated presentations 
was compared against the reference score.  Both clinicians demonstrated an ICC of 
1.0 (95% CI 1.0-1.0), percent agreements of 65 and 70% and perfect agreement for 
diagnosis of ICU-AW with Kappa statistics of 1.0 (95% CI 1.0-1.0).  Table 3-8 and 
Table 3-9 report each clinician’s individual muscle group scores against the 







Table 3-8 Inter-observer agreement between Clinician 1 and reference scores for 
individual muscle groups  
 
Muscle group Kappa (95% CI) ICC (95% CI) % agreement 
Shoulder Abd L 0.9 (0.71 – 1.09) 0.98 (0.95 – 0.99) 95 
Shoulder Abd R 0.9 (0.7 – 1.09) 0.98 (0.95 – 0.99) 95 
Elbow flexion L 0.86 (0.58 – 1.13) 0.96 (0.91 – 0.99) 95 
Elbow flexion R 1.0 (1.0 – 1.0) 1.0 (1.0 – 1.0) 100 
Wrist extension L 0.88 (0.64 – 1.11) 0.98 (0.94 – 0.99) 95 
Wrist extension R 1.0 (1.0 – 1.0) 1.0 (1.0 – 1.0) 100 
Hip flexion L 1.0 (1.0 – 1.0) 1.0 (1.0 – 1.0) 100 
Hip flexion R 0.86 (0.58 – 1.13) 0.95 (0.88 – 0.98) 90 
Knee extension L 1.0 (1.0 – 1.0) 0.97 (0.91 – 0.99) 90 
Knee extension R 1.0 (1.0 – 1.0) 1.0 (1.0 – 1.0) 100 
Ankle DF L 1.0 (1.0 – 1.0) 0.99 (0.97 – 0.99) 95 
Ankle DF R 1.0 (1.0 – 1.0) 0.97 (0.94 – 0.99) 90 
Kappa statistic using binary outcome of clinical weakness (Medical Research Council score <4;≥4). 
 
Abbreviations: Abd = abduction.  DF = dorsiflexion.  L = left.  R = right.  CI = confidence interval.  ICC = 
intra-class correlation coefficient 
 
 
Table 3-9 Inter-observer agreement between Clinician 2 and reference scores for 
individual muscle groups  
 
Muscle group Kappa (95% CI) ICC (95% CI) % agreement 
Shoulder Abd L 0.9 (0.71 – 1.09) 0.98 (0.95 – 0.99) 95 
Shoulder Abd R 0.9 (0.7 – 1.09) 0.96 (0.89 – 0.98) 90 
Elbow flexion L 1.0 (1.0 – 1.0) 1.0 (1.0-1.0) 100 
Elbow flexion R 1.0 (1.0 – 1.0) 0.98 (0.94 – 0.99) 95 
Wrist extension L 1.0 (1.0 – 1.0) 0.98 (0.94 – 0.99) 95 
Wrist extension R 1.0 (1.0 – 1.0) 0.98 (0.95 – 0.99) 95 
Hip flexion L 1.0 (1.0 – 1.0) 1.0 (1.0-1.0) 100 
Hip flexion R 0.88 (0.64 – 1.11) 0.98 (0.94 – 0.99) 90 
Knee extension L 1.0 (1.0 – 1.0) 1.0 (1.0-1.0) 100 
Knee extension R 1.0 (1.0 – 1.0) 0.97 (0.92 – 0.99) 90 
Ankle DF L 0.86 (0.58 – 1.13) 0.99 (0.97 – 1.0) 95 
Ankle DF R 1.0 (1.0 – 1.0) 1.0 (1.0-1.0) 100 
Kappa statistic using binary outcome of clinical weakness (Medical Research Council score <4;≥4). 
 
Abbreviations: Abd = abduction.  DF = dorsiflexion.  L = left.  R = right.  CI = confidence interval.  ICC = 




3.3.2 Study 2 - Clinical predictive value of the MRC-SS 
 
3.3.2.1 Clinical predictive value for ability to perform MRC-SS testing at 
awakening 
 
94 patients were eligible for enrolment in the 3-month study period (Figure 3-4).  
Baseline demographic data for the cohort are reported in Table 3-1.  18 patients 
died prior to any testing, and 11 patients were consistently unable to perform 
(UTP) MRC-SS testing throughout their ICU stay due to cognitive impairment.  
MRC-SS were obtained in 65 patients at awakening.  Categorising the cohort into 
those patients able to perform (ATP) MRC-SS testing and those UTP at awakening, 
significant differences between groups were evident for age (ATP 35.3±14.9years 
vs. UTP 60.6±20.0years; p<0.0001), illness severity on ICU admission (APACHE II) 
(ATP 18.5±5.1 vs. UTP 14.9±4.6; p=0.03) and hospital length of stay (LOS) (ATP 
33.0 (14.5-55.5) days vs. UTP 15.0 (7.0-37.0) days; p=0.02).  Groups were similar 
for gender, ICU LOS and total mechanical ventilation (MV) days.  Duration of MV 
prior to awakening MRC-SS was 5.0 (3.0-9.5) days in the ATP group, and following 
testing 0.0 (0.0-6.5) days.  In the UTP group, number of attempted MRC-SS 
assessments was 4.0 (2.0-8.0).  ICU mortality was 12.3% and 0.0%, and hospital 
mortality 24.6% and 18.2%, for ATP and UTP groups, respectively. 
 
Fisher’s exact testing was performed to examine any association between ability to 
perform the test at awakening and ICU and hospital mortality and LOS.  All tests 
were non-significant and therefore further analysis of test characteristics was not 
considered appropriate (Table 3-10). 
 
At Day 7, 45 of the 65 patients with awakening scores had been discharged from 
the ICU (8 patients had died, 37 patients transferred to the ward or repatriated) 
and a further 6 were unable to perform the test.  MRC-SS for the 14 patients with 
scores at this time-point was 33.5 (22.3-44.8).  11 patients had ICU-AW (MRC-SS 






























Figure 3-4 Flow diagram of patient enrolment in study 
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UTP 0 11 








UTP 2 9 








UTP 3 8 








UTP 4 7 
ATP 38 27 
p values calculated using Fisher’s exact test.  n=76. 
ICU mortality, p=0.59; Hospital mortality, p=1.0; ICU LOS, p=0.51; Hospital LOS, p=0.20. 
 
Abbreviations:  MRC-SS = Medical Research Council sum-score.  UTP = unable to perform.  ATP = able 
to perform.  LOS = length of stay. 
 
3.3.2.2 Clinical predictive value of an MRC-SS <48 and ≥48 at awakening 
 
Sixty-five patients had MRC-SS at awakening; 33 with scores of 0-36 (50.8%), 15 
(23.1%) scored 37-47, and 17 (26.1%) ≥48.  Prevalence of ICU-AW (MRC-SS <48) 
in the cohort was 73.9% (M:F 35:13).  When these scores were examined in detail, 
there was no pattern indicating a trend of proximal-distal distribution of muscle 
group weakness, nor any consistent symmetry to the weakness presentation. 
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There was no association between MRC-SS and ICU and hospital mortality 
demonstrated (p=0.67 and p=0.53, respectively) and therefore further analysis of 
test characteristics was not performed.  However a significant association was 
found for ICU and hospital LOS (p=0.004 and p=0.04, respectively (Table 3-11).  
The clinical predictive value of MRC-SS <48 at awakening was therefore 
determined (Table 3-12).  Using a cut-off of 75%, high sensitivity was evident for 
ICU and hospital LOS.  Specificity and PPV were poor across both, and high NPV 
was evident for ICU LOS. 
 
In addition, receiver-operator characteristic (ROC) analysis was performed on the 
65 awakening MRC-SS measurements for each clinical outcome (ICU and hospital 
mortality, and ICU and hospital LOS) to assess sensitivity and specificity at levels of 
MRC-SS from zero to 60 (Table 3-13).  Greatest sensitivity was observed at an 
MRC-SS <35 (64.3%) with 64.9% specificity (area under curve (AUC) 0.69 (95%CI 
0.56-0.82)) for ICU LOS, and greatest specificity was observed at an MRC-SS <29.5 
































<48 7 41 








<48 13 35 








<48 26 22 








<48 32 16 
≥48 6 11 
p values calculated using Fisher’s exact test.  n=65. 
ICU mortality, p=0.67; Hospital mortality, p=0.53; ICU LOS, p=0.004; Hospital LOS, p=0.04. 
 
Abbreviations: MRC-SS = Medical Research Council sum-score (scored/60).  UTP = unable to perform.  












Table 3-12 Clinical predictive value of an MRC-SS <48/60 at awakening 
 
 ICU LOS 
(≤14 days and >14days) 
Hospital LOS 
(≤28 days and >28 days) 
 % 95% CI % 95% CI 
Sensitivity 92.9 76.5-99.1 84.2 68.7-94.0 
Specificity 40.5 24.8-57.9 40.7 22.4-61.2 
PPV 54.2 39.2-68.6 66.7 51.6-79.6 
NPV 88.2 63.6-98.5 64.7 38.3-85.8 
Abbreviations: ICU = intensive care unit.  LOS = length of stay.  PPV = positive predictive value.  NPV = negative predictive value.  
CI = confidence intervals. 
 
 











AUC (95%CI) p value 
ICU mortality <29.5 62.5 70.2 0.63 (0.42-0.83) 0.3 
ICU LOS <35 64.3 64.9 0.69 (0.56-0.82) 0.009 
Hospital 
mortality 
<35 62.5 57.1 0.55 (0.4-0.7) 0.6 
Hospital LOS <36.5 60.5 63.0 0.65 (0.51-0.79) 0.04 
n=65.  Cut-offs reported represent those at which greatest levels of sensitivity and specificity were 
identified.  
 
Abbreviations: MRC-SS = Medical Research Council sum score.  ICU = Intensive Care Unit.  LOS = length 
of stay.  AUC = area under the curve.  CI = confidence interval. 
 
3.3.2.3 Relationship between MRC-SS at awakening and handgrip strength 
and physical function at ICU discharge 
 
MRC-SS at awakening demonstrated significant positive correlations with Barthel 
scale (r=0.4, p=0.005), EMS (r=0.4, p=0.005), and bilateral handgrip strength (left 
(r=0.5, p=0.0003), right (r=0.5, p<0.0001)) performed at ICU discharge (Figure 
3-5).  Measures of physical function and handgrip strength were also compared 
according to diagnosis of ICU-AW (MRC-SS <48/60; ≥48/60) (Table 3-14).  
Significant differences were evident between groups for left (p=0.04) and right 
(p=0.002) handgrip strength.  Furthermore handgrip strength values at ICU 
discharge for those patients with ICU-AW at awakening were consistent with a 
diagnosis of ICU-AW according to previously reported handgrip cut-offs [36].  
Differences for Barthel and EMS scores approached significance.   
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Table 3-14 MRC-SS at awakening and measures of handgrip strength and physical 
function at intensive care unit discharge 
 
 MRC-SS <48 (n=48) MRC-SS ≥48 (n=17) p value 
L HGD (kg) 7.0 (2.0-15.0) 12.0 (9.0-24.0) 0.02 
R HGD (kg) 7.0 (2-13.5) 16.0 (11.0-25.0) 0.002 
Barthel score (/20) 2.0 (0-8.5) 8.0 (1.0-11.0) 0.05 
EMS (/20) 2.0 (0.0-8.0) 6.0 (2.0-15.0) 0.07 
Data are presented as median (interquartile range).  p values derived from Mann-Whitney analysis.  
For Barthel and EMS, higher score indicate a better level of physical function.   
 
Abbreviations: MRC-SS = Medical Research Council Sum-score.  EMS = Elderly Mobility Scale.  L = left.  










































































































Figure 3-5 Relationship between MRC-SS at awakening and measures of physical 
function on ICU discharge  
 
p and r values derived from Spearman’s correlation coefficient.  n=52 
 
Abbreviations: MRC-SS = Medical Research Council Sum-score.  ICU = intensive care unit.   EMS = 





Data from the current study demonstrate high levels of inter-observer agreement 
between two expert clinicians assessing both ICU patients and simulated 
presentations of weakness, but only moderate agreement was observed for the 
diagnosis of ICU-AW in the clinical ICU patient cohort.  The inter-observer 
agreement using the MRC-SS to diagnose ICU-AW was therefore an effect of patient 
variability rather than clinician variability during assessment, and is not 
unexpected due to the volitional nature of the test.  At awakening, almost one third 
of patients were unable to complete MRC-SS testing, but there was no relationship 
between the ability to perform the MRC-SS at awakening and ICU and hospital 
mortality or length of stay.  Similarly there was no association found between an 
MRC-SS <48/60 at awakening, considered as the diagnostic ‘cut-off’ for ICU-AW, 
and ICU or hospital mortality.  Furthermore, whilst a significant association was 
evident for ICU and hospital length of stay, further test characteristic analysis 
revealed limited positive predictive value for both, and a high negative predictive 
value for an ICU length of stay of more than 2 weeks.  Clinically, this confirms that a 
diagnosis of ICU-AW based on an MRC-SS <48/60 had poor predictive value, 
whereas an MRC-SS greater than 48 predicted a more favourable outcome albeit 
only in relation to the specific outcomes assessed.  Finally, only moderate 
correlations were evident between MRC-SS and two measures of physical function, 
and diagnosis of ICU-AW had limited clinical relevance in terms of physical 
function in ICU survivors.  These data highlight the limitation and clinical utility of 
the MRC-SS for diagnosing ICU-AW and its predictive consequences. 
 
3.4.1 Critique of the method 
 
3.4.1.1 Inter-observer agreement 
 
Determining the ideal protocol for establishing inter-observer agreement of the 
MRC-SS in critically ill patients within ICU and controlling for potentially 
confounding variables is challenging.  Patient testing was separated by 30 minutes 
to minimise effect of clinical fluctuation and limit patient exhaustion, albeit a 
greater duration may have been required for this purpose and specific assessment 
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of fatigability was not conducted to ensure this was not the case.  Conversely, it 
could be argued that extending the time interval between each clinician’s testing 
offers greater opportunity for alteration in patient clinical status that may 
negatively influence reliability in itself.   
 
Whilst the inter-observer cohort studied could be considered relatively small 
(n=20) which limits generalisability of the findings, it is within the range of sample 
sizes previously reported in similar studies [59, 60, 244].  Furthermore, the cohort 
included a range of illness acuity, duration of ICU stay and requirements for 
mechanical ventilation.  In addition nearly half of the patients had endotracheal 
tubes in situ at the time of testing.  Despite clinical status, all patients were 
screened as suitably awake and cognitively intact to proceed with assessment.  For 
this reason, manual muscle testing will exclude those patients in the early stages of 
critical illness when the patient is likely to have impaired cognition due to high 
sedation load, septic or metabolic encephalopathy, or neurological deficit [38].  
Actual testing occurred at various points within each patient’s ICU admission, 
which could have affected reliability.  Performing assessments at a standardised 
time-point may offer further insight into the usefulness and reliability of the 
measure, and comparison between patient groups.    
 
A standardised protocol for MRC-SS measurement was adopted for testing 
according to patient position to limit clinician variability, a strategy previously 
reported in only one other recent study [38], and the process for screening for 
level of awakening and alertness, and ability to undergo testing has been widely 
reported in the literature [11, 36, 37, 60].  However, despite these approaches it is 
acknowledged that patient-related factors may have influenced ability to perform 
the assessment irrespective of successfully meeting screening criteria on each 
occasion.  Intervening clinical events, such as administration of sedation, could 
have attributed to this but were not documented.   
 
3.4.1.2 Predictive value of the MRC-SS 
 
Predictive value and test characteristics of the MRC-SS have not been investigated 
previously, but as a diagnostic test for ICU-AW this evaluation is warranted.  
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Clinical outcomes of mortality and length of stay were selected based on findings 
from previous observational cohort studies investigating ICU-AW, diagnosed using 
the MRC-SS (cut-off of <48/60 indicative of a positive test result) and clinical 
course [11, 36, 37].  However these outcomes are influenced by multiple factors in 
critically ill patients and peripheral muscle strength may not represent the most 
relevant diagnostic tool.  Furthermore, only one-quarter of patients with an 
awakening MRC-SS value did not have ICU-AW, and hence these data require 
careful interpretation.   
 
A proportion of the cohort were unable to complete MRC-SS testing due to 
persistent inability to understand or follow the necessary instructions, suggesting 
screening using simple one-stage commands may be inadequately sensitive to 
detect cognitive ability sufficient for MRC-SS assessment.  More thorough 
assessment of delirium and complex cognitive ability may have addressed this 
[245], but the study aimed to reflect the common approach employed previously 
[11, 36, 37, 60].   
 
In the current study, awakening was defined as the first occasion on which an 
MRC-SS could be obtained from a patient.  This was in contrast to the landmark 
study of De Jonghe et al [11], who defined ICU-AW as an MRC-SS less than 48 at 
seven days post awakening.  Whilst this definition ensured that the weakness 
detected was persistent, and not a fluctuating finding in the early stages of patient 
waking, in the current patient cohort due to high rates of patient discharge from 
the ICU by day 7, scores at this time were considerably less useful.  Specifically, the 
majority of patients in the ICU at day 7 post awakening demonstrated ICU-AW, but 
this was a small subgroup of the general ICU patient cohort studied (15%) and 
analysis of these data were extremely limited.  It is likely these findings represent, 
in part, an overall change in clinical ICU practice toward earlier discharge as a 
result of implementation of structured weaning and reduced-sedation protocols, 






3.4.1.3 MRC-SS and physical function and handgrip strength 
 
There are few recognised, validated outcome measures for critically ill patients on 
discharge from the ICU.  Two measures were selected that represented a range of 
physical functional activities potentially requiring rehabilitation intervention 
following ICU discharge, albeit these measures originated from different patient 
populations [235, 241].  Only moderate correlations were demonstrated with the 
MRC-SS, which could be a result of the poor validity of these measures in the post 
ICU population, rather than a function of the MRC-SS as a measure.  Furthermore, 
MRC-SS and physical function were measured at differing time-points, at 
awakening and within 72 hours of ICU discharge respectively.  The latter time 
frame was adopted for clinical reasons (to ensure patient stability on transfer to 
the ward and for undergoing assessment) and pragmatic reasons (to enable one 
assessing clinician to be available for testing) reasons.  However global clinical 
improvement in the interim period may have influenced the relationship observed.  
Contemporaneous measurements of MRC-SS and physical function may have 
yielded stronger correlations, but physical function manoeuvres are generally not 
possible at awakening and MRC-SS measurements beyond awakening limit use of 
the score as a predictor of both ICU and hospital outcome.   
 
3.4.2 Clinical interpretation 
 
3.4.2.1 Inter-observer agreement 
 
Although inter-observer agreement was determined in a small sample of ICU 
patients recovering from critical illness, this allowed testing in a relatively stable 
group of patients with potentially less clinical fluctuation, whilst still in the ICU.  
Patients demonstrated a range of ICU length of stay.  However, overall only 
moderate agreement for MRC-SS less than 48, diagnostic of ICU-AW, was evident, 
with wide confidence intervals including both poor and almost perfect agreement 
due to sample size and prevalence of weakness.  For simulated weakness 
presentations, levels of agreement between clinicians were completely matched 
for the value of MRC-SS and diagnosing ICU-AW.  These data strongly support the 
conclusion that inter-observer variability was the result of patient-related 
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variation in ability to perform the volitional MRC-SS, rather than variability 
between clinicians in performing the assessment.  Whilst previously assumed, 
these results confirm this source of error in determining inter-observer agreement 
of MRC-SS measurement, and represent an important and novel aspect of the 
current study.   
 
Inter-observer agreement of the MRC-SS was examined, rather than intra-observer 
or repeated assessment, given that in routine clinical practice it is likely that more 
than one therapist would be involved in management of critically ill patients, and 
any potentially diagnostic measure requires consistency between clinicians.  In 
order to examine the optimum potential agreement that could be observed, 
experienced raters were employed to reduced bias.  However it is also 
acknowledged that clinicians with varying experience may be involved in patient 
care, and demonstrate greater variability in scoring.  Data have been reported 
suggesting that with adequate training, novices may demonstrate good reliability 
compared with an expert reference, although the patient cohort in question was a 
combination of simulated weakness and patients post ICU in stable recovery phase 
[59].   
 
That only moderate agreement was evident between clinicians for the diagnosis of 
ICU-AW may have an impact on the delivery of therapeutic rehabilitation 
interventions, assuming those presenting with ICU-AW would have the greatest 
requirement and be most likely to benefit.  Furthermore, lack of strong agreement 
restricts clinicians’ ability to accurately monitor patient progress during recovery.   
 
3.4.2.2 Predictive value of the MRC-SS 
 
Although previous data have associated ICU-AW with poor clinical outcome [11, 
36, 37, 40], determining the test characteristics of the MRC-SS as an assessment 
tool has never previously been reported in the literature.  Hence the clinical 
interpretation of these data is significant.  Inability to perform the test did not 
predict a poor outcome in terms of ICU and hospital mortality and length of stay; 
indeed there was no association between ability to perform the test and these 
clinical outcomes and thus rendering calculation of test characteristics unfeasible.  
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Likewise, there was no relationship observed between preserved peripheral 
muscle strength (MRC-SS >48) and ICU-AW (MRC-SS ≤48) and mortality.  Despite 
an association being demonstrated between MRC-SS and ICU and hospital length of 
stay, test characteristics revealed that whilst higher scores predicted favourable 
outcome, lower scores did not predict a poor clinical outcome.  That sensitivity was 
high for both ICU and hospital length of stay is of limited clinical relevance in this 
scenario.  Positive and negative predictive values are the properties that enable to 
judgement to be made prospectively on a patient’s outcome based on their 
presentation on assessment at awakening.    
 
In essence ability to perform the test and consequently scoring highly, were able to 
indicate a more favourable outcome in terms of ICU and hospital length of stay.  
However, ‘negative’ test status i.e. either inability to perform the test or scoring 
≤48/60 provided no predictive value of outcome.  These observations are, in 
principle, similar to those made when using volitional measurements of 
respiratory muscle strength, whereby a high value supports confirmation of 
preserved muscle strength, but a low value is not necessarily representative of 
muscle weakness, but related to ability to perform the test effectively [246-249].  
In addition further analysis using receiver operator curves to define an MRC-SS 
cut-off for each of the important clinical outcomes of ICU and hospital mortality 
and length of stay failed to identify clinically meaningful values of the MRC-SS.   
 
These data highlight the limitations in the robustness of the MRC-SS for use in day-
to-day clinical practice for considering outcome, albeit the sample size in this study 
is likely to be too small to be definitive and the confidence intervals around all test 
characteristic values are wide.  Alternative outcome measures are required for 
monitoring the progression of muscle wasting and weakness in critically ill 
patients, which need to be correlated with physical performance.  Recent data has 
demonstrated a reduction in quadriceps rectus femoris cross sectional area during 
early critical illness measured using ultrasound [250] with muscle layer thickness 
negatively correlated with length of stay [82].  These simple non-volitional and 
effort-independent tests have the potential for further clinical application in the 
intensive care unit to provide more physiologically accurate and robust data on 
muscle structure and function during critical illness. 
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3.4.2.3 MRC-SS and physical function 
 
Patients diagnosed with ICU-AW demonstrated reduced handgrip strength 
compared to those without ICU-AW, which is similar to previously reported data 
[36].  However, the current data only demonstrated a moderate direct relationship 
between MRC-SS at awakening and handgrip strength at ICU discharge which is 
not wholly unexpected.  This is in part a consequence of both the different timings 
of assessment as well as the different muscle groups that are assessed during each 
test.  MRC-SS testing does not include distal muscle function, such as hand muscle 
strength, a muscle group often affected early on as part of a motor neuropathy [5].  
Furthermore, ability to perform handgrip dynamometry according to standard 
guidelines [233] requires upper limb strength and thus upper limb weakness 
demonstrated by those patients with MRC-SS less than 48 would have been 
expected to influence performance of this measure.  Data regarding hand 
dominance was not recorded and hence it is not possible to comment on the 
influence of this on the current results.   
 
Only a moderate correlation was shown between MRC-SS and two common 
measures of physical function, which again is not unexpected given these 
represent different domains of muscle impairment and function.  In addition to the 
different timings of the assessments, the MRC-SS is a composite score of peripheral 
muscle strength, based on single muscle group manoeuvres.  It fails to capture the 
spectrum of complex motor tasks and interaction between skeletal muscle 
strength and endurance, balance, co-ordination and higher-level cognition 
required for complex physical function activities.  Many activities assessed with 
the Barthel and EMS scales involve hand function, not measured by MRC-SS 
testing.  It was not possible to assess physical function at awakening and testing 
MRC-SS at discharge was not central to the current study, which focussed on the 
usefulness of MRC-SS testing during the early stage of critical illness.  Furthermore 
there was no difference in physical function measures between groups with and 
without a diagnosis of ICU-AW, albeit this may be attributable to the smaller 
sample of patients without ICU-AW following ICU discharge and p values 
approached statistical significance.  Nonetheless these findings suggest that using 
the MRC-SS to grade strength in critically ill patients may not accurately reflect 
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level of physical functional ability, which has implications for provision of targeted 
rehabilitation interventions.   
 
3.4.3 Comparison with previous studies 
 
3.4.3.1 Inter-observer agreement 
 
In addition to the current dataset inter-observer agreement for manual muscle 
testing using the MRC-SS in critically ill patients has been reported by a small 
number of previous authors.  In a minor subset of their main critically ill patient 
cohort (n=12, out of 174), Ali et al [36] reported complete agreement between two 
examiners for diagnosing ICU-AW.  It is unclear, however, at which time point 
during admission these assessments were performed to enable comparison.  
Further high Kappa agreement values of 88% for diagnosing ICU-AW have also 
been demonstrated, albeit in a combined cohort (n=19) of simulated and stable, 
recovery-stage patients post ICU-discharge [59].  The earliest data on agreement 
documented on ICU patients assessed whilst within the ICU came from a cohort 
studied by Hough et al in 2011 [60] where only 10 patients were able to undergo 
testing, and only modest agreement for scoring MRC-SS <48/60 was evident 
(Kappa 0.38).  Agreement in patients assessed following ICU discharge was 
complete (Kappa 1.0).  In a larger cohort of 75 ICU patients, a third of whom were 
long-stay admissions of ≥15 days, agreement for identifying patients with MRC-SS 
<48/60 was moderate to good (Kappa 0.68±0.09).  For identifying severe 
weakness i.e. MRC-SS <36/60 agreement was almost complete (0.93±0.07). 
 
These contrasting datasets challenge the clinical usefulness of using the MRC-SS to 
measure ICU-AW in patients within the ICU and early in their critical illness.  
Although original reports of MRC-SS testing by Kleyweg et al [35] demonstrated 
high levels of inter-observer reliability of the MRC-SS, this was in a cohort of 
recovering stable patients with Guillain-Barré syndrome, albeit the cohort 
included bedbound patients still requiring invasive ventilatory support.  Inherent 
clinical variation and unpredictability during early critical illness highlight the 
major limitations of employing volitional testing in this population thus affecting 
reliability.  Agreement is poorer in patients within the ICU compared to those more 
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stable patients following ICU discharge, or where simulated weakness is utilised as 
a comparator as in the current study.  Furthermore levels of disagreement within 
the ICU are influenced by the construct of the MRC grading scale itself, such that 
levels 3 and below which are objective to score, demonstrate strongest agreement, 
and levels 4 and above, involving arbitrary levels of applied resistance are more 
challenging.  Thus, as mentioned previously, disagreement centres on patient-
related variability in turn compounded by the nature of the score itself.   
 
In addition to the MRC-SS, Vanpee et al [244] examined inter-observer agreement 
of handheld dynamometry, an alternative form of manual muscle testing.  In their 
cohort of 39 critically ill patients, Vanpee and colleagues reported good levels of 
agreement in the six muscle groups comprising the MRC-SS (ICC ranging 0.76-
0.96).  However testing was restricted to only those awake and cooperative 
patients, scoring >3 on the MRC scale i.e. movement against gravity.  These findings 
were echoed by Baldwin et al [50] who reported good levels of inter-rater 
reliability across handgrip, elbow flexion and knee extension dynamometry, 
although it was noted that improvements of approximately 20% would be 
required to reflect real force changes in critically ill patients. 
 
In contrast to previous reports, we found no pattern in distribution of weakness of 
either a proximal-to-distal nature, or regarding symmetry.  However dominance 
was not recorded to examine if this was a contributing factor, nor presence of 
specific lines, attachments or other similar monitoring device at the time of testing 
that may have accounted for individual variation in particular muscle group scores.   
 
3.4.3.2 Predictive value of the MRC-SS 
 
Whilst many observational studies have shown associations between ICU-AW and 
both short-term and long-term outcomes, including mortality and length of stay 
[11, 36, 37, 43], surprisingly there have been no previous data reported 
investigating the test characteristics of the MRC-SS for these important clinical 
outcomes.  Given its role as a diagnostic tool for ICU-AW such analysis is 
warranted, and the current study provides novel data in an attempt to address this, 
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presenting unique findings that challenge the usefulness of the MRC-SS for 
predicting outcome in critically ill patients.     
 
In the present cohort a proportion of patients never regained conscious to undergo 
testing.  This is in keeping with a number of other reports and highlights the 
challenging feasibility of the MRC-SS in the ICU population [11, 36, 38, 60].  In such 
patients the usefulness or relevance of a diagnosis of ICU-AW is debatable, and 
whether any change in clinical course or management would be influenced by such 
a finding [60, 251].  However confirming muscle weakness or impairment at an 
early stage may alert clinicians to directing physical rehabilitation therapy or other 
medical strategies aimed at ameliorating muscle wasting and weakness, and thus 
potentially altering clinical outcome.  Nonetheless it is important to understand 
and assess muscle strength, physical function and/or exercise capacity at ICU 
discharge in order to optimise ongoing rehabilitation input beyond the ICU. 
 
3.4.3.3 Physical function and handgrip strength 
 
Data from the current study demonstrating a significant difference between those 
patients with and without ICU-AW in terms of handgrip strength are in keeping 
with those previously reported [36].  Furthermore, in the study by Ali et al [36] 
gender-specific thresholds were identified for handgrip strength that could be 
used to identify ICU-AW.  Whilst advantageous in that this would minimise the 
number of muscle groups requiring assessment for diagnosis, handgrip strength is 
limited by the same caveats associated with volitional measures.. 
 
However there are limited available data evaluating the relationship between ICU-
AW and physical function.  Whilst this was not the focus of the current study, 
follow-up of those patients with awakening MRC-SS values permitted some 
investigation of this.   There was no difference in physical function characterised 
using two commonly implemented measures for hospital in-patients, between 
those patients with (MRC-SS <48/60) and without (MRC-SS ≥48/60) ICU-AW, 
although it is acknowledged that statistical significance was approached.  These 
are similar to the findings from Kleyweg et al’s original MRC-SS work [35] who 
reported that in patients with higher physical function levels, the MRC-SS offered 
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little additional information.  One explanation for this change in MRC-SS without a 
change in functional level, is the lack of sensitivity in the MRC grading scale to 
diagnose clinical weakness despite the presence of underlying electrophysiological 
changes [27].  Further investigation of this concept is required in prospective 
studies with contemporaneous assessment points, but the current data suggests 
that MRC-SS may not be an accurate marker to predict physical function in 
critically ill patients. Indeed, level of physical function itself, may be more 
appropriate reflection of impairment in muscle function developed during critical 
illness, and be used to direct physical rehabilitation interventions.   
 
3.4.4 Future studies 
 
A number of methodological factors arising through the studies discussed in this 
chapter could be considered in order to enhance the conduct of future similar 
investigations.  Whilst patients were assessed for awakening using widely reported 
screening criteria (categorisation on a known sedation scale and completion of 
simple, one-stage commands), it is acknowledged that a thorough assessment of 
confusion and delirium prior to testing would provide greater insight into patients’ 
appropriateness to perform volitional manual muscle testing to an optimum 
capability.  The Confusion Assessment Method for the ICU (CAM-ICU) [245] is a 
commonly reported technique for this purpose and undertaking such an 
assessment would add robustness to this stage of the protocol.  In tandem with 
this, a future protocol should carefully consider timing of testing in relation to 
delivery of any sedation dose and any sedation hold performed.  This is in itself 
would require clear definition, as practice in this area can vary between different 
clinicians and ICUs.  Accurately capturing data on intervening pharmacotherapy 
between testing by both clinicians would ensure the clinical status of patients is 
fully characterised and that results could be interpreted fully in the context of the 
influence of any agents on reliability.  These aspects particularly focussing on 
patient testing are significant as it is essentially intra- and inter-observer reliability 
and agreement in the patient population that is of most clinical importance, as 




The current studies focussed on the MRC-SS cut off of less than 48 out of 60 as the 
diagnostic threshold for ICU-AW.  Whilst we undertook preliminary analysis to 
identify any other cut-off levels with acceptable test characteristics, and found 
none that met suitable levels, further investigation could be warranted to examine 
this area in the critically ill population.  Of particular interest would be to correlate 
levels of weakness with performance on physical functional tests in order to 
determine clinically important levels of weakness.  In addition, the current studies 
found variability in precision of reliability and agreement in scores across different 
muscle groups.  Future studies may benefit from examining performance of 
individual muscle groups in greater detail, as the current use of six functional 
upper and lower limb muscle groups may be in excess of requirements, especially 
in light of any relationships with physical function where certain muscle groups 
may be predominantly used.   
   
3.5 Conclusion  
 
The current data have identified the limitations of using the MRC-SS test to 
diagnose ICU-AW during the early stages of critical illness, which have important 
clinical considerations.  Even when performed by expert clinicians, the fluctuating 
clinical status of patients significantly reduced inter-observer agreement of the 
test.  Furthermore, inability to perform the test and a score indicative of ICU-AW 
demonstrated limited clinical usefulness in considering outcome.  In addition, 
there was only a weak relationship between MRC-SS value and the level of physical 
function in ICU survivors.  The findings of the current study reflect the inherent 
limitations of volitional strength testing in critically ill patients, in particular, in the 
early stages of the process.  This strongly supports the need for alternative non-
volitional techniques that can be applied to all patients, for objective assessment 
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Ultrasound has recently emerged as a potentially valuable and effective tool for 
measuring the changes in a variety of parameters detailing peripheral skeletal 
muscle structure during critical illness [81, 250, 252, 253].  It is an effort-
independent technique that avoids ionising radiation, and it is quick, simple, cost-
effective and easy to perform at the bedside.  Furthermore it is widely accessible in 
the majority of intensive care units and, with basic training, can be implemented by 
a variety of non-specialist clinicians.   
 
Characteristics of peripheral skeletal muscle that can be investigated using 
ultrasound include anatomical cross-sectional area (ACSA).  One of the muscle 
groups commonly assessed is quadriceps rectus femoris as it is easily identifiable 
through its size and location [81-83, 86, 250, 252-254].  Previous data have 
reported a relationship between anatomical cross-sectional area of quadriceps 
rectus femoris (RFCSA) and volitional and non-volitional measures of quadriceps 
muscle force in patients with chronic respiratory disease and healthy age-matched 
subjects [65, 73].  These data support the use of ultrasound in patient groups 
where accurate measurement of muscle force can be technically challenging, such 
as those with critical illness in the intensive care unit.  Indeed, RFCSA could act as a 
surrogate marker for muscle strength.  In these studies RFCSA was measured at a 
point three-fifths distance from the anterior superior iliac spine to the superior 
patellar border (3/5 distance).  The anthropomorphic presentation of patients 
with chronic disease, often with disease-related skeletal muscle wasting, cachectic 
body composition and age-related muscle changes, is such that complete 
visualisation of RFCSA is technically feasible at this measurement point.  In the 
critically ill population, including younger patients without chronic co-morbidity 
or preceding muscle decline, this may not always be possible due to the current 
technical limitations of the device and the whole RFCSA image is outside the 
scanning window of the probe.  In these cases a more distal measurement point 
such as two-thirds distance from the anterior superior iliac spine (2/3 distance) 
allows entire RFCSA image acquisition as muscle dimensions are smaller due the 
natural shape of the rectus femoris muscle as it extends towards insertion on the 
patella [82, 250].  This measurement point has also successfully been used to 
131 
 
determine muscle layer thickness in patients in the ICU [82].  However a 
relationship between RFCSA measured at the ‘two-thirds distance’ measurement 
point and quadriceps force has not been previously confirmed. 
 
In addition, in clinical research there has been little attention focussed on 
pennation angle, the angle of muscle fibre insertion [98], which can also be 
assessed using ultrasound.  Measurement of pennation angle permits calculation of 
the physiological cross-sectional area (PCSA) of a muscle.  This combination of 
anatomical cross-sectional area and fibre angle of the muscle allow both the size 
and the mechanical contractile properties of the muscle to be assessed.  
Physiological cross-sectional area could be hypothesised to demonstrate a 
stronger correlation with muscle strength [98], which may be clinically useful 
when considering use of this measurement in critically ill patients.  However this 
has not been tested.  Finally, there are few data reporting intra- and inter-observer 
reliability for use of ultrasound for the measurement of muscle size.  
Demonstrating acceptable levels of agreement of the technique would further 
support its use in the clinical setting.   
 
4.1.1 Aims of study 
 
The aims of this study were threefold: 
 
1. To determine the relationship between RFCSA measured at 2/3 distance, and 
volitional and non-volitional assessments of quadriceps force 
2. To investigate the relationship between quadriceps rectus femoris 
physiological cross-sectional area (RFPCSA), measured at both 3/5 and 2/3 
distance, and volitional and non-volitional assessments of quadriceps force 










4.2.1 Study design 
 
This was a two-part, single-centre observational study.  Study 1 investigated the 
relationship between RFCSA and RFPCSA, and volitional and non-volitional 
measurement of quadriceps force (quadriceps maximum voluntary contraction 
(QMVC), and twitch tension, (TwQ) respectively) in healthy subjects.  Study 2 





Healthy adult volunteers (≥18years of age) were eligible for inclusion for Study 1.  
Exclusion criteria included musculoskeletal pathology precluding ability to 
perform maximum voluntary quadriceps contractions.  Pregnancy, presence of 
cardiac devices, and metal implants in the field excluded participation as 
documented contraindications to magnetic stimulation. 
 
For Study 2, intra-observer agreement was investigated in a cohort of healthy 
subjects, and inter-observer agreement was investigated in critically ill adult 
patients (≥18years of age), all of whom were participating in existing research 




4.2.3.1 Quadriceps rectus femoris anatomical cross-sectional area and 
pennation angle 
 
Quadriceps rectus femoris anatomical cross-sectional area (RFCSA) and pennation 
angle (RFPA) were measured with real-time B-mode ultrasonography using an 
8MHz 5.6cm linear transducer (PLM805, Toshiba Medical Systems Ltd, Crawley, 
UK) in keeping with previously described techniques [73, 95].  Measurements 
were taken at two-thirds (2/3 distance) and three-fifths (3/5 distance) distances 
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from the anterior superior iliac spine to the superior patellar border.  Further 
detail for this technique is described in Chapter 2.7.1.  
 
4.2.3.2 Quadriceps rectus femoris physiological cross-sectional area 
 
Quadriceps rectus femoris physiological cross-sectional area (RFPCSA) was 
calculated using the following equation,   
  
RFPCSA(cm2) = RFCSA(cm2)cosθ 
 
where θ is pennation angle [94, 98], and cosine of pennation angle normalises fibre 
angulation to the line of action of the muscle [99].  Physiological cross-sectional 
area is discussed in greater detail in Chapter 1.5.2.1. 
 
4.2.3.3 Quadriceps maximum voluntary contraction and twitch tension 
 
Strength was measured volitionally using the technique of isometric quadriceps 
maximum voluntary contraction, and non-volitionally using twitch tension 
following femoral nerve magnetic stimulation.  Equipment set-up using a purpose-
built strength-testing bench system was employed [74].  These techniques are 
described in further detail in Chapter 2.6.1. 
 
4.2.3.4 Anthropometric measurements 
 
Height, weight and fat-free mass were determined using bio-electrical impedance 
analysis (Bodystat® 1500, Bodystat®, Isle of Man, UK) (Chapter 2.8).  
 
4.2.4 Study 1 – Relationship between anatomical and physiological 
quadriceps rectus femoris cross-sectional area and strength 
 
Healthy subjects underwent ultrasound measurement of RFCSA and RFPA at both 
measurement points, volitional and non-volitional measurement of quadriceps 
force (QMVC and TwQ), and anthropometrics, on a single occasion. 
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4.2.5 Study 2 – Intra- and inter-observer agreement for use of ultrasound to 
measure quadriceps rectus femoris anatomical cross-sectional area 
 
Healthy subjects underwent repeated measurements of RFCSA separated by one 
hour (by the researcher, BC).  Critically ill patients either within the ICU, or within 
twenty-fours of ICU discharge, underwent ultrasound measurement of RFCSA by 
two experienced clinicians (BC and colleague).  Measurements were performed 
independently and in a random order within 15minutes of each other.   
 
4.2.6 Statistical analysis 
 
For Study 1, unmatched group analysis of gender-specific quadriceps muscle force 
and cross-sectional data was performed using either unpaired or Mann-Whitney 
testing.  Subsequent correlation testing determined the relationship between the 
variables of quadriceps muscle force and cross-sectional area. 
 
In Study 2, inter-observer agreement between both clinicians for measurements of 
RFCSA was determined using intra-class correlation coefficients (ICC) calculated 
using a two-way random effects for absolute agreement [242], and Bland-Altman 
analysis.  This process was conducted for the whole set of measurements, and 




4.3.1 Study 1 - Relationship between anatomical and physiological 
quadriceps rectus femoris cross-sectional area and strength 
 
Twenty-one healthy adults participated.  Ultrasound measurements of RFCSA and 
RFPA at 3/5 and 2/3 distances were obtained from all subjects.  QMVC and TwQ 
were not obtained in one subject due to equipment failure, and TwQ in one further 
subject who was unable to tolerate magnetic stimulation.  Anthropometric 
measures were obtained in all subjects.  Baseline characteristics of the group are 




Table 4-1 Demographic and anthropometric data for the cohort 
 
Characteristic Value 
Age (years) 31.0 (24.5-37.0) 
Gender (M:F) 9:12 
Height (m) 1.7±0.1 
Weight (kg) 68.5±10.8 
BMI (kg/m2) 23.7±2.3 
FFM (%) 77.1±8.6 
Thigh length (cm) 45.0±2.5 
Data are presented as mean±SD or median (interquartile range) as appropriate.  Thigh length is the 
distance from the anterior superior iliac spine to superior patellar border. 
 
Abbreviations: BMI = body mass index.  FFM = fat-free mass.   
 
Combined, and gender-specific, data for quadriceps strength and size are 
presented in Table 4-2.  In all measures, with the exception of pennation angle and 
% activation, a significant difference between males and females was evident.  
There was no significant correlation found between pennation angle at either 3/5 
or 2/3 distances, or anthropometric measures of age, height, weight, BMI, FFM or 
thigh length when data for both genders were analysed in combination.  Analysis 
separating for gender also revealed no clinically relevant findings.  Significant 
differences were evident between measures of force/unit area at each 
measurement point (3/5 vs. 2/3 distances, TwQ/RFCSA 11.8±5.4g/mm2 vs. 
16.3±7.9g/mm2, QMVC/RFCSA 59.6±18.1g/mm2 vs. 81.9±25.6g/mm2, TwQ/RFPCSA 
12.0±5.4g/mm2 vs. 16.5±8.0g/mm2, QMVC/RFPCSA 60.7±18.5g/mm2 vs. 


















Males      (n=9) Females   
(n=12) 
p value  
QMVC (kg) 44.8±12.0 55.2±7.1 36.3±7.5 <0.0001 
TwQ (kg) 9.6±4.0 12.6±3.6 7.4±2.5 0.0002 
% activation                            85.5±9.5 83.9±9.3 86.9±9.8 0.5 
3/5 RFCSA (mm2) 720.6±206.7 891.9±167.7 592.1±123.4 0.0001 
3/5 RFPA (°) 10.4 (9.8-11.5) 10.3 (9.7-10.7) 10.8 (9.8-12.1) 0.4* 
3/5 RFPCSA  (mm2) 708.1±204.3 877.2±166.2 581.2±121.6 0.0001 
2/3 RFCSA  (mm2) 520.7±148.2 627.2±111.8 440.9±120.9 0.002 
2/3 RFPA(°) 8.8 (8.3-9.6) 8.8 (8.2-10.9) 8.8 (8.4-9.4) 0.8* 
2/3 RFPCSA (mm2) 513.7±145.5 618.3±108.8 435.3±119.3 0.002 
Data are presented as mean±SD or median (interquartile range) as appropriate.  p values derived 
from unpaired t tests, or Mann-Whitney test (indicated by *) and compare M:F.   
TwQ males, n=8; QMVC, TwQ, TwQ females, n=10. 
 
Abbreviations: QMVC = quadriceps maximum voluntary contraction.  TwQ = quadriceps twitch force.  
RFCSA = rectus femoris cross-sectional area.  RFPA = rectus femoris pennation angle.  RFPCSA = rectus 
femoris physiological cross-sectional area.   3/5 = three-fifths distance from anterior superior iliac 
spine to superior patellar border.  2/3 = two-thirds distance from anterior superior iliac spine to 
superior patellar border.   
 
 
Quadriceps strength showed a linear relationship with RFCSA (vs. QMVC, r=0.7, 
p=0.001 and vs. TwQ, r=0.7, p=0.001) and RFPCSA (vs. QMVC, r=0.7, p=0.001, and vs. 
TwQ, r=0.7, p=0.001) at 3/5 distance as shown in Figure 4-1.  Figure 4-2 shows the 
relationship was similar at 2/3 distance - RFCSA (vs. QMVC, r=0.6, p=0.002 and vs. 
TwQ, r=0.6, p=0.01) and RFPCSA (vs. QMVC, r=0.6, p=0.002 and vs. TwQ, r=0.6, 
p=0.01). 
 
There was no correlation between RFPA and either RFCSA or RFPCSA measured at 
either 3/5 or 2/3 distances.  RFCSA at 3/5 distance correlated strongly with RFCSA 
measured at 2/3 distance (r=0.9, p<0.0001) and a similar relationship was evident 























































































Figure 4-1 Measures of quadriceps muscle force and architecture at 3/5 distance 
 
A.  RFCSA and QMVC.  B.  RFCSA and TWQ.   C.  RFPCSA and QMVC.  D.  RFPCSA and TwQ. 
p and r values derived from Pearson’s correlation 
 
Abbreviations: QMVC = quadriceps maximum voluntary contraction.  TwQ = quadriceps twitch force.  
RFCSA = rectus femoris cross-sectional area.  RFPCSA = rectus femoris physiological cross sectional area.  























































































Figure 4-2 Measures of quadriceps muscle force and architecture at 2/3 distance 
 
A.  RFCSA and QMVC.  B.  RFCSA and TWQ.   C.  RFPCSA and QMVC.  D.  RFPCSA and TwQ. 
p and r values derived from Pearson’s correlation 
 
Abbreviations: QMVC = quadriceps maximum voluntary contraction.  TwQ = quadriceps twitch force.  
RFCSA = rectus femoris cross-sectional area.  RFPCSA = rectus femoris physiological cross sectional area.  










4.3.2 Study 2 – Intra- and inter-observer agreement of RFCSA measurements  
 
4.3.2.1 Intra-observer agreement 
 
Five healthy subjects (M:F 2:3), with a median (IQR) age of 26.0 (21.0-30.5)years, 
height of 1.64 (1.62-1.74)m and weight 63.2 (57.4-76.0)kg, underwent three 
measurements of RFCSA at both 3/5 and 2/3 measurement points, separated by a 
minimum of 60 minutes.  Results are shown in Table 4-3 and Table 4-4.  Average 
co-efficients of variation were 0.4% and 0.9% for measurements performed at 3/5 
and 2/3 measurement points respectively.  Intra-class correlation coefficients 
(ICC) of 1.0 (95%CI 0.98-1.0) and 0.92 (95%CI 0.61-0.99) were found for 
measurements at 3/5 and 2/3 distances respectively, showing high levels of 
agreement.   
 
Table 4-3 Intra-observer variability of RFCSA measurements at 3/5 distance 
Subject Measurement point Occasion mean SD CV (%) 
1 2 3 
1 3/5 901.0 903.0 899.3 901.1 1.5 0.2 
2 3/5 737.0 747.7 742.7 742.5 4.4 0.6 
3 3/5 722.0 735.0 722.7 726.6 6.0 0.8 
4 3/5 736.3 742.7 746.0 741.7 4.0 0.5 
5 3/5 695.0 697.3 695.7 696.0 1.0 0.1 
Mean   761.6 3.4 0.4 
All ultrasound measurements in mm2. 
 
Abbreviations: 3/5 – three-fifths distance from anterior superior iliac spine to superior patellar border 













Table 4-4 Intra-observer variability of RFCSA measurements at 2/3 distance 
 
Subject Measurement point Occasion Mean SD CV (%) 
1 2 3 
1 2/3 571.3 560.0 573.3 568.2 5.9 1.0 
2 2/3 539.0 542.0 531.0 537.3 4.6 0.9 
3 2/3 568.0 563.0 560.7 563.9 3.1 0.5 
4 2/3 594.3 574.0 581.5 583.3 8.4 1.4 
5 2/3 523.3 517.0 520.3 520.2 2.6 0.5 
Mean   554.6 4.9 0.9 
All ultrasound measurements in mm2. 
 
Abbreviations: 2/3 – two-thirds distance from anterior superior iliac spine to superior patellar border 
measurement point.  SD = standard deviation.  CV = coefficient of variation 
 
 
4.3.2.2 Inter-observer agreement 
 
Twenty patients (M:F=14:6) with a mean (SD) age of 57.3±20.3years underwent 
measurement of RFCSA by two clinicians (BC, Clinician 1, and a second colleague, 
Clinician 2).  Table 4-5 summarises demographic and measurement data for the 
cohort.  RFCSA was measured at both 3/5 (n=6) and 2/3 (n=18) distances.  Four 
patients had measurements performed at both points.  
 
Bland-Altman analysis (Figure 4-3) demonstrates mean differences between the 
two clinicians for RFCSA measurements (95% limits of agreement -74.4 to 64.9mm2, 
mean (SD) bias -4.8(35.5)mm2), with the majority showing very close agreement.  















Table 4-5 Demographic and measurement data for critically ill cohort 
 






1 64 M 2-3 346.3 356.0 
2 82 M 2-3 206.3 214.0 
3 86 M 2-3 482.0 490.7 
4 63 F 2-3 292.3 368.7 
5 64 M 3-5 421.0 450.7 
6 82 M 3-5 303.3 315.3 
7 63 F 3-5 505.3 504.7 
7 63 F 2-3 260.0 260.3 
8 46 M 2-3 992.0 948.3 
9 59 F 2-3 228.0 206.7 
9 59 F 3-5 293.7 291.0 
10 27 M 2-3 828.7 865.7 
11 53 M 2-3 533.7 619.7 
12 45 F 2-3 360.7 257.7 
13 79 M 2-3 609.0 625.0 
14 18 M 2-3 498.0 481.0 
15 60 M 2-3 818.7 811.7 
16 28 F 2-3 371.7 383.7 
16 28 F 3-5 461.7 472.7 
17 65 M 2-3 454.3 458.3 
18 31 F 2-3 453.0 445.7 
18 31 F 3-5 573.3 583.0 
19 48 M 2-3 750.0 717.7 
20 83 M 2-3 273.3 261.0 
 
When the cohort of measurements was categorised and agreement investigated 
according to measurement point, high levels of agreement were evident for both 
3/5 (ICC 0.99 (95%CI 0.92-1.0), Bland-Altman 95% limits of agreement -82.8-
81.3mm2 (Bias -0.8mm2) and 2/3 distances (ICC 0.98 (95%CI 0.96-0.99), Bland-
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Figure 4-3 Bland-Altman plot of inter-observer agreement of average RFCSA 
measurements 
 




Data from the current study demonstrated that in a cohort of young healthy 
individuals, quadriceps rectus femoris physiological cross-sectional area (RFPCSA) 
showed no stronger relationship with volitional and non-volitional measures of 
quadriceps force than the simpler measurement of quadriceps rectus femoris 
anatomical cross-sectional area.  Interestingly, these data also showed that 
quadriceps rectus femoris pennation angle was independent of anthropometric 
factors.  A relationship between RFCSA measured at 2/3 distance and volitional and 
non-volitional measures of quadriceps strength was demonstrated, confirming and 
complementing the published data of the measurement at the 3/5 distance.  This 
finding is of technical and clinical importance with regard use of ultrasound to 
measure RFCSA in critically ill patients as these data support the reliable use the 
measurement of RFCSA at both distances.  In addition, high levels of intra- and inter-
observer agreement were demonstrated for RFCSA measurement, which further 










Participants in Study 1 were healthy individuals with no musculoskeletal 
pathology that would influence ability to perform maximum quadriceps 
contraction manoeuvres or preclude magnetic stimulation, or suggest changes in 
muscle appearance due to pathology.  Furthermore, the median age of the group 
was 31years.  Despite a maximum age of 71years, this still represents a relatively 
young cohort and as such limits the ability to generalise the results to a wider age 
range or disease group.  However, this does not detract from the importance of the 
study that demonstrated the limited clinical utility of incorporating the more 
complex measurement of pennation angle and physiological cross-sectional area 
compared with the simple measurement of anatomical cross-sectional area. 
 
To minimise testing burden in acutely unwell critically ill patients, a cohort of 
those healthy individuals participating in Study 1 completed the intra-observer 
agreement protocol and only inter-observer agreement was investigated in the 
patient group.  This process is mirrored by a recent study also examining reliability 
of measuring muscle wasting in ICU patients using ultrasound [255], whereas in a 
separate study involving patients with coronary artery disease, patients were used 
to test both intra- and inter-observer agreement, albeit these were a stable 
outpatient cohort [256].   Whilst limited demographic data are reported for this 
patient cohort, such as preceding ICU length of stay or duration of mechanical 
ventilation, they represent a sample taken from a larger cohort in whom the 
trajectory of muscle wasting was sequentially measured using ultrasound (loss 
from Day 1 of admission to Day 10, 17.7% [95% CI, −25.9% to 8.1%]; p<0 .001 
[250]), and can be considered reflective of a general ICU patient cohort.   
 
4.4.1.2 Technical considerations  
 
In critically ill patients peripheral skeletal muscle wasting, superimposed with 
fluid retention, can limit the value of alternative techniques to demonstrate muscle 
loss such as anthropometric measures of mid-thigh circumference or fat-free mass 
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that rely on a balanced state of hydration [86, 257].  For example, in a pilot cohort 
of ICU patients RFCSA was shown to significantly reduce over a ten day period, 
whilst thigh circumference remained unchanged [73].  Ultrasonography, which is 
not influenced by clinical state, has therefore been suggested as a technique to 
quantify muscle wasting in oedematous patients with multiple organ failure [254], 
and a number of investigators have reported on RFCSA and muscle layer thickness 
using ultrasound in critically ill patients in the ICU [81-83, 86, 250, 252-254].  
However the caveat to these quantitative measures is the lack of qualitative data 
reflecting muscle composition.  Echogenicity data are emerging that may give some 
indication of muscle quality [81] as well as quantity.  In addition contemporaneous 
measures of muscle force and cross-sectional area obtained in critically ill patients 
would confirm use of ultrasound as a surrogate marker for strength.  Despite this, 
acquiring such muscle force data in the ICU are technically challenging, particularly 
for the quadriceps muscle.  For this reason healthy subjects were investigated in 
the current study, but two measurement points on the muscle were analysed in 
order to provide technical validation for application of ultrasound of RFCSA in 
critically ill patients.  Previous studies have employed use of CT scans to validate 
RFCSA measurements in both healthy subjects and patients with chronic respiratory 
or cardiac disease [73, 256].  Whilst these data have proven the accuracy of 
ultrasonographic measurement in these patient groups, this method of 
confirmation of findings was not feasible for the ICU patient population in the 
current study.  Furthermore reliability of measures over time was also not possible 
due to the potential for further muscle wasting during interim days.   
 
Quadriceps rectus femoris pennation angle data in the current study were 
obtained from the average of three consecutive readings.  Image acquisition 
occurred when individual fibres could be visualised inserting into the aponeurosis 
separating quadriceps rectus femoris from the vastus intermedius muscle beneath 
[93, 97, 99, 102].  Calculation of RFPA was performed using offline imaging 
software.  Variation in screen resolution between the ultrasound and offline 
‘measurement’ screens could have affected image quality making discernment of 
the insertion point of fibres onto the aponeurosis difficult to establish resulting in 
potential over or underestimations of angles.  However, the agreement between 
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online and offline measurement has been demonstrated earlier in this thesis 
(Chapter Three, Methods), although only for RFCSA.   
 
Repeatability of quadriceps rectus femoris pennation angle was not undertaken in 
this study which could be considered a limitation of the protocol.  Future studies 
should examine reliability and validity of ultrasonographic assessment of all 
parameters of peripheral skeletal muscle architecture in critically ill patients, and 
this may also include echogenicity.  Acquisition of these data would further 
substantiate use of ultrasound as a method of muscle evaluation in this patient 
population.     
 
4.4.2 Clinical interpretation 
 
A correlation between RFCSA measured at 3/5 distance and both volitional and non-
volitional quadriceps force was demonstrated in keeping with that found in similar 
studies [65, 73].  Furthermore, this relationship was also observed at 2/3 distance, 
strongly supporting that both measurement points may be used in clinical practice 
as a surrogate marker of muscle force generation.  This is relevant for those 
critically ill patients who present without any pre-existing muscle pathology or 
wasting and where complete visualisation of RFCSA at the more proximal 
measurement point is often not possible due to the size of the muscle itself.  In the 
current study, quadriceps rectus femoris physiological cross-sectional area 
showed a similar relationship with volitional and non-volitional quadriceps muscle 
force as RFCSA, and thus the principle variable contributing to physiological cross-
sectional area is, in fact, anatomical cross-sectional area rather than pennation 
angle.  In part, this is a reflection of the muscle adopting a pennate arrangement to 
facilitate muscle location in the body, whereas a parallel fibre arrangement is not 
possible, and with pennate muscles losing a proportion of strength relative to the 
size of the pennation angle. 
 
Rutherford et al [97] found a significant correlation between pennation angle, 
derived from an average angle for vastus intermedius and lateralis muscle 
components of quadriceps, and cross-sectional area.  The different anatomical 
position of rectus femoris could explain the findings of the current study where 
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there was no such relationship between rectus femoris pennation angle and cross-
sectional area observed, if varying muscle position results in differing fibre 
pennation angles.  Further exploration of the relationship between pennation 
angle and quadriceps strength in disease groups where muscle pathology may be 
evident, such as critical illness may still be warranted, in particular if the angle was 
shown to alter with effects of training programmes to address muscle loss.  
Significant reductions in pennation angle of the vastus lateralis muscle have been 
shown in healthy subjects following five weeks of horizontal bed rest [93], a 
scenario applicable to acute patients experiencing critical illness.  It could be 
anticipated that similar findings, if not greater reductions, may be evident in this 
patient group especially those with chronic co-morbidity that may further 
exacerbate muscle pathology.    
 
As expected, quadriceps force measures differed significantly between males and 
females but with similar levels of percentage muscle activation demonstrated 
during manoeuvres.  As previously mentioned, participants were healthy subjects 
with no musculoskeletal pathology to influence performance of maximum 
volitional efforts for force generation.  The range of muscle activation evident 
showed that some individuals were delivering their maximum effort, whilst others 
may have had the capacity for further force generation.  This would be akin to 
scoring either Level 5 or Level 4 on the MRC scale [34].  If, using accurate 
physiological measurement under laboratory conditions, healthy individuals can 
demonstrate muscle strength performance that would translate to variable scoring 
on the MRC scale, then the potential for inaccuracy in measuring patients in acute 
clinical settings such as the in ICU is likely to be greater still.  This has potentially 
significant clinical implications if, for example, observed strength is one factor used 
in guiding delivery of physical rehabilitation interventions.  Furthermore the crude 
nature of ordinal MRC scale, means that variation in force between levels may not 
be detected.  That females demonstrated reduced force compared to males has 
been similarly reported in patients with ICU-acquired weakness, where cut-offs for 
handgrip dynamometry were lower in women than in men [36].  Levels of intra- 
and inter-observer RFCSA agreement were in keeping with previous studies [73, 
255, 256] albeit the smaller sample size for intra-observer agreement in the 
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current study (n=5) resulted in a greater impact from individual subject variation 
meaning 95% confidence intervals were very wide for the 2-3 distance.   
   
4.5 Conclusion 
 
Surprisingly, in a cohort of young healthy individuals, quadriceps rectus femoris 
physiological cross-sectional area failed to demonstrate a stronger relationship 
with quadriceps force than quadriceps rectus femoris anatomical cross-sectional 
area.  Pennation angle was found to be independent of anthropometric 
measurements and there was no correlation between pennation angle and either 
anatomical or physiological cross-sectional area.  At present it is reasonable to use 
anatomical cross-sectional area to investigate the trajectory of muscle wasting 
during critical illness.  Nonetheless, further exploration of pennation angle in 
disease states may still be valuable and indeed assessment of pennation angle 
before and after training needs investigation.  A relationship between quadriceps 
rectus femoris anatomical cross-sectional area measured at the 3/5 distance and 
2/3 distance and quadriceps strength was confirmed supporting the use of either 
measurement point in clinical practice, depending on the premorbid clinical state 
of the patient.  The high levels of intra- and inter-observer agreement for 
quadriceps rectus femoris anatomical cross-sectional area also strongly support 
the clinical reliability of ultrasound cross-sectional area measurement as a tool for 





























Chapter 5    Ultrasound for the Assessment of 
Peripheral Skeletal Muscle Architecture in 


















Peripheral skeletal muscle wasting and weakness are major complications of 
critical illness.  Loss of muscle strength is commonly referred to as intensive care 
unit acquired weakness (ICU-AW) [5] and observational studies report a high 
prevalence of ICU-AW affecting up to two-thirds of all critically ill patients [37].  As 
expected, ICU-AW is associated with prolonged weaning, delayed rehabilitation, 
increased hospital length of stay and increased mortality [11, 29, 30, 36, 37, 40-42, 
258].  In survivors of critical illness, significant and prolonged physical functional 
impairment and disability are evident, with deficits persisting up to five years 
following the index ICU admission [103-105, 259]. 
 
Early identification of those patients at risk of developing peripheral skeletal 
muscle wasting and ICU-AW using clinically useful tools for monitoring muscle 
dysfunction is key to successful patient management [140].  Risk stratifying 
patients with peripheral skeletal muscle wasting and weakness will allow exercise 
therapy, rehabilitation and other therapeutic interventions to be directed to those 
patients who are most likely to benefit.  Volitional methods of measuring muscle 
strength, such as manual muscle testing including the MRC-SS [35] and handgrip 
dynamometry [36], are often appealing due to their speed, ease of application and 
minimal testing equipment.  However these assessments are restricted to those 
alert, awake and cognitively intact patients, able to produce maximal efforts during 
testing.  Distinguishing between actual muscle weakness, poor motivation and 
inability to complete the task is challenging, and hence their use in patients in the 
early stages of critical illness is limited [57, 60]. 
 
Although non-volitional techniques involving electrical [65, 66] and magnetic [63, 
64, 260, 261] nerve stimulation of peripheral motor nerves to elicit a twitch force 
response of a muscle require limited patient cooperation, these techniques are 
technically complex to perform, in particular, within the ICU environment.  
Furthermore these tests require expensive, dedicated equipment and skilled 




Given the caveats associated with both volitional and non-volitional strength 
measurement in critically ill patients, recent attention has focused on the utility of 
ultrasound to monitor the trajectory of muscle wasting in critically ill patients 
[262].  Ultrasonographic differences have been demonstrated between healthy and 
diseased muscle [263, 264] and studies in healthy subjects and patients with 
chronic respiratory disease have demonstrated that peripheral skeletal muscle 
cross-sectional area, measured using ultrasound, correlate closely with muscle 
strength [73, 102, 265].  Ultrasound therefore acts as a surrogate where direct 
strength measurement is not feasible.  The technique of peripheral skeletal muscle 
ultrasound has been reported in previous reviews [87-89, 91] and a number of 
characteristics of peripheral skeletal muscle, including cross-sectional area, fibre 
pennation angle, muscle layer thickness and echogenicity [98] have been 
described.  The use of ultrasound also has both pragmatic and clinical advantages, 
which have been discussed in earlier chapters of this thesis.   
 
5.1.1 Aim of study 
 
The objective of this study was to conduct a systematic review to critically evaluate 
and synthesise evidence for the use of ultrasound to measure peripheral skeletal 
muscle architecture during critical illness.  This review was conducted and 
reported according to the Preferred Reporting Items for Systematic Reviews and 




5.2.1 Protocol registration 
 
The protocol for this systematic review was registered on the National Institute for 
Health Research (NIHR) International Prospective Register of Systematic Reviews 






5.2.2 Eligibility criteria 
 
Study characteristics for eligibility are detailed in Table 5-1, including details of 
participants, interventions, control groups and outcome measures.  
 
Table 5-1 Eligibility criteria for studies 
 
Characteristic Inclusion Exclusion 
Study Design Quantitative study design including 
randomised controlled trials, 
pseudo-randomised controlled 
trials, cohort, cross-sectional, case 
series, case control studies or case 
studies [267, 268] 
Studies not reported in a peer-
reviewed journal, descriptive 
commentary, conference abstracts 
or proceedings, preliminary 
reports when results are published 
in full in a later version 
Participants Adult patients (aged ≥18years) 
admitted to the intensive care unit 
with critical illness (irrespective of 
causal diagnosis) 
Animal studies; studies conducted 
solely in high dependency, long-
term weaning or acute ward 
settings 
Intervention Ultrasound for measurement of any 
characteristic of peripheral skeletal 
muscle architecture 
Non-peripheral skeletal muscle.   
Control/Comparator Not applicable.  No control or 
comparators. 
 
Outcome measures Measures of any characteristic of 
peripheral skeletal muscle 
architecture 
 
Publication No publication date or language 
restriction will be applied during 
the initial search 
Non-English language studies will 
be excluded from further review 
after the initial search 
 
5.2.3 Information sources 
 
Prior to conducting this review, the Cochrane Library, Physiotherapy Evidence 
Database (PEDro) and the NIHR PROSPERO database were searched to confirm a 
review of this nature had not been published or was in progress, and this was 
confirmed. 
 
Electronic databases (n=7) were searched by one reviewer (the researcher, BC) 
using a systematic comprehensive and reproducible search strategy to identify 
published evidence studies (Table 5-2).  Databases were accessed via the author’s 
institution, King’s College London, and included Medline (1946-present), 
Cumulative Index to Nursing and Allied Health Literature (CINAHL) (1981-
present), Cochrane Library (2013), PEDro (1993-present), Scopus (1960-present), 
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Excerpta Medica Database (EMBASE) (1980-present) and Web of Science 
(including Science Citations and Conference Proceedings) (1900-present), with the 
last search run 16th October 2013.  Details of full search strategies are included in 
Appendix IV.  Additional references were identified by cross-checking reference 
lists of included articles and searching the personal library of the author.   
 
Table 5-2 Search strategy 
  
Name of database Search fields Search terms (MESH Indexing 
and free text) 
Medline,                  Cochrane 
Library, CINAHL, EMBASE, 
PEDro, Web of Science, Scopus 
Title, abstract, key words i) intensive care; critical care; 
critical illness; critically ill; 
multi organ failure; sepsis;  
ii)ultrasound; ultrasonography;  
iii) muscle; muscle wasting; 
muscle mass; cross-sectional 
area; fibre (or fiber) pennation 
angle; muscle layer thickness; 
echo intensity; echogenicity; 
muscle architecture 
iv) #1 and #2 and #3 
Abbreviations: CINAHL = Cumulative Index of Nursing and Allied Health Literature.  EMBASE = 
Excerpta Medica Database.  PEDro = Physiotherapy Evidence Database.   
 
5.2.4 Search  
 
Trial registries, conference proceedings and electronic databases were searched 
using the following terms as MESH Indexing subject headings and free text search 
terms: intensive care, critical care, critical illness, critically ill, multi-organ failure, 
sepsis, ultrasound, ultrasonography, muscle, muscle wasting, muscle mass, cross-
sectional area, fibre pennation angle, muscle layer thickness, echo intensity, 
echogenicity, muscle architecture (Table 5-2). 
 
5.2.5 Study selection 
 
Figure 5-1 summarizes the study selection process.  Two independent reviewers 
(BC and a second reviewer) assessed studies for eligibility following a 
standardized process.  The title and abstract of all articles identified through the 
initial search process were used to determine eligibility against the predefined 
eligibility criteria (Table 5-1).  If there was insufficient information to inform a 
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decision, full text was sourced and independently reviewed again (BC and a second 
reviewer).  At both stages, in the event of disagreement a consensus approach was 
taken.  If agreement could not be reached, a third reviewer was employed to make 
the final decision.  At each eligibility assessment stage, level of agreement was 
determined using percentage agreement and Kappa statistic (SPSS for Windows, 
Statistical Version 20, IBM, New York, NY).  All references were stored in Endnote 
software, Version 6 (Thomson Reuters, Philadelphia, PA).   
 
5.2.6 Data extraction 
 
A bespoke data collection form was designed, and data extraction from included 
studies performed by one reviewer (BC) and cross-checked by a second reviewer.  
Data were stored in either Microsoft Excel or Word for PC 2007 (Windows 7, 
Microsoft Corporation, Redmond, WA). 
 
5.2.7 Data items 
 
Data extraction was conducted on all eligible studies including: (1) study design – 
type, author first name and country, publication journal and year, aim/objective; 
(2) participant characteristics; (3) ultrasound detail – timing of measurement, 
muscle groups and muscle architecture characteristics assessed, detail of 



















































Figure 5-1 Flow diagram summarising article selection 
 
Abbreviations: CINAHL = Cumulative Index to Nursing and Allied Health Literature.  EMBASE = 
Excerpta Medica Database.  PEDro = Physiotherapy Evidence Database.  ICU = intensive care unit.  US 


































Records identified through database 
searching Medline (1946-present), 
(CINAHL) (1981-present), Cochrane 
Library (2013), PEDro (1993-present), 
Scopus (1960-present), EMBASE (1980-
present), Web of Science (including Science 





through other sources: 
 









Records (titles/abstract) screened by two 










 Non-ICU patients 
n=1 
 Literature review 
n=3 
 Non-peripheral 
skeletal muscle n=9 
 Not relevant n=1 
 Protocol paper n=1 
 Non-English 
language n=1 
 US not primary 
intervention n=4 
 No use of US n=1 
Full text articles assessed for eligibility by 







 Non-ICU n=1 
 Conference abstract 
n=3 





5.2.8 Risk of bias in individual studies 
 
Two independent reviewers (BC and a second reviewer) assessed the included 
studies.  Study design was determined using a published classification algorithm 
from the Scottish Intercollegiate Guidelines Network (SIGN) and the National 
Institute for Health and Care Excellence, with associated relevant checklists 
employed to assess study quality [267, 269].  Studies were graded according to the 
Oxford Centre for Evidence-Based Medicine Levels of Evidence [268].  In addition 
methodological quality and risk of bias in randomised controlled trials (RCTs) 
were determined using the PEDro scale [270], and the Newcastle-Ottowa Scale 
(NOS) [271] for nonrandomised observational studies.   
 
5.3 Results  
 
5.3.1 Study selection 
 
Searching of the seven databases resulted in 672 potentially eligible studies, with a 
further 11 articles identified through cross-referencing and personal libraries 
(Figure 5-1).  Studies not published in English were excluded (n=1).  Two 
conference proceedings were checked but there were no relevant studies 
identified.  For the remaining conference abstracts (n=10), two studies within the 
author’s own library contained data pertaining to four of these abstracts.  The 
authors of a further two abstracts were contacted to determine if data were 
available in peer-reviewed publication format, following which neither study was 
included.  No contact was made with the remaining four abstract authors as data 
had been collected in non-ICU settings (n=2), in healthy subjects (n=1) or no email 
address or other contact details were available (n=1).        
 
High levels of agreement between the two independent reviewers were evident for 
potentially relevant titles/abstracts (BC and a second reviewer) (percentage 
agreement=90.2%, Kappa=0.72) and full-text articles (BC and a second reviewer) 
(percentage agreement=100.0%, Kappa 1.0).  The reviewers disagreed on four 
potentially eligible studies based on title and abstract.  Following consensus, 
agreement was reached on all four studies and none of these studies were 
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included.  Input from a third reviewer was therefore not required.  Review of title, 
abstract and full text resulted in the inclusion of seven original articles each 
evaluating unique patient cohorts.      
 
5.3.2 Study characteristics 
 
Study design characteristics are summarized in Table 5-3.  None of the seven 
included studies [81, 82, 86, 250, 252-254] were randomised controlled trials.  Six 
were primarily single group studies, classified as case series [81, 82, 86, 250, 253, 
254].  One of these studies involved comparison with an unmatched control group 
[253].  The final study adopted a case-control design [252].  All studies were Level 
4 evidence grade [268].  Significantly, the majority of included studies were 
published between 2012 and 2013 [81, 250, 252, 253] indicating the recent 
increasing research interest in ultrasound as a technique for evaluating changes in 
peripheral skeletal muscle architecture during critical illness.  Five studies were 
based in Europe [82, 83, 250, 253, 254], with one conducted in Australia [252] and 
one in North America [81].  Patient characteristics of included studies are reported 
in Table 5-4. 
 
Of the seven studies included, each involved independent general ICU patient 
populations, totaling 300 patients overall where the primary purpose involved 
assessment of peripheral skeletal muscle function during critical illness with 
ultrasound as the evaluation tool.  Sample sizes ranged between 9 [254] and 118 
[82] patients (Table 5-4).  Eligible patient populations in studies were 
characterized according to either clinical diagnostic descriptors (e.g. multi-organ 
failure and sepsis) [81, 253, 254], ICU admission-related descriptors (e.g. duration 
of mechanical ventilation and length of stay) [82, 250], or a combination of both 
[86, 252].  Only four studies reported actual illness severity of their patient cohorts 
using standard critical care scoring systems (APACHE scores) [86, 250, 252, 253], 
of which three further reported actual duration of mechanical ventilation for their 






Table 5-3 Outline of aims and design of included studies 
 
Reference Study Aim(s) Detail of Study Design Study Classification and 
Evidence Level 
Campbell et al 
[254] 
Establish a relation in normal individuals between fat-free mass derived 
from body weight and skinfold thickness measurements and muscle 
thickness measured by ultrasound, and compare lean tissue mass in 
subjects with and without oedema 
Prospective double group; separate 
cohorts of patients and  healthy 
subjects; groups investigated 
individually and not compared 
Non-comparative case series 
 
Level 4 
Gruther et al 
[82] 
Determine if ultrasound measurements are valid and practical for assessing 
muscle mass in daily routine in ICU patients; measure muscle wasting in 
ICU patients over a 28day period and determine the relationship with LOS  
Prospective “two-fold”; two patient 
cohorts; groups investigated 
individually and not compared 
Non-comparative case series 
 
Level 4 
Reid et al [86] Determine if ultrasound measurement of muscle wasting is applicable to a 
larger and sicker ICU population than previously reported ([254]); 
determine the relationship between muscle wasting and energy balance 
Prospective single patient cohort Non-comparative case series 
 
Level 4 
Baldwin et al 
[252] 
Determine muscle strength and size in respiratory and limb muscles of 
critically ill survivors of sepsis compared to healthy controls; determine 
relative effects in the degree of dysfunction between muscle groups 
Prospective cross-sectional design 
with case-controlled element; 
patient cohort and healthy 
matched control subjects 





Track changes during ICU admission of muscle layer thickness and 
echotexture in distal and proximal muscles, including the diaphragm 
Prospective single patient cohort Non-comparative case series 
 
Level 4 
Grimm et al 
[253] 
Evaluate if muscle ultrasound allows visualisation of changes in the muscle 
architecture during the early course of sepsis 
Prospective double group; patient 
cohort and unmatched healthy 
control subjects; groups compared 




et al [250] 
Characterise and evaluate the time course and pathophysiology of acute 
muscle loss in critical illness and the role of alterations in protein synthesis 
and breakdown in such changes 
Prospective single patient cohort Non-comparative case series 
 
Level 4 
Study classification determined according to algorithms from Scottish Intercollegiate Guidelines Network and National Institute for Health and Care Excellence [267, 269].  Evidence level according to the Oxford 
Centre for Evidence Based Medicine [268] 






Muscle thickness was the most common characteristic of muscle architecture 
evaluated (five studies) (Table 5-5) [81, 82, 86, 252, 254].  In one study, this was 
termed muscle layer thickness and used to reflect muscle mass [82].  Muscle 
composition using echogenicity was investigated in two studies [81, 253], and 
cross-sectional area in one [250].  A combination of mid-upper arm, forearm and 
thigh muscle groups were all measured in four studies [86, 252-254].  In addition, 
tibialis anterior and abductor digiti minimi muscle were also reported [81, 253].  
The quadriceps muscle alone was measured in two studies [82, 250].  Details of 
measurement procedure were provided in all studies (Table 5-5).  Timings of 
measurements varied between single measurements performed at specific time-
points during ICU admission [81, 82, 250, 252, 253], or sequentially throughout the 
duration of ICU admission [86, 254].            
 
5.3.3 Results of individual studies 
 
Results of individual studies are reported in Table 5-6.  Change in muscle 
architecture of critically ill patients was evident in six studies and associated with 
duration of time in the ICU [81, 82, 86, 250, 253, 254].  In the remaining case-
controlled study, muscle thickness was found to be significantly reduced compared 
to case-controlled healthy subjects at the single time-point assessed [252].  Rates 
of reported muscle wasting varied between 6.0% per day [254] and 1.6% per day, 
with more notable wasting in patients with greater muscle layer thickness at 
baseline [86].  A third study reported a 12.5% reduction between days 1 and 7, 
which further differed significantly between those with single-organ failure and 
multi-organ failure [250].  A quantifiable measurement of the degree of muscle 
wasting was not given in one study [82].  Muscle quality (echogenicity) was shown 
to be affected during critical illness with increases in image grey-scale values [81, 
253] which were significantly different to healthy controls, albeit an unmatched 
population [253].  Three studies reported high levels of ultrasound image 
reproducibility in critically ill patients (intraclass correlation coefficients (ICC) 
>0.9), for inter-image (muscle thickness and muscle echogenicity) [252, 253], 
intra-rater (muscle echogenicity) [253] and inter-observer (muscle cross-sectional 
area) [250] agreement.  Reid et al [86] also presented reproducibility data, 
reporting a coefficient of variation (CV) for total muscle thickness of 2.5% although 
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this was in a separate cohort of healthy volunteers rather than their ICU patient 
cohort.  Similarly, Campbell et al [254] reported an intra-observer CV of 1.5% and 
an inter-observer CV of 1.9% for total muscle thickness in a cohort of healthy 
subjects assessed within their study.   
 
5.3.4 Risk of bias within studies 
 
Two independent reviewers (BC and a second reviewer) agreed on the study 
design of included studies (percentage agreement=100%).  Due to the nature of 
study design assigned to the majority of studies (n=6, case series) involving single 
groups of patients receiving ultrasound measurements of peripheral skeletal 
muscle architecture during critical illness using ultrasound, there was no tool 
available to assess risk of bias in these studies [269].  The reviewers considered 
that the design of one of these studies [253], involving a comparison with an 
unmatched control group, did not meet the criteria for categorisation as a case-
controlled study with associated quality review.  The single identified case-
controlled study (Baldwin et al [252]) demonstrated positive scoring on seven out 
of eleven binary outcome criteria according to the SIGN checklist (63.6%), and 
percentage agreement of 84.6%, however no grading system exists to equate this 
to an overall descriptor of quality level [269].  This article scored 6 on the NOS 
indicating ‘good’ overall quality [271].     
 
5.3.5 Synthesis of results 
 
Meta-analysis or pooling of results was not appropriate due to the observational 
nature and design of studies included, heterogeneity of patient cohorts, and 
varying results related to different aspects of peripheral skeletal muscle 





Table 5-4 Patient characteristics in included studies 
  
Author, location Population n Age (years) Gender M:F Illness Severity Duration MV (days) 
Campbell et al, 
UK [254] 
MOF requiring artificial 
support of ≥2 organs 
9 63 (58-68) 8:1 No specific marker reported; 
patients were (1) fed via IV, 
enteral, or both; (2) 
mechanically ventilated; (3) 
invasively haemodynamically 
monitored with inotropic 
support 
Not specified 
Gruther et al, 
Austria [82] 
Group A, ICU LOS 
>28days 
Group B, ICU LOS 
>7days 
Group A, n=17 
Group B, n=101 
Group A, 55±17 
Group B, 55±15 
Group A, 14:3 
Group B, 74:27 
No specific marker reported;  
Patients received standard drug 
treatment 
Not specified 
Reid et al, UK 
[86] 
Sepsis or SIRS, 
mechanical ventilation 
>5 days 
50 57 (19-79) 26:24 APACHE II            17 (2-43) Not specified 





16 62±17 9:7 APACHE III 94±36 13 (7-27) 




16 59.3 7:9 No specific measure reported Not specified 
Grimm et al, 
Germany [253] 
Severe sepsis or septic 
shock 
28 69.5 (61.5-75.3) 25:3 APACHE II     22.5±6.5 20.5±13.7 
Puthucheary et 
al, UK [250] 
Intubated >48hrs, 
critical care LOS >7days, 
predicted ICU survival 
63 
 
54.5 (50.0-59.1)* 37:26 APACHE II            23.5 (21.9-
25.2)* 
10 (6-22) 
     Data presented as mean±standard deviation, median (Interquartile range), or mean (95% confidence intervals)* 
    
     Abbreviations: MV = mechanical ventilation.  M = males.  F = females.  MOF = multi-organ failure.  SIRS = systemic inflammatory response syndrome.  IV = intravenous.  ICU = intensive care unit.  LOS = length of stay.                 







Table 5-5 Detail of peripheral skeletal muscle architecture measured using ultrasound in included studies 
  
Reference Technical Detail Muscle Architecture Parameter/ 
Muscle group(s)/ 
Procedure 
Campbell et al 
[254]* 
ALOKA SSD 500 portable US 
machine, equipped with 3.5MHz 
linear array transducer 
 
Measurements made using built-
in electronic calipers on frozen, 
real-time cross-sectional images 
 
Mean of three measurements at 




Biceps (biceps brachia and coracobrachialis); Forearm; Thigh (quadriceps muscle group) 
 
Mid-Upper arm anteriorly 
Patient supine, elbow flexed to 90°, point marked on the skin midway between the tip of acromion and tip of 
the olecranon.  Subject supine, elbow extended, forearm supinated, thickness of the flexor compartment 
measured over biceps between the superficial fat-muscle interface and the humerus 
 
Forearm 
Patient supine, elbow extended, forearm supinated, point marked midway between antecubital skin crease and 
the ulnar styloid.  Flexor compartment thickness measured anteriorly between superficial fat-muscle interface 
and the interosseus membrane 
 
Thigh 
Patient supine, knee extended, midway point marked between tip of the greater trochanter and lateral joint 
line of knee.  Thickness of the quadriceps muscle group between the superficial fat-muscle interface and the 
femur measured anteriorly 
Gruther et al 
[82] 
HDI-100 ATL portable US 
machine with an L7-4 transducer 
with a 5cm linear array footprint 
 
Mean MLT calculated as mean of 
measurement i) and ii)) on each 
leg 
Muscle mass (muscle layer thickness) 
 
Quadriceps vastus intermedius and rectus femoris 
 
Vastus intermedius and rectus femoris assessed bilaterally at i) border between lower and upper two-thirds, 








Reid et al [86] ALOKA Echo Camera SSD-
210DXII portable ultrasound 
machine with a 5MHz linear array 
transducer 
 
Measurements made using built-
in electronic calipers on frozen, 
real-time cross-sectional images 
 
Mean of three measurements 
used for statistical analysis 
 
Mean values from three sites 




Mid-upper arm (biceps and brachialis); Forearm; Thigh 
 
Mid-Upper arm 
Patient positioned in supine.  Measured over the biceps down to the humerus, at a point midway between the 
tip of the acromion and the tip of the olecranon, with elbow extended and forearm supinated 
 
Forearm 
Patient positioned in supine.  Measured down to the interosseus membrane at a point midway between the 
antecubital skin crease and ulnar styloid, with elbow extended and forearm supinated 
 
Thigh 
Patient positioned in supine.  Measured down to the femur, on the anterior surface of the thigh, midway 
between the tip of the greater trochanter and the lateral joint line of the knee identified 
Baldwin et al 
[252]* 
DP-6600 Shenzhen Mindray Bio-
medical Electronics portable US 
machine with a 10MHz  38mm 
linear transducer array 
 
Three measurements taken per 
muscle group 
 
Transducer placed at the most 
anterior facing aspect of each 
segment, in the transverse plane 
from the mid-segment point 
 
Technique in keeping with that 
previously reported by Baldwin 
et al  [272] 
Muscle thickness 
 
Mid-upper arm; Mid-forearm; Mid-thigh 
 
Mid-upper arm 
Measured to the humerus, with patient supine, elbow extended and arm neutrally rotated in slight abduction 
(≈10°) alongside the body 
 
Mid-forearm 
Measured to either mid-way point between radius and ulna along the interosseus membrane, or, where 
interfaces most parallel, depending on individual patient anatomy; forearm positioned with sufficient 
supination to improve visualization of interosseus membrane.  Patient positioned in supine 
 
Mid-thigh 











Esaote Biosound MyLab 25 
portable ultrasound machine 
with an 18-MHz linear-array 
transducer 
 
Settings - overall gain 76%, time-
gain compensation in the neutral 
position, single focal zone, power 
of 75%, mechanical index 0.5, 
constant depth settings (except 
where large volume of 
subcutaneous edema require 
alterative settings to view 
muscle) 
 
For grey-scale data,  2cmx2cm 
region of interest was placed over 
the representative muscle 
(1cmx1cm for abductor digiti 
minimi) 
Muscle thickness, subcutaneous tissue thickness, mean (standard deviation) of grey-scale values 
 
Tibialis anterior; Rectus femoris; Abductor digiti minimi; Biceps brachii and brachialis complex 
 
Measurements taken at 5cm distal to fibular head (tibialis anterior), 15cm proximal to the superior portion of 
the patella (rectus femoris), middle of the fifth metacarpal (abductor digiti minimi), 10cm proximal to the 
antecubital fossa (biceps brachii and brachialis complex).  Patient position not specified 
 
 
Grimm et al 
[253] 
Siemens Acuson portable US 
machine with a 9-13MHz linear 
transducer array scanner 
 
Settings – kept constant during all 
examinations excluding depth, 
which was altered individually to 
visualize complete muscle 
 
Echogenicity graded using the 
Heckmatt scale – 4-point scale 
where higher grades of 
echotexture correlates to severity 
Muscle echogenicity 
 
Biceps brachii; Quadriceps femoris; Forearm extensors; Tibialis anterior 
 
Patients supine with arms and legs in relaxed extension; measurements taken at the midline between origin 
and insertion (biceps brachii and quadriceps femoris), the first third distance between elbow and processus 








of muscle impairment; 
echotexture scores for four 
muscle regions averaged to 
generate a mean echotexture 
score 
Puthucheary 
et al [250] 
PLM805 Toshiba Medical Systems 
portable US machine, B-mode 
with an 8MHz 5.6cm linear 
transducer array; Philips Envisor 
HD 1.3 portable US machine, B-
mode with a 6-15MHz 4cm linear 
transducer array 
 
Overall cross-sectional area taken 





Quadriceps rectus femoris 
 
Transducer placed perpendicularly along the superior aspect of the thigh, two-thirds distance between 
anterior superior iliac crest and the superior patellar border; patients in supine with 30° head elevation unless 
clinically unfeasible 
*only detail provided regarding peripheral skeletal muscle data in critically ill patients.  Campbell et al [254] additionally measured calf, trunk and triceps muscle groups in healthy subjects, Baldwin et al [252] 
additionally measured the diaphragm in the critically ill cohort, and all muscle groups in healthy controls, Cartwright et al [81] additionally measured the diaphragm. 
 
















Table 5-6 Data demonstrating changes in muscle architecture measured using ultrasound from included studies 
  
Reference Timing of Measurement Results 
Campbell et al 
[254]* 
Commenced within 5days of MOF 
onset and ICU admission 
 
Serial measurements performed 
every 1-4days for between 5 and 
11 days, with a minimum of 5 
measurements per patient 
Median (max-min) rate of muscle wasting (expressed as percentage of first measurement), 6.0 (2.0-9.2)% 
per day 
 
Significant negative correlation between muscle thickness and time (max-min r=-0.919 to -0.978, p=0.027 to 
<0.001) 
Gruther et al 
[82] 
Group A: measurements 
performed twice, once at baseline 
(random LOS, at least 1 day after 
ICU admission) and after 28d of 
ICU admission 
 
Group B: one measurement 
performed after a random ICU 
LOS 
Group A 
MLT measurements in both legs showed a reduction (n=27 thighs) and an increase (n=7 thighs) between 
time-points; high significant negative correlation between MLT of the right (p=0.005) and left (p=0.004) 
thigh, and MLTD (MLT difference at 28days) for the right (p=0.006) and left (p=0.003) thigh, and LOS at ICU 
baseline measurement time; LOS at ICU baseline measurement time the only variable influencing MLTD on 
the right (p=0.006) and left (p=0.003) thigh 
 
Group B 
High significant negative correlation between MLT of the right (p<0.0001) and left (p<0.0001) thigh and LOS 
at ICU baseline measurement; LOS at ICU baseline measurement (p<0.0001) and thigh circumference 
(p=0.006) only variables that influenced right thigh MLT; LOS at ICU baseline measurement (p<0.0001), 
thigh circumference (p<0.0001) and height (p=0.016) only variables influencing left thigh MLT 
Reid et al [86]               Measurements performed every 
1-3days, in keeping with method 
described by Campbell et al 
[254], for between 7 (5-39)days 
Total muscle thickness decreased with time in 96% of patients (n=48/50) (r2=-0.953, p<0.001); median 
(range) rate of decrease as percentage of baseline 1.6 (0.2-5.7)%/day; 2 patients demonstrated increases of 
1.1 and 0.6%/day 
 
Non-significant difference in percentage change in muscle thickness between those patients whose mid-
upper arm circumference decreased (% change -1.3(-0.2 to -4.0)) or remained the same (% change -1.6 (-0.3 
to -4.2)) 
 












baseline (at baseline ‘thicker’ muscle 5.25 (4.3 to 6.8)cm vs. ‘thinner’ muscle 3.75 (2.6 to 4.2)cm, p<0.001; 
total change in 7 days -0.8 (-0.2 to -2.3)cm vs. -0.35 (0.0 to -1.1)cm, p=0.001); when loss expressed as 
percentage of first measurement p=0.051 
Baldwin et al 
[252]* 
Measurements performed at 
median (IQR) 16 (11-29)days of 
ICU admission 
Excellent reproducibility of triplicate measurements of peripheral skeletal muscle thickness (ICC ≥0.976) 
 
Muscle thickness significantly lower in critically ill patients compared to healthy controls - upper arm 
(25.1±4.3 vs. 20.6±4.4mm, mean difference 4.5mm, 95% CI 1.3-7.6mm, p<0.01), forearm (29.8±4.6 vs. 
22.6±4.9mm, mean difference 7.2mm, 95%CI 3.8-10.6mm, p≤0.001), thigh (29.0±5.8 vs. 16.8±6.1mm, mean 
difference 12.2mm, 95%CI 7.9-16.5, p≤0.001) – when corrected for fat-free mass, only thigh muscle thickness 
was significantly correlated                                                                                                  
 
Significant difference in all peripheral skeletal muscle thicknesses compared to the diaphragm (p≤0.001) 
Cartwright et 
al [81]* 
Measurements performed at 
baseline (within 80hours of ICU 
admission), and days 3, 7, 14 
after baseline (if still in hospital); 
2, 4 and 6 months after hospital 
discharge 
Significant increase in TA mean grey-scale value over 14days of ICU admission (138.39 to 166.39, p=0.027), 
with significant reduction in grey-scale standard deviation (33.87 to 28.01, p=0.001), no difference in TA 
muscle or subcutaneous tissue thickness 
 
Significant decrease in RF cross-sectional view grey-scale standard deviation (31.4 to 28.73, p=0.041) and 
significant increase in subcutaneous RF tissue thickness (1.13 to 1.41cm, p=0.033), no difference in RF 
muscle thickness or mean grey-scale value 
 
No changes in any muscle features of adductor digiti minimi or biceps 
 
Following hospital discharge, only mean subcutaneous tissue thickness over all sites showed a significant 
reduction (n=4, 0,74 to 0.31cm, p=0.002); changes at individual muscle sites did not reach significance 
Grimm et al 
[253] 
Measurements performed 
between days 2-5, and day 14, 
after onset of severe sepsis or 
septic shock 
Inter-image measurements of echogenicity demonstrated inter-rater ICC of 0.915 and intrarater ICC of 0.972. 
 
75% of patients demonstrated a mean echotexture >1.5 (the maximum reported in a comparative non-
matched healthy control group); a significant difference in mean muscle echotexture between patients and 
controls was found at  both measurement time-points (both p<0.001); non-significant increase in mean 
echotexture grades in patients between measurement time-points (p=0.085); non-significant difference in 
comparison of echogenicity between proximal and distal muscles in patients at either measurement time-









et al [250] 
Measurements performed on 
days 1, 3, 7 and 10 of ICU 
admission 
Significant reduction in rectus femoris cross-sectional area from days 1 to 7 (-12.5% (95%CI -35.4 to 24.1%), 
p=0.002), with a continued decrease to day 10 (-17.7% (95%CI -25.9 to 8.1%), p<0.001); significant 
association seen between change in RFCSA and ICU length of stay (p<0.001); increased organ failure 
correlated with change in RFCSA (r2=0,23, p<0.001); change in RFCSA differed between patients with multi- and 
single-organ failure (day 3, -8.7% (95%CI -59.3% to 50.6% vs. -1.8% (95%CI -12.3% to 10.5%) respectively, 
p=0.03), day 7, -15.7% (95%CI -27.7 to 11,4% vs. -3.0% (95%CI -5.3 to 2.1%) p<0.001); change in  RFCSA 
greater in those with ≥4 failed organs (-20.3% (95%CI -34.7 to 17.5%)) vs. 2-3 failed organs (-13.9% (95%CI 
-25.7 to -9.8%)) (p<0.001) 
 
Change in RFCSA at day 10 was negatively associated with serum bicarbonate, PaO2:FiO2 and Hb concentration 
at ICU admission (r2=0.51, p<0.001) and positively associated with degree of organ failure, mean C-reactive 
protein level and total protein delivered during study period 
 
Age (odds ratio (OR) 1.05/yr, 95%CI (1.01-1.07/yr)), bicarbonate level at admission (OR 0.72mmol (95%CI 
0.65-1.00mmol)), and PaO2:FiO2 (OR 0.88, 95%CI (0.87-0.97)) found to be associated with >10% loss in RFCSA 
at day 10 
 
Inter-observer agreement ICC 0.97 (n=21 patients), Bland Altman analysis demonstrated bias (SD) and 95% 
limits of agreement of 7 (37)mm2 and -66.1 to +80.5mm2  
*only detail provided regarding peripheral skeletal muscle data in critically ill patients. 
 
Abbreviations: MOF = multi-organ failure.  MLT = muscle layer thickness.  MLTD = muscle layer thickness difference.  LOS = length of stay.  ICU = intensive care unit.  ICC = intraclass correlation coefficient.  RF = rectus 










The current systematic review identified and included seven studies evaluating the 
effect of critical illness on peripheral skeletal muscle architecture using ultrasound 
as the measurement tool.  Each study assessed an independent general ICU 
population, with patients presenting with sepsis and multi-organ failure with an 
ICU length of stay of at least seven days.  There were changes in a variety of muscle 
architecture parameters observed using ultrasound across a range of anti-gravity 
and non-gravity muscle groups, with ultrasound assessment demonstrating both 
clinical reliability and utility. 
 
5.4.1 Significance of findings 
 
Ultrasound data reported by all the studies included in this review demonstrated 
the negative effect of critical illness on peripheral skeletal muscle architecture.  
Despite this, meta-analyses of data were not possible due to the wide variation in 
muscle groups and architecture parameters assessed, the differing study protocols 
adopted, and the extent and clarity of data reporting.  Hence consideration of the 
overall effects of confounding factors such as age, acuity of illness at ICU admission 
or nutritional management on muscle architecture during critical illness are also 
limited.   
 
Five studies measured muscle thickness [81, 82, 86, 252, 254] with only two 
reporting illness severity using differing forms of APACHE scoring [86, 252], all 
with differing results.  There was no consistent baseline adopted across these 
studies with muscle wasting occurring between actual time of ICU admission and 
the first measurement point potentially not captured.  Furthermore, three of these 
studies analysed total muscle thickness which was calculated as the average across 
all muscle groups measured [82, 86, 254].  Individual variations in degree of 
muscle wasting could also have contributed to findings.  In two studies where 
muscle thicknesses for individual muscle groups were reported, [81, 252], 
comparison was not made.  These protocol and data presentation variations also 
limit consideration of whether the effects of critical illness vary across distribution 
of peripheral skeletal muscle.  Muscle echogenicity increased in two studies, 
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although measured using different methods, reporting the presence of myopathic 
changes in the muscle occurring during critical illness possibly due to muscle 
oedema from capillary leak during acute sepsis and/or loss of the typically 
organized muscle architecture occurring during muscle breakdown [81, 253].  Data 
from muscle biopsy analysis (quadriceps vastus lateralis) on Days 1 and 7 of ICU 
admission confirm this, reporting muscle necrosis and macrophage cellular 
infiltrate [250].           
 
No study investigated the relationship between muscle wasting in critically ill 
patients and functional outcome.  Indeed, there are currently no defined minimum 
clinically important differences in terms of the threshold for muscle loss and 
functional outcome, even if the studies in the present systematic review achieved 
changes in muscle loss of statistical significance.  Strength has been shown to 
correlate with peripheral muscle cross-sectional area in both healthy subjects, and 
patients with chronic cardiac and respiratory disease [73, 102, 256, 265] although 
there are few data for critically ill patients.  In patients able to undergo peripheral 
muscle strength assessment using dynamometry, Baldwin et al [252] found 
significant correlations with relevant muscle group thickness ranging from weak to 
moderate.  Ideally, contemporaneous measures of peripheral skeletal muscle force 
would validate ultrasound measures of muscle architecture, and which could then 
be mapped to levels of physical functional ability.   
 
Interestingly, there were no studies reporting the measurement of fibre pennation 
angle, which in combination with anatomical cross-sectional area values provides 
data on physiological cross-sectional area, in turn associated with the force-
generating capacity of a muscle [98].  However, as shown in Chapter 4, there is 
limited clinical advantage of assessing the complex measure of pennation angle 
and physiological cross-sectional area compared to the relatively simple 
measurement of anatomical cross-sectional area.              
 
5.4.2 Technical considerations 
 
Ultrasound measurements were feasible in all patients in all studies with the 
exception of two circumstances.  Puthucheary et al [250] reported one patient 
170 
 
from their cohort was unable to complete assessment of rectus femoris cross-
sectional area due to morbid obesity, and echotexture was not assessed in the 
diaphragm of patients in the study by Cartwright et al [81] as the muscle was too 
thin for accurate measurement.  High reliability of the ultrasound technique in 
critically ill patients was evident in three of the studies included in the current 
review [250, 252, 253].  Furthermore, very low inter-observer variation has also 
been reported by Jorgensen and colleagues (Bland-Altman bias, -0.07cm2, 95% 
limits of agreement, -0.188 to 0.048cm2) [255] albeit as abstract data only.   
  
All studies reported technical detail of ultrasound image acquisition including the 
make and model of machinery and the type of transducer employed.  A number of 
studies measured similar muscle groups however variation was evident in level of 
detail provided for patient positioning during measurement and precise location 
on the muscle group for imaging.  Whilst standardisation of protocols within 
studies provides internal validity for the use of ultrasound as a tool for monitoring 
change in muscle architecture, variation across studies precluded pooling of data 
to determine overall effect.  Future consensus on the exact detail of ultrasound 
measurement for various muscle groups would facilitate consistency with its 
increasing clinical use.  
 
Ultrasound findings all indicated superiority over measures of limb circumference, 
where performed, due to the confounding problem of subcutaneous oedema 
influencing accuracy of limb circumference data.  Typically whilst muscle cross-
sectional area or thickness decreased, limb circumference remained unchanged 
[82, 86, 254].  Furthermore, previous data has shown that ultrasound measures of 
peripheral skeletal muscle architecture correlated closely with data obtained via 
magnetic resonance imaging [84] or computed tomography [73] scanning 
modalities, supporting the use of ultrasound over other techniques that are more 
costly, time-consuming and which involve radiation.  Although these data originate 
from healthy subjects and stable patients with chronic respiratory disease, they 
are nonetheless valuable as conducting similar comparative studies in critically ill 
patients has limited feasibility.  However, additional investigation by Puthucheary 
et al [250] suggests some caution in interpretation of ultrasound data.  In their 
cohort of critically ill patients a subset also underwent additional measures of 
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muscle wasting, namely muscle biopsy and quantification of protein to 
deoxyribonucleic acid (DNA) ratio.  Ultrasound of muscle cross-sectional area was 
shown to underestimate muscle fibre cross-sectional area, but of more concern 
was that the greatest reduction was observed in the protein/DNA ratio over 10 
days highlighting that ultrasound underestimated the actual loss in muscle mass.  
In this study differences in the muscle groups studied, in particular ultrasound 
measurement of quadriceps rectus femoris vs. fibre cross-sectional analysis and 
protein/DNA ratio of quadriceps vastus lateralis, were proposed explanations in 
part, for the variation in muscle loss.  However, of more significance was that the 
protein/DNA ratio was unaffected by the water content of the muscle, which 
strongly supports the observation that ultrasound underestimates muscle loss as a 
consequence of muscle oedema.  Investigation of muscle composition using grey-
scale analysis may assist in determining the level of intramuscular fluid to provide 
a clinically applicable assessment of muscle quality which, as well as muscle 
quantity, should be reported in future studies, albeit further validation of 
echogenicity findings against data from MRI imaging is still required.  
Furthermore, the additional analyses undertaken by Puthucheary et al [250] were 
invasive, costly, required expertise for conduct, analysis and interpretation and 
were only feasible in a very select patient group.  As previously described, 
ultrasound demonstrated advantages over invasive testing in all these areas, and 
these data should not detract from the clinical utility of ultrasound provided 
clinicians are aware of the potential limitations that may exist in data acquired. 
 
5.4.3 Critique of the method 
 
This systematic review was conducted and reported in line with PRISMA 
guidelines [266].  Relevant search terms chosen aimed to identify studies where 
the primary intent was to evaluate changes in peripheral skeletal muscle 
architecture during critical illness using ultrasound.  In this way reference to 
effects of critical illness on respiratory musculature, in particular the diaphragm, 
were excluded.  However use of ultrasound as a technique for this purpose has 
been recently reported in two comprehensive reviews [273, 274], with a growing 
body of data documenting diaphragm atrophy during critical illness and the 
process of weaning from mechanical ventilation [81, 252, 275-277].  Notably two 
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of these studies, included in this review, assessed diaphragm muscle architecture 
contemporaneously with that of peripheral skeletal muscle [81, 252].  Baldwin et 
al [252] reported a significant reduction in peripheral skeletal muscle thickness 
and thickness/fat-free mass compared to the diaphragm in critically ill septic 
patients (where muscle thickness expressed as z-scores albeit exact values not 
reported).  Cartwright et al [81] assessed muscle thickness and echotexture in a 
range of peripheral skeletal muscles, although as previously mentioned, grey-scale 
analysis was not possible on the diaphragm muscle.  A significant increase in 
subcutaneous tissue when imaging the diaphragm was evident between days 1 and 
14 of critical illness (0.88 to 1.03cm, p=0.024), although diaphragm thickness did 
not change.  Diaphragm and peripheral skeletal muscle groups were not compared.              
 
Furthermore studies involving change in peripheral skeletal muscle architecture as 
an outcome measure to determine effectiveness of an intervention were also 
excluded.  The majority of these related to a number of randomised controlled 
trials of electrical stimulation to preserve muscle mass in critically ill patients 
[278-282], itself the topic of a recent, more focused systematic review [151].  
However, that the search terms adopted in the current review failed to identify all 
studies reported by Parry et al [151], only serves to highlight the pragmatic 
limitations of robustly identifying all potential interventional trials where 
peripheral skeletal muscle architecture measured using ultrasound could be an 
outcome measure.  Prior knowledge of the intervention would be required to 
facilitate database searching using relevant indexing terms.  
 
Only studies based within the ICU were included, focusing on the early stages of 
critical illness.  Despite this, two sources of excluded evidence (one only available 
in abstract form), and one included study, reported use of ultrasound 
measurements of peripheral skeletal muscle architecture following ICU discharge 
on the ward [283], and up to 6 [81] and 12months [83] post discharge, reporting 
benefit of the technique for longitudinal monitoring of the trajectory of recovery of 
peripheral skeletal muscle architecture following critical illness.  This could further 
assist in identifying the optimum time for delivery of exercise-based rehabilitation 




Data available in abstract form only were excluded from this review due to the lack 
of detail provided in these summaries.  On further inspection and following 
attempted author contact, only one abstract remained excluded that contained 
potentially relevant data of interest to the review question.  Mampilly et al [284] 
reported significantly reduced rectus femoris muscle cross-sectional area values 
for critically ill patients (n=5) compared to healthy subjects, but similar to those 
found in ambulatory patients with chronic obstructive pulmonary disease.  
 
In categorising the study design for included studies, this review adhered to a 
recognized published classification algorithm [269].  However, the majority of 
included studies were found to be non-comparative case series.  Whilst this is 
perhaps not wholly unsurprising, given the nature and purpose of the review 
investigating the clinical utility of a measurement technique such as ultrasound 
rather than the effectiveness of a particular intervention, there was no tool 
available for assessing the quality of these studies which is a limiting factor to their 
methodological robustness.       
 
5.4.4 Future considerations 
 
Currently, there is no gold standard for the measurement of peripheral skeletal 
muscle architecture using ultrasound, and this review demonstrated wide 
variation in reporting and methodology of a variety of parameters examined in the 
critical illness population.  Further work is necessary to determine uniformity of 
technical application.  Minimum reporting detail would include make and model of 
machine, probe specification, image acquisition settings, and precise description of 
patient position and location on the muscle for measurement.  In addition detail on 
online and offline image analysis should be provided.  For future studies, in 
particular multi-site trials, where ultrasound measurements were to be used to 
collect data, establishing acceptable intra- and inter-observer reliability will be 
important.  This would in turn facilitate determining a clinically important 
difference in muscle architecture parameter.  In Chapter 4, Bland Altman analysis 
revealed quite wide variation for some critically ill patients even between two 
experienced clinicians, and hence this must be accounted for when considering 
effect size in response to an intervention, or over time.   
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Inclusion of standard operating protocols as supplementary materials to 
publications would strongly facilitate future consensus on this.  Building on this, 
expert consensus on adoption of a standardised ‘checklist’ of reporting items could 
be valuable for the literature.  Future studies should also aim to determine the 
relationship between ultrasound measurements, both single and sequential 
measurements, and clinically relevant functional outcomes of the patient and the 




This review has shown that ultrasound has increasing popularity as a tool for 
evaluating changes in peripheral skeletal muscle architecture during critical 
illness.  Data can be acquired simply, easily and over sequential time points to fully 
track peripheral skeletal muscle loss.  Ultrasound has a number of practical and 
clinical advantages which, when supplemented with data demonstrating high 
levels of reliability, confirm the clinical utility of the tool.  Further investigation 
with regards to muscle composition using grey-scale analysis of images will assist 
in corroborating detailed muscle biopsy data.  Furthermore, standardisation of the 
protocol of acquisition, such as measurement of cross-sectional area at 2/3 
distance or 3/5 distance from the anterior superior iliac spine to the superior 
patellar border (Chapter 4) would permit future meta-analyses of data.  This would 
allow detailed investigation of the influence of confounding factors associated with 
ICU management on alteration of peripheral skeletal muscle architecture during 
























Chapter 6    Exercise-Based Rehabilitation 
Following Critical Illness: A Pilot Feasibility 
















6.1 Introduction  
 
The long-term consequences of critical illness are increasingly recognised.  More 
recently, the constellation of physical, psychological and mental health impairment 
has been termed ‘post intensive care syndrome’ [125] with physical rehabilitation 
advocated in the management of the physical and functional deficit observed in 
survivors of critical illness.  Although still limited, the data are increasing to 
support the use of early mobilisation interventions within the ICU [142, 154, 163, 
164, 285] and following transfer to the ward [174, 177].  However, beyond hospital 
discharge, exercise-based rehabilitation tends to be more inconsistent in delivery 
with few randomised controlled data available [186].  Indeed three recent 
randomised controlled trials focussing on exercise-based rehabilitation from 
hospital to home demonstrated little or no clinical benefit [177, 179, 180].  
Interestingly, none of these recent trials stratified patients by the presence of ICU-
AW or peripheral muscle wasting as an inclusion criterion and thus the target 
population may have been less likely to benefit from the intervention.    
 
In the UK, attention on rehabilitation practice spanning the continuum of recovery 
for ICU survivors has been driven by publication of national guidelines by the 
National Institute for Health and Care Excellence in 2009 (NICE CG83) [136].  
Despite this, practical implementation of these recommendations has been 
restricted by both lack of evidence supporting this approach and limited detail 
outlining the type, intensity and frequency of any exercise-based rehabilitation 
programme.   
 
6.1.1 Aims of study 
 
The aim of this study was to conduct a pilot, feasibility exploration of a post 
hospital discharge exercise-based rehabilitation programme for survivors of 
critical illness with ICU-AW, to assess impact on a range of outcome including 







6.2.1 Study design 
 
This was a pilot feasibility study adopting a randomised controlled trial (RCT) 
design investigating the physiological-centred and patient-centred effects of a 
sixteen-session, exercise-based rehabilitation programme delivered following 
hospital discharge in survivors of critical illness with intensive care unit-acquired 
weakness (ICU-AW).  The trial was registered on an international trials registry 
(Clinical Trials, www.clinicaltrials.gov, NCT00976807).  Outcomes included 
exercise capacity, health-related quality of life, measures of peripheral skeletal 
muscle size and strength, anthropomorphic data and physical function.    
 
Patients were recruited following their admission to the general ICUs of St.Thomas’ 
Hospital and King’s College Hospital, two University of London teaching hospitals 
within an Academic Health Sciences Centre framework (60 beds in total).  
St.Thomas’ Hospital is a regional severe respiratory failure centre, and King’s 
College Hospital has a regional major trauma and neurosciences centre.  Both 
hospitals also admit a mixed cohort of medical and surgical populations. 
 
6.2.1.1 Observational study of clinically strong patients 
 
This sub-study was designed to explore the trajectory of recovery of those patients 
without ICU-AW.  For the purposes of this study these patients have been defined 
as ‘clinically strong’.  The aim of the study was to assess the suitability of using the 
diagnosis of ICU-AW (MRC-SS <48/60) as an inclusion criterion into post critical 
illness rehabilitation programmes.  This sub-group of patients were followed-up in 
a similar manner as the standard treatment arm of the trial as part of an embedded 




Patients were eligible for inclusion into the RCT if they met the following criteria: 
1. Aged ≥18years 
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2. Received mechanical ventilation (MV), either via endotracheal tube or non-
invasive mask for ≥48hours during ICU admission 
3. Demonstrated ICU-AW as measured by MRC-SS <48/60 at ICU discharge 
4. Glasgow Coma Scale 15/15, and Abbreviated Mini Mental Test ≥8/10 
5. Expected survival to hospital discharge 
6. Demonstrated sufficient mobility to participate in an exercise-based 
rehabilitation programme at hospital discharge 
 
Patients were excluded from the study if they met the following criteria: 
1. Terminal/palliative prognosis 
2. Unstable coronary artery syndrome or other severe cardiac disease 
3. Acute limb amputation 
4. Peripheral vascular disease awaiting revascularisation 
5. Acute stroke or other neurological disease 
6. Musculoskeletal disabling condition precluding ability to exercise 
7. Psychiatric illness 
8. Requirement for ongoing renal dialysis 
9. Extra-contractual ICU referral (if unable to attend the hospital twice-weekly 
if randomised to receive the intervention) 
10. Extensive medical co-morbidity precluding regular participation in exercise 
11. Existing rehabilitation pathway in place e.g. post cardiac surgery, chronic 
respiratory disease 
 
6.2.2.1 Observational study of clinically strong patients 
 
These patients were required to meet the same inclusion criteria except with 
regard to MRC-SS at ICU discharge.  Instead, these patients were considered as 
‘clinically strong’ demonstrating an MRC-SS ≥48/60.  Similar exclusion criteria 
applied to this observational cohort of patients, with the exception of geographical 
residence.  As these patients would be managed within the study as per the 
standard treatment arm of the RCT, and only be required to return to the hospital 
for one completion assessment at three months, they were eligible for inclusion if 




6.2.3 Screening and recruitment 
 
All patients who had received mechanical ventilation during their ICU admission 
were screened for potential eligibility into either the RCT or observational cohort 
study prior to ICU discharge.  Screening occurred over six sessions per week 
depending on the availability of the researcher (BC) at each study site.  Patients 
meeting inclusion criteria were approached to discuss the study prior to their ICU 
discharge and provided with a patient information sheet.  Consenting patients 
were asked to complete a consent form, a copy of which was given to the patient 
and a further copy filed in their medical notes.  
 
6.2.4 Randomisation and masking for the randomised controlled trial 
 
Subsequent to consent, patients were allocated to treatment groups (standard 
treatment or intervention) through the Mental Health and Neuroscience Clinical 
Trials Unit (London, UK).  Treatment allocation to either the intervention arm or 
standard treatment (control) arm was undertaken independently of the trial team.  
The first fifteen participants randomised were allocated with straightforward 
simple randomisation.  Thereafter, and following review of the demographic and 
anthropometric data identified by the trial team, important cofounding variables 
were identified and allocation was stratified by gender (M:F), APACHE II score 
(<18, ≥18), duration ICU LOS (≤21 days, >21 days), study site (King’s College 
Hospital, St.Thomas’ Hospital), and MRC-SS (37-48, ≤36) with computer-generated 
probabilistic minimisation.  The minimisation factor of ICU LOS was amended from 
≤7 days;>7 days following interim review of the initial 17 patients recruited and 
their randomisation characteristics.   
 
6.2.5 Blinding  
 
Once notified of treatment allocation by the Clinical Trials Unit, the researcher (BC) 
informed the patient and relevant clinicians.  As with many therapy trials, and in 
particular given the pilot nature of the current trial, patients, therapists, and 
doctors were not blinded to treatment allocation.  Furthermore it was impractical 
to blind the researcher (BC) who was responsible for all aspects of trial conduct 
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including screening, consent, baseline and completion assessment, follow-up and 
intervention delivery.   
 
6.2.6 Screening for awakening and assessment of peripheral muscle strength 
 
Conscious level of patients in both the randomised controlled trial and 
observational cohort study was determined using the Richmond Agitation 
Sedation Scale (RASS) [49], which is an ordinal scale ranging from -5 (unrousable) 
to +4 (combative behaviour), and including 0 (alert and calm) and a nominal ‘A’ 
indicating the subject is asleep.  A score of -1 (drowsy) to +1 (restless) was 
considered indicative of wakefulness.   
 
Awake patients were then required to demonstrate positive response to four 
simple one-stage commands including ‘open and close your eyes’, ‘stick out your 
tongue’ and ‘squeeze my fingers’.  Successful completion of these commands was 
followed by muscle strength assessment using the MRC-SS which is a 6 point 
grading scale ranging from 0 (no visible contraction) to 5 (normal power) applied 
to six upper and lower limb muscle groups bilaterally [35] (Chapter 2.3).  ICU-AW 
was defined as an MRC-SS <48/60 [30, 36, 40, 41, 240].  This protocol for 
screening for awakening and assessment of peripheral muscle strength was in 
keeping with previous reported studies investigating the MRC-SS and ICU-AW [11, 
36, 37], 
 
6.2.7 Outcome measures 
 
A range of outcomes measures were assessed at baseline (hospital discharge) and 
at three-month completion (Figure 6-1) including: 
 
i) Anthropometric data 
ii) Exercise capacity - Incremental Shuttle Walk Test (ISWT) and Six Minute 
Walking Test (6MWT) 
iii) Health-related quality of life (HRQL) – Short Form-36 Physical (SF-36 PCS) 
and Mental (SF-36 MCS) Component Scores and Hospital Anxiety and 
Depression Scale (HADS) 
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iv) Peripheral skeletal muscle strength - quadriceps maximum voluntary 
contraction (QMVC) and handgrip dynamometry 
v) Peripheral skeletal muscle size - quadriceps rectus femoris cross-sectional 
area (RFCSA) 
vi) Physical function - SF-36 Physical Function domain (SF-36 PF), Barthel 
scale, Timed Up And Go (TUAG), Sit-to-Stand 5 (STS-5) 
Details for all assessment measures can be found in Chapter 2. 
 
6.2.8 Standard treatment arm of the randomised controlled trial 
 
Patients randomised to the standard treatment arm received a weekly telephone 
call from the researcher (BC) to monitor general progress of recovery.  Although 
this was not necessarily in keeping with routine standard care, this was mandated 
by the ethical review board.  No specific advice on exercise rehabilitation was 
provided. 
 
6.2.9 Intervention arm of the randomised controlled trial 
 
Given the absence of detailed guidance or existing data on optimum structure, 
content, format and delivery of post hospital discharge rehabilitation for survivors 
of critical illness [186], the exercise-based rehabilitation programme (EBRP) 
intervention was modelled closely on current pulmonary rehabilitation (PR) 
programmes in operation at both recruitment sites and part of the established 
clinical and research rehabilitation programmes, widely studied within the 
author’s research group [187, 188].  The clinical programmes have been 





































Figure 6-1 Schematic outline of the randomised controlled trial pathway 
 
Abbreviations: ISWT = Incremental Shuttle Walk Test.  6MWT = Six Minute Walk Test.  SF-36 = Short-
Form 36.  HADS = Hospital Anxiety and Depression Scale.   
 
6.2.9.1 EBRP delivery format 
 
The EBRP was a sixteen-session hospital-based, outpatient intervention conducted 
at both study sites, in which patients exercised under supervision and 
independently, accompanied by a printed manual containing all warm-up, cool-
down and individually prescribed exercises.  For pragmatic and logistical reasons, 
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chronic respiratory diseases, in operation at each study site.  Patients commenced 
participation in the programme within two weeks of hospital discharge, and 
transport was provided for patients to attend.  Successful completion was defined 
a priori as attendance at ≥50% of sessions. 
 
6.2.9.2 EBRP structure 
 
The EBRP consisted of 16 sessions scheduled to run twice-weekly.  Each session 
lasted one hour (40minutes exercise including warm-up and cool-down), and the 
programme was ‘rolling’ in structure i.e. patients could start and finish the EBRP at 
any point in time.  Typically there were 1-2 patients enrolled at any time, 
supervised by one highly experienced critical care and rehabilitation clinical 
specialist physiotherapist (BC).  Patients exercised according to their own 
individualised plan.  
 
6.2.9.3 EBRP content 
 
The EBRP included cardiovascular, strength, balance and functional exercises.  
Specifically, cardiovascular exercises included step-ups, treadmill, cross-trainer 
and static cycling; strength exercises included those for upper and lower limb 
muscle groups including quadriceps, biceps and triceps, utilising weights and 
theraband (exercise bands) for resistance work; balance activity included static 
and dynamic exercises, and functional activities included sit-to-stand and walking. 
Exercises were tailored to individual patients depending on clinical assessment 
and patient-specific goals, and could include some or all of the aforementioned.  In 
this way both clinician judgement and patient input determined methods of 
exercise prescription.  More objectively, exercise prescription was based on the 
results of walking tests for cardiovascular (for walking speed), and use of the 
repetition maximum (RM) principle for strength (initial weight, 80% 10RM).   
 
Target Borg scores for perceived exertion (level 3-5, moderate to severe) were 
used to monitor exercise intensity during sessions.  In addition, and depending on 
individual patient clinical status, oxygen saturation (SpO2) and heart rate (HR) 
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levels were also used.  At all times, patient verbal feedback and clinician judgement 
of patients was used to ensure patient safety whilst exercising.    
 
The EBRP contained an informal education component, where patients were 
invited to participate in sessions covering management of breathlessness, benefits 
of exercise, nutrition and energy conservation, that were running as part of the 
main PR programme, and which could be relevant to them.  In addition the 
researcher was available to offer specific 1:1 education and advice on patient-
specific matters, or organise onward referral where necessary to appropriate 
multidisciplinary healthcare colleagues. 
 
Supplementary to the two supervised exercise sessions per week, patients were 
strongly encouraged to undertake one independent session using a leaflet 
containing their individual exercises, and to record this in an exercise diary.  
Adherence to this independent exercise session was not formally monitored by the 
researcher. 
 
6.2.9.4 EBRP evaluation 
 
In addition to the outcome measures described above for EBRP evaluation, 
patients were asked to complete acceptability questionnaires at the end of their 
programme to obtain patient-specific feedback. 
 
6.2.10 Observational cohort study of ‘clinically strong’ patients 
 
Patients recruited to the observational cohort study of ‘clinically strong’ patients 
without ICU-AW (MRC-SS >48/60) were followed-up in a similar manner as the 
patients in the standard treatment arm of the trial.  These patients received weekly 
telephone calls from the researcher (BC) during the three month follow-up period. 
 
6.2.11 Statistical analysis 
 
All data are expressed as mean ± standard deviation (SD) or median with 
interquartile range (IQR) as appropriate.  Paired t-tests or Wilcoxon signed rank 
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tests for parametric and non-parametric data respectively were performed to 
determine differences between baseline and completion for standard treatment 
and intervention arms of the RCT, and for the observational cohort study.  To 
establish differences between standard treatment and intervention arms of the 
RCT, unpaired t-tests or Mann-Whitney tests were applied for parametric and non-
parametric data respectively.  These same tests were applied to determine 
differences between the randomised cohort overall (with ICU-AW) and the 
observational cohort study (‘clinically strong’), however only outcomes related to 
physical performance were selected for comparison based on the rationale that 
these had the potential to be more influenced by degree of global peripheral 




6.3.1 Randomised controlled trial 
 
Patients were recruited between February 2010 and May 2012 with follow-up 
completed by August 2012.  Patient flow-through the trial is described in the trial 
Consolidated Standards of Reporting Trials (CONSORT) diagram (Figure 6-2).  A 
large proportion of potentially eligible patients were excluded (n=743).  Table 6-1 
details the frequency of occurrence of meeting the predefined inclusion and 
exclusion criteria at ICU discharge.   
 
Twenty patients consented and were randomised, ten each into the standard 
treatment and intervention arms of the trial.  Baseline characteristics of the cohort 
are reported in Table 6-2, with no differences between standard treatment and 
intervention arms for any factor (all p=ns).  Median (IQR) MRC-SS for the trial 






















































Figure 6-2 CONSORT diagram detailing patient flow-through within the 
randomised controlled trial 
 
Abbreviations: ICU = intensive care unit 
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Table 6-1 Factors accounting for ineligibility into the randomised controlled trial 
 
Factor Frequency of 
occurrence (%) 
Classification 
Ventilation ≥48hrs 294 (39.6) Inclusion criterion not met 
Extra-contractual tertiary referral 185 (24.9) Exclusion criterion met 
MRC-SS <48/60 132 (17.8) Inclusion criterion not met 
Existing rehabilitation pathway  131 (17.6) Exclusion criterion met 
Sufficient mobility 97 (13.1) Inclusion criterion not met 
ICU admission ≥48hrs 95 (12.8) Inclusion criterion not met 
Expected survival to hospital discharge 93 (12.5) Inclusion criterion not met 
Palliative/terminal prognosis 89 (12.0) Exclusion criterion met 
Complex medical co-morbidity 82 (11.0) Exclusion criterion met 
Disabling condition precluding exercise 80 (10.8) Exclusion criterion met 
Unstable cardiac diagnoses 75 (10.1) Exclusion criterion met 
Neurological diagnoses 64 (8.6) Exclusion criterion met 
Impaired Glasgow Coma Scale 42 (5.7) Exclusion criterion met 
Psychiatric diagnoses 42 (5.7) Exclusion criterion met 
Ongoing renal haemodialysis 32 (4.3) Exclusion criterion met 
Acute limb amputation 13 (1.7) Exclusion criterion met 
Acute peripheral vascular disease 5 (0.7) Exclusion criterion met 
Age >18years 4 (0.5) Inclusion criterion not met 
Data are presented as n (%), and report frequency of reported occurrence of each criterion, 
therefore total percentages exceed 100%.  n=743.  Multiple factors could apply per patient.   
 



















Table 6-2 Baseline characteristics for standard treatment and intervention arms 
of the randomised controlled trial 
 
Characteristic Standard Treatment Group 
(n=10) 
Intervention Group (n=10) 
Age (years) 68.5 (64.3-78.0) 63.0 (46.8-71.8) 
Gender (M:F) 3:7 3:7 





















APACHE II 23.5 (21.0-30.3) 24.5 (18.8-29.5) 
SOFA (ICU admission) 12.0 (7.5-14.3) 9.5 (8.0-12.5) 
Duration MOF (days) 10.5 (5.8-13.3) 9.5 (6.8-15.3) 
MV (days) 11.2 (6.0-15.2) 9.3 (6.0-13.9) 
CPAP (days) 2.0 (0.3-4.6) 1.3 (0.04-6.9) 
Tracheostomy (%) 3 (30) 5 (50) 
ICU LOS (days) 13.0 (9.8-20.5) 14.5 (7.0-17.8) 
CC LOS (days) 18.0 (13.8-36.5) 17.5 (9.0-27.3) 
Ward LOS (days) 27.5 (10.0-46.3) 20.0 (10.0-43.0) 
Hospital LOS (days) 47.5 (26.5-68.5) 39.0 (22.3-66.5) 
Data are presented as median (interquartile range) or n(%).  *ICU diagnosis and chronic disease 
indicates frequency of occurrence.  Patients could present with more than one comorbidity.  #Other 
chronic comorbidities included diabetes mellitus, osteoarthritis/gout, stable chronic renal disease.   
 
Abbreviations: ICU = intensive care unit.  APACHE = Acute Physiology and Chronic Health Evaluation.  
SOFA = Sequential Organ Failure Assessment.  MOF = multi-organ failure.  MV = mechanical 
ventilation.  CPAP = continuous positive airway pressure.  LOS = length of stay.  CC = critical care. 
  
 
6.3.1.1 Results of outcome measures of patients with intensive care unit-
acquired weakness in the randomised controlled trial 
 
Table 6-3 summarises the results of the outcome measures investigated.  There 
were no significant differences between standard treatment and intervention 
groups at baseline, completion or in degree of change for any outcome measure (all 
p=ns and therefore not reported).  A wide range of variability in results was 
evident as demonstrated by the size of interquartile ranges.  For measures where 
minimum clinically important difference (MCID) data were available, albeit these 
data are established for chronic respiratory disease, both groups improved beyond 
these values of 47.5m for the ISWT [209], 54m for the 6MWT [213] and 10 points 
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for the SF-36 PF domain [226, 227].  However, there were no patients that 
achieved their predicted values for 6MWT at completion [288].  Median predicted 
6MWT for the cohort was 490.1 (459.8-536.5)m, and percent predicted 6MWT 
achieved was 66.4 (46.2-89.1)%.  There was no evident trend across outcome 
measures, for whether standard treatment or intervention group showed 
numerically more positive results.   
 
At hospital discharge, median (IQR) MRC-SS of the trial cohort was 56.0 (52.0-
58.0), and at completion, 60.0 (56.0-60.0) indicating that these patients no longer 






Table 6-3 Results of outcome measures used to evaluate intervention effectiveness in the randomised controlled trial  
 
Outcome measure 
Standard treatment group (n=6) Intervention group (n=10) 
Baseline Completion Change from 
baseline 
Baseline Completion Change from 
baseline 
ISWT (m) 20.0 (10.0-60.0) 190.0 (70.0-355.0) 170.0 (40.0-315.0) 55.0 (7.8-120.0) 200.0 (132.5-340.0) 115.0 (-2.5-237.5) 
6MWT (m) 150.0 (100.5-207.0) 335.0 (177.5-455.0) 185.0 (40.0-285.0) 180.0 (125.0-221.5) 328.5 (230.0-393.8) 140.0 (35.8-210.3) 
SF-36 PCS (/100) 20.6 (19.4-33.3) 42.3 (27.9-47.6) 11.0 (4.3-28.3) 29.8 (24.1-33.2) 33.2 (23.8-45.4) 1.8 (-6.8-15.9) 
SF-36 MCS (/100) 50.9 (35.6-57.8) 45.6 (34.3-54.7) -11.4 (-19.0-19.1) 31.6 (28.6-49.1) 53.4 (39.5-58.8) 14.3 (-3.2-26.7) 
SF-36 PF (/100) 7.5 (3.8-31.3) 37.5 (17.5-72.5) 15.0 (0.0-67.5) 15.0 (5.0-22.5) 40.0 (17.5-76.3) 22.5 (-5.0-60.0) 
HADS total (/42) 14.0 (9.0-20.0) 6.5 (5.5-10.3) -4.5 (-13.3- - 2.5) 13.0 (7.0-19.0) 9.0 (3.5-10.3) -6 (-9.3- -2.8) 
HADS anxiety (/21) 6.0 (1.5-11.5) 4.0 (0.8-6.0) 0.0 (-7.0-0.0) 7.0 (4.5-9.3) 4.0 (1.8-5.5) -3.5 (-5.0--1.3) 
HADS depression (/21) 8.5 (7.3-10.0) 2.5 (2.0-8.0) -4.5 (-6.3--1.8) 5.5 (2.8-11.0) 4.5 (1.0-7.3) -1.5 (-3.3-2.0) 
QMVC (kg) 17.7 (16.2-20.7) 23.7 (17.8-36.7) 6.0 (1.6-16.0) 10.0 (6.6-24.6) 14.0 (8.2-26.3) 2.1 (0.8-4.5) 
RFCSA (mm2) 395.0 (343.0-487.1) 497.5 (410.6-673.6) 61.7 (36.5-261.5) 241.3 (238.3-296.3) 487.3 (344.0-519.0) 222.7 (102.7-249.0) 
Handgrip (kg) 17.0 (14.0-22.0) 22.0 (17.5-28.5) 3.5 (2.0-11.3) 22.0 (9.0-22.0) 24.0 (18.0-30.0) 8.0 (4.0-9.0) 
Barthel (/100) 82.5 (75.0-95.0) 100.0 (88.8-100.0) 10.0 (2.5-25.0) 87.5 (65.0-96.3) 100.0 (82.5-100.0) 7.5 (0.0-21.3) 
TUAG (s) 25.0 (17.3-34.0) 12.5 (8.0-19.0) -11.5 (-25.5-0.8) 18.0 (13.5-125.0) 10.0 (7.3-41.5) -7.0 (-86.3--4.0) 
STS-5 (s) 23.0 (19.8-30.5) 17.3 (14.3-20.0) -3.8 (-16.3--0.8) 17.5 (14.9-27.3) 13.0 (9.3-26.5) -2.3 (-17.3-8.6) 
FFM (kg) 51.8 (34.6-59.9) 43.6 (34.4-62.9) 2.3 (-2.3-4.7) 45.1 (38.4-55.1) 49.7 (42.3-51.3) 0.6 (-3.5-5.1) 
FFMI (kg/m2) 18.3 (13.0-19.7) 15.5 (14.1-20.7) 0.7 (-0.8-1.6) 17.4 (13.4-19.9) 16.7 (16.0-19.6) 0.3 (-1.3-1.6) 
Data are presented as median (interquartile range).  Handgrip, n=7 for intervention group due to patient inability to perform the test.  QMVC, n=3 for the control arm and n=4 for the intervention arm due to death or 
withdrawal prior to assessment, inability to perform measure, and time permitting for assessment due to patient clinical commitments.  RFCSA, n=4 for control arm n=3 for the intervention arm due to death or 
withdrawal prior to assessment, time permitting for assessment due to patient clinical commitments and image quality.  TUAG and STS-5, n=5 and 4 respectively for intervention group due to subsequent protocol 
amendments including these measures, inability to perform the measure, and time permitting for assessment. 
 
Abbreviations: ISWT = Incremental Shuttle Walk Test.  6MWT = Six Minute Walking Test.  SF-36 PCS = Short Form-36 Physical Component Score.  SF-36 MCS = Short Form-36 Mental Component Score.  SF-36 PF = Short 
Form-36 Physical Function domain.  HADS = Hospital Anxiety and Depression Scale.  QMVC = quadriceps maximum voluntary contraction.  RFCSA = rectus femoris cross-sectional area.  TUAG = Timed Up And Go.  STS-5 = St 








6.3.1.2 Adherence to the intervention 
 
Of the ten patients randomised to receive the EBRP, eight successfully completed 
the programme (attending ≥50% of sessions).  Median (IQR) number of sessions 
attended was 16.0 (9.3-16.0).  One patient unable to complete the programme 
attended only one session due to recurrent chest infections, and a subsequent 
reluctance to continue with the intervention.  The second patient failing to 
complete the programme attended seven sessions, and was unable to continue 
participation due to a general deterioration in health that was related to a separate 
illness diagnosis which was later confirmed as Addison’s disease.  For two of the 
eight patients who successfully completed the intervention, reasons for not 
attending the full sixteen sessions included seasonal chest infections, family 
circumstances and separate clinical appointments necessitating hospital 
attendance.   
 
Within each session of the EBRP, there was potential for patients to exercise for 25 
minutes (40minutes less warm-up and cool-down time), albeit this was also 
dependent on time taken for individual patients to move between exercise 
stations, which in itself could constitute an exertive activity (although not formally 
monitored).  On average, patients exercised for a median (IQR) of 21.9 (20.9-
23.4)minutes per session.  Excluding non-completers did not change this value 
(median (IQR) 21.9 (21.0-23.2minutes/session)).  There was insufficient 
documentation of independent unsupervised exercise sessions undertaken by 
participants for formal analysis.   
 
Patients attended an average of 5 education sessions during the programme, with 
subject topics varying for each patient.  Individual advice or education provided by 
the researcher was harder to quantify and analyse in a standardised format. 
 
6.3.1.3 Adverse events during the trial period 
 
No adverse events occurred during any of the exercise-based rehabilitation 
sessions.  One patient in the intervention arm was admitted to hospital for 
investigation of cardiac symptoms occurring outside of the programme and noted 
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as unrelated to exercise participation.  On discharge this patient was medically 
approved to resume full participation in the programme.   
 
6.3.1.4 Patient-reported acceptability of the intervention 
 
Six of the eight patients successfully completing the EBRP, completed a simple 
acceptability questionnaire asking for opinion on experience of participation.  All 
six patients reported that overall, they were ‘very satisfied’ with the programme.  
When asked in greater detail regarding the exercise component, the following 
responses to these statements were noted: 
 
1) Attending the exercise programme helped recovery from my illness 
66.7% strongly agree, 33.3% agree 
2) I have a clear picture of how exercise will help my fitness 
66.7% strongly agree, 33.3% agree 
3) I have a clear picture of how fitness will help in daily activities of my life 
66.7% strongly agree, 33.3% agree 
4) I feel confident doing exercise 
66.7% strongly agree, 33.3% agree 
5) I worry that exercise may be harmful to me 
33.3% strongly disagree, 66.7% disagree 
6) I felt very stressed doing the exercise 
33.3% strongly disagree, 66.7% disagree 
7) I found the visits to the hospital too tiring 
50% strongly disagree, 33.3% disagree, 16.7% agree 
8) The exercise has not helped me 
66.7% strongly disagree, 33.3% disagree 
 
Participants had the opportunity to attend education sessions that they felt 
relevant to them (noting that the intervention ran in tandem with an existing 
pulmonary rehabilitation programme for patients with chronic respiratory 
disease), and were also able to ask the researcher (BC) for any specific advice, 
information or guidance they required at any time.  All participants attended at 
least four of the “formal” education sessions covering topics such as 
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breathlessness, energy conservation, smoking cessation and diet.  One participant 
was unable to attend any of these sessions due to additional clinical appointments.   
 
When responding to the following statements regarding level of satisfaction, 
participants were asked to consider the “formal” and individual education they had 
received: 
 
1) The way the information was presented: 
16.7% very satisfied, 66.7% satisfied, 16.7% unable to comment (UTC) 
2) The information given: 
16.7% very satisfied, 66.7% satisfied, 16.7% UTC 
3) The opportunities you had to discuss any concerns: 
16.7% very satisfied, 66.7% satisfied, 16.7% UTC 
4) The way the staff answered your questions: 
33.3% very satisfied, 50% satisfied, 16.7% UTC 
5) The range of education topics covered: 
16.7% very satisfied, 50% satisfied, 16.7% neither, 16.7% UTC 
 
The following qualitative comments were also reported in the acceptability 
questionnaires: 
“...disappointed the discussions were mostly about COPD.  Others were there 
– including myself – were recovering from other conditions.  And so these 
discussions did not benefit me at all.” 
 
“...I would have liked a speaker on my condition to help me to learn more.  I 
don’t think there is any need to change the exercise programme, I felt it 
worked very well for me.” 
 
“...The exercise has helped me a lot.  I feel much better for doing it, also all 
the staff were very helpful and very caring.  I would recommend this to 
anybody who has problems with their breathing, it has been a joy working 
with a nice group of people.” 
 
 
6.3.2 Observational cohort study of ‘clinically strong’ patients 
 
Of the 743 patients excluded from the RCT, 132 failed to meet the inclusion 
criterion of demonstrating an MRC-SS <48/60 i.e. a diagnosis of ICU-AW.  Of these, 
194 
 
21 were eligible and consented to participate in the observational cohort study of 
those ‘clinically strong’ patients (MRC-SS ≥48/60).  One patient was withdrawn 
due to medical management during the hospital stay and did not complete any 
baseline testing.  Participant flow-through is presented in Figure 6-3 with baseline 
characteristics for the cohort reported in Table 6-4.  Median (IQR) MRC-SS for the 

























Figure 6-3 Flow-diagram detailing participant flow through observational study of 
clinically strong patients 
 
Abbreviations: MRC-SS = Medical Research Council Sum-score 
 
 
6.3.2.1 Results of outcome measures of clinically strong patients 
 
The results for the observational cohort study of ‘clinically strong’ patients are 
presented in Table 6-5.  As evident in the randomised cohort, large interquartile 
Observation cohort study of 




































 Excluded from analysis  n=0 
 n=1 death prior to 
hospital discharge 
 n=2 lost to follow-up 
 n=3 declined return for 
follow-up 
 
 n=1 withdrawn due to 
medical management 
during hospital stay; no 




ranges indicated high variability in results.  Significant improvements were evident 
for both measures of exercise capacity (ISWT and 6MWT) beyond minimum 
clinically important differences for each test [209, 213].  However, median 
predicted 6MWT distance at completion for this cohort was 552.0 (480.2-621.6)m 
and median percent predicted distance achieved was 74.4 (58.0-93.5)%.  There 
were significant improvements observed in health-related quality of life (SF-36 
PCS and MCS), physical function (SF-36 PF domain, TUAG and STS-5), QMVC and 
RFCSA.  Change in SF-36 PF domain also exceeded the previously reported 10-point 
MCID [226, 227].  Change in Barthel score approached significance, although this 
cohort of patients was already highly functioning at baseline with maximum scores 
evident in some patients.  Median (IQR) MRC-SS for the observational cohort at 
hospital discharge was 60.0 (57.0-60.0) and at completion, 60.0 (60.0-60.0). 
 
Table 6-4 Baseline characteristics of observational cohort of ‘clinically strong’ 
patients 
 
Characteristic Observational cohort (n=21) 
Age (years) 63.0 (49.5-70.0) 
Gender (M:F) 16:5 














APACHE II 17.0 (12.5-19.5) 
SOFA (ICU admission) 10.0 (7.5-12.0) 
Duration MOF (days) 9.0 (3.5-14.5) 
MV (days) 9.0 (4.3-20.4) 
CPAP (days) 1.5 (0.4-2.6) 
Tracheostomy (%) 8 (38.1) 
ICU LOS (days) 10.0 (6.5-27.0) 
CC LOS (days) 13.0 (10.0-37.0) 
Ward LOS (days) 13.0 (6.5-19.5) 
Hospital LOS (days) 30.0 (19.5-47.5) 
Data are presented as median (interquartile range) or n (%).  ).  *ICU diagnosis and chronic disease 
indicates frequency of occurrence.  Patients could present with more than one comorbidity.  #Other 
chronic comorbidities included diabetes mellitus, osteoarthritis/gout, stable chronic renal disease.   
 
 
Abbreviations: APACHE = Acute Physiology and Chronic Health Evaluation.  SOFA = Sequential Organ 
Failure Assessment.  MOF = multi-organ failure.  ICU = intensive care unit.  LOS = length of stay.  MV = 
mechanical ventilation.  CPAP = continuous positive airway pressure.  CC = critical care. 
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Table 6-5 Results of outcome measures for the ‘clinically strong’ observational cohort study 
 
Outcome measure Baseline Completion Change  p 
ISWT (m) 80.0 (30.0-212.5) 365.0 (250.0-477.5) 265.0 (207.5-300.0) 0.0002 
6MWT (m) 167.0 (60.0-293.5) 433.5 (318.3-481.0) 157.5 (131.3-321.3) 0.0002 
SF-36 MCS (/100) 44.4 (34.9-52.6) 51.4 (43.1-57.2) 4.7 (-1.8-11.4) 0.03 





















QMVC (kg) 17.0 (12.6-33.3) 28.4 (20.3-40.3) 9.9 (-0.2-16.1) 0.04 
RFCSA (mm2) 477.3 (314.5-711.3) 526.1 (442.0-898.0) 100.0 (59.4-186.7) 0.01 
Handgrip (kg) 20.0 (16.0-27.5) 25.0 (23.0-27.5) 5.0 (-2.5-9.0) 0.1 
Barthel (/100) 97.5 (85.0-100.0) 100.0 (98.8-100.0) 0.0 (0.0-15.0) 0.06 
TUAG (s) 14.8 (13.1-18.5) 8.0 (6.8-10.0) -6.0 (-9.3--3.8) 0.002 
STS-5 (s) 19.0 (10.8-26.0) 11.4 (8.9-17.5) -3.5 (-11.0--0.5) 0.008 
FFM (kg) 52.5 (38.8-58.9) 52.5 (40.4-64.8) 2.5 (-0.7-9.7) 0.13 
FFMI (kg/m2) 18.9 (12.9-20.2) 18.2 (13.8-22.3) 1.0 (-0.2-3.4) 0.1 
Data are presented as median (interquartile range).  n=14.  Handgrip, n=13 due to presence of arterial line in dominant hand restricting test performance.  p values derived from Wilcoxon signed rank test and reflect 
change from baseline to completion.  QMVC, n=9 due to equipment failure and patient clinical commitments.  RFCSA, n=11 due to patient clinical commitments. 
 
Abbreviations: ISWT = Incremental Shuttle Walk Test.  6MWT = Six Minute Walk Test.  SF-36  PCS  = Short Form-36 Physical Component Score.  SF-36 MCS = Short Form-36 Mental Component Score.  SF-36 PF = Short 
Form-36 Physical Function domain.  HADS = Hospital Anxiety and Depression Scale.  QMVC = quadriceps maximum voluntary contraction.  RFCSA = rectus femoris cross-sectional area.  TUAG = Timed Up and Go.  STS-5 = Sit 







6.3.3 Comparison between ‘clinically strong’ patients and those with ICU-AW 
 
The comparison of baseline characteristics between the ICU-AW and ‘clinically 
strong’ patients are presented in Table 6-6.  The proportion of males to females 
was greater in the observational cohort (p=0.005).  Patients with ICU-AW were 
sicker at ICU admission, with significantly higher illness severity (APACHE II) 
scores than ‘clinically strong’ patients (23.5 (20.3-29.5) vs. 17.0 (12.5-19.5), 
p<0.0001) and furthermore these patients also experienced a significantly longer 
ward stay (23.5 (10.3-43.0)days vs. 13.0 (6.5-19.5)days, p=0.03), and a 
numerically greater, albeit not statistically significant, overall hospital admission 
(46.0 (25.0-61.8)days vs. 30.0 (19.5-47.5), p=0.2).   
 
The comparison of outcomes between the ICU-AW and ‘clinically strong’ patients 
are summarised in Table 6-7.  There were no differences between groups at 
completion with the exception of ISWT distance.  Whilst both groups were similar 
at baseline, ‘clinically strong’ patients demonstrated greater distances walked at 
completion (365.0 (250.0-477.5)m vs. 200.0 (120.0-330.0)m, p=0.03), with 
significantly greater change from baseline to completion (265.0 (207.5-300.0)m vs. 
120.0 (10.0-230.0), p=0.047).  In addition, ‘clinically strong’ patients had higher 
SF-36 scores in the Physical Component Score (34.0 (282.2-41.4) vs. 29.4 (19.7-
32.9), p=0.03) and Physical Function domain (40.0 (15.0-66.3) vs. 12.5 (5.0-27.5), 
p=0.005) at baseline although this difference between groups was not present at 
completion.  Furthermore, ‘clinically strong’ patients, compared to those with ICU-
AW performed better in terms of physical function as measured by the TUAG test 
at baseline (14.8 (13.1-18.5)s vs. 21.0 (16.0-36.0), p=0.04) although there were no 
differences between groups observed in the Barthel and STS-5 tests.  No difference 
was evident between groups at completion or in change from baseline for any of 









Table 6-6 Comparison of baseline characteristics between patients with ICU-AW 
and ‘clinically strong’ patients  
 
Characteristic Trial Cohort          
(ICU-AW)      
(n=20) 
Observational Cohort                
(‘clinically strong’)           
(n=21) 
p 
Age (years) 66.5 (54.5-73.3) 63.0 (49.5-70.0) 0.3 
Gender (M:F) 6:14 16:5 0.005~ 




























APACHE II 23.5 (20.3-29.5) 17.0 (12.5-19.5) <0.0001 
SOFA (ICU admission) 11.0 (8.0-13.5) 10.0 (7.5-12.0) 0.4 
Duration MOF (days) 10.0 (6.0-12.8) 9.0 (3.5-14.5) 0.6 
MV (days) 10.2 (6.8-14.0) 9.0 (4.3-20.4) 1.0 
CPAP (days) 1.3 (0.2-5.0) 1.5 (0.4-2.6) 0.6 
Tracheostomy (%) 8 (40) 8 (38.1) - 
ICU LOS (days) 13.5 (8.5-19.3) 10.0 (6.5-27.0) 0.9 
CC LOS (days) 18.0 (11.5-31.8) 13.0 (10.0-37.0) 0.8 
Ward LOS (days) 23.5 (10.3-43.0) 13.0 (6.5-19.5) 0.03 
Hospital LOS (days) 46.0 (25.0-61.8) 30.0 (19.5-47.5) 0.2 
Data are presented as median (interquartile range) or n (%).  *ICU diagnosis and chronic disease 
indicates frequency of occurrence.  Patients could present with more than one comorbidity.  #Other 
chronic comorbidities included diabetes mellitus, osteoarthritis/gout, stable chronic renal disease.  
p values derived from Mann-Whitney test or Fisher’s exact test~.  Note one p-value applicable for 
contingency analysis of proportion of medical and surgical patients across both groups.  
 
Abbreviations: ICU = intensive care unit.  APACHE = Acute Physiology and Chronic Health Evaluation.  
SOFA = Sequential Organ Failure Assessment.  MOF = multi-organ failure.  MV = mechanical 
ventilation.  CPAP = continuous positive airway pressure.  LOS = length of stay.  CC = critical care.  ICU-













Table 6-7 Comparison of outcome measures between patients with ICU-AW and 
‘clinically strong’ patients 
 
Characteristic Trial cohort                   
(ICU-AW)                     
(n=16) 
Observational Cohort                
(‘clinically strong’)           
(n=14) 
p 
















































































































Data are presented as median (interquartile range).  p values derived from Mann Whitney test 
analysis.  n=14 for TUAG and STS-5 for the randomised cohort.  
 
Abbreviations: ISWT = Incremental Shuttle Walk Test.  6MWT = Six Minute Walk Test.  SF-36 PCS = 
Short Form-36 Physical Component Score.  SF-36 PF = Short Form-36 Physical Function domain.  
TUAG = Timed Up and Go.  STS-5 = Sit to Stand 5 times.     
 
 
6.3.4 Effect of diagnosis of ICU-AW on physical performance at early study 
milestone points 
 
Patients were recruited into both the interventional trial and observational cohort 
study at ICU discharge according to MRC-SS.  Follow-up of patients and delivery of 
the EBRP commenced at hospital discharge, termed baseline.  As previously 
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detailed, patients in the trial cohort had improved MRC-SS by hospital discharge 
with an absence of ICU-AW by this time-point (Chapter 6.3.1.1).  To investigate the 
influence of ICU-AW diagnosis on physical performance between these two study 
milestones, results of exercise capacity (ISWT and 6MWT) and physical function 
(Barthel scale, TUAG and STS-5) were analysed according to MRC-SS.        
  
6.3.4.1 ICU discharge 
 
At ICU discharge, only measures of MRC-SS and physical function were examined.  
Assessment of exercise capacity was not considered clinically appropriate in 
patients at this time-point.   
 
18 patients with ICU-AW (MRC-SS <48/60) from the trial cohort (Figure 6-2) and 
20 patients ‘clinically strong’ patients without ICU-AW (MRC-SS ≥48/60) from the 
observational cohort (Figure 6-3) had physical function data at ICU discharge.  All 
patients, with the exception of missing data for one with ICU-AW, had Barthel 
scores and SF-36 PF scores.   
 
There was a difference in Barthel score between those patients with and without 
ICU-AW (20.0 (15.0-22.5) vs. 62.5 (40.0-78.8), p<0.0001).  With data combination 
from both groups, MRC-SS demonstrated a direct relationship with Barthel score 
(r=0.8, p<0.0001).  a similar relationship was observed between MRC-SS and SF-36 
PF domain (r=0.8, p<0.0001).  ‘Clinically strong’ patients demonstrated greater SF-
36 PF domain scores than patients with ICU-AW (15.0 (5.0-55.0) vs. 0.0 (0.0-5.0), 
p=0.0007).  When the data from both groups were combined, MRC-SS showed a 
direct correlation with SF-36 PF domain (r=0.6, p<0.0001).            
 
In the ICU-AW patient cohort, TUAG and STS-5 were not possible in one patient 
due a rapid discharge process and 2 patients unavailable for testing.  A further 13 
patients were either unable to perform the testing when attempted (n=5), or 
testing was not considered clinically appropriate due to mobility status (n=8).  In 
the cohort of ‘clinically strong’ patients, 4 patients were unable to perform both 
TUAG and STS-5 when attempted.  None of the patients were deemed unable to 
undergo physical functional assessment.  This ability to complete measures of 
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physical function differed between patients with and without ICU-AW (unable to 
perform/able to perform, 13/2 vs. 4/16, Fisher’s exact test, p=0.001).  Due to 
limited data for TUAG and STS-5 for the ICU-AW group, analysis of differences in 
scores between groups was judged not to be statistically useful.  Overall, when data 
from the groups were combined, MRC-SS demonstrated a negative relationship 
with STS-5 (r=-0.6, p=0.009) and TUAG (r=-0.5, p=0.047). 
 
6.3.4.2 Hospital discharge 
 
At hospital discharge 17 patients from the trial cohort were able to undergo 
assessment (Figure 6-2) and 19 patients from the observational cohort study 
(Figure 6-3).  All patients completed the Barthel test and SF-36 PF domain scores.  
Data were unavailable from 3 patients from the trial cohort for TUAG and STS-5 (as 
previously reported, for one patient due to rapid hospital discharge, and missing 
data for 2 further patients).  All patients completed ISWT and 6MWT.  There was 
no patient unable to perform measures on attempt, nor did clinical status i.e. 
mobility levels, preclude testing in any patients.  Statistical analysis of differences 
between groups for ability to perform measures was not appropriate as numbers 
were too small.  When the groups were combined, MRC-SS observed to correlate 
with Barthel score (r=0.6, p=0.0002), TUAG (r=-0.5, p=0.007), STS-5 (r=-0.4, 
p=0.01), SF-36 PF domain (r=0.4, p=0.009) and ISWT (r=0.5, p=0.004).  There was 
no relationship observed between MRC-SS and 6MWT (r=0.3, p=0.08).  The 
comparison between study groups for physical function and exercise capacity 
measures is reported previously in Table 6-7.  Interestingly no patient from either 
the trial or observational cohort study, demonstrated ICU-AW according to 
handgrip dynamometry thresholds (11kg for males, 7kg for females [36]) at either 
baseline or completion.   
 
6.3.5 Eligibility criteria into the randomised controlled trial and discharge 
outcomes of excluded patients 
 
Eligibility criteria applied to patient enrolment into the current interventional trial 
were determined based upon clinical, pragmatic and logistical rationale.  However 
this resulted in a large number of patients who were excluded due to failure to 
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meet relevant entry criteria (Figure 6-2, Table 6-1).  To determine if these 
eligibility criteria were different from previous studies, a comparison was made 
with inclusion and exclusion criteria reported from similar interventional trials 
(Table 6-9).  Consistency was demonstrated across all studies.   
 
To gain insight and understanding of the potential ongoing rehabilitation 
requirements following hospital discharge of the excluded cohort, hospital 
discharge status and outcomes for these 743 patients documented on hospital 
electronic databases were reviewed (Table 6-8).  Almost 40% (292/743) of 
patients demonstrated a level of mobility sufficient for discharge home, albeit it is 
not known whether this represented a return to their premorbid levels of physical 
functional ability.  24.4% (181/243) of patients required ongoing rehabilitation 
input delivered either in a residential setting or by domiciliary services.  Whilst not 
specified, current practice at both study sites would suggest that these were 
generic rather than specific post-ICU services.  The community discharge 
destination of repatriated patients was unknown.  It is possible, and likely, that a 
proportion of these patients may also have required ongoing rehabilitation input. 
 
Table 6-8 Hospital discharge outcomes for patients excluded from the randomised 
controlled trial 
 
Hospital discharge outcome n (%) 
Home; documented return to pre-morbid level of mobility safe for 
discharge 
292 (39.3) 
Death 181 (24.4) 
Not known 76 (10.2) 
Discharged to rehabilitation setting 72 (9.7) 
Home; ongoing rehabilitation needs 66 (8.9) 
Repatriation to referring institution* 56 (7.5) 
n=743. *community discharge destination and ongoing rehabilitation needs unknown
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Table 6-9 Eligibility criteria of post hospital discharge rehabilitation studies 
 
Study Inclusion Criteria Exclusion Criteria 
Batterham et 
al [179, 195] 
Age between 18 and 65yrs; traumatic or primary sepsis event; emergency 
ICU admission; mechanical ventilation ≥3days; discharged home within 6m 
of admission; not currently involved in a rehabilitation programme; able to 
climb a flight of stairs unaided 
Hospitalised >6m post ICU admission; enrolment in exercise or 
rehabilitation programme; inability to complete initial CPET; 
contraindication to CPET procedure; moderate to severe heart failure; 
moderate or above aortic stenosis; hypertrophic cardiomyopathy; 
symptomatic arrhythmias; severe disability; spinal cord injury; primary 
muscular disorder; uncontrolled epilepsy; pregnancy; BMI >40 
Denehy et al           
[177, 196] 
Resident within access to hospital; no neurological, spinal or 
musculoskeletal dysfunction preventing participation in physical 
rehabilitation; ICU length of stay ≥5days; age ≥18years; English-speaking 
and understanding  
Major CNS disorders resulting in permanent weakness non-responsive to 
exercise; conditions rendering participation in exercise hazardous, such as 
unstable fractures; imminent death or planned palliative management 
within 48hrs; inability to perform study physical outcome measures pre-
morbidly due to a condition impairing mobility 
Jackson et al        
[183] 
Age ≥18years; English-speaking and understanding Cumulative ICU LOS >5days within previous 30days excluding current 
admission; severe cognitive or neurodegenerative disease preventing 
independent living at baseline; HBI; mental health issues; imminent death 
or planned palliation; resident beyond study site region; onset of causal ICU 
admission >72hrs pre-admission; cardiac bypass surgery within 3m; 
normal cognitive and physical function at hospital discharge; lack of 
telecommunication equipment to receive intervention   
Elliott et al            
[180, 198] 
Age ≥18years; ICU LOS ≥48hrs; mechanical ventilation ≥24hrs; discharged 
home to self-care or carer (non-institutionalised); resident with hospital 
geographical region to permit home visits 
Neurological, spinal or skeletal dysfunction preventing participation in 
physical rehabilitation; palliative care; organised rehabilitation related to 
ongoing chronic disease management; insufficient cognitive function for 
completion of outcome measures  
McWilliams et 
al  [185] 
Invasive mechanical ventilation ≥48hrs  Physical inability to undergo gym-based rehabilitation programme; 
terminally ill; mental impairment precluding cooperation with 
rehabilitation programme 
Jones et al            
[178] 
Admitted to ICU; received mechanical ventilation ICU LOS <48hrs; burn injuries; inability to follow the interventional manual 
or language difficulties; neurosurgical diagnoses; pre-existing psychotic 










al [184, 199] 
ICU admission at any point during hospital stay Age <18yrs; not expected to survive to leave hospital; unable to complete 
questionnaires or attend clinics 
O’Neill et al         
[192] 
Age ≥18years; ICU admission requiring >96hrs mechanical ventilation; 
planned discharge to home (self-care/carer); willing and able to participate 
in exercise; medically fit to participate in intervention 
Inability to participate due to neurological, spinal or skeletal dysfunction 
affecting ability to exercise; cognitive impairment affecting ability to 
understand the intervention or complete outcome measures; participation 
in another rehabilitation programme due to ongoing chronic disease; other 
medical contraindications to participation in an exercise programme 
Battle et al            
[191] 
Age ≥18years; ICU LOS >48hrs; discharged home and attending follow-up 
clinic within 6m of ICU discharge; capacity to follow instructions; not 
already enrolled in a rehabilitation programme; live within commutable 
distance to study site 
Medical contraindications to exercise including unstable angina or 
myocardial infarction within preceding month, unmanaged valvular 
problems, patients awaiting further definitive treatment e.g. open 
abdominal wound, pregnancy where patient advised against exercise  
Griffiths et al 
[190] 
Age ≥45yrs; ICU LOS ≥5days Physically not capable of engaging with the practical requirements of the 
study 
Abbreviations: CNS = central nervous system.  HBI = hypoxic brain injury.  ICU = intensive care unit.  LOS = length of stay.  CPET = cardiopulmonary exercise test.  BMI = body 








6.3.6 Power calculations based on current data 
 
Data from the current study were used to determine the power calculation for any 
potential future trial.  Given the inconsistency in differences between the trial and 
observational study cohorts, these data were pooled.  This resulted in a total of 30 
patients, which meets suggested sample sizes for estimating outcome [289, 290].  
Outcome measures of ISWT, 6MWT, SF-36 Physical Component Score and Physical 
Function domain were considered as these are commonly reported outcome 
measures used in similar studies.  Often MCID values are used to define a difference 
between standard treatment and intervention groups in randomised trials, and the 
power calculation determined based on this expected difference.  In the current study 
all patients demonstrated change over the three month follow-up period that 
exceeded known MCID data, albeit for chronic respiratory disease.  A predicted 
difference of 20% between the standard treatment arm and intervention group was 
therefore used to undertake power calculations.   
 
Based on a mean change in the current standard treatment group of 193 (130)m for 
the ISWT, and assuming a 20% difference with intervention, 184 patients in each 
group would be required at 80% power, and p<0.05.  For the 6MWT this figure 
increases to 210 patients per group (current standard treatment arm mean change 
171 (121)m).   
 
Far greater sample sizes would be required to detect a potential 20% difference 
between standard treatment and intervention groups based on current data for the 
SF-36 PCS (current standard treatment arm mean change 7 (10)points) requiring 732 
patients per group, and for the SF-36 PF domain, 446 patients per group (current 




This pilot randomised controlled trial investigating an exercise-based rehabilitation 
programme delivered following hospital discharge in survivors of critical illness with 
ICU-AW, demonstrated there was no beneficial effect across a range of clinical and 
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physiological outcomes.  However the feasibility of the intervention was evident with 
a high completion rate, an absence of associated adverse events, and high patient-
reported acceptability.  Although ‘clinically strong’ patients, who were observed over 
the same three month period, demonstrated significant improvements in exercise 
capacity, health-related quality of life and physical function, a comparison between 
the trial cohort with ICU-AW and the observational cohort showed an inconsistent 
pattern in physiological, clinical and patient-centred outcomes.  Patients with ICU-AW 
at ICU discharge, and who were eligible for trial enrolment, subsequently had an 
improvement in their MRC-SS by hospital discharge when the intervention 
commenced.   
 
These data highlight the limited sensitivity of MRC-SS as a measure to base inclusion 
into a post critical illness rehabilitation programme following hospital discharge.  
Indeed, the timing of assessment for eligibility and enrolment needs to be 
contemporaneous with the treatment commencing.  In addition, this pilot study 
highlighted a number of important methodological considerations in the design, 
conduct and evaluation of a future trial, not least with regard to eligibility criteria, as 
demonstrated by the high screening rates of patients failing to meet the inclusion or 
meeting the exclusion criteria.  Furthermore, the timing, frequency and intensity of 
rehabilitation delivery require careful consideration as the ‘dose’ of rehabilitation 
needs to accelerate and enhance the natural recovery that was observed.  Finally, in a 
future trial there must be close attention focussed on the selection of the most 
appropriate primary outcome to evaluate the effectiveness of the intervention, and 
the balance between clinically focussed objective and patient-centred subjective 
measures which impose differing burdens on the patient.   
 
6.4.1 Clinical relevance of the findings in the context of previous data 
 
In this RCT there were no differences observed between those patients receiving the 
exercise-based rehabilitation intervention and those receiving standard care at three 
months, albeit the trial was not powered for this purpose.  A mixed pattern was 
observed in baseline, completion and degree of change values between groups with 
the change in ISWT and 6MWT being greater in the standard treatment group, but the 
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exercise-based rehabilitation group demonstrated greater improvement in SF-36 PF 
domain score and HADS score. 
 
These findings are not dissimilar to previously reported data of post hospital 
discharge exercise-based rehabilitation programmes [177, 179, 180] but the current 
cohort had greater illness severity, longer duration of mechanical ventilation, and 
longer ICU and hospital admission compared to these studies.  The intervention 
investigated by Batterham et al [179] comprised twice-weekly supervised exercise 
sessions using cycle ergometry to achieve target levels of perceived exertion, with 
encouragement to undertake one additional unsupervised session.  Whilst a small 
benefit was observed in the intervention group for the primary outcome of anaerobic 
threshold in the short term (week 9) this was not sustained at the end of the trial 
(week 26).  A suggested benefit to physical and mental health-related quality of life 
was also proposed but this was not substantively demonstrated on examination of the 
confidence intervals of results.  Denehy et al [177] investigated a triple-phase 
intervention delivered in the ICU, following transfer to the ward, and post hospital 
discharge.  Post hospital discharge, the intervention consisted of an eight-week, twice-
weekly, outpatient, hospital-based exercise programme with cardiovascular, strength 
and functional content.  There were no significant differences observed for the 
primary outcome, six minute walking distance, or other measures of physical 
performance or health-related quality of life at 12 months, albeit the rate of change of 
recovery was greater for the six minute walking distance in the intervention arm.  
Elliott et al [180] investigated a post hospital discharge intervention of an outpatient, 
home-based, semi-supervised programme of endurance and strength training, and 
reported that there were no differences between intervention and standard treatment 
groups at 8 and 26weeks follow-up.  
 
Additional recent data have also reported improvements in physiological parameters 
of physical fitness including peak oxygen consumption and anaerobic threshold 
measured during cardiopulmonary exercise testing, as well as mental and physical 
health-related quality of life following exercise training programmes [182].  However 
not all changes were significant, and the data are currently only available in abstract 
form, limiting detailed comparison to the current study in this thesis.  The clinical 
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utility of cardiopulmonary exercise testing, (CPET), as an outcome measure in such 
trials is useful in terms of understanding the physiological effect of rehabilitation in 
this patient group, but is lacks detail on clinical and cost effectiveness.  Whilst 
previous data have reported safety and feasibility of CPET in survivors of critical 
illness [291], such testing is costly, time-consuming, and limited to institutions with 
the necessary equipment, expertise and personnel for conduct and interpretation.  As 
such it may have limited wider uptake, but could serve to validate results of field 
walking tests which represent a more pragmatic approach to assessment of exercise 
capacity in this population [53].  
 
Only one randomised controlled trial to date reports significant improvement in six 
minute walking distance and balance in patients receiving a six-week supervised 
exercise programme, with improvements in anxiety and depression, and grip strength 
[181].  Again, these early results from a small sample, whilst promising, are available 
in abstract form only with, as expected limited detail provided of the intervention, and 
therefore comparison with other trial interventions is not possible.  In the past, 
rehabilitation manuals guiding self-directed exercise have been shown to improve 
physical function [178], although it is difficult to ascertain from this type of 
intervention and delivery, the exact nature and intensity of exercise prescription. 
 
The current trial is novel as it required all patients to have a diagnosis of ICU-AW at 
ICU discharge as a specific inclusion criterion.  Indeed, given the previous published 
data that reported the association between ICU-AW and prolonged ventilation, ICU 
and hospital length of stay, and ongoing physical functional impairment [11, 30, 36, 
37, 105, 106, 292], incorporating the diagnosis of ICU-AW as an inclusion criterion 
was considered appropriate.  Based on previous evidence, it was hypothesised that 
these patients demonstrating peripheral skeletal muscle weakness on discharge from 
the ICU would have ongoing impairment of physical function and a rehabilitation 
intervention would accelerate and enhance recovery. 
 
However, these data, combined with the data from Chapter 3, have shown that manual 
muscle testing using the MRC-SS test and a score less than 48 out of 60 as a diagnosis 
of ICU-AW lacks sensitivity and specificity to predict clinical outcome.  Specifically, in 
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the current trial, MRC-SS test added limited clinical utility to categorise patients with 
ICU-AW to define the most appropriate target group for exercise-based rehabilitation 
intervention.  When compared to the observational cohort of ‘clinically strong’ 
patients with MRC-SS greater than 48, patients who demonstrated ICU-AW at ICU 
discharge were similar for all baseline characteristics with the exception of gender, 
illness severity at ICU admission and ICU length of stay.  The gender difference is 
interesting as it would be expected that men would be stronger than women in the 
pre-morbid state prior to ICU admission and this again highlights a further caveat in 
the MRC-SS approach.  This is also paradoxically supported by the association 
between MRC-SS and physical function.  These correlations were driven by the MRC-
SS values from ‘clinically strong’ patients as there were limited physical function data 
from patients with ICU-AW. 
 
Interestingly by hospital discharge and start of the follow-up period patients who had 
previously presented with a clinical diagnosis of ICU-AW at ICU discharge, all had 
MRC-SS greater than 48 out of 60 and would have re-categorised as ‘clinically strong’.  
This demonstrates the ceiling effect limitation of MRC-SS testing.  One would argue 
that all patients, both in the trial and observational cohort study, were similar in 
terms of peripheral skeletal muscle strength, albeit the gender and severity of critical 
illness had affected the trajectory of recovery.  Patients with the greatest skeletal 
muscle weakness at ICU discharge, who were indeed the sickest patients at ICU 
admission were likely to have undergone greater muscle wasting during their ICU 
admission as previously demonstrated by our group [250].  Hence it would be 
postulated that their ward stay was protracted whilst they received more intense 
rehabilitation interventions than those without ICU-AW in order to achieve a level of 
function sufficient for hospital discharge, at which point the MRC-SS was not able to 
distinguish between groups.  These data were not formally captured in the current 
study but any future trial must collect the type, frequency and intensity of ward-based 
rehabilitation.   
 
Denehy et al [177] are the only other investigators to report prevalence of ICU-AW, 
based on MRC-SS testing.  At enrolment, within ICU, levels were at approximately 20% 
across control and intervention arms.  Whilst not specifically re-evaluated at the start 
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of their post hospital discharge intervention, given the initial relatively low 
percentages of patients it is highly possible for the proportion of patients with ICU-
AW to have reduced further, and for the cohort at this stage to have been ‘clinically 
strong’.  The value of the MRC-SS to characterise survivors of critical illness in the 
context of delivering rehabilitation interventions appears therefore limited. 
 
Both the trial and observational study cohorts demonstrated improvements above the 
reported MCID values for exercise capacity and subjective physical function scores 
(ISWT, 6MWT and SF-36 PF domain), albeit specific MCID data for the post critical 
illness population have yet to be established.  Although application of the MCID can be 
conceptually problematic [293], consideration of these values permits clinical 
interpretation rather than basing conclusions solely on statistical analyses [177].  
Natural recovery in the patient groups from the trial and observational cohort study 
was above the MCID of an intervention, which is an important observation as any 
future rehabilitation intervention will be required to accelerate and enhance the 
natural history of recovery following critical illness.  We need to consider whether 
rehabilitation should be withheld for the first 3 months at a time when the trajectory 
of recovery, with the addition of standard treatment, is satisfactory.  This would 
reduce the clinical and physical burden on the patient at a time when they are 
recovering in the community, supported by family networks, outside the hospital.  
This approach of delayed rehabilitation until natural recovery reaches a plateau must 
be balanced against the observation that the exercise capacity achieved, in terms of six 
minute walking distance, across all patients was lower than predicted values [288].   
 
6.4.2 Critique of the method 
 
The current trial was intended as a pilot feasibility process to investigate an exercise-
based rehabilitation programme for post critical illness patients with ICU-AW, 
delivered following hospital discharge.  The evaluation of this process offered valuable 
insight into the methodological considerations which would be important in the 
development of a future trial.  Specifically, it provided data to guide defining the target 
population as well as the timing and type of rehabilitation intervention.  These current 
data, as discussed in Chapter 6.4.1, must be interpreted with caution as the trial was 
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not powered to detect a difference in any outcome measure.  A small sample size, 
requiring non-parametric analyses restricted to limited inferential testing, denied 
definitive conclusions about the effect of rehabilitation to be drawn.   
 
Due to complexity of both the intervention under investigation, exercise-based 
rehabilitation, and the target patient population, survivors of critical illness, process 
evaluation represents a useful approach for distinguishing failure of the intervention 
to cause an effect, which reflects the underlying concept or theory, from failure of the 
implementation of an effective intervention delivery [294, 295].  Process evaluation 
accounts for the multifaceted nature of trials of complex interventions, where there 
are often several interacting components [296], to understand underlying 
mechanisms relating to context, setting and relevant stakeholders which can influence 
outcome [297], and this is embedded in recent Medical Research Council (MRC) 
guidance on the development, evaluation and reporting of complex interventions 
[298].  Whilst ideally a prospective and systematic process evaluation would form an 
allied component of such an RCT [294, 295, 297], in this instance it has been 
considered retrospectively to facilitate review of the pilot process. 
 
The following discussion adopts a relevant model used in a recent editorial by 
Salisbury and Walsh [299] to accompany a systematic review of rehabilitation 
interventions for patients within the ICU, namely that of the “PICO” principle 
(Population, Intervention, Control, Outcome) which is the cornerstone for 
development of well-built clinical questions [300].  More recently, this concept has 
been expanded to include review of the current evidence pertaining to the subject of 
interest, and also appropriate study type [301]. 
 
6.4.2.1 Evidence on the subject 
 
The current evidence, or relative lack thereof, regarding rehabilitation interventions 
for post critical illness patients following hospital discharge has been reviewed in 
detail in Chapter One, Introduction, and previously published by the researcher (BC) 
[186].  Whilst not systematic in design as suggested by the MRC Framework [298], the 
integrative nature of this narrative review allowed for inclusion of varied sources of 
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evidence, including study protocols, to further inform the limited knowledge-base.  At 
the time of designing the current study, minimal data existed to guide the content of 
exercise-based rehabilitation for this patient population, albeit national guidelines 
advocated their implementation [136] and there was a growing research interest in 
the field.  Instead, development of the intervention was directed by the data and 
international guidelines detailing the effectiveness of pulmonary rehabilitation 
programmes for patients with chronic respiratory disease, including from the 
researcher’s own group [187, 188, 204, 286, 287, 302].     
 
6.4.2.2 Target population 
 
Critically ill patients are a challenging population for rehabilitation research at any 
stage of their recovery pathway.  Marked heterogeneity arising from a multitude of 
causal diagnoses for ICU admission, wide-ranging illness severity from single- to 
multi-organ failure, chronic comorbidity and trajectory of illness progression mean 
that patterns of response to interventions will inherently vary between individual 
patients, even if eligibility criteria have been applied in an attempt to achieve a more 
‘homogenous’ cohort included in a trial. 
 
In the current study, eligibility criteria included a range of clinical, pragmatic and 
logistical factors.  During the course of the pilot study, when recruitment was 
identified as slower than anticipated, these were compared to those used in similar 
studies and consensus appeared evident.  Nonetheless application of these criteria 
resulted in an extremely high ratio of excluded to included patients.  Denehy et al 
[177], Elliott et al [180] and Batterham et al [179] similarly experienced this, with 
recruitment levels of 150 patients out of 764 screened, 195 patients from 5980 
screened, and 59 patients from 740 screened respectively, and two trials failing to 
reached a priori calculated sample sizes [177, 180].  
 
Assuming existing eligibility criteria for post hospital discharge rehabilitation trials 
are maintained, the time-frame required to recruit sufficient patient numbers for a 
larger-scale trial necessitates consideration.  Clearly multi-centre trials would 
facilitate speed of recruitment, but involvement of both district general hospitals as 
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well as specialist centres would also contribute to enhancing enrolment, as evidenced 
by the difficulties encountered in recruitment in the current study attributable to the 
tertiary referral status of both organisations.      
 
Defining the patient population most likely to benefit from post hospital discharge 
rehabilitation requires better understanding [132].  Experience from the current 
study, which specifically included patients with ICU-AW diagnosed using the MRC-SS 
cut-off of less than 48 out of 60 suggests that this approach is less useful given the 
inconsistent differences between these patients and ‘clinically strong’ patients, and 
lack of rigour of the MRC-SS tool itself [57].  Clinically-relevant peripheral skeletal 
muscle weakness may better be characterised by functional outcomes which could 
form eligibility criteria or be used to stratify groups.  Furthermore, screening and 
randomisation may be better conducted at the point at which an intervention is 
scheduled to commence.  Failing this, studies need to accurately capture and record 
interim treatments that may influence recovery and outcome of patients.  Hence, in 
the current trial, randomisation may have been more appropriate occurring at 
hospital discharge prior to the start of the rehabilitation programme, especially as 
standard ward-based input to trial patients following recruitment at ICU discharge 
was not formally recorded. 
   
6.4.2.3 Intervention 
 
Dictionary definitions of rehabilitation define a process of restoring an individual to 
health or normal life [303].  In the context of recovery following critical illness, 
residual impairments range across physical, psychological, cognitive and functional 
domains which is now reported by some as the ‘post intensive care syndrome’ [125].  
A comprehensive rehabilitation programme must encompass strategies addressing 
each of these facets, demonstrate a flexible, adaptable approach to meet the individual 
needs of patients, and furthermore consider the impact and burden placed on family 
and care-givers [123, 124].  The current trial focussed on an exercise-based 
intervention primarily to manage physical deficits in patients.  However failure to 
address other ‘morbidities of critical illness’ [132] may have contributed to the 
results.  In the future multidisciplinary and multimodal rehabilitation programmes 
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may elicit greatest response through the synergistic effect of optimising one element 
of impairment on another e.g. the benefit observed in physical performance  as a 
result of improved mental health, and vice versa.  The Enhanced Recovery After 
Surgery pathway offers one approach that critical illness rehabilitation programmes 
could model incorporating evidence-based ‘care bundles’ of practices [304].         
 
Variability currently exists with regard to structure, content, format of delivery, 
intensity, frequency and timing of exercise prescription amongst current published 
trials and available protocols, and to date there has been no optimum level 
established.  This lack of consistency challenges synthesis of data and implementation 
of research findings into clinical practice.  The current trial attempted to describe the 
intervention with as much detail as possible, in keeping with recommendations for 
nonpharmacological trials [305]. 
 
The current trial adopted an outpatient, hospital-based style of intervention which 
may be an important option for managing frailer, more dependent patients who 
require closer supervision whilst undertaking exercise.  However, this more 
‘traditional’ method of intervention delivery may not be ideal for engaging all 
potential patients, and in the future use of alternative technologies such as mobile 
phone and tablet applications, websites and interactive patient forums may offer more 
appealing options.  Nonetheless the current trial achieved a high completion rate, 
although this could be attributable to provision of transport to attend sessions, which 
may otherwise have precluded patients from travelling to the hospital.  Clinical factors 
were responsible for the majority of non-attendances, which may also affect 
adherence to rehabilitation delivered via other formats. 
 
A combination of cardiovascular, upper and lower limb strength, balance and 
functional exercises were included in sessions, and tailored to meet each patient’s 
ability.  Initial exercise prescription was based on objective outcome measures and re-
evaluated during the course of the programme.  Furthermore patients exercised for 
nearly all of the available time during each session.  Despite this, within each session 
exercise intensity was determined using the subjective Borg scale of perceived 
exertion, although target levels were set aiming for moderate to severe exertion.  
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Patients may not have exercised at levels sufficient to elicit physiological benefit 
through reluctance or anxiety regarding undertaking exercise, or over-exertion, and 
the intervention may have been too conservative.  The former scenario requires 
emphasis on patient education regarding safe levels of exercise, the latter a close 
attention to individual exercise prescription.  The contrast between the relatively high 
attendance rates for the intervention versus the potential for suboptimal exercise 
intensity suggests lack of intervention effectiveness rather than implementation 
although this is difficult to confirm given the small size of the cohort.  
Cardiopulmonary exercise testing could have a role in determining if patients are 
exercising at an intensity sufficient to evoke a physiological training effect. 
 
Adopting a pragmatic approach and delivering the exercise-based rehabilitation 
intervention in parallel with existing pulmonary rehabilitation programmes, 
permitted patients to attend education sessions offered, although these varied in 
relevance as they were primarily targeted towards patients with chronic respiratory 
disease.  This was a theme echoed within the acceptability feedback.  Individual advice 
or education was available from the researcher (BC), but the ad hoc nature of this 
limited formal quantification or analysis.  A recent review of studies involving delivery 
of education to post critical illness at the post hospital stage identified that few adhere 
to the content advised by NICE CG83, and that there were limited outcome measures 
available to evaluate education provision [306].  
 
6.4.2.4 Standard treatment group 
 
Accurate description of the standard treatment (control) arm involved in a trial of a 
complex intervention is important for greater interpretation and generalisability of 
results [307, 308].  Methods such as benchmarking or point prevalence studies to 
detail and evaluate existing levels of care or practice have recently been reported, 
particularly in reference to exercise rehabilitation standards within the ICU [309-
311].  Standardised reporting of usual practice and the context and processes of care 
typically in operation, has a number of benefits including improving safety 
monitoring, facilitating translation of findings into local context, and enhancing 
understanding of the differences between groups with regard to intensity of 
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interventions received [312, 313].  This latter point is exemplified by the findings of 
Denehy et al [177] at the ‘in ICU’ stage of their tripartite intervention when 
considering previous literature on early mobilisation within the ICU.  Usual care for 
their ICU patients was reflected by 52% of patients receiving active mobilisation 
including sitting out of bed or marching on the spot [155], in excess of the intervention 
arm delivered by other authors [163, 164, 285] although international differences in 
physiotherapy practice are acknowledged to be a contributory factor to this [177].  
That the host institution in Denehy et al’s study was also reported as demonstrating 
usual care over and above that across other Australian ICUs [309] further highlights 
this point.  Undertaking a benchmarking exercise would be valuable by all 
organisations participating in any multi-centre study involving delivery of a 
rehabilitation intervention to ascertain a common level of’ ‘standard treatment’ 
practice and to ensure that results were not influenced by variation of practice at an 
organisational level. 
 
In the current study, usual care post hospital discharge within the study involved the 
standard treatment arm receiving a weekly telephone call from the researcher.  This 
was not detailed in the original protocol, but was strongly advised by the ethical 
review board as a means of ensuring all study participants were monitored during the 
study period.  Whilst no specific advice regarding exercise rehabilitation was provided 
during these phone-calls, this does represent enhanced post ICU input than these 
patients would normally receive.  Furthermore standard treatment arm patients could 
also be discharged from hospital in receipt of generic rehabilitation services such as 
intermediate care or community therapy at the discretion of the clinical team.  All 
standard treatment patients in the current trial were discharged to their home 
environment, however lack of formal evaluation of additional services received by 
these patients represents a weakness of the current protocol as these interventions 




A range of different instruments for measuring physical functional performance have 
been used in survivors of critical illness, although sensitivity, specificity, 
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reproducibility and clinical utility of these tools has yet to be ascertained [53].  As 
such appropriate outcome measures for evaluation of rehabilitation interventions 
remain to be determined [132].  Outcome measures must be sensitive to change over 
time and the relative ‘floor’ and ‘ceiling’ effects must be considered.  For example in 
the current study, a number of patients in both the trial and observational study 
groups demonstrated high Barthel scores at baseline indicating that this clinical tool 
has limited usefulness to track the trajectory of recovery.  The World Health 
Organisation International Classification of Functioning, Disability and Health outlines 
a multi-dimensional framework that can guide outcome measure at an individual, 
institutional and social level, considering domains of structure, activity and 
participation [314].   
 
In this way a ‘package’ of outcome measures may be required to best reflect response 
to interventions, flexible to address the range of impairments evident across the 
continuum of recovery [177].  However implementing such a battery of assessment 
measures may be difficult to achieve in research and clinical practice.  The current 
trial utilised a range of outcomes including exercise capacity, health-related quality of 
life, peripheral muscle mass and strength, and physical function.  All these outcomes 
varied in the amount of “effort” required from patients for performance.  This 
extensive investigation was challenging to complete by this post critical illness patient 
cohort and contributed to missing data.  When considered individually, each outcome 
measure may not appear time-consuming but the cumulative effect resulted in a 
burden of assessment to patients, which may have influenced the quality of their 
performance and willingness for ongoing participation (Figure 6-4).  Consideration is 
required for the logistical practicalities of acquiring such a volume of data in often 
frail patients with existing clinical consultations and investigations.  In addition 
experience in the current trial observed that testing at hospital discharge could be 
influenced by patient availability on the ward, and changes to discharge planning at 
short notice.  At completion, appointments were often coordinated with other hospital 
attendances to minimise patient inconvenience, but this imposed time constraints on 
data acquisition.  Future consensus from a range of clinical and patient stakeholders 
for sets of core outcomes to evaluate effectiveness of rehabilitation interventions in 
















































Figure 6-4 Schematic outline of outcome measure selection in trial management 
 
Using exercise capacity, muscle strength, muscle mass, health-related quality of life, return to work and 
physical activity as examples.  This outline demonstrates the balance between ‘clinically focussed’ and 
‘patient-centred’ outcomes in terms of considering outcome measure selection on burden to patients 
and trial management. 
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6.4.2.6 Study design  
 
The terms pilot study and feasibility study are often used synonymously in the 
literature.  Essentially these processes can be considered ‘test-runs’ for some of the 
key components of the main trial to be conducted, answering the question ‘Can this 
study be done?’ [290, 316-319].  A thorough piloting stage is recommended in the 
development of complex interventions [298].  Randomisation is not an essential 
component of a pilot, feasibility study, even if the main trial in preparation will have a 
randomised controlled design [320].  Nonetheless some authors use the term ‘pilot 
trial’ where a randomised element is included [317, 321] although the lack of 
consensus for definitions of study types means that this is not widely adhered to.  
 
As a pilot study, the current trial allowed testing of eligibility criteria to determine 
recruitment and retention rates, acquisition of data on a range of outcome measures, 
and implementation of the intervention on a small, albeit varied, cohort of patients, in 
keeping with the aforementioned purpose of a pilot feasibility study.  In addition 
randomising patients provided valuable insight regarding the extent of natural, 
independent recovery of control patients, to further inform development of future 
interventions.  The current study included 20 patients and 21 patients in the 
randomised trial and observational cohort study respectively.  These are considered 
acceptable numbers for estimation of outcome measures and sample size calculations 
[289, 290].  Indeed these are within the range recently reported in a systematic 
review of UK Clinical Research Network-registered pilot and feasibility studies [322], 
albeit both randomised and observational groups experienced lack of completion.  
Variability in outcomes, with often large standard deviations, resulted in a range of 
estimated sample size estimates.  With emerging data from other RCTs, a more 
sensible approach would be to base power calculations on pooled findings from 
across these trials to achieve greater robustness.   
 
The current pilot study could be criticised for limited patient involvement in the 
design of the trial.  Whilst acceptability feedback was acquired from patients receiving 
the intervention following completion, it is acknowledged that greater levels of input 
throughout the process would have offered further insight and informed decisions 
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regarding conduct of the study [298].  Furthermore, only a single researcher (BC) was 
involved in the conduct of all aspects of the pilot study for pragmatic reasons.  Whilst 
potential researcher bias was essentially equal across all groups, this is a 
methodological limitation.  
 
6.4.3 Future considerations 
 
This study successfully met a number of intended feasibility outcomes namely to 
determine recruitment rate (numbers of patients screened vs. number eligible to 
participate and consenting to enrolment), the logistics of delivering the intervention 
and practical factors for consideration, compliance with the protocol in particular the 
exercise-based rehabilitation programme and patient acceptability of the 
intervention, and evaluation of potentially valuable outcome measures.  Experience 
gained from this pilot trial could be of value in the future when designing, 
implementing and evaluating a larger-scale trial.    
 
We observed a natural improvement in MRC-SS from the point of randomisation (at 
which point eligible patients were required to demonstrate ICU-AW as reflected by an 
MRC-SS <48/60) to the start of the intervention (at hospital discharge, by which stage 
the cohort no longer demonstrated ICU-AW).  Whilst this signals that the MRC-SS may 
not be a sensitive tool to stratify patients for ongoing physical rehabilitation input, 
supported by observational data from a cohort of patients who never demonstrated 
ICU-AW, this would also highlight that in future trials, timing of randomisation must 
be contemporaneous with intervention commencement.  Where this is not possible, 
detailed characterisation of clinical management received by patients in the interim 
period must be documented in order to ascertain the influence of this on patient 
performance.   
 
We included a range of clinical, physiological and patient-reported outcomes, and 
whilst not formally measured, it is highly likely this introduced an element of outcome 
measure burden or fatigue.  Certainly on a practical note, it was difficult to complete 
all measures at all time points due to additional constraints on patient time and 
availability.  Future consensus on the most appropriate outcome measures for 
 221 
 
evaluation in rehabilitation trials for survivors of critical illness will facilitate selection 
of outcomes in trials.  Ideally a core outcome measure set would include measures 
representing domains of activity, restriction and participation as reflected by the 




In this pilot feasibility study of exercise-based rehabilitation following hospital 
discharge for survivors of critical illness with ICU-AW outcomes measured at three 
months, including exercise capacity, peripheral skeletal muscle mass, health-related 
quality of life and physical function, were not different between standard treatment 
and exercise-based rehabilitation intervention groups.  Furthermore, differences 
between randomised patients, and an observational cohort of ‘clinically strong’ 
patients revealed inconsistent differences.  In addition, the use of a diagnosis of ICU-
AW based on the MRC-SS cut-off of less than 48 out of 60, conferred limited clinical 
usefulness in identifying patients with ongoing rehabilitation requirements and who 
may respond to rehabilitation treatment post hospital discharge.  Evaluation of the 
process highlighted methodological factors for further consideration.  Notably, a 
consensus on eligibility criteria would be beneficial to optimise recruitment rates, and 
these may be further influenced by potential for delivery of the intervention in 
different formats.  An emphasis on physical functional performance at the time of 
intervention delivery, in addition to the clinical factors related to the ICU admission 
may be warranted.  Certainly this would enable a patient-focussed approach to trial 
enrolment.  Furthermore, engaging patient stakeholders in all aspects of trial design 
would strengthen a future protocol.  The variation in natural recovery observed in 
patients in the current study highlights the need to track the trajectory of recovery in 
this patient population to permit the timely implementation of interventions when a 
plateau of improvement is reached, which may vary widely between individual 
patients.  This approach may therefore facilitate determining the optimum ‘dose’ of 
exercise prescription required for clinical effectiveness.  The establishment of a 
consensus on core outcomes for use in future trials of complex interventions will also 
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The catastrophic and often long-term consequences of critical illness for survivors are 
well documented.  Physical and psychological impairments, including reduced 
exercise capacity and health-related quality of life are known to persist for up to 5 
years post index admission [103-105, 111, 324].  These features are now referred to 
as the ‘post intensive care syndrome’ [125].  In recent years the importance of 
survivorship, or the quality of survival, has been increasingly recognised [131], and 
the role of rehabilitation interventions to facilitate the recovery pathway for these 
patients has become a major focus for both clinicians and researchers [325].   
 
In the UK, the National Institute of Health and Care Excellence (NICE) in 2009 
published clinical guideline 83 (CG83) focussed on ‘Rehabilitation after Critical Illness’ 
[136] (available at http://publications.nice.org.uk/rehabilitation-after-critical-illness-
cg83).  This guideline profiled the importance of this area of clinical practice aiming to 
improve the standards of care and previously unmet clinical needs of this patient 
group. NICE CG83 advocated a continuum of multidisciplinary rehabilitation along the 
recovery pathway from within the ICU, following transfer to the ward, and beyond 
hospital discharge.  Specifically at the point of hospital discharge it was recommended 
that patients were referred to appropriate rehabilitation services if ongoing needs 
were identified.  At 2-3 months following hospital discharge, a review and functional 
reassessment of the patient were advised to determine the extent of recovery and 
additional rehabilitation input in the event of a slower than anticipated recovery or 
identification of new physical and/or psychological morbidity 
 
However despite the intentions, widespread clinical implementation of these 
guidelines has been challenged by the limited evidence underpinning 
recommendations, and minimal detail provided to characterise optimum type, 
intensity, frequency and duration of exercise therapy and rehabilitations 
interventions [186].  In particular following hospital discharge survivors of critical 
illness can experience inadequate and poorly coordinated multidisciplinary care with 
inconsistent service provision which can be strongly influenced by local resources and 




Failure to implement national guidelines or respond to published evidence is not 
uncommon.  Disparity between the prevalence of conditions such as chronic 
cardiorespiratory disease, diabetes mellitus and sleep=related disorders, and 
availability of recommended services for their management, is evident across the UK 
[326-328].  Previous surveys relating to critical care rehabilitation provision have 
focussed on ICU follow-up clinics [329] or physiotherapy practice within the ICU [330-
337].  Two recent surveys have reported on NICE CG83 implementation but these 
were limited in volume and content, particularly at the post hospital discharge stage 
of the patient pathway, and restricted in geographical distribution [200, 201]. 
  
7.1.1 Aims of study 
 
The aims of this study focussed on the implementation of NICE CG83 across the UK 
and rehabilitation practice at the post hospital discharge stage of the patient pathway: 
 
1. To determine current UK prevalence of post hospital discharge follow-up for 
critical illness patients  
2. To determine availability of post hospital discharge rehabilitation programmes for 
post critical illness patients, including structure, format, content and evaluation   
3. To investigate barriers influencing provision of rehabilitation services, and use of 




7.2.1 United Kingdom Intensive and Critical Care Units 
 
Details for all adult ICUs across the UK (England, Wales, Scotland and Northern 
Ireland) were obtained via direct communication with the Intensive Care National 
Audit and Research Centre (ICNARC) and the Scottish Intensive Care Society Audit 
Group (SICSAG).  Details of organisations in which these units were based were 
recorded in an Excel spreadsheet.  Organisations with general ICUs were identified for 
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inclusion, and totalled 240 organisations (85 university teaching (UT) and 155 district 
general (DG) hospitals) of which 193 were based in England, 23 in Scotland, 15 in 
Wales and 9 in Northern Ireland.  Specialist ICUs e.g. neurosciences, cardiothoracic 
surgery or cancer were excluded.  For the purposes of the current study, where 
institutions were listed in duplicate on the original ICNARC or SICSAG database for 
multiple critical care units (e.g. both Intensive Care Unit and High Dependency Unit 
detailed), this counted for only one survey distribution.   
 
Addresses for the hospital where each ICU was located were obtained from national 
health websites (www.nhs.uk, www.wales.nhs.uk, www.n-i.nhs.uk and 
www.show.scot.nhs.uk). 
 
7.2.2 Post hospital discharge follow-up and rehabilitation survey 
 
A predominantly closed-question survey, targeted at critical care physiotherapists, 
was developed evaluating current clinical practice regarding provision of follow-up 
and available rehabilitation services for survivors of critical illness following hospital 
discharge, to include detail on content, format, delivery and evaluation of specific 
rehabilitation programmes, and use of alternative rehabilitation streams where 
necessary (Appendix V).   
 
The survey was divided into three main sections.  Initial demographic data were 
requested regarding the number, level, speciality, and bed-capacity of critical care 
areas within respondents’ organisations.  Secondly, detail of availability and 
physiotherapy involvement in provision of follow-up for post critical illness patients 
in line with that recommended in NICE CG83 was sought.  If follow-up was available, 
respondents were asked in what format this took, which members of the MDT were 
involved, and what content was included e.g. exercise capacity recovery, health-
related quality of life, psychosocial issues.  Specifically, whether follow-up included a 
functional re-assessment was also asked.  
 
The final section of the survey comprised the largest component.  Respondents were 
requested to indicate whether their institution offered a specific post hospital 
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discharge rehabilitation programme for survivors of critical illness i.e. separate to 
generic rehabilitation streams such as supported discharge, intermediate care or 
similar.  If respondents indicated positively, further questions focussed on patient 
eligibility, structure, format, delivery, content and evaluation of these programmes.  
Barriers to service provision were sought if none were currently in operation.  These 
were selected from a non-hierarchical list of options that included clinical, pragmatic, 
managerial and administrative.  Respondents were requested to indicate all potential 
barriers, and then which they considered to be the single, main limiting factor.    
 
Finally in this section of the survey, information was also requested regarding referral 
of post critical illness patients into alternative rehabilitation streams if no specific 
services were available e.g. pulmonary rehabilitation, exercise on prescription or 
similar programmes. 
 
The majority of questions throughout the survey were formatted to allow respondents 
to select from various tick-box options.  These options were not ranked in any order, 
nor were respondents asked to mark their responses in terms of perceived 
importance or grading (with the exception of the ‘main limiting barrier to 
rehabilitation’ question previously described).  Free text space was also available for 
additional independent detail.  At the end of the survey, respondents were asked to 
provide any other comments regarding any aspect of post critical illness rehabilitation 
not covered by the survey.   
 
The survey received initial feedback from a clinical academic physiotherapy professor 
with more than thirty years experience in the field, and piloted using three senior 
critical care physiotherapists, (ICU clinical experience ranging 7-14years), including 
one full-time clinician, one clinical academic (50:50 split post), and one full-time 
academic, all having practiced in critical care within the last 2 years.  Constructive 
critique of the survey design, content, structure, user-acceptability and completion 






7.2.3 Participants and survey distribution 
 
In March 2013, the survey and a covering letter of invitation to participate were 
distributed by post, addressed to the ‘Senior Physiotherapist in Critical Care’ in the 
physiotherapy department at each of the identified organisations.  Stamped, self-
addressed envelopes (SAEs) were provided for return of the questionnaire to the 
author.  Surveys were coded to assist with identification of responses.  Throughout 
the period of survey distribution, a variety of strategies were employed to assist with 
survey promotion to enhance rates of completion and return.  These included use of 
the interactive physiotherapy respiratory network forum (iCSP, www.iCSP.org.uk), 
the Association for Chartered Physiotherapists in Respiratory Care (ACPRC) Critical 
Care sub-group conference and membership email, and circulation of advertisement 
information via relevant national physiotherapy clinical and research networks 
(Figure 7-1). 
  
Six weeks following initial survey distribution, a reminder letter was sent to non-
responders with a second copy of the survey and further SAEs.  A further six weeks 
later, telephone calls were made to remaining non-responders.  Direct contact was 
attempted with the senior ICU physiotherapist to determine willingness to participate.  
Respondents were offered the choice of telephone completion of the survey, or 
electronically via email if details were provided.  Respondents were also contacted via 
email of telephone if there were missing data.   
 
In line with guidance produced by the UK National Research Ethics Service (available 
at http://www.nres.nhs.uk/) the project was deemed an evaluation of service 
provision, and therefore ethical approval was not required.  Completion and return of 
the survey was considered indicative of willingness to participate in the survey and 
implied consent. 
 
7.2.4 Data and statistical analysis 
 
All data was stored in Excel spreadsheets, transcribed from hard copies of returned 
surveys.  Due to the nature of the study and data collected, descriptive statistics were 
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used to analyse quantitative responses including number, percentage and 95% 
confidence intervals where appropriate, and additional qualitative review of free-text 
comments made.  A completion response rate of 65% rate was determined a priori to 




7.3.1 Survey distribution and response 
 
One hundred and eighty-two surveys of the 240 distributed surveys were returned, 
indicating an overall 75.8% (95%CI 70.4-81.2) response rate.  Figure 7-1 summarises 
the response rate at each stage of survey distribution.  Specifically, nearly three-
quarters of all surveys distributed to both university teaching (UT) and district 
general (DG) hospitals were returned (66/85, 75% and 115/155, 74.2% respectively) 
indicating that the groups of respondents were a representative sample of the original 
cohort of organisations.  One survey was returned blank, with the respondent 
indicating that they lacked sufficient time for completion of the survey.   
 
7.3.2 Demographics of critical care units in responding organisations 
 
Demographic data from the organisations surveyed are reported in Table 7-1 and 
Table 7-2.  The majority were DG hospitals, with ICUs and HDUs on the whole 
managing mixed general medical and surgical patient casemixes.  A large number of 














































Figure 7-1 Flow-chart of survey distribution stages, response rates and promotional 
activities 
 
Abbreviations: iCSP = interactive Chartered Society of Physiotherapy.  ACPRC = Association of Chartered 
Physiotherapists in Respiratory Care. 
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Table 7-1 Classifications of level of care 
 
Level Classification 
0 Patients whose needs can be met through normal ward care in an acute 
hospital. 
1 Patients at risk of their condition deteriorating, or those recently located 
from higher levels of care, whose needs can be met on an acute ward with 
additional advice and support from the critical care team. 
2 Patients requiring more detailed observation or intervention including 
support for a single failing organ system or post-operative care and those 
‘stepping down’ from higher levels of care. 
3 Patients requiring advanced respiratory support alone or basic respiratory 
support together with support of at least two organ systems.  This level 
includes all complex patients requiring support for multi-organ failure. 




































Table 7-2 Demographics of respondent organisations 
 
Characteristic  n (%) 
















Total number of Critical Care Units*  
Level 3 (ICU) 
Level 2 (HDU) 





Total number of Critical Care Beds* 
Level 3 (ICU) 
Level 2 (HDU) 





Frequency of reported types of patients admitted 



























n=181 responses (except for response rate according to country, n=192 responses).  Critical care units 
and bed numbers refer to the total number within respondent organisations overall e.g. one 
organisation may have multiple critical care areas.  *n=2 non-responses.  #Data presented indicates 
frequency of reported occurrence of type.  Multiple responses could be given.  ~Other e.g. haematology, 
infectious disease, maxillo-facial, vascular.    
 








7.3.3 Current post hospital discharge rehabilitation research studies 
 
Five respondents reported that available rehabilitation programmes at their 
organisations occurred as a result of a currently active research study (three studies 
overall, [190-192]).  These responses were considered separately to those from 
hospitals where services had been ‘regularly’ implemented, as the aim of the survey 
was to characterise existing typical clinical practice rather than research activity 
(Figure 7-2).  These five respondents completed the section asking for barriers to 
offering regular services had the research study not been in implementation at their 
local site.  Further detail regarding the study protocols for these current studies is 



























































Figure 7-2 Flow-chart outlining available follow-up services and rehabilitation 
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7.3.4 Follow-up for survivors of critical illness patients after hospital discharge 
 
Forty-eight organisations (27.3% 95%CI (20.7-33.9)) reported availability of follow-
up of post critical illness patients at 2-3months following hospital discharge (Figure 
7-1); 66.7% (n=32) of these were from DG hospitals and 33.3% (n=16) from UT 
hospitals.  Forty-five organisations offering follow-up were located in England, two in 
Scotland, one in Northern Ireland and none in Wales.   
   
7.3.4.1 Format of follow-up 
 
Two respondents did not report details of the format of follow-up.  Of the remaining 
responses (n=46), ICU follow-up clinics were the most frequently reported form of 
follow-up for post critical illness patients (Table 7-3).  11 respondents reported more 
than one form of follow-up was available.   
   
Table 7-3 Forms of follow-up reported for survivors of critical illness patients at 2-
3months post hospital discharge  
 
Form of follow-up n (%) 
Intensive care unit follow-up clinic 39 (84.8) 
Rehabilitation class 10 (21.7) 
Other 6 (13.0) 
Did not specify 2 (4.3) 
Postal survey 1 (2.2) 
Telephone call 1 (2.2) 
Medical outpatient appointment 0 (0) 




Other forms of follow-up reported included an informal coffee morning for all ICU 
survivors (with >7day length of stay) every 3months, a patient support group, 
rehabilitation delivered as part of physiotherapy outreach, attendance at a local ICU 
Steps support group, individual physiotherapy referral by lead nurse, and ad hoc 
appointments with critical care nursing staff.  No further detail was given to 
characterise these services in greater detail. 
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7.3.4.2 Multidisciplinary team members involved in follow-up 
 
All respondents reporting available follow-up services completed this question 
(n=48).  Forty-three respondents (89.6%) reported that physiotherapists were part of 
the multidisciplinary team (MDT) involved in follow-up of post critical illness patients.  
However just under one-third of these (n=13, 30.2%) reported that this was on an ad 
hoc or referral basis only, at the discretion of other staff involved in the follow-up, and 
which could be infrequent or occasional.  Other MDT members with reported 
involvement in follow-up are detailed in Table 7-4, albeit in five cases access to critical 
care doctors, occupational therapists, psychologists or dieticians was also reported to 
be on a referral basis only.  Where critical care nurses were involved in follow-up, this 
was always on a ‘fixed’ basis i.e. they were the permanently featured MDT member.  
Occupational therapists or dieticians were rarely involved in follow-up.  The scale of 
MDT involvement ranged from one member (n=5, 10.4%) to five members (n=1, 
2.0%) with three being the most common (n=21, 43.8%).  No follow-up service 
included all listed members of the MDT nor were alternative healthcare professionals 
mentioned.       
 
Table 7-4 Multidisciplinary teams members involved in post hospital discharge 
follow-up for survivors of critical illness 
 
Multidisciplinary team member n (%) 
Physiotherapist 43 (89.6) 
Critical Care nurse 42 (87.5) 
Critical Care doctor 31 (64.6) 
Psychologist 10 (20.8) 
Dietician 2 (4.2) 
Occupational therapist 2 (4.2) 
n=frequency of reported occurrence out of 48 responses.  Multiple team members could be listed 
 
7.3.4.3 Content of follow-up services 
 
One response was blank for whether follow-up services included a functional 
reassessment based on previous assessment conducted at the time of hospital 
discharge.  Of the remaining 47 responses, 20 (42.6%) reported that a functional re-
assessment was performed, and 27 (57.4%) that it was not.  Table 7-5 presents other 
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aspects included in follow-up services, with health-related quality of life (83.3%) and 
psychological status (81.3%) being the most frequently reported items.  Exercise 
capacity and nursing-related issues were included in approximately half of cases.     
 
Nine responses included other comments such as that follow-up adopted a 
“...discussion of the common side-effects of critical illness e.g. reduced functional 
capacity, joint pain, anxiety, nightmares and hallucinations” and “...formal physio 
follow-up from appropriate services e.g. musculoskeletal” as deemed necessary.    
Other topics listed as being discussed at follow-up included sleep, mood, carer 
concerns, goals for work, tracheostomy site/wound management.  
 
Table 7-5 Content of post hospital discharge follow-up for survivors of critical illness  
 
Content of follow-up n (%) 
HRQL 40 (83.3) 
Psychological status 39 (81.3) 
Medical status 34 (70.8) 
Nursing-related issues 29 (60.4) 
Exercise capacity 28 (58.3) 
Diet/nutrition 24 (50.0) 
Other 9 (18.8) 
n=frequency of reported occurrence out of 48 responses.  Multiple content could be listed.   
Abbreviations: HRQL = health-related quality of life 
 
One response reported that follow-up was “...guided by recommendations by iCAN-
UK.  Our assessments are problem-based”.  Another indicated that content was 
modelled on educational session typically included in pulmonary rehabilitation 
classes, and a further that follow-up content was “...patient-dependent”.  One response 
highlighted that whilst all the aforementioned topics were discussed in follow-up, 
outcome measures were not used to formally assess these parameters.  Furthermore 
one response described follow-up as “...more of a general chat regarding coping at 




7.3.5 Rehabilitation programmes for survivors of critical illness post hospital 
discharge  
 
7.3.5.1 Availability, leadership, and enrolment 
 
Twelve organisations reported a rehabilitation programme available following 
hospital discharge for post critical illness patients (6.8% 95%CI (3.1-10.5)) (Figure 7-
2).  Two reported that their programme was available on an ad hoc or inconsistent 
basis – these are reported separately.  Of the remaining ten programmes implemented 
on a regular basis, all were based at organisations in England.  All had also reported 
offering a follow-up service, with eight of these in the form of an ICU follow-up clinic.  
Four organisations offering regular rehabilitation programmes were UT hospitals, and 
6 were DG hospitals.   
 
Physiotherapists led all of these available rehabilitation programmes.  In the majority 
of cases (n=9) this was a senior ICU physiotherapist (median (IQR) Agenda for Change 
banding 7 (6-7), median (IQR) duration ICU experience 7.0 (4.0-13.0)years), albeit full 
details of grade and experience were not provided by all respondents. A rehabilitation 
physiotherapist led one rehabilitation programme.  One programme reported 
additional involvement of an occupational therapist and fitness instructor, three 
others included a critical care nurse.  No other multidisciplinary team members were 
reported as being involved in any of the rehabilitation programmes.   
 
There were limited data provided regarding detail of enrolment of patients into 
rehabilitation programmes (Table 7-6).  Both the category of eligibility criterion and 
specific detail of the assessment measure were requested from a pre-defined list e.g. 
duration of mechanical ventilation (category) and >48hours (assessment measure), 
and free text was also provided for independent detail.  No detail of eligibility criteria 







Table 7-6 Detail of enrolment criteria into post hospital discharge rehabilitation 
programmes 
 
Eligibility criteria n (%)  Detail of assessment measure 
Duration MV 7 (70.0) >5 days; >4 days; >3 days; 48hours 
ICU LOS 3 (30.0) >5 days; >4 days 
Hospital LOS 2 (20.0) “lengthened” 
PF: ICU discharge 2 (20.0) “reduced from pre-admission” 
Muscle strength: ICU discharge 2 (20.0) No detail provided 
Exercise capacity: ICU discharge 2 (20.0) No detail provided 
HRQL: ICU discharge 0  - 
PF: hospital discharge 4 (40.0) No detail provided 
Muscle strength: hospital discharge 3 (30.0) No detail provided 
Exercise capacity: hospital discharge 3 (30.0) No detail provided 
HRQL: hospital discharge 1 (10.0) No detail provided 
All patients eligible 1 (10.0) “any ITU stay” 
Other  2 (20.0) “those with profound weakness or functional 
limitation regardless of LOS”; 
 
“screen for low or high risk throughout 
ICU/hospital stay.  If high risk, exercise plan, 
goals and rehab class if suitable.  All plus 2 day 
ICU are automatically sent SF8 and depending 
on score, either 1:1 or group follow-up” 
n=10 responses.  Multiple criteria could be reported per response.   
 
Abbreviations: ICU/ITU = intensive care/therapy unit.  MV = mechanical ventilation.  HRQL = health-
related quality of life.  LOS = length of stay.  PF = physical function.  SF8 = Short Form-8 (a health-related 
quality of life survey).   
 
7.3.5.2 Format of delivery 
 
Nine rehabilitation programmes were hospital-based and one was home-based. 
Patients exercised under supervision in four programmes, and with a combination of 
supervised and independent exercise in the remaining six.  Only one programme used 
an accompanying rehabilitation manual, however, three others reported providing 
printed, individualised home exercises for patients.  Detail of any accompanying 
rehabilitation manual or alternative material was not reported for one programme.  
 
All programmes were stand-alone rehabilitation programmes designed for post 
critical illness patients, and not combined with existing disease-specific services such 
as pulmonary or cardiac rehabilitation.  Four commenced immediately following 
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hospital discharge, 1 within one week of discharge, three within two weeks, and one 
each within one month and at 2-3months respectively following hospital discharge.  In 
addition it was reported that for two programmes, rehabilitation could commence 
whilst patients were still on the wards, and five reported that the exact starting point 
following hospital discharge depended on patient fitness and readiness.  Only one 




The number of sessions included in rehabilitation programmes varied greatly, ranging 
from 6 to 12 excluding additional assessment sessions.  Three programmes had the 
capacity and/or flexibility to allow patients to continue until certain goals had been 
achieved or further time was required to achieve an individual’s target physical 
functional level.  Number of sessions was not reported for two programmes.   
 
Typically sessions ran weekly (7 programmes) or twice-weekly (3 programmes); no 
other frequency of sessions was reported, and all programmes included sessions of 
60mins duration.  Eight programmes were ‘rolling’ in operation programmes, 
meaning patients could start and finish the programme at any point in time, and one 
was stand-alone, such that cohorts of post critical illness patients all started and 
completed programmes simultaneously.  This detail was not reported for one 
programme.     
 
Reported group size and staff:patient ratio across rehabilitation programmes was also 
highly variable.  One programme incorporated a 1:1 staff:patient structure, whilst 
another adopted a flexible approach that depended on the complexity of the patient 
and individual rehabilitation needs.  Across the remaining programmes group sizes 
ranged from 5 up to 14, with approximately one qualified staff member for every 3 
patients.  Most programmes adopted patient-specific exercise plans (n=7) whilst three 





7.3.5.4  Content 
 
All rehabilitation programmes included an exercise component, involving a 
combination of cardiovascular, strength, balance and functional activity.  Table 7-7 
provides further details of frequency of inclusion of specific types of these exercises.  
Nine programmes utilised at least two different forms of exercise prescription during 
the programme.  Clinician judgement was the most commonly utilised form in seven 
programmes, followed by results of walking tests (n=6) and physical function 
assessment (n=5).  Physiological parameters such as target perceived rate of exertion 
and heart rate, and results of balance assessment were used relatively infrequently 
(n=2, n=2, n=1 programmes respectively).  No programme incorporated use of the 
repetition maximum principle to prescribe exercise.   
 
Table 7-7 Detail of exercises included in post hospital discharge rehabilitation 
programmes 
 
Category of exercise Specific exercise n (%) 
Cardiovascular  Static bike 10 (100.0) 
 Step-ups 9 (90.0) 
 Treadmill  7 (70.0) 
 Cross-trainer 2 (20.0) 
Strength  Lower limb 10 (100.0) 
 Upper limb 10 (100.0) 
 Theraband/resistance 9 (90.0) 
 Free weights 7 (70.0) 
Balance  Dynamic  9 (90.0) 
 Static 5 (50.0) 
Functional  Sit-to-stand 8 (80.0) 
 Walking  6 (60.0) 
 Timed Up And Go 2 (20.0) 
n=frequency of reported occurrence out of 10 responses.  Multiple exercises could be listed/response.   
 
 
Similarly, all programmes included at least two forms of patient monitoring during 
exercise sessions, based on a range of physiological and clinical factors.  Seven 
programmes reported use of target rates of perceived exertion, 4 used oxygen 
saturation levels, and 3 monitored heart rate.  Contrastingly, patient-related 
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parameters were also adopted - 8 programmes monitored exercise based on verbal 
patient feedback, 6 based on clinician judgement of the patient, and 2 based on visual 
analogue scales.  Four programmes reported incorporating reassessment of baseline 
measures as a form of monitoring.   
 
Less than half of programmes included an education component (n=4).  A range of 
topics were covered including exercise, stress management/relaxation, nutrition, 
return to work, energy conservation, medications, recovery following critical illness, 
smoking cessation, managing breathlessness and breathing control, delivered 
predominantly by physiotherapists but with additional input from occupational 
therapist and nursing colleagues.   
 
7.3.5.5 Evaluation  
 
Table 7-8 reports the category and detail of outcome measures used to evaluate 
rehabilitation programmes.  Exercise capacity and health-related quality of life 
outcome measures were the most commonly utilised. 
 
Table 7-8 Outcome measures used to evaluate post hospital discharge rehabilitation 
programmes 
 
Outcome measure n (%) Detail of outcome measure 
HRQL 10 (100.0)  SF-36, HADS, EQ5D, FIM, SF-8 
Exercise capacity 9 (90.0) 6MWT; ISWT 
Other  3 (30.0) Achievement of patient-specific goals; BMI; 
Impacts of Events Score 
Functional  2 (20.0) TUAG; patient-specific goals 
Strength  1 (10.0) 2 minute step-ups   
Mental/cognitive 0 - 
n=frequency of reported occurrence out of 10 responses.  Multiple outcome measures could be 
reported/response.   
 
Abbreviations: HRQL = health-related quality of life.  6MWT = Six Minute Walk Test.  ISWT = Incremental 
Shuttle Walk Test.  SF-36 = Short Form 36 v2.  HADS = Hospital Anxiety and Depression Scale.  EQ5D = 
EuroQol 5 Dimensions.  FIM = Functional Independence Measure.  SF-8 = Short Form 8.  TUAG = Timed Up 





7.3.5.6 Barriers to offering post hospital discharge rehabilitation programmes  
 
Respondents were requested to report barriers to delivery of post hospital discharge 
rehabilitation programmes in their organisations as part of routine clinical practice 
for post critical illness patients from a non-hierarchical list that included clinical, 
pragmatic and managerial and administrative options.  From those selected, 
respondents were also asked to confirm the main reason.  Out of a potential 171 
responses from organisations (i.e. excluding one blank response and the ten regularly 
implemented rehabilitation programmes in operation), there were seven non-
responses to both parts of this question, and a further 8 non-responses to specifying 
the main barrier.  Table 7-9 reports frequency of reported barriers to post hospital 
discharge rehabilitation programme service provision.  Ninety-one percent (n=149) of 
respondents reported lack of funding as one barrier to offering post hospital 
discharge rehabilitation programmes, and three-quarters reported lack of staff 
numbers.  A minority of respondents reported that a lack of evidence was a barrier to 
implementing a post hospital discharge rehabilitation programme.  ‘Time constraints’ 
was the single other barrier listed.  Ten respondents reported only one barrier, 33 
reported two reasons, and 120 reported multiple (>2) barriers.   
 
Table 7-9 Barriers reported to offering post hospital discharge rehabilitation 
programmes 
 
Barrier n (%) 
Lack of funding 149 (90.9) 
Lack of sufficient staff 128 (78.0) 
Resources prioritised to other patient groups/clinical areas 71 (43.3) 
Not considered required service at managerial level 66 (40.2) 
Lack of available space 50 (30.5) 
Insufficient patient numbers to justify 35 (21.3) 
Extra-contractual (out-of-area) patient caseload 15 (9.1) 
Lack of trained staff 13 (7.9) 
No evidence 4 (2.4) 
Not sure what to include in a programme 2 (1.2) 
Other 1 (0.6) 





Lack of funding was also reported as the main barrier to service provision (n=99, 
63.5%), and this far exceeded any other barrier (Table 7-10).  ‘Not required at 
managerial level’, ‘Lack of sufficient staff’ and ‘Insufficient patient numbers’ were the 
other main barriers most frequently reported. 
 
Table 7-10 Main barriers reported to offering post hospital discharge rehabilitation 
programmes 
 
Main barrier n (%) 
Lack of funding 99 (63.5) 
Not considered required service at managerial level 22 (14.1) 
Lack of sufficient staff 17 (10.9) 
Insufficient patient numbers to justify 11 (7.1) 
Resources prioritised to other patient groups/clinical areas 4 (2.7) 
Lack of available space 2 (1.3) 
Other (time constraints) 1 (0.6) 
Not sure what to include in a programme 0 (0.0) 
Lack of trained staff 0 (0.0) 
Extra-contractual (out-of-area) patient caseload 0 (0.0) 
No evidence 0 (0.0) 
n=frequency of reported occurrence out of 156 responses. 
 
 
A number of free-text comments were made in relation to this question, and further 
elucidate the themes of funding restriction, resource allocation/availability (including 
staffing) and strategic management priorities and policy as key limiting factors in 
implementing post hospital discharge rehabilitation programmes (Note: words in 
italics added by the author for full interpretation): 
 
“...we at times struggle to fight for staff for in pt rehab (in-patient 
rehabilitation) let alone fight for a budget for op (out-patient) care 
 
"...we run a voluntary f-u (follow-up) clinic but have had to withdraw the 
rehab (rehabilitation) and psych (psychology) elements due to no (sic) 
support from therapy managers 
 
"...despite extensive work the business case was declined 
 
"...a rehab (rehabilitation) programme was run for 12m using charitable 





“...historically no service available, no need established by current ICU 
services 
 
“...and not considered required at managerial level; Some years ago 
charitable funding was available to open follow-up clinic to include rehab 
(rehabilitation) service but Trust board refused the 2 year funding as they 
could not commit to continuing to fund the service once the charitable 
monies expired. So the reason we didn’t introduce the service at that time 
was a mix of funding and managerial issues.  Currently I would think staffing 
would be another issue. 
 
"...previously ran post ICU rehab (rehabilitation) class but had to stop because 
reduced staffing (prioritising in-pt) and difficult to get numbers (no transport 
provided) 
 
“...The main barriers to this aspect are time constraints, lack of staff and 
funding alongside limited knowledge of potential co-morbidities following 
ICU stay. Critical Care follow up clinics do not take place in an adequate time 
frame in this trust and as such many people do not attend, therefore we are 
missing potential problems. Additionally the clinic is not an MDT run clinic, 
limiting clinical identification of potential problems. 
 
“...absence of vertical integration of health and social care 
 
"...not so much not considered as required - sure the team believe it's 
required just not enough resources 
 
"6.5WTE PT (6.5 whole-time equivalent physiotherapists) in team covering 7 
different ward specialities, 3x critical care areas, resp o/p (respiratory out-
patients), resp pts (respiratory patients) in A&E/admissions 
 
 
Other comments described the interaction between acute and primary care services, 
which in some cases offer a route for ongoing rehabilitation input, and clinical and 
logistical factors for consideration in determining need for specific critical care 
services: 
"...inpt (in-patient) and outpt (out-patient) services are provided by two separate 
organisations, therefore although the inpt (in-patient) team would like to provide 
a service the community team will not lend support 
 




"...not sure if we would have individual class therefore combined with PR 
(pulmonary rehabilitation); we would like to set one-up 
 
“...numbers are very small and tends to be post-op (post-operative); back to 
baseline 5/7 (at five days). not seen need to provide service separate to our 
IRS (in-patient rehabilitation or integrated respiratory service) 
“...We have a follow up clinic run by our CCORT (critical care outreach team), 
but no physical rehab (rehabilitation) post D/C (discharge) home (unless 
needing regular community physio (physiotherapy) input) 
 
"...very structured in hospital critical care rehab (rehabilitation) service to 
maximise pt (patient) status at hospital d/c (discharge), has significantly 
reduced LOS (length of stay), readmissions to critical care, QOL (quality of 
life) scores and ongoing co-morbidity/health problems.  Insufficient numbers 
for group rehab (rehabilitation) specific to CCD (critical care disease) post d/c 
(discharge) 
 
"...patients who need long-term rehab (rehabilitation) are followed up by 
community staff 
 
"...we use PR (pulmonary rehabilitation) programme for many post ITU 
patients 
 
“...cardiac patients go to CR (cardiac rehabilitation) 
 
 
7.3.5.7 Utilisation of alternative rehabilitation streams 
 
The majority of respondents (98/171, 57.3%) reported that in the absence of a 
specific post hospital discharge rehabilitation programme for survivors of critical 
illness at their organisation, these patients were referred into alternative 
rehabilitation streams, including pulmonary and cardiac rehabilitation (albeit solely 
for those patients with cardiac diagnoses), and various community-based services 
(Table 7-11).  Seventy-two respondents (42.1%) reported this approach was not 









Table 7-11 Alternative rehabilitation streams used for post critical illness patients 
following hospital discharge 
 
Rehabilitation stream n (%) 















Exercise on prescription 42 (42.9) 
Cardiac rehabilitation 38 (38.8) 
Community gym session 21 (21.4) 
n=frequency of reported occurrence out of 98 responses.  Multiple options could be listed.  Note there 
may be some overlap between various other community services depending on local terminology. 
 
 
7.3.5.8 Non-regular rehabilitation programmes 
 
One of the non-regular programmes was described as “...ad hoc gym sessions run by 
the ITU (intensive therapy unit) physios...” – no further detail was reported on this.  
The second programme was reported as being run by an ICU physiotherapist, AfC 
Band 7 with 13 years ICU experience.  Enrolment criteria included physical function, 
muscle strength and exercise capacity measured at both ICU and hospital discharge 
although no specific detail of assessments measures was reported to characterise 
these criteria further.  This programme was offered as either home, or hospital or 
community based, “...depending on requirements – ICU staff may supervise/direct 
other PT (physiotherapy) staff...”.   
 
Patients exercised under supervision and independently, and their programmes were 
accompanied by handouts of their individual exercises.  This was a stand-alone 
programme that commenced immediately following hospital discharge, as soon as 
feasible for patients, and reported no waiting list.  Sessions of 40minutes duration 
could be weekly or twice-weekly, and the overall programme duration lasted “...as 
required to reach (the patient’s) desired functional/physical level...”.  Exercises 
included cardiovascular, upper and lower limb strengthening, balance and functional 
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activities.  Exercise prescription was based on the results of walking tests, physical 
function and balance assessments, and clinician judgement.  Progression and 
monitoring of exercise incorporated the Borg score (for perceived exertion), patient 
verbal feedback and clinician observation/judgement.  There was no education 
component to this programme.   
 
Programme evaluation included strength-based outcome measures (Oxford grading 
scale), exercise capacity (Incremental Shuttle Walk Test), and functional performance 
(Timed Up And Go test).  The respondent for this non-regular rehabilitation 
programme concluded by giving the following comments: 
“...we’ve always provided physical/functional rehab (rehabilitation) to our 
critical care patients post discharge but numbers are relatively low so 
provide individual programme based upon clinical need as and when 
required.  ICU physio usually required to delegate rehab delivery to TI 
(physio support worker) or local physio staff but oversee programme and 
progression.  If appropriate patients may also be slotted into next available 
pulmonary rehab programme, but prefer to provide individual gym based 
exercise programme if no preceding lung condition. 
 
Both respondents for the organisations running non-regular rehabilitation 
programmes completed the question asking for information on barriers to offering a 




These data from the first comprehensive UK survey highlight the limited 
implementation of NICE CG83 and the poor delivery across the UK of post hospital 
rehabilitation services for survivors of critical illness.  Indeed, of one hundred and 
eight-two surveys returned, less than one-third of all organisations provided any form 
of follow-up for these patients.  Of major clinical concern is that only 5% of 
respondents reported provision of a regular rehabilitation programme, a major focus 
of NICE CG83.   Lack of funding was the most frequently reported and main barrier to 
service availability.  Furthermore lack of managerial support for this type of service 
and prioritisation of resource allocation to other clinical areas were reported as 
barriers by over 40% of respondents.  Whilst survey data can have a number of 
potential limitations, in particular bias introduced through non-response, the current 
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study benefited from a high response rate achieved through utilisation of a variety of 
promotional activities and diligent follow-up to enhance completion and return.  
These data indicate that inadequate clinical infrastructure exists for hospitals and 
community teams to successfully adhere to NICE CG83.  The limited impact of NICE 
guidance on clinical practice is not unique to critical care rehabilitation and is, rather 
disappointingly, a theme observed in other healthcare areas that have been subject to 
the development of national guidance.   
 
7.4.1 Clinical interpretation 
 
7.4.1.1 Implementation of NICE CG83 across the UK 
 
Data from this survey indicate a lack of implementation of NICE CG83 guidelines with 
a limited number of follow-up services available post hospital discharge, and even 
fewer rehabilitation programmes.  This could have reflected poor motivation on the 
part of clinicians to actively engage in the delivery of the recommendations.  However, 
the key barriers to service delivery were reported as lack of funding, limited resources 
and infrastructure with reduce priority at managerial level.  In the current climate of 
the National Health Service (NHS), such obstacles to the application of NICE CG83 are 
at either a clinical commissioning or clinical operational level, or both, rather than at 
the level of the clinicians.  This theme is echoed in the content of free-text comments 
by respondents that highlighted frustrations and disappointment at the difficulty in 
securing support for such services.  Interestingly, the paucity of data to support the 
effectiveness of post ICU rehabilitation was not perceived as a barrier by the vast 
majority of clinicians (only 4% reported this as a potential barrier), and highlights the 
complexities in the management and clinical delivery of a critical care rehabilitation 
service.  A conflict between clinicians, managers and commissioners has developed as 
the lack of high level clinical evidence supporting NICE CG83 provides a major 
challenge to the funding of a critical care survivor rehabilitation service by both 
managers and commissioners.  At present the evidence base for post hospital 
discharge rehabilitation interventions is slowly developing, as described in detail in 




7.4.1.2 Alternatives to specific post hospital discharge rehabilitation 
programmes for survivors of critical illness 
 
Rehabilitation for survivors of critical illness represents a challenge for researchers, 
designing and evaluating complex interventions in a complex patient group [339].  
Further translational studies and clinical trials are required to develop the evidence-
base.  Until such data are available, the unmet clinical need will remain evident and 
unaddressed in this patient population.  Referral of patients into established 
rehabilitation programmes, such as cardiac and pulmonary rehabilitation, offers one 
potential resolution with over 50% of respondents reporting the use of alternative 
rehabilitation programmes for critical care survivors.  This may further be influenced 
by the designated speciality of the ward destination of patients following ICU 
discharge.  Indeed, the most recent guidelines for pulmonary rehabilitation advocate 
an individualised approach to patient management [287], and these interventions 
could easily be adapted for patient recovering from critical illness, albeit that 
additional referrals may place an increased burden on such services.  Furthermore, 
whilst valuable resources, these programmes are disease-specific and may not fully 
address the range of impairments demonstrated by survivors of critical illness as part 
of the ‘post intensive care syndrome’ [125]. 
 
7.4.1.3 Clinical usefulness of post ICU clinics 
 
The vast majority of follow-up services (84.8%) in the current survey were conducted 
in the form of an ICU follow-up clinic.  These were first profiled in the late 1990s and 
early 200s following updating of the NHS Agenda for critical care [329, 338, 340], and 
have been reported by patients to represent a valuable contribution to their physical, 
emotional and psychological recovery providing them with a source of information 
and support to understand their ICU experience  [341].  However previous survey 
data have indicated poor implementation of these early recommendations with a low 
prevalence of available follow-up clinics [329], and trials data have failed to 




With reference to NICE CG83, the management of ICU patients beyond ICU discharge 
requires closer attention.  An alternative strategy for the conduct and purpose of post 
ICU clinics would be to robustly monitor over time the trajectory of recovery of ICU 
survivors with onward referral into specific speciality care where identified as 
required.  This would require a coordinated multidisciplinary team approach, lacking 
in the services reported in the current study.  Wide variability in responses regarding 
post hospital discharge rehabilitation programmes for ICU survivors severely limits 
any consensus on the optimum approach for these services.  The marked 
heterogeneity of the patient population makes it increasingly likely that a bespoke, 
individualised approach, akin to personalised medicine, may be more appropriate. 
 
7.4.1.4 Barriers to implementation of clinical guidelines 
  
Implementation of and adherence to clinical guidelines can be inconsistent [342-345].  
In a systematic review examining this, Cabana et al [346] identified a framework of 
seven factors influencing successful uptake of guidelines – lack of awareness, lack of 
familiarity, lack of agreement, lack of self-efficacy, lack of outcome expectancy, inertia 
of previous practice and external barriers.  These are similar to the model outlined by 
the Scottish Intercollegiate Guidelines Network (SIGN) who defined internal barriers 
to the guideline itself (which can be addressed by development in accordance with a 
robust methodology) and external barriers relating to the clinical environment and 
specific local circumstances [269].   
 
Lack of awareness and familiarity were assumed not to be major limiting factors.  
Whilst the current study did not specifically ask regarding this, NICE CG83 has been in 
circulation since 2009 and much work in the field of early mobilisation and 
rehabilitation practice for ICU survivors has appeared in the literature in the 
intervening time [141, 142, 146, 163, 172, 176, 177, 180].  Furthermore, 83% of lead 
ICU physiotherapists were reported as aware of the guideline in a previous survey 
[200] and the researcher (BC) has empirically observed significant discussion around 
the guidelines and sharing of ICU rehabilitation practices on the UK professional 




In addition, whilst also not specifically surveyed, there were no responses indicating 
lack of agreement from clinicians with NICE CG83.  Only 2 respondents reported 
uncertainty as to what to include in a programme was a barrier (self-efficacy).  Whilst 
qualitative comment provided by respondents was not analysed formally there was 
no indication of a theme suggesting clinicians did not perceive that rehabilitation 
would be of benefit (lack of outcome expectancy), albeit a minority of respondents 
reported that lack of evidence was a barrier.  This suggests that for these respondents 
in particular it was important to have robust grounds to support offering services, and 
proof of effect was required prior to local implementation. 
  
Inertia of previous practice reflects a lack of motivation or inability to overcome 
previous practice.  That a large proportion of those clinicians unable to offer specific 
rehabilitation service for post ICU patients, instead utilised alternative forms of 
rehabilitation suggests this was not evident in the current study, and that there was a 
willingness to consider other options to address the issue of availability of 
rehabilitation services.  By far the greatest challenge to implementation of NICE CG83 
were external factors, which can broadly be categorised further into guideline-related, 
patient-related and environmental-related [346] and may encompass challenges 
associated with infrastructure, organisation, resources and local attitudes and 
practice [269].   
 
The relatively broad nature of the guideline, encompassing three distinct stages of the 
patient pathway and the transition between each, and lack of specific detail challenge 
its translation into clinical practice.  Given the current economic climate within the 
NHS it is increasingly difficult to secure funding to develop and establish services 
without existing evidence and where the remit is broad and relatively undefined.  
Lack of prioritisation from senior management was also influential, with resources 
directed to other clinical services.  There have been no data published examining the 
patient perception of the importance of NICE CG83, or indeed awareness of the 
guideline at all.  However at an organisational level, patient-related barriers were 
reported in the current study including demand for services, tertiary referral status 
and geographic residency.  In the future a ‘joined-up’ network of services across 
regional areas could facilitate the transition of patients between teams and 
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organisations to ensure a seamless pathway of care, and a more co-ordinated system 
of working between ICU and rehabilitation clinicians, facilitated by offering patients a 
more individualised approach to their rehabilitation requirements.  Examining the 
rehabilitation infrastructure in existence in other disease pathologies such as stroke 
(which also has guidelines to direct practice) may also provide a useful template for 
addressing some of the factors currently challenging NICE CG83 implementation 
[347].  
 
This is the first survey to investigate reasons behind failure to implement such a 
national guideline and the current data offer significant insight into the requirements 
necessary for successful clinical application of recommendations designed to enhance 
patient care.  Essentially limited guideline detail, staff infrastructure, organisation and 
resources were the main restrictions to implementation [346].  Whilst the goals of 
NICE CG83 were important and raised the profile of this area of clinical practice the 
influence will be short-lived without further investment in support systems at 
operational and staffing level.  Disappointingly, this scenario appears to be mirrored 
in other common clinical conditions.  Although evidence supports the use of early 
pulmonary rehabilitation (PR) following acute exacerbation of chronic obstructive 
pulmonary disease (AECOPD) to enhance exercise capacity, health status and reduce 
hospital readmissions [187, 188, 287, 348], recent data suggest that only one-third of 
eligible patients are referred to early PR programmes and less than 10% of all hospital 
discharges for AECOPD complete early post-hospitalisation PR [327].  This 
implementation failure is also observed following NICE guidance on the management 
of obstructive sleep apnoea [349] with a recent national mapping exercise 
highlighting a significant mismatch between predictive healthcare requirements, 
based on prevalence of known associated risk factors, and delivery of related services 
[328].  Furthermore, the 2012 NHS Atlas of Variation in Healthcare for People with 
Diabetes [326] revealed substantial numbers of patients were not in receipt of the 
basic clinical standards of care.  The barriers to the implementation of these 
guidelines are specific to each clinical area, but those generic ones such as lack of 
adequate funding and resources need to be considered carefully.  However, it must be 
highlighted that robust clinical trial and other data are required to support a guideline 
 253 
 
if it is to be commissioned within the NHS and delivering a guideline prematurely will 
lead to implementation failure, despite major enthusiasm by clinicians. 
 
7.4.2 Comparison with previous studies 
 
There is little published data available regarding availability of follow-up services for 
survivors of critical illness.  Two previous surveys have reported a low incidence of 
ICU follow-up post hospital discharge; the National Outreach Survey estimated 41 
ICUs (12%) provided outpatient services (cited by [329]), a figure that was 
subsequently reported as being somewhat greater in a 2006 survey by Griffiths et al 
[329] at 30% (80 ICUs).  The current study found that 48 (27.3%) organisations 
reported an available follow-up service.  Whilst it is possible that an actual decline in 
services may have occurred in the intervening years, especially in view of published 
data challenging the effectiveness of follow-up clinics in improving health-related 
quality of life in ICU survivors and cost-effectiveness [184], it is also not possible to 
ensure that all datasets surveyed the exact same populations in order to make firm 
comparison.  Data regarding ICUs originated from the central database available at the 
time of surveying but this may provide a source of variability particularly if not kept 
up-to-date accurately.  Furthermore the current study directed surveys to 
physiotherapy clinicians, whereas previously medical and nursing staff were 
identified as recipients.  If physiotherapists were not directly involved in follow-up, 
then this service may not have been reported thus influencing results.     
 
In keeping with the NHS climate at the time of surveying, Griffiths et al [329] assumed 
clinics to be the only route for follow-up, and certainly this format was the most 
prevalent reported in the current survey.  However in more recent times additional 
options have become available including rehabilitation classes, postal survey, 
telephone call and informal support groups.  Additionally the current survey asked 
about multiprofessional involvement, in contrast to the sole involvement of only 
medical or nursing staff in the past.  Both surveys reported that lack of funding was 




Two previous surveys have reported adherence to NICE CG83 albeit limited in content 
and geographical distribution.  Appleton and colleagues [200] conducted a survey 
solely in Scotland and directed towards both medical and physiotherapy staff.  These 
authors attempted to encompass the entirety of the guidelines with content including 
rehabilitation practice in ICU, on the ward and post hospital discharge.  As a result the 
latter stage is significantly brief and data not comparable to the current study, which 
focussed specifically on post hospital discharge in greater detail.  Perhaps whilst more 
time-consuming to complete this provides greater characterisation of services 
available at this stage of patient recovery.  Notably in the former survey, 
physiotherapy staff were targeted to respond to questions on providing follow-up at 
2-3months and use of outcome measures to assess physical dimensions of 
rehabilitation following hospital discharge [200], mirroring the target respondents in 
the current survey.  A recent survey by Berry et al [201] aimed to examine all 
recommendations within NICE CG83 but distribution excluded key regions, and 
further missing data limited data analysis and findings.  Nonetheless at the post 
hospital stage of recovery, adherence to NICE CG83 was found to be severely lacking.   
 
The current survey response rate of 76% is at the higher end of the range reported by 
all these surveys, and greater than a large number (22-86.5%).  The current study 
adopted a similar protocol with regard survey design and target population to the 
majority of these surveys i.e. a postal survey distributed to senior physiotherapy 
clinicians, which appears to anecdotally be considered the most effective strategy for 
such surveys according to this literature pool.  However further comparison of results 
is limited by the differing purpose and content of these surveys relating to various 
aspects of ICU patient management across the recovery pathway. 
 
7.4.3 Critique of the method 
 
7.4.3.1 Designing the optimum survey process 
 
A postal survey was the format of choice for the current study due to the large sample 
size of the target population (n=240) and its geographical distribution [350].  Postal 
surveys are cost-effective and can be simpler and quicker to distribute than 
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alternative forms such as telephone interviews [351-353].  Furthermore they have 
been shown to result in greater response rates compared to telephone interviews 
[352], and email format albeit with a longer time to response [354].  In addition postal 
surveys offer all recipients the opportunity to respond, whereas email or internet 
formats exclude those without adequate computer and internet access.  However an 
email or internet-based platform would have been restricted in the current study due 
to lack of available electronic contact details for named critical care physiotherapy 
clinicians, and where postal distribution offered a more standardised approach for 
monitoring and identifying respondents.  Return of a completed survey was taken to 
represent consent to participate in the study, and those not wishing to participate 
simply failed to return the survey, similar in principle to an ‘Active Decline’ approach 
which has been shown to be associated with higher response rates, improved time-
efficiency and cost-effectiveness [353]. 
 
Survey formatting is an important consideration in design – questions should be easy 
to read in a clear font and layout, be numbered, organised, structured, unambiguous, 
and specific; responses should clearly relate to the question but can be either open-
ended inviting free text, or closed, with fixed choices (in the current survey, in the 
form multiple tick-box options) [355-357].  In addition factors such as printing single- 
or double-sided can influence appearance to the reader and therefore response 
likelihood [351], although practical and financial resources may determine the extent 
to which researchers can focus on these aspects.  The current survey adopted a 
number of these factors, and furthermore included a credible, personalised cover 
letter that outlined the purpose and aims of the survey [355-357].  Furthermore the 
current survey also underwent a review process with three senior physiotherapy 
clinicians and clinical-academics for critique on questionnaire structure, clarity, layout 
and ease and timing of completion.  Based on this feedback, further refinement was 
made to the survey prior to wider distribution.  Whilst it could be argued that a larger 
pilot sample could have been helpful at this stage, it was considered this may place a 
greater burden on those respondents who may be required to repeat completion 




Stamped addressed envelopes were included with all mailed surveys, a highly 
recommended strategy for facilitating response [350, 355, 356].  Following round 
three of postal distribution, non-responders were contacted via telephone and 
requests made for either completion via telephone or email (if details were provided).  
Contacting non-responders in this way was more feasible at this stage due to smaller 
numbers, as the relative expense and time required for this process would have been 
prohibitive during earlier rounds of distribution.  However only 50% of non-
responders were contactable which demonstrates a limitation with the telephone 
approach.  Hocking et al [352] found similar difficulties with achieving successful 
telephone contact to senior clinicians, with calls restricted by fielding from secretarial 
staff, and challenges locating the correct clinician when individual names were 
unknown.  Nonetheless this process still resulted in a conversion rate of 36% of non-
respondents in the current study.    
 
The ICUs identified for inclusion in the current survey originated from two national 
databases, ICNARC and SICSAG, in order to provide a comprehensive target 
population.  Specialist-only and private ICUs were excluded as it was considered that 
patient cohorts at these ICUs may have pathology-specific rehabilitation requirements 
and existing pathways in place, be extra-contractual (including overseas) and be 
influenced by different funding and resource streams due to their status.  It was 
anticipated that the population identified through this process would be 
representative of general ICUs across the country; whilst it is possible that some ICUs 
may not be registered on these databases, this was considered unlikely.  However 
information regarding rehabilitation services at excluded organisations may add value 
in a future survey to provide a more thorough reflection of rehabilitation service 
provision.     
 
As mentioned above, there is currently no central registry of respiratory critical care 
physiotherapists working in the UK that would include contact details, grade and 
experience.  Hence it was not possible to direct the current survey to any named 
individual at each organisation, instead a generic title of ‘Senior Physiotherapist for 
Critical Care’ was used and the survey directed to the physiotherapy department at 
each organisation.  It was thought that senior, experienced clinicians would be able to 
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comment not only on the availability and detail of any services, but also on potential 
barriers preventing service availability.  However it is acknowledged that the survey 
may have been completed by more junior staff depending on local staffing 
arrangements, perceived importance and the time constraints of senior clinicians.   
 
The current study was physiotherapy discipline-specific in nature assuming these 
clinicians would be well-placed to report on available follow-up and rehabilitation 
services for post ICU survivors given their key role within the MDT, and involvement 
in patient care throughout the rehabilitation pathway.  However as rehabilitation is a 
multidisciplinary intervention, surveying multiple members of the MDT responsible 
for delivering follow-up and rehabilitation may provide a more thorough and rounded 
picture of existing services, and the extent of multiprofessional involvement.  It is 
possible that some respondents may have been unaware of available services if they 
were not directly involved in them, and furthermore barriers reported to offering 
services are reflective of one clinical discipline.   
 
The content of the survey was designed to be as comprehensive as possible whilst 
reflecting the outline provided by NICE CG83 and the existing evidence-base.  
Therefore questions broadly summarised availability and content of follow-up 
services, but greater attention was paid to the detail of available post hospital 
discharge rehabilitation programmes which have been an area of growing research 
interest in recent years [177, 180, 185].  Existing published data regarding such 
programmes are limited [186], however it was anticipated that the survey would 
facilitate acquisition of information on programmes that were not part of previous or 
current research studies, assuming that local practice may well be in operation but 
less familiar outside of the host organisation.  Exploring barriers to offering services 
provided an additional depth of information from those respondents who indicated 
these were not available although these were predominantly related to rehabilitation 






7.4.3.2 Survey non-response 
 
A strength of the current study is the employment of a variety of strategies to optimise 
survey completion and return, including promotional activities, inclusion of stamped 
addressed envelopes with all mailed surveys, and follow-up using telephone and email 
routes [350, 355, 356].  Adopting this approach resulted in a 76% response rate, 
considered to be an excellent return [355, 357, 358].  Higher response rates confer 
external validity [355].  Nonetheless, survey non-response is a challenge to the 
robustness of the current findings, and poses a major dilemma for researchers [358].  
Non-response introduces a potential source of bias whereby it is unclear or often 
difficult to confirm whether non-respondents vary significantly from responders [357, 
358].  Results require careful interpretation to consider how well they reflect the 
whole population, including those who failed to respond.  Researchers can attempt to 
compare responders versus non-responders to demonstrate both groups are alike, 
albeit demographic or other data on which to do this may be limited [357, 358].  
However despite the level of non-response in the current survey, 95% confidence 
intervals around results were relatively narrow confirming representativeness of 
responders to the general population of interest.  The high response rate in the 
current study may represent the clinical concern of respondents with regard poor 
implementation of NICE CG83, in particular as the core standards for care of the 
critically ill patient have been recently published highlighting rehabilitation as an 
important core standard [359]. 
 
In addition, to minimise non-response five rounds of participant contact are 
recommended, a pre-notice letter of introduction, the initial survey, a thankyou or 
reminder, a repeat follow-up survey, and a final reminder [360].  Given the time 
constraints on busy senior clinicians working in the critical care environment, this 
extensive approach was considered excessive by the current study, and that it may 
feel overwhelming to recipients of this volume of correspondence such that it had the 
opposite effect and deterred response.  It was also not pragmatic within the time and 
budgetary resources available.  Instead survey distribution was accompanied by 
promotion on easily recognised and viewed forums to potential respondents including 
professional specialist interest group websites, conferences and interactive media.  
 259 
 
Two rounds of postal distribution (approximately 40% response rate at each) were 




Data from this first comprehensive UK survey of post hospital discharge follow-up and 
rehabilitation programmes for survivors of critical illness have demonstrated a low 
reported prevalence and a failure to implement NICE CG83.  Lack of funding and 
clinical prioritisation was reported by clinicians as the major cause for this failure, but 
the paucity of evidence to underpin the guideline must be regarded as a major 
contributor to the discord between clinicians, managers and commissioners in 
delivery.  Without clinical and cost effectiveness data, commissioning these services 
would be challenging in the current NHS climate.  Clinical focus must be to ensure that 
guidelines have a robust evident base to maximise implementation and enhance 

















































8.1 Summary  
 
Intensive care unit-acquired weakness (ICU-AW) is a significant complication of 
critical illness arising from peripheral skeletal muscle wasting and dysfunction.  
Residual physical functional impairment can be present for many years and can 
impact profoundly on recovery for ICU survivors.  The primary aim of this thesis was 
to investigate the clinical assessment and treatment of ICU-AW.  The studies centred 
on the utility of the Medical Research Council sum-score (MRC-SS) for diagnosing ICU-
AW, the emergence of ultrasound as a technique to track peripheral skeletal muscle 
wasting during critical illness, exercise-based rehabilitation following hospital 
discharge for survivors of critical illness with ICU-AW, and the extent of UK 
implementation of national guidelines on the rehabilitation of post ICU patients.   
 
The MRC-SS, a form of volitional manual muscle testing, is the most commonly 
reported volitional tool for the diagnosis of ICU-AW.  Observational studies have 
associated presence of ICU-AW in patients at awakening, based on MRC-SS 
assessment, with prolonged mechanical ventilation and delayed weaning, respiratory 
muscle weakness, protracted ICU and hospital lengths of stay and increased mortality.  
Whilst inter-observer agreement of the MRC-SS has previously been established in 
healthy subjects mimicking weakness and stable post ICU patients in the recovery 
stage with high levels reported, determining agreement in patients whilst still in the 
ICU has proven more challenging with contrasting data reported particularly for ICU-
AW diagnosis.  In Chapter 3, a cohort of 20 ICU patients underwent MRC-SS testing by 
two experienced clinicians.  High levels of inter-observer agreement were found (ICC 
0.94 (95%CI 0.85-0.98)), but only moderate agreement for the diagnosis of ICU-AW 
(Kappa 0.6 (95%CI 0.25-0.95)).  In comparison in a healthy individual who simulated 
a range of weakness presentations observed in the ICU cohort, close for both MRC-SS 
overall and agreement of ICU-AW diagnosis was evident (ICC 1.0 (95%CI 0.99-1.0) 
and Kappa 1.0 (95%CI 1.0-1.0) respectively).     
 
As a diagnostic tool there have been no previous data reporting test characteristics of 
the MRC-SS.  In a separate cohort of 94 patients, MRC-SS at awakening and clinical 
outcomes of ICU and hospital mortality and length of stay were prospectively 
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measured to evaluate the clinical predictive value of the measure.  Eighteen patients 
died prior to awakening, and a further 11 were unable to perform the MRC-SS at 
awakening despite meeting screening criteria for suitable levels of consciousness and 
cognition.  There was no association between ability to perform the test at awakening 
and clinical outcomes of ICU and hospital mortality and length of stay (all p=ns).  In 
patients able to complete MRC-SS testing at awakening (n=65), prevalence of ICU-AW 
was 73.9%.  There was no association evident between MRC-SS and ICU and hospital 
mortality (p=0.67 and 0.53 respectively), but a significant association was revealed for 
ICU and hospital length of stay (p=0.004 and p=0.04 respectively).  Further analyses of 
test characteristics were therefore conducted demonstrating high sensitivity of the 
test (ICU LOS 92.9% (95%CI (76.5-99.1) and hospital LOS (84.2% (68.7-94.0)).  
However specificity and positive predictive value were poor across both outcomes.  
Receiver-operator characteristic analysis revealed no clinically meaningful MRC-SS 
thresholds, with sensitivity and specificity below acceptable levels.  
 
Ultrasound of peripheral skeletal muscle architecture has recently emerged as an 
alternative effort-independent technique for monitoring the trajectory of muscle 
wasting in critically ill patients with a growing body of published data available.  In 
the second study of this thesis (Chapter 4), data for quadriceps rectus femoris 
anatomical cross-sectional area (RFCSA) demonstrated significant correlations with 
volitional (quadriceps maximum voluntary contraction) and non-volitional (twitch 
quadriceps) measures of quadriceps force at two measurement points along the 
length of the rectus femoris muscle (2/3 distance, r=0.6, p=0.002 for both, 3/5 
distance, r=0.7, p=0.001 for both) in a cohort of healthy subjects.  Using pennation 
angle data to derive physiological cross-sectional area failed to improve the strength 
of these correlations.  Furthermore, there were no anthropomorphic factors found to 
be associated with pennation angle.  High levels of both intra- and inter-observer 
agreement of ultrasound to measure RFCSA were also demonstrated (n=5 healthy 
subjects, ICC 1.0 (95%CI 0.98-1.0) for 3/5 measuring distance, ICC 0.78 (95%CI 0.29-
0.97) for 2/3 measuring distance, and n=20 ICU patients, ICC 0.99 (95%CI 0.97-0.99) 
respectively).  These data support the technical application of ultrasound, in 
particular measures of peripheral skeletal muscle cross-sectional area, in the critically 
ill population and its use as a surrogate marker where strength cannot be measured.  
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However, a direct relationship between muscle size and force has yet to be 
established for this patient population.    
 
Chapter 5 of this thesis builds on the aforementioned data from Chapter 4 and 
presents a systematic review (PROSPERO database registration CRD42013004892) 
investigating the use of ultrasound for measurement of peripheral skeletal muscle 
architecture in critically ill patients.  Adhering to PRISMA guidelines for conduct and 
reporting, findings from seven identified studies were extracted and synthesised, 
reporting various characteristics of peripheral skeletal muscle architecture measured, 
protocols for assessment and data describing muscle dysfunction.  Meta-analyses of 
data were limited due to individual variability in included studies, however all studies 
reported data demonstrating the negative effects of critical illness on peripheral 
skeletal muscle.  Whilst ultrasound demonstrates a number of technical and pragmatic 
advantages, data from one study demonstrated that ultrasound measures of 
peripheral skeletal muscle size underestimated changes evident on direct biopsy 
sampling of muscle tissue, highlighting that caution must be taken in interpreting 
results albeit this should not detract from the clinical utility of the technique.   
 
Rehabilitation has been advocated in the management of ongoing physical functional 
impairment in survivors of critical illness.  Early mobilisation is now common practice 
in many ICUs with ward-based intervention promoting restoration of functional levels 
in preparation for hospital discharge.  Following hospital discharge service provision 
for post ICU patients is typically more inconsistent in availability.  The feasibility of a 
post hospital discharge exercise-based rehabilitation programme for survivors of 
critical illness with ICU-AW was investigated in a pilot randomised controlled trial 
(RCT) (Chapter 6).  Eligible patients included those with ICU-AW at ICU discharge 
based on MRC-SS assessment with intervention patients receiving a sixteen session 
exercise-based rehabilitation that commenced within two weeks of hospital discharge.  
Patients in the standard treatment arm received a weekly phone call in addition to 
standard care, which consists of no specific post ICU follow-up.  Outcomes, including 
exercise capacity and health-related quality of life, were assessed at hospital discharge 
and at three months.  In addition a parallel observational cohort study of those 
patients without ICU-AW was also performed.     
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In the RCT, no differences were observed between the standard treatment (n=10) and 
intervention groups (n=10) for any of the outcomes measured (all p=ns), although the 
study was not powered for this.  In addition, and surprisingly, there was a variable 
pattern in terms of outcomes between the trial group and observational study cohort.  
These data do not support the use of the MRC-SS to categorise patients with a 
diagnosis of ICU-AW, and more specifically the MRC-SS test to diagnose ICU-AW was 
not a reliable indicator of physical functional or useful in identifying patients with 
ongoing rehabilitation needs and likely to respond to exercise-based rehabilitation 
treatment.  A number of methodological factors were identified to enhance the design, 
conduct and analysis of a future trial, including development of an intervention 
effective above that of the trajectory of natural recovery.  This is wholly important in 
the context of trials evaluating complex interventions delivered to complex patient 
groups. 
 
In the final study of this thesis a national UK survey was conducted to determine 
implementation of NICE clinical guidelines detailing rehabilitation following critical 
illness at the post hospital discharge stage of patient pathway (Chapter 7).  Data from 
two previous surveys indicated a low adherence to this guideline, albeit these were 
limited by level of detail and geographical coverage.  In the current study, 240 
organisations were identified from national databases, and a 76% response rate (182 
responses) was achieved from across England, Wales, Scotland and Northern Ireland.  
Forty-eight (27.3%, 95%CI (20.7-33.9)) reported offering follow-up of post ICU 
patients at 2-3months as per NICE guidance, and only 12 offered a rehabilitation 
programme (6.8%, 95%CI (3.1-10.5)), of which 10 were in regular operation.  Barriers 
to service provision were primarily funding, resource limitation and managerial 
prioritisation.  These data highlight the current inadequacy of clinical services to 
address the ongoing health deficits in this patient population despite publication of 
national guidelines five years ago.    
 
8.2 Future work 
 
The work conducted in this thesis has highlighted a number of areas for further 
investigation.  Specifically robust techniques for assessing muscle wasting and 
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weakness in critically ill patients are required as well as the delivery of optimal 
rehabilitation interventions for ICU survivors with ongoing physical functional 
impairment following hospital discharge.  Volitional measurement of peripheral 
skeletal muscle strength demonstrates a number of caveats to their reliable use in 
critically ill patients.  The technique of ultrasound as an alternative effort-independent 
technique is gaining increasing research popularity and has important clinical utility.  
However, whilst a relationship between muscle mass and muscle strength has 
previously been demonstrated in healthy subjects and patient groups, this 
relationship has yet to be determined for the critically ill population.  Establishing the 
relationship between peripheral skeletal muscle mass, exercise capacity and physical 
function would offer additional validation of ultrasound as a surrogate marker in this 
setting and population.   
 
A number of unanswered questions remain regarding the clinical field of 
rehabilitation for the post ICU patient population following hospital discharge.  The 
‘PICO’ approach (Population, Intervention, Control, Outcome) is beneficial to consider 
with regard these.  Defining the target population of post critical illness patients 
requiring ongoing physical rehabilitation and likely to benefit from intervention has 
yet to be clarified.  Eligibility criteria used for clinical trials may be too prescriptive in 
an attempt to standardise an inherently heterogeneous patient group, and those 
patients with clinical need may be excluded.   Certainly use of manual muscle testing 
and the MRC-SS test to diagnose ICU-AW have been shown to have limited value in 
identifying those with ongoing rehabilitation requirements at hospital discharge.  An 
alternative approach is to consider the population at an individual patient level and 
longitudinally track the trajectory of recovery with regular follow-up including a 
range of assessments to target the physical, psychological and cognitive impairments, 
and intervene with bespoke rehabilitation when natural recovery slows or reaches a 
plateau.  In this way, both the timing and type of rehabilitation delivered is 
personalised to each individual patient.  Although there may be considerable burden 
to healthcare systems to provide such an approach, this would be balanced by the 
potential for enhanced recovery post critical illness, minimising the cost and extent of 




Defining the constituent components of a rehabilitation programme also remains 
unclear.  Given the variability in nature and degree of impairment post critical illness, 
access to a multimodal package of interventions is most likely to be required although 
this requires further investigation and each component will need to be validated.  In 
particular with regard physical interventions, the optimum ‘dose’ of effective exercise 
prescription remains unknown.  Benchmarking of existing clinical services will 
accurately define the standard treatment arm of any future interventional trial, 
especially if multiple sites are to be involved.  It will also allow evaluation of service 
implementation in line with established guidelines.  Finally, defining the appropriate 
outcomes to determine clinical and cost effectiveness of an intervention is essential.  
Ideally, an agreed set of core outcome measures would be implemented across all 
clinical trials in the area of critical illness rehabilitation to represent the range of 
impairments evident.   
 
8.3  Conclusion  
 
Data from this thesis have demonstrated limitations to the use of volitional strength 
testing to diagnose ICU-AW in critically ill patients.  Ultrasound of peripheral skeletal 
muscle architecture represents a feasible effort-independent alternative to monitor 
change in peripheral skeletal muscle during critical illness with clinical utility and a 
number of pragmatic advantages.  Further work to confirm the relationship between 
peripheral skeletal muscle mass and force, and correlating this with exercise capacity, 
physical activity and physical function will strongly support its widespread use.  Post 
critical illness patients can be considered as a highly complex patient group due to the 
wide variability in demographics, clinical diagnostic grouping and illness severity 
amongst patients combined with varying trajectories of recovery of physical, 
psychological and cognitive impairment.  The delivery of an effective complex 
rehabilitation intervention that addresses these important clinical features represents 
a significant challenge for researchers and clinicians.  Establishing a robust evidence-
base from carefully designed interventional trials will facilitate improvement of 
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Patient position  Supine with 30° head elevation, with the exception of 
upright sitting for assessment of shoulder abduction (to 
allow for movement against gravity) 
 Remove all extra pillows 
 Ensure central, midline position determined by pelvic and 
shoulder symmetry 
Order of testing of limb 
muscle group 
 Distal to proximal anti-clockwise starting with right lower 
limb i.e. right lower limb, left lower limb, left upper limb, 
right upper limb 
 Shoulder abduction is the last muscle group assessed 
following repositioning (see above) 
Passive range of movement 
assessment 
 Allows for assessment of sensation, available joint range of 
movement, presence of velocity-dependent tonal changes 
that may influence measurement 
 Instruction to patient “Do not do anything, keep as relaxed 
as possible” 







- Ankle dorsiflexion 
 
 






- Hip flexion 
 





 Allows for grading of muscle strength according to MRC 
scale  
 Observe and palpate muscle group for sign of activity 
(Levels 0 and 1) e.g. quadriceps for knee extension 
 Instruction to patient “Move your (limb segment) towards 
(appropriate direction) as much as you can and hold it 
there” 
- Tester fixes ankle with one hand to ensure midline 
position 
- Resistance applied along dorsum of foot with 
opposite hand for >Grade 3 
- Tester rests patient leg over their knee in flexed 
position, and fixes knee with one hand to ensure 
midline position 
- Resistance applied at distal two-thirds shin with 
opposite hand for >Grade 3 
- Grade 3 = movement from supine to hip flexion 
achieving foot flat on bed 
- With hip in 90° hip flexion, resistance applied to 
mid thigh for >Grade 3 
- Wrist is isolated by fixing the forearm above the 
joint line, in pronated position 
- Resistance applied over dorsum of hand for >Grade 
3 
- A pillow can be used, or the elbow can be flexed to 





- Elbow flexion 
 
 




- Tester ensures neutral midline forearm position; a 
pillow may be used to ensure upper arm is 
horizontal with body 
- Resistance is applied to the forearm for >Grade 3 
- Elbow flexion is advised to create a shorter lever 
for movement, and to achieve a neutral scapular 
position with some horizontal flexion and external 
rotation as comfort requires 
- Grade 3 = 90° shoulder abduction 
- Resistance is applied to the upper arm for >Grade 
3 
‘Break’ test for   >Grade 3  Performed in mid- to inner-range of movement; this 
position can be demonstrated by tester 
 Instruction to patient “Hold your (limb segment) there, 
don’t let me move you’ 
 Force is gradually applied opposing the direction of limb 
segment movement, up to near maximal levels to ‘break’ 
patient resistance to movement 
 Grade 4 = On application of force,  tester can ‘break’ the 
patient’s static position 
 Grade 5 = on application of force, tester unable to move the 
body segment without involvement of other muscle 





Patient position  Upright sitting, as near to 90° as possible 
 Remove all extra pillows 
 Ensure central, midline position determined by pelvic and 
shoulder symmetry and knee position 
Order of testing of limb 
muscle group 
 Distal to proximal anti-clockwise starting with right lower 
limb i.e. right lower limb, left lower limb, left upper limb, 
right upper limb 
Passive range of movement 
assessment 
 Allows for assessment of sensation, available joint range of 
movement, presence of velocity-dependent tonal changes that 
may influence measurement 
 Instruction to patient “Do not do anything, keep as relaxed as 
possible” 











- Knee extension 
 
 Allows for grading of muscle strength according to MRC scale 
(Table E2a) 
 Observe and palpate muscle group for sign of activity (Levels 
0 and 1) e.g. quadriceps for knee extension 
 Instruction to patient “Move your (limb segment) towards 
(appropriate direction) 
- Patient sits with hips in midline, knees flexed to mid-
range and heels resting on stable surface 
- Testers kneels by patients and fixes ankle with one 
hand to ensure midline position 
- Resistance applied along dorsum of foot with 
opposite hand for >Grade 3 
- Patient sits with hips in midline, knees flexed to mid-
range and heels resting on stable surface 
















- Elbow flexion 
 
 




under knee in flexion, and fixes knee with one hand 
to ensure midline position 
- Resistance applied with other hand at distal two-
thirds shin by applying body weight 
- Patient is seated with hips in passive flexion 
- Tester fixes at knee to ensure lower limb is in midline 
- Grade 3 = active movement beyond degree of passive 
seated hip flexion 
- Resistance is applied to patient’s thigh for >Grade 3 
- Forearm rests in pronation on a stable surface by 
patient 
- Tester stands perpendicular to patients and isolates 
wrist by fixing forearm above joint line 
- Resistance is applied through dorsum of hand for 
>Grade 3 
- Tested with elbow at patient’s side in neutral 
pronation/supination 
- Resistance applied to forearm for >Grade 3 
- Elbow flexion is advised to create a shorter lever for 
movement, and to achieve a neutral scapular position 
with some horizontal flexion and external rotation as 
comfort requires 
- Grade 3 = 90° shoulder abduction 
- Tester stands wide stance perpendicular to patient  
- Resistance is applied to the upper arm for >Grade 3 
‘Break’ test for >Grade 3  Performed in mid- to inner-range of movement; this position 
can be demonstrated by tester 
 Instruction to patient “Hold your (limb segment) there, don’t 
let me move you’ 
 Force is gradually applied opposing the direction of limb 
segment movement, up to near maximal levels to ‘break’ 
patient resistance to movement 
 Grade 4 = On application of force,  tester can ‘break’ the 
patient’s static position 
 Grade 5 = on application of force, tester unable to move the 
body segment without involvement of other muscle 















Appendix II. Short-Form 36 v2 Questionnaire (Acute Recall version) 
 
 
Your Health and Well-Being 
 
This survey asks for your views about your health.  This information will help keep track of how you 
feel and how well you are able to do your usual activities. Thank you for completing this survey! 
 
For each of the following questions, please tick the one box that best describes your answer. 
1. In general, would you say your health is: 
Excellent Very good Good Fair Poor 
    
   1    2    3    4    5 
 
2. Compared to one week ago, how would you rate your health in general now? 
Much better 








one week ago 
Somewhat 
worse 
now than one 
week ago 
Much worse 
now than one 
week ago 
    














3. The following questions are about activities you might do during a typical day.  Does your health 













    
 a Vigorous activities, such as running, lifting  
heavy objects, participating in strenuous sports .........................................  1 ................  2 ................  3 
 b Moderate activities, such as moving a table, pushing  
a vacuum cleaner, bowling, or playing golf ...............................................  1 ................  2 ................  3 
 c Lifting or carrying groceries .......................................................................  1 ................  2 ................  3 
 d Climbing several flights of stairs ................................................................  1 ................  2 ................  3 
 e Climbing one flight of stairs .......................................................................  1 ................  2 ................  3 
 f Bending, kneeling, or stooping ...................................................................  1 ................  2 ................  3 
 g Walking more than a mile ..........................................................................  1 ................  2 ................  3 
 h Walking several hundred yards ..................................................................  1 ................  2 ................  3 
 i Walking one hundred yards ........................................................................  1 ................  2 ................  3 





4. During the past week, how much of the time have you had any of the following problems with your 
work or other regular daily activities as a result of your physical health? 











    
 a Cut down on the amount of  
  time you spent on work or  
  other activities ............................................  1 ................  2 ................  3 .................  4................  5 
 b Accomplished less than you  
  would like ...................................................  1 ................  2 ................  3 .................  4................  5 
 c Were limited in the kind of  
  work or other activities ...............................  1 ................  2 ................  3 .................  4................  5 
 d Had difficulty performing the 
  work or other activities (for  
  example, it took extra effort) ......................  1 ................  2 ................  3 .................  4................  5 
 
 
5. During the past week, how much of the time have you had any of the following problems with your 
work or other regular daily activities as a result of any emotional problems (such as feeling 
depressed or anxious)? 











    
 a Cut down on the amount of  
  time you spent on work or  
  other activities ............................................  1 ................  2 ................  3 .................  4................  5 
 b Accomplished less than you  
  would like ...................................................  1 ................  2 ................  3 .................  4................  5 
 c Did work or other activities 





6. During the past week, to what extent has your physical health or emotional problems interfered 
with your normal social activities with family, friends, neighbours, or groups? 
Not at all Slightly Moderately Quite a bit Extremely 
    






7. How much bodily pain have you had during the past week? 
None Very mild Mild Moderate Severe Very severe 
     





8. During the past week, how much did pain interfere with your normal work (including both work 
outside the home and housework)? 
Not at all A little bit Moderately Quite a bit Extremely 
    





9. These questions are about how you feel and how things have been with you during the past week.  
For each question, please give the one answer that comes closest to the way you have been feeling.  
How much of the time during the past week… 
 
 











    
 a Did you feel full of life? .............................  1 ................  2 ................  3 ................  4 ................  5 
 b Have you been very nervous? .....................  1 ................  2 ................  3 ................  4 ................  5 
 c Have you felt so down in the  
dumps that nothing could  
cheer you up? ..............................................  1 ................  2 ................  3 ................  4 ................  5 
 d Have you felt calm and   
peaceful? .....................................................  1 ................  2 ................  3 ................  4 ................  5 
 e Did you have a lot of energy? .....................  1 ................  2 ................  3 ................  4 ................  5 
 f Have you felt downhearted   
and low? .....................................................  1 ................  2 ................  3 ................  4 ................  5 
 g Did you feel worn out? ...............................  1 ................  2 ................  3 ................  4 ................  5 
 h Have you been happy? ................................  1 ................  2 ................  3 ................  4 ................  5 




10. During the past week, how much of the time has your physical health or emotional problems 











    
   1    2    3    4    5 
     
 
 
    











     
 a I seem to get ill more 
easily than other people ..............................  1.................  2 ...............  3 .................  4 ................  5 
 b I am as healthy as  
anybody I know ..........................................  1.................  2 ...............  3 .................  4 ................  5 
 c I expect my health to  
get worse ....................................................  1.................  2 ...............  3 .................  4 ................  5 






















Appendix III.  Hospital Anxiety and Depression Scale 
HAD Scale 
 
Doctors are aware that emotions play an important part in most illnesses.  If your doctor knows about these 
feelings he/she will be able to help you more.  This questionnaire is designed to help your doctor know how 
you feel.  Read each item and place a tick in the box opposite to the reply, which comes closes to how you 
have been feeling over the past week.  Don’t take too long over your replies; your immediate reaction to each 
item will probably be more accurate than a long thought out response.   
 
Tick on one box in each section 
I feel tense or wound up     I feel as if I am slowed down 
 
Most of the time     Nearly all the time    
A lot of the time     Very often     
From time to time, occasionally   Sometimes     
Not at all      Not at all     
 
I still enjoy things I used to enjoy  I get a frightened feeling like ‘butterflies in the 
stomach’ 
Definitely as much    Not at all     
Not quite so much    Occasionally     
Only a little     Quite often     
Hardly at all     Very often     
 
I get a frightened feeling as if something  
awful is about to happen    I have lost interest in my appearance 
 
Very definitely & quite badly   Definitely      
Yes, but not too badly    I don’t take as much care as I should  
A little, but it doesn’t worry me   I may not take as much care   
Not at all     I take just as much care as ever   
 
I can laugh & see the funny side of things   I feel restless as if I have to be on the move 
 
As much as I always could   Very much indeed    
Not quite so much now    Quite a lot     
Definitely not so much now   Not very much      
Not at all      Not at all     
 
Worrying thoughts go through my mind   I look forward with enjoyment to things 
 
A great deal of the time    As much as I ever did    
A lot of the time     Rather less than I used to     
From time to time but not that often  Definitely less than I used to    
Only occasionally    Hardly at all     
 
I feel cheerful      I get sudden feelings of panic 
 
Not at all     Very often indeed    
Not often     Quite often     
Sometimes     Not very often     
Most of the time     Hardly at all     
 
I can sit at ease and feel relaxed  I can enjoy a good book or radio or TV programme 
Definitely     Often      
Usually      Sometimes     
Not often     Not often     
Not at all     Very seldom     
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Appendix IV. Systematic review search strategies (Chapter 5) 
 
Search strategies for electronic databases used in this systematic review are 
presented below (Cumulative Index to Nursing and Allied Health Literature (CINAHL), 
Medline, Excerpta Medica Database (EMBASE), Web of Science and Cochrane).  
Searching Scopus resulted in no results (search strategy not reported), and searches 
were not storable in the Physiotherapy Evidence Database (PEDro) however the 
search involved terms used in the summaries below. 
 
CINAHL search strategy (EbscoHost) 
S15 S7 and S10 and S14 
S14 S11 OR S12 OR S13 
S13 muscle* 
S12 (MH "Muscle, Skeletal") 
S11 muscle wasting OR muscle mass OR cross-sectional area OR fibre pennation 
angle OR pennation angle OR muscle thickness OR muscle layer thickness OR echo 
intensity OR echogenicity OR muscle architecture 
S10 S8 OR S9 
S9 ultrasound OR ultrasonography 
S8 (MH "Ultrasonography") 
S7 S1 OR S2 OR S3 OR S4 OR S5 OR S6 
S6 intensive care OR critical care OR critical illness OR ICU OR critically ill OR 
multi-organ failure OR sepsis 
S5 (MH "Sepsis") 
S4 (MH "Multiple Organ Dysfunction Syndrome") 
S3 (MH "Intensive Care Units") 
S2 (MH "Critical Illness") OR (MH "Critically Ill Patients") 
S1 (MH "Intensive Care Units") OR (MH "Critical Care") 
 
 
MEDLINE search strategy (OvidSp) 
1.  intensive care/ 
2.  critical illness/ 
3.  intensive care/ or intensive care unit/ 
4.  sepsis/ or multiple organ failure/ or septic shock/ 
5.  sepsis/ 
6.  (intensive care or critical care or critical illness or ICU or critically ill or multi-
organ failure or sepsis).mp. [mp=title, abstract, subject headings, heading word, drug 
trade name, original title, device manufacturer, drug manufacturer, device trade name, 
keyword] 
7.  1 or 2 or 3 or 4 or 5 or 6 
8.  (ultrasonography or ultrasound).mp. [mp=title, abstract, subject headings, 
heading word, drug trade name, original title, device manufacturer, drug 
manufacturer, device trade name, keyword] 
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9.  muscle mass/ or muscle weakness/ or skeletal muscle/ or muscle/ or muscle 
atrophy/ 
10.  muscle mass/ 
11.  muscle/ or ultrasound/ or muscle atrophy/ 
12.  muscle thickness/ or thickness/ or muscle/ 
13.  skeletal muscle/ or muscle atrophy/ 
14.  (muscle* or muscle wasting or muscle mass or cross-sectional area or fibre 
pennation angle or pennation angle or muscle thickness or muscle layer thickness or 
echo intensity or echogenicity or muscle architecture).mp. [mp=title, abstract, subject 
headings, heading word, drug trade name, original title, device manufacturer, drug 
manufacturer, device trade name, keyword] 
15.  9 or 10 or 11 or 12 or 13 or 14 
16.  ultrasound/ 
17.  8 or 16 
18.  7 and 15 and 17 
 
 
EMBASE search strategy (OvidSp) 
1. intensive care/ 
2.  critical illness/ 
3.  intensive care unit/ 
4.  critically ill patient/ 
5.  multiple organ failure/ 
6.  sepsis/ 
7.  (intensive care or critical care or critical illness or ICU or critically ill or multi-
organ failure or sepsis).mp. [mp=title, abstract, subject headings, heading word, drug 
trade name, original title, device manufacturer, drug manufacturer, device trade name, 
keyword] 
8.  1 or 2 or 3 or 4 or 5 or 6 or 7 
9.  ultrasound/ 
10.  (ultrasound or ultrasonography).mp. [mp=title, abstract, subject headings, 
heading word, drug trade name, original title, device manufacturer, drug 
manufacturer, device trade name, keyword] 
11.  9 or 10 
12.  muscle/ 
13.  muscle atrophy/ 
14.  muscle mass/ 
15.  muscle thickness/ 
16.  (muscle* or muscle wasting or muscle mass or cross-sectional area or fibre 
pennation angle or pennation angle or muscle thickness or muscle layer thickness or 
echo intensity or echogenicity or muscle architecture).mp. [mp=title, abstract, subject 
headings, heading word, drug trade name, original title, device manufacturer, drug 
manufacturer, device trade name, keyword] 
17.  12 or 13 or 14 or 15 or 16 








Web of Science search strategy (Web of Knowledge) 
#4 #3 AND #2 AND #1  
#3 Topic=(muscle* OR muscle wasting OR muscle mass OR cross-sectional area 
OR fibre pennation angle OR pennation angle OR muscle thickness OR muscle layer 
thickness OR echo intensity OR echogenicity OR muscle architecture) 
#2 Topic=(ultrasound OR ultrasonography)  
#1 Topic=(intensive care OR critical care OR critical illness OR ICU OR critically ill 
OR multi-organ failure OR sepsis)  
 
 
Cochrane search strategy (Cochrane) 
#1 intensive care or critical care or critical illness or ICU or critically ill or multi-
organ failure or sepsis:ti, ab, kw 
#2 ultrasound or ultrasonography:ti, ab, kw 
#3 muscle* or muscle wasting or muscle mass or cross-sectional are or fibre 
pennation angle or pennation angle or muscle thickness or muscle layer thickness or 
echo intensity or echogenicity or muscle architecture:ti, ab, kw 
#4 MeSH descriptor: (Intensive Care) explode all trees 
#5 MeSH descriptor: (Critical Care) explode all trees 
#6 MeSH descriptor: (Critical Illness) explode all trees 
#7 MeSH descriptor: (Critical Illness) explode all trees 
#8 MeSH descriptor: (Sepsis) explode all trees 
#9 MeSH descriptor: (Ultrasonograhpy) explode all trees 
#10 MeSH descriptor: (Muscles) explode all trees 
#11 #4 and #5 and #6 and #7 and #8 
#12 #1 or #11 
#13 #3 or #10 
#14 #2 and #9 




















SECTION 1 YOUR CRITICAL CARE SERVICES 
 
1) Is your hospital a:   Teaching (University) hospital □ 
 
District General hospital           □ 
 
Other    □ 
 
 
2) Please indicate the number, size and speciality of any critical care areas in your hospital (include all 
individual intensive care unit (ICU, Level 3), high dependency unit (HDU, Level 2) and/or combined 
Level areas) 
 
CC area Level Speciality Beds 
1   
 
 
2   
 
 
3   
 
 
4   
 
 
5   
 
 
6   
 
 
7   
 
 
8   
 
 
9   
 
 
10   
 
 



















SECTION 2 FOLLOW-UP FOR POST CRITICAL ILLNESS PATIENTS  
 
 
Are you involved in follow-up for post critical illness patients 2-3 months after discharge? 
 
YES  □ (please go to Question 1.)   NO  □        (please go to SECTION 3) 
 
 
1. What form does this follow-up take: 
  
ICU follow-up clinic         □ 
 
Medical outpatient appointment (as part of other medical follow-up)   □ 
 
Telephone call         □ 
 
Postal survey         □ 
 
Rehabilitation class         □ 
 
Other (please specify) 
 
...................................................................................................................................................................... 
2. Who is involved in this follow-up? 
 
Physiotherapist   □  Occupational Therapist  □ 
 
Critical Care Nurse   □  Critical Care Doctor  □ 
 
Psychologist   □  Dietician   □ 
 




3. Does this follow-up involve a functional reassessment based on previous assessment at hospital 
discharge? 
 
YES  □    NO □ 
 
4. What else is covered in this follow-up? 
 
Exercise capacity   □ Health-related quality of life  □ 
 
Psychological status   □ Nursing-related issues   □ 
 
Medical status   □ Diet/nutrition    □ 
 














SECTION 3 REHABILITATION SERVICES FOLLOWING CRITICAL ILLNESS 
 
 
Does your hospital offer a rehabilitation programme following hospital discharge 
specifically for post critical illness patients as part of routine clinical practice? 
 
(separate to generic services such as intermediate care, supported discharge, hospital-at-home or 
similar) 
 




1. Who is responsible for leading this rehabilitation programme? 
 
Physiotherapist  □  Critical Care Doctor   □ 
 
Occupational Therapist □   Critical Care Nurse   □ 
 
Speech and Language Therapist □ Exercise/sports therapist  □ 
 





2. If a physiotherapist, is this..... 
 
ICU physiotherapist  □   Rehabilitation physiotherapist □ 
 
Current banding/position     ...................................  
 
Duration of ICU rehabilitation experience   ................................... 
 
 
3. How do you select patients for inclusion into the programme? 
Assessment measure (if applicable) 
 
Duration of mechanical ventilation in ICU □ ......................................................... 
 
Duration of ICU admission   □ ......................................................... 
 
Duration of hospital admission  □ ......................................................... 
 
Physical function at ICU discharge  □ ......................................................... 
 
Muscle strength at ICU discharge   □ ......................................................... 
  
Exercise capacity at ICU discharge  □ ......................................................... 
 
Health-related quality of life at ICU discharge □ ......................................................... 
 
Physical function at hospital discharge □ ......................................................... 
 




Exercise capacity at hospital discharge □ ......................................................... 
 
Health-related quality of life at hospital discharge □ .........................................................  
         
Not applicable – all post ICU patients are eligible □ ......................................................... 
 




FORMAT OF DELIVERY 
 
4. Is your programme: 
 
Home-based □ Hospital-based  □          Community-based  □ 
 




5. In your programme, do patients exercise: 
 
Under supervision □ Independently  □       Combination  □ 
 
Do you use an accompanying rehabilitation or exercise manual YES □ NO □ 
 




6. Is your programme: 
 
A stand-alone programme for post critical illness patients    □ 
 
Part of existing rehabilitation services including patients with other disease groups □ 
 
If so which  ......................................................................................................................................... 
 




7. At what time point post hospital discharge does the programme commence: 
 
Immediately post hospital discharge □ One week post hospital discharge  □ 
 
Two weeks post hospital discharge □ One month post hospital discharge  □ 
 
2-3 months post hospital discharge □ 
 




Does your service have a waiting list:  YES  □  NO □ 
 










9. How often are the sessions? 
 





10. How long is each session? 
 





11. Is this a: Rolling programme  □ Stand alone  □ 
 
12. How many patients are in the group?    ................................................. 
 
What is the staff:patient ratio?    ................................................. 
 








14. Does your rehabilitation programme include an exercise component 
 
YES  □  (please continue)  NO  □  
(please go to Question 17.) 
 




Cardiovascular Strength  Balance  Functional 
 
Step-ups □ Lower limb □ Static □ Sit-to-stand □ 
 
Treadmill □ Upper limb □ Dynamic□ Timed Up and Go□ 
 
Static bike □ Free weights □   Walking □ 
  
Cross-trainer□ Theraband/ □ 
    resisted □ 
 
Other/comments (please give detail) 
 
............................................................................................................................................................................ 




How are these exercises prescribed? 
 
Results of walking tests  □ Results of balance assessment  □  
Results of physical function assessment□ Repetition maximum principle  □ 
 
Target heart rate   □ Target Borg (please specify range) □ 
 
Clinician judgement   □ 
 




15. How do you monitor and/or progress exercise intensity during the exercise session? 
 
Heart rate targets  □ SpO2  □  Borg  □  
Visual analogue scale □ Clinical observation/judgement of patient  □  
Patient verbal feedback  □  No formal monitoring   □  
Reassessment of baseline measures □ 
 




16. Does your rehabilitation programme include an education component 
 
YES  □    NO  □ 
 
If YES....what topics are included 
 
Subject      Delivered by (please list MDT member) 
 
Exercise     □ ................................................. 
 
Stress management    □ ................................................. 
 
Nutrition     □ ................................................. 
 
Return to work    □ ................................................. 
 
Energy conservation    □ ................................................. 
 
Medications     □ ................................................. 
 
What to expect of recovery   □ ................................................. 
 
Motivational coaching/training  □ ................................................. 
 
 













17. What outcome measures do you use with patients participating in your rehabilitation programme? 
 




Exercise capacity e.g. field walking tests (e.g. 6 Minute Walk Test, cardiopulmonary exercise testing 




Health-related quality of life e.g. SF-36 survey, Hospital Anxiety and Depression scale  








Functional performance e.g. Timed Up and Go, Short Physical Performance Battery  
          □ 
   
Please specify................................................................................................................................................ 
 


































NO AVAILABLE REHABILITATION SERVICE 
 
 
19.  If the answer to offering a rehabilitation service/programme at the start of this section was’ NO’ 






All reasons                 Main reason 
      (tick all that apply)                (tick one only) 
 
Lack of sufficient staff numbers   □    □ 
 
Lack of suitably trained staff    □    □ 
 
Lack of available space/venue   □    □ 
 
No evidence to suggest benefit   □    □ 
 
Lack of funding     □    □ 
 
Not considered required service at managerial level □    □ 
 
Insufficient patient numbers to justify  □    □ 
 
Not sure what to include in a rehabilitation programme □   □ 
 
Resources prioritised to other patient groups/clinical areas □   □ 
 
Extra-contractual (out-of-area) patient caseload □    □ 
 




20.  Do you refer ICU patients routinely into other rehabilitation programmes/services, either in-
patient or community-based? 
 
YES  □ (please continue) NO □ (please go to Question 21.) 
 
Pulmonary rehabilitation  □  Cardiac rehabilitation  □  
Exercise on prescription (or similar)  □  Community gym sessions   □  




21. Does your organisation offer a post hospital discharge rehabilitation programme to survivors of 
critical illness as part of a research study? 
 
YES  □    NO □  
 




(End of survey – many thanks for completing) 
  
 
